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Abstract 
Over the last few decades, an increasing number of neurodevelopmental disorders has 
been associated with molecular causes – such as genetic mutations, or autoantibodies 
affecting synaptic transmission. Yet understanding the pathophysiology that leads from 
particular molecular disruptions at the synapse to patients’ signs and symptoms remains 
challenging, even today.  
The work presented in this thesis illustrates how computational models can help bridge 
the explanatory gap between disruptions at the molecular scale and brain dysfunction at 
the level of integrated circuits. I utilise computational models at different scales of 
neuronal function, ranging from the neuronal membrane, to integrated cortical 
microcircuits and whole-brain sensory processing networks. These computational models 
are informed with, and further constrained by both empirical data derived from a number 
of model systems of neurodevelopmental disorders, and clinical patient data. The worked 
examples in this thesis include the biophysical characterisation of an epilepsy-causing 
mutation in the voltage-gated sodium channel gene SCN1A, calcium imaging in a larval 
zebrafish model of epileptic seizures in the immature brain, electrophysiological 
recordings from patients with NMDA receptor antibody encephalitis as well as from a 
mouse model of the disorder, and pharmacologically induced NMDA receptor blockade 
in young adults that captures features of acute psychosis and schizophrenia.  
The combination of this diverse range of empirical data and different computational 
models offers a mechanistic, multi-scale account of how specific phenotypic features in 
neurodevelopmental disorders emerge. This provides novel insights both in regard to the 
specific conditions included here, but also concerning the link between molecular 
determinants and their neurodevelopmental phenotypes more broadly.  
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 Introduction 
The explosion in genomic technologies that are now accessible to clinical medicine has 
recently renewed research interest in a broad range of neurodevelopmental disorders. The 
ability to comprehensively investigate patients with disabling neurological and 
neuropsychiatric conditions that have a significant impact on development has provided 
a whole host of break-through insights: Even just within the last five years, the Deciphering 
Developmental Delays (DDD) study has provided compelling evidence for the role of de 
novo mutations in >90 genes as the cause of intellectual disabilities (Deciphering 
Developmental Disorders Study, 2017); the Schizophrenia Working Group of the 
Psychiatric Genomics Consortium has provided evidence for >100 genes conferring a risk 
for schizophrenia, highlighting a number of biological mechanisms (Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2014); the Epi4K Consortium 
provided similar evidence for the role of de novo mutations in epileptic encephalopathies 
(Epi4K Consortium and Epilepsy Phenome/Genome Project, 2013). 
The increasing availability of genetic testing has led to a number of major broad insights 
regarding the molecular basis of neurodevelopmental conditions: Even genes that have 
been identified from well-defined clinical cohorts are often associated with a much broader 
phenotypic spectrum than initially anticipated (e.g. the voltage-gated sodium channel 
SCN1A was first described in a specific familial syndrome, but is now recognised as a risk 
factor for common epilepsies (Escayg et al., 2000; International League Against Epilepsy 
Consortium on Complex Epilepsies, 2014)). This broad association of individual genetic 
risk factors can even span disease categories – it is now becoming clear, that e.g. epilepsy 
 20 
and schizophrenia share genetic risk factors despite very distinct phenotypic expressions 
of this shared molecular dysfunction (Vonberg and Bigdeli, 2015).  
This leaves translational neuroscience (and in fact neurology and psychiatry) with the next 
big challenge – how do we relate molecular abnormalities that can be diagnosed with 
increasing precision and technological sophistication to phenotypes observed in patients. 
How do we identify which part of the phenotype is associated with which molecular 
disruption in order to make sense of the increasingly ‘genomic view’ on many 
neurodevelopmental disorders (Thomas and Berkovic, 2014)? 
In this thesis, I will offer a particular strategy that may help address this question in the 
future. I am proposing that the use of computational models that capture some of the 
biophysical properties of real neuronal systems can help us link neurobiological 
abnormalities at the microscale with observable features of clinical phenotypes. I will 
illustrate this approach using a few examples and model systems where there is a known 
strong effect of the molecular abnormality on the phenotype. As such, these are models of 
the extremes of single-molecule-deficit neurodevelopmental disorders, but these models 
will illustrate different strategies in applying computational models to the broader 
questions applicable also in the more common conditions.  
In Chapter 2, I review the principal stages of postnatal human brain development, in order 
to give context to different neurodevelopmental disorders. I then provide an overview over 
two distinct groups of such disorders: the epilepsies, and schizophrenia and related 
disorders. In contrasting these two examples, I highlight the differential impact even 
shared molecular abnormalities may have at different stages in brain development. I also 
highlight how different types of computational models may capture phenotypic features 
characteristic for the disorders, which leads me to the next chapter.  
In Chapter 3, I provide an overview of different strategies that can link measures of 
neuronal (dys-)function with quantitative models of the biophysical setup of neuronal 
systems. For this chapter, I focus particularly on the types of models used later in this 
thesis, in order to illustrate the principles under which these models can operate. Here, I 
place particular emphasis on the mesoscale models – models that sit somewhere between 
a molecular representation of neuronal function, and phenotypes that are observable at the 
whole-brain scale – as these may help us in the future to bridge the explanatory gap 
between phenotypes and molecular dysfunction specified in Chapter 2.   
 21 
The subsequent 4 chapters are worked examples of multiscale computational analysis 
strategies – using a diversity of empirical data in a range of model systems of 
neurodevelopmental disorders, I highlight the potential applications of this analysis 
approach. Each of the individual projects presented carries their own biological 
hypotheses, and in combination they reveal the power of using computational models at 
different explanatory scales to link our understanding of the micro- and the macroscale 
(Figure 1.1). 
In the first of these chapters – Chapter 4 – I employ empirical estimates of channel gating 
behaviour from patch-clamp recordings in a cell-based model of a human epilepsy 
 
Figure 1.1 – Linking micro- and mesoscale in the empirical chapters of this thesis. This thesis 
contains 4 empirical chapters illustrating worked examples of using computational models 
at different scales to explain neuronal pathology. These integrate insights from different 
data modalities, each with their specific advantages and disadvantages: Whilst genetics and 
cell models allow detailed examination of microscale abnormalities, they do not allow 
examination of developmental trajectories. On the other hand, imaging and 
neurophysiological recordings in human subjects allows whole-brain functional evaluation 
at different stages in development but do not easily relate to microscale abnormalities. The 
arrows indicate the scale at which the different models employed in this thesis operate.  
 
‘SCN1A’ refers to Chapter 4, ‘Zebrafish’ refers to Chapter 5, ‘NMDAR-Ab’ refers to Chapter 
6, ‘Ketamine’ refers to Chapter 7 of this thesis.  
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mutation (in SCN1A) in a computational model of the neuronal membrane. Exploration 
of the dynamic behaviour of this patient-derived in-silico model then provides an insight 
into possible mechanism of how the microscale abnormalities caused by the mutation can 
induce the heat-induced seizures seen in the patient.  
The following chapter, Chapter 5, applies network-models of neuronal population activity 
to light-sheet imaging data of induced epileptic seizures in the developing zebrafish brain. 
I use the models to infer the types of network-wide changes that occur during an epileptic 
seizure caused by a pharmacological intervention. The detailed imaging possible in this 
animal models allows an integration of insights from local coupling changes and larger 
between-region changes in synaptic coupling during such an induced seizure.  
In Chapter 6, I focus on NMDA-receptor antibody (NMDAR-Ab) encephalitis. In this 
autoimmune condition, patients can show both neuropsychiatric symptoms and develop 
EEG abnormalities and epileptic seizures – making it an attractive model system to 
investigate the link between NMDAR dysfunction and a range of neurodevelopmental 
disorders. I combine models of neuronal population dysfunction with clinical EEG 
recordings of patients with NMDAR-Ab encephalitis, and local field potential recordings 
in a mouse model of the disorder. This approach allows me to harness the experimental 
control afforded by the animal model alongside clinical EEG recordings in patients to 
identify the sort of circuit abnormalities responsible for the observed EEG phenotypes 
associated with the disorder.  
The last empirical chapter – Chapter 7 – focusses on a placebo-controlled experiment 
investigating the effects of pharmacological NMDAR-blockade (with ketamine) on 
neurophysiological markers typically impaired in schizophrenia. Here the combination of 
a pharmacological intervention and human subject EEG data, together with network 
models of cortical circuitry allows me to infer the localised neuronal effects of NMDAR-
blockade and relate these to models of psychopathologies in schizophrenia.  
Lastly, in Chapter 8, I draw overall conclusions that emerge from these thematically 
consistent approaches at distinctive scales – distinct, both in terms of biological insights 
they offer (regarding the relation of mesoscale neuronal behaviour, and the disruption of 
synaptic function); and in terms of the types of inference we can draw from empirical data 
using the multi-scale modelling approaches in future applications. 
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 Dysfunction in the developing brain 
During childhood and adolescence, the human brain undergoes dramatic developmental 
changes that affect the brain at every scale – from basic synaptic neurotransmission and 
neuronal membrane properties, all the way to the organisation of dynamic coordinated 
whole-brain oscillatory networks (Courchesne, 1990; Gogtay et al., 2004; Whitford et al., 
2007). There are a number of conditions that can be characterised as neurodevelopmental 
disorders, in that they interact with, or disrupt some of these developmental processes (Hu 
et al., 2014). These conditions are often characterised by incidence peaks around well-
defined age ranges, which suggests that they are associated with specific vulnerabilities of 
the developing brain that emerge at distinct stages in brain development.  
In this chapter I discuss the neuronal dysfunction underlying two sets of 
neurodevelopmental disorders: epilepsy (and in particular a group of conditions known as 
epileptic encephalopathies) and schizophrenia and associated psychotic disorders. Whilst 
the epilepsies have a peak incidence in the neonatal period, early infancy and childhood 
(Olafsson et al., 2005), schizophrenia and psychosis are classically conditions of 
adolescence and young adulthood (Paus et al., 2008). In combination, these example 
groups of disorders allow a window on the importance of distinct developmental processes 
and illustrate how neuronal dysfunction unfolds in the context of very different 
developmental stages.  
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2.1 Stages of development in the human brain 
Human infants are born at a comparatively early stage in their brain development, with 
many developmental processes taking place postnatally – full functional and structural 
brain ‘maturity’ is only achieved well into the third decade of life. Evidence of this 
protracted developmental trajectory can be measured both in terms of basic neuronal 
physiology, and in behavioural experiments (Silbereis et al., 2016). Thus, brain 
development in infants, children and adolescents sits at a complex and changing interface 
between genetic determinants, developmental trajectories, and environmental influences. 
Aberrations in each can contribute to neurodevelopmental disorders, with the differential 
contribution to overall risk changing with age of onset of the various neurodevelopmental 
conditions.  
In the following section, I provide a brief overview over different stages in human brain 
development at three different scales – ranging from cellular and synaptic development, to 
 
 
 
Figure 2.1 – Cellular processes during postnatal development. This figure illustrates brain 
morphology across the human life span (top panel) and identifies the time windows during 
which specific cellular processes occur (bottom panel). Infancy, childhood and adolescence 
are the temporal windows associated with glial growth and maturation (astrogliogenesis, 
oligodendrogenesis, and myelination), as well as synaptic development (synaptogenesis, 
and synaptic pruning), whilst most of the neurogenesis is complete at the time of delivery.  
[Reproduced with permission, (Silbereis et al., 2016)] 
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circuit development, and whole brain functional architecture. By necessity, this is a 
focussed review, highlighting key stages in postnatal development, in particular those that 
are relevant to the processes under investigation throughout the rest of this thesis and 
those that are mechanistically implicated in the disease processes at hand. 
2.1.1 Cellular changes in development 
Brain function depends on the properties of individual neurons and their synaptic 
coupling. Whilst prenatal brain development involves a complex array of cell production, 
migration and functional integration, the vast majority if neurons are already in place at 
the time of a normal term delivery, with post-natal neurogenesis only playing a limited 
role in postnatal functional changes (Jiang and Nardelli, 2016).  
Thus, many changes observed in brain function during human brain development are 
ultimately associated with maturational changes of the properties of existing neurons and 
alterations in their synaptic connections. Figure 2.1 highlights distinct cellular changes 
that occur postnatally during infancy, childhood and adolescence. I will discuss the distinct 
developmental profiles of two classes of changes here: changes at the synapse (i.e. 
synaptogenesis and synaptic pruning), and glial changes (gliogenesis and myelinsation). 
These illustrative examples highlight how whole-brain development is shaped by the 
interaction of a range of developmental trajectories of distinct, but related cellular 
processes.  
2.1.1.1 Synaptogenesis, functional maturation, and synaptic pruning 
Effective connections between individual neurons are essential for information processing 
and thus nervous system function. In the central nervous system, the majority of such 
connections are mediated through chemical synapses – allowing signalling from a 
presynaptic neuron via neurotransmitter release to a postsynaptic neuron. Immature 
neurons in the brain start the process of forming synapses approximately half-way through 
gestation, but the process continues until mid-childhood for some brain regions and 
neuronal subtypes. This initial burst of synaptogenesis appears to be an ‘over-production’, 
with only a fraction of the synaptic connections made in early infancy surviving into 
adulthood (Huttenlocher and Dabholkar, 1997; Silbereis et al., 2016). 
The developmental drive invoking synaptogenesis appears to be genetic – with the timing 
and number of synapses formed being relatively experience-independent. However, the 
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specific morphology and function of newly formed synapses in early development is 
significantly shaped by experience (Bourgeois et al., 1989).  
 
The time window of synaptogenesis can be tracked in humans through gene expression 
studies. Molecular markers of synapse formation peak within the first two years of life and 
follow a developmental trajectory that broadly resembles the cortical hierarchy – with 
subcortical regions and early sensory cortices peaking earlier and association cortices 
peaking later in terms of gene expression (Figure 2.2). Such spatiotemporal patterning of 
synapse formation may help direct the experience-dependent modulation of brain regional 
circuitry, effectively linking the experiences and learning demands of different 
 
 
Figure 2.2 – Gene expression levels tracking developmental processes in the human brain. (A) 
Identifies key cortical and subcortical regions for which gene expression measures are available. (B) The 
selection of genes associated with specific developmental functions for which transcription levels are 
tracked. (C) Longitudinal expression of genes associated with these functions. Plots are ordered 
according to peak expression levels – with neurogenesis genes peaking first, and myelination genes 
peaking latest in their expression.   
[Reproduced with permission from (Shultz et al., 2018)] 
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developmental stages with brain regions generating new synaptic connections (Silbereis et 
al., 2016).  
In addition to synaptogenesis, the first few years of postnatal development in humans are 
also associated with profound functional changes of synaptic function. These functional 
changes at structurally already established synapses may alter the fundamental properties 
of a given synapse over the course of development and affect future survival of the synapse 
as well as long-term and experience dependent plastic changes. Functional changes may 
be as profound as switching the function of γ-aminobutyric acid (GABA) from excitatory 
to inhibitory, which is believed to occur early in postnatal development (Ben-Ari et al., 
2012); or fundamentally altering the temporal integration of signals at excitatory synapses, 
by altering the role of glutamatergic synapses in learning (Liu, 2004).  
 
Glutamate is the predominant excitatory neurotransmitter throughout the central nervous 
system (Pankevich et al., 2011). There are different subtypes of glutamate receptors, 
including both ionotropic receptors (i.e. ion channels that allow direct passage of 
electrically charged ions across the neuronal cell membrane), and metabotropic receptors 
(i.e. receptors that exert their downstream effects through an intracellular messaging 
cascade).   Particularly the two ionotropic glutamate receptors – the α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptor, and the N-methyl-D-aspartate 
(NMDA) receptor have well characterised roles in excitatory synaptic transmission: Whilst 
AMPAR mediates fast excitatory postsynaptic potentials mainly consisting of sodium, 
 
 
 
Figure 2.3 – Normalised expression of NMDA-receptor subunit-2 subtypes during development. 
NMDAR transmission undergoes a dramatic shift during normal development. Normalised expression 
levels are shown for four different subtypes of the NMDA receptor subunit 2. There is a developmental 
shift from GRIN2B to GRIN2A over the course of antenatal and postnatal development.  
[Data from publicly available repository: Allen Developmental Transcriptome at www.brainspan.org, accessed 
on 24/07/2018]  
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NMDAR mediate slower post-synaptic currents of more unselected cations. In addition to 
the glutamate-gating, NDMAR are also weakly voltage-gated due to larger cations (such as 
Mg2+) blocking the channel pore at resting membrane potentials. This renders glutamate 
transmission through NMDAR dependent on recent or concurrent excitatory 
neurotransmission, which plays a key role in mechanisms of synaptic plasticity (Malenka 
and Nicoll, 1993). NMDARs are heterotetrameric, usually comprising two GluN1 subunits 
(encoded in the GRIN1 gene), and two GluN2A-D subunits (encoded in the GRIN2A-D 
gene family). Interestingly the subunit 2 undergoes a drastic developmental shift in 
expression – whilst most synaptic NMDAR antenatally contain GluN2B subunits, by 
around adolescence most cortical synapses will have changed to GluN2A (Monyer et al., 
1992; Wenzel et al., 1997). This developmental shift can be seen in the GRIN2 gene family 
expression patterns (Figure 2.3). The balance between different ionotropic glutamate 
receptors (AMPAR/NMDAR) and their subtypes affects most neuronal functions, from 
message passing (Sanchez et al., 2015), to oscillatory dynamics (Roopun et al., 2008), and 
synaptic plasticity (Kullmann et al., 1996; Moreau and Kullmann, 2013; Thiele, 2012).  
Whilst the first two years of life are characterised by synaptogenesis and the establishment 
of new functional synapses, over the course of childhood and adolescence, mammalian 
brains lose a significant amount of their synapses. This pruning of excitatory synapses 
appears to occur in two distinct stages: (1) in early childhood, pruning targets 
predominantly functionally immature synapses – characterised by their prolonged 
postsynaptic responses arising from shifts AMPAR/NMDAR ratio and the NMDAR-
subtype expression; (2) in the transition from adolescence to adulthood, functionally 
apparently mature synapses are significantly pruned: In parts of primate cortex the density 
of excitatory synapses decreases drastically (up to 40-50%) during this late adolescence 
(Gonzalez-Burgos et al., 2008).  
2.1.1.2 Gliogenesis 
The majority of cells in the brain is non-neuronal: glia cells make up >50% of all cells. 
There are two main types of CNS macroglia: astrocytes and oligodendrocytes. Glial cells 
(and in particular astrocytes) share embryonal progenitors with neurons, and are 
produced in distinct spatiotemporally defined waves of gliogenesis (Rowitch and 
Kriegstein, 2010). 
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Astrocytes and their precursors are established soon after neurogenesis as a possible 
terminal differentiation for radial glia (which act as precursors to both astrocytes and 
cortical neurons). Committed astrocyte precursors then migrate towards their final 
position, and – apart from in response to injury or insult – are largely quiescent after 
terminal maturation there. The peak of astrocytogenesis in animal models occurs in late 
prenatal or early postnatal development. Mature astrocytes play an important role in 
glutamate metabolism and potassium homoeostasis, and they assume this role during early 
postnatal development. This functional maturation (unlike astrocytogenesis, and 
migration) is directly dependent on neuron-astrocyte interactions (Yang et al., 2013).  
Oligodendrocytes are produced in three distinct waves during embryonal, foetal and 
postnatal development, arising from progressively more dorsal origins and unlike 
astrocytes continue active genesis and functional remodelling until late in life. Compared 
 
Figure 2.4 – Cortical column intrinsic connectivity structure. Mammalian neocortex shows a 
laminar organisation, in which different cell subtypes follow certain connectivity principles. 
Thalamocortical afferents mainly target cells in layer 4, whilst corticocortical output mainly 
derives from L2/3 pyramidal cells. Predominant synaptic connectivity patterns within a cortical 
column for different morphologically defined cells is are shown in the left panel. The right 
panel shows presumed non-synaptic (volume conduction) connectivity between neuroglia 
cells and other neuronal subtypes.  
This connectivity follows three broad patterns: There are highly connected ‘master regulator’ 
cells that provide broad inhibitory connectivity across the cortical column (eNGC/NGC – 
elongated neurogliaform cells / neurogliaform cells; MC – Martinotti cells). Some interneuron 
subtypes selectively target other interneurons (Interneuron-selective interneurons: BPC – 
bipolar cell; DC – deep projecting cell; SBC-like – single-bouquet cell-like cell); Other 
interneuron subtypes selectively target pyramidal cells, alongside some connectivity to the 
same subtype (pyramidal-neuron-targeting interneurons: BC – basket cell; BTC – bitufted cell; 
ChC – chandelier cell; DBC – double-bouquet cell; HEC – horizontally elongated cell; SC – 
shrub cell) 
 
[reproduced with permission from (Jiang et al., 2015)] 
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to astrocytes, the peak of their genesis occurs later in postnatal development. In rodents 
(where this can be measured empirically), oligodendrocyte genesis peaks at a 
developmental stage comparable to mid-to-late infancy in human development (Dutta and 
Sengupta, 2016).  
2.1.2 Maturation of micro- and macrocircuits  
Alongside (and closely related to) the changes at single cells and synapses, significant 
changes also occur at higher organisational levels. Throughout infancy and until late in 
childhood, there are significant changes of functional organisation at the level of integrated 
neuronal microcircuits (i.e. within a brain region, at the level of a single ‘cortical column’), 
as well as in the coupling between distinct macroscopic brain regions.   
Mammalian cortex is arranged in layers that follow certain generic connectivity principles 
and are organised into functional units in adults (Figure 2.4). Developmental changes in 
the function of these microcircuits is mostly related to changes in the synaptic connectivity: 
synaptogenesis, synaptic pruning, and myelin maturation all contribute to the changing 
functional integration at these cortical columns. In experimental animal models such 
developmental changes can be tracked at the level of single cells. These studies give a 
detailed picture of neuronal integration into functional circuits that emerges at different 
times in development within specific functional domains (Ko et al., 2013).  
 
 
Figure 2.5 – Magnetisation transfer (MT) mapping of  intracortical myelination. (A) 
Illustration of how fractional cortical depths are defined for MT measurement. (B) Increasing 
cortical depth is associated with a higher degree of cortical myelin content reflected in 
increased magnetisation transfer (maximum in the white matter). (B-E) However, rates of MT 
change show a different profile, with the largest developmental increase occuring on cortical 
layers IV – VI.  
 
[reproduced with permission from (Whitaker et al., 2016)] 
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In normally developing children, there is limited access to measures of microcircuit 
maturation empirically. Neuroimaging and non-invasive neurophysiological recordings 
offer one strategy to assess maturation of cortical microarchitecture. In particular, 
quantitative analysis of structural magnetic resonance imaging has recently provided more 
detailed insight into regional variations in the developmental trajectories of different areas 
in the cortex, with measures of cortical myelin linking macroscopic changes in cortical 
structure (T1/T2 signal changes, cortical thickness) with the cellular mechanism (e.g. 
intracortical myelinisation and oligodendrocyte homeostasis, shown to be remodelled 
until late in life (Deoni et al., 2012; Hill et al., 2018). Local cortical circuits achieve their 
mature myelination and thickness at different times in development – with primary 
cortices maturing earlier than association cortices, some of which may only mature in the 
third decade of life. Furthermore, myelination changes more within specific aspects of the 
cortical microcircuit (Figure 2.5). At least some of this spatiotemporal distribution is 
patterned through expression of myelination relevant genes. Notably, cortical regions that 
mature later play a more central role in cortical networks, assuming hub-like positions 
(Vértes et al., 2016; Whitaker et al., 2016) 
This regionally patterned maturation of local circuits is further shaped through maturation 
of corresponding large-range white matter connections. Most of the structural modules in 
the human connectome are already in place and structurally connected by the age of 2 
years, with subsequent developmental changes – that continue until late adolescence – 
including extensive changes in regional myelinisation of white matter tracts. This 
reshaping of existing structural connections over the course of childhood brain 
development leads to more efficient networks with an increasingly close correlation 
between functional and structural network architecture (Hagmann et al., 2010; Kaiser, 
2017).  
2.1.3 Functional integration of whole-brain dynamics 
There are significant changes in the composition, structure, and function of neuronal 
networks at all levels throughout childhood – ranging from changes in the ratio of specific 
neurotransmitter receptors to maturation of regional brain connectivity. The combination 
of all these changes has a significant impact on whole-brain function at different stages of 
development, something that can become observable in whole-brain functional brain 
recordings as afforded by fMRI and EEG in healthy children and adolescents.  
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EEG is characterised by ongoing oscillatory activity that shows characteristic distributions 
over the scalp and is significantly affected by age. Overall, there is an increase of the 
frequency of the predominant rhythms with age – whilst in the neonate, most of the 
activity is in the lower frequency bands (delta to theta range), by mid-childhood, a faster 
predominant rhythm in the alpha range should normally have been established.  Whilst 
EEG in the neonatal period and early infancy during sleep is often polymorphic, and 
transitions between different stages are relatively diffuse, throughout childhood, more 
discrete and recognisable sleep patterns emerge during the transition from infancy to 
childhood and continue to evolve until adolescence (Eisermann et al., 2013).  
Electrophysiological markers of sensory processing also show distinct 
neurodevelopmental changes. The mismatch negativity – a stereotyped event-related 
potential (ERP) associated with surprising or novel sounds – starts off as a positive 
response in neonates (Kushnerenko et al., 2007). In later childhood, ERPs tend reduce in 
their amplitude and latency, usually approximating the responses seen in adults closely by 
puberty (Uppal et al., 2016). More complex cognitive tasks show a developmental 
improvement in performance that is closely correlated to increased long-range synchrony, 
suggestive of increased network efficiency later in development (Uhlhaas et al., 2009).  
Functional networks can also be evaluated using fMRI across a broad range of children – 
including neonates and infants who will tolerate the scans whilst asleep (Fransson et al., 
2007), and older children as young as about 6 years old (Van Essen and Glasser, 2016). 
Functional imaging studies of brain networks associated with specific function indicates 
that functional integration across a network reflects is associated with domain-specific 
mechanisms that increase efficient processing for those tasks (Weiss-Croft and Baldeweg, 
2015). Network changes are also apparent in functional network descriptions derived from 
resting state recordings of children at different ages. Evaluation of these resting state 
network changes is methodologically challenging – resting state functional connectivity 
estimates are sensitive to movement artefacts, which itself is age dependent (Power et al., 
2012; Tierney et al., 2016). However, measures derived from these functional connectivity 
studies broadly reflect the kinds of changes observed in the structural connectome: Over 
the course of development, functional networks organise in an architecture structure with 
reduced characteristic path lengths, increased global efficiency and reduced network 
clustering coefficients (Hulvershorn et al., 2014).  
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2.2 Disruptions of fundamental oscillatory rhythms: 
Insights from epilepsy 
Epileptic seizures are defined as the occurrence of signs and/or symptoms caused by 
excessive, hypersynchronous activity in the brain (Fisher et al., 2005). Epilepsy is defined 
as the persistent tendency of a patient to experience these epileptic seizures and represents 
a heterogeneous mixture of aetiologically diverse neurological conditions (Thomas and 
Berkovic, 2014). Whilst epilepsy remains a clinical diagnosis (Fisher et al., 2014), in many 
cases there are associated abnormalities on EEG recordings, such as spike-and-wave 
discharges, or spreading fast activity at the onset of a seizure (a more detailed description 
of different EEG features will be given in section 2.2.2). Clinical features and EEG patterns 
together allow classification of different epilepsies into particular electroclinical 
syndromes. In childhood, these are particularly diverse reflecting both a diverse range of 
underlying aetiologies, and the interaction of those aetiologies with developmental 
processes. In the following section I discuss the features of classically recognised 
electroclinical epilepsy syndromes of childhood.  
Despite this diversity of electroclinical epilepsy syndromes, there are some key features 
across them that are preserved (indeed justifying the shared diagnostic label of ‘epilepsy’ 
across these conditions). These include particular EEG features both during epileptic 
seizures and during interictal ‘epileptiform’ discharges. Some of these can be identified 
with relatively high reliability and are strongly suggestive of a diagnosis of epilepsy (Adachi 
et al., 1998; Schulz et al., 2000; Smith, 2005). Some such features can be related to basic 
mathematical properties of dynamic systems, which I discuss in section 2.2.2.   
This section gives an insight into (1) into both the diversity of epilepsy, which in childhood 
unfolds across a wide range of diverse syndromes; and (2) some key dynamic features in 
the measurable brain signals that allow linking the diverse abnormalities within a common 
mathematical framework.    
2.2.1 Epileptic syndromes of childhood 
The diagnosis of epilepsy is constantly evolving in line with novel insights into the 
underlying brain pathology afforded by improvements in neuroimaging (Adler et al., 2017; 
Neal et al., 2018), genetic and genomic testing (Martin et al., 2014; McTague et al., 2018; 
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Oates et al., 2018) and increasing efforts to map features associated with different possible 
syndrome categories (Chowdhury et al., 2014; von Spiczak et al., 2010). 
This is reflected in the frequently updated official classifications released by the 
International League Against Epilepsy (ILAE) (Commission on Classification and 
 
Table 2-1 – List of commonly diagnosed electroclinical epilepsy syndromes. This list contains 
diagnoses within particular age brackets as summarised in the ILAE 2008 terminology (Berg 
et al., 2010). 
 
Neonatal Period 
Early myoclonic encephalopathy (EME)1 
Ohtahara syndrome1 
Benign familial neonatal epilepsy (BFNE) 
Infancy 
Epilepsy of infancy with migrating focal seizures1 
West syndrome1 
Myoclonic epilepsy in infancy (MEI)1 
Dravet syndrome1 
Myoclonic encephalopathy in non-progressive disorders1 
Benign infantile epilepsy 
Benign familial infantile epilepsy 
Childhood 
Epilepsy with myoclonic atonic (previously astatic) seizures1 
Lennox-Gastaut syndrome1 
Epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS)1 
Landau Kleffner syndrome (LKS)1 
Febrile seizures plus (FS+) (can start in infancy) 
Panayiotopoulos syndrome 
Benign epilepsy with centrotemporal spikes (BECTS)  
Autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) 
Late onset childhood occipital epilepsy (Gastaut-type)  
Epilepsy with myoclonic absences2 
Childhood absence epilepsy (CAE)2 
Adolescence-Adult 
Juvenile absence epilepsy (JAE)2 
Juvenile myoclonic epilepsy (JME)2 
Epilepsy with generalised tonic-clonic seizures alone2 
Progressive myoclonus epilepsy (PME) 
Autosomal dominant epilepsy with auditory features (ADEAF) 
Other familial temporal lobe epilepsies 
Other categories 
Distinctive constellations (e.g. mesial lobe epilepsy with hippocampal sclerosis) 
Epilepsies attributed to structural or metabolic causes (e.g. malformations of cortical 
development) 
 
1Diagnoses usually considered within the epileptic encephalopathy spectrum; 2Diagnoses 
within the genetic/idiopathic generalised epilepsy spectrum 
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Terminology of the International League Against Epilepsy, 1989; Fisher et al., 2005; 
Scheffer et al., 2017).  
The most recent iteration of the ILAE classification does away completely with officially 
approved syndrome classification, instead focussing on intersections of aetiological, EEG 
and clinical categories to support clinical decision making (Smith, 2005). However, up to 
this most recent version, lists of recognised electroclinical syndromes were an integral 
component of the ILAE classification. The ones included in the 2010 ILAE classification 
(Berg et al., 2010) are summarised and grouped according to their age-of-onset in Table 
2-1 . 
This list focusses on syndromic diagnosis where epilepsy is the primary feature. There are 
many other conditions of childhood that are associated with epilepsy, which generally 
classified according to the overall diagnosis, rather than the particular features of patients’ 
epilepsies. Examples for this are the various epileptic phenotypes that can be associated 
with cerebral palsy (Bruck et al., 2001), complex neurodevelopmental syndromes such as 
Angelman’s syndrome (Pelc et al., 2008), or epilepsies that are associated with a clear 
structural cause, such as focal cortical dysplasia (Thornton et al., 2011), or polymicrogyria 
(Perucca et al., 2014).  
This list of syndromes where epilepsy is the primary pathology, does however allow a 
number of observations: 
 
1. Most electroclinical epilepsy syndromes are very age specific – the majority of the 
diagnostic labels listed start within a clearly defined age range, which fall into 
distinct developmental stages (broadly categorised here into neonatal period, 
infancy, childhood, and adolescence).  
2. The most severe epilepsy syndromes appear to cluster earlier in life – this is 
particularly true for the epileptic encephalopathies, which make up a majority of 
primary electroclinical epilepsy syndrome diagnoses in the neonatal and infantile 
age categories (Berg and Rychlik, 2015).   
3. On the whole, the majority of electroclinical syndromes (that are not attributed to 
structural or metabolic causes) are diagnoses made in the paediatric age ranges, 
with only a smaller number of epilepsy syndromes seen in older patients, typically 
with an onset in the young adult (e.g. juvenile myoclonic epilepsy).  
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The close relationship between development and epilepsy will be discussed in the following 
sections using three broad groups of conditions to map out the distinct patterns observed: 
(1) Epilepsies that are attributed to structural or metabolic causes, which are some of the 
most common epilepsies across different age groups; (2) Epileptic encephalopathies, which 
is a group of devastating epileptic disorders that occur mostly in early childhood and 
infancy; and (3) Idiopathic generalised epilepsies (more recently relabelled genetic 
generalised epilepsies), which are highly heritably epilepsy syndromes that can have an 
onset in late adolescence and young adults.  These categories are presented here as 
pragmatic tools for thinking through issues associated with epilepsies and are not perfectly 
discrete conceptual entities – for example, some patients with a diagnosis of an early 
epileptic encephalopathy have an identifiable underlying structural abnormality. Yet this 
selection will illustrate some of the breadth of the clinical reality when considering the 
epilepsies in childhood.  
2.2.1.1 Epilepsies attributed to structural or metabolic causes 
The particularly high incidence of epilepsies in the first decade of life is a reflection both 
of the inherent susceptibilities of the developing brain, particularly in infancy (Rakhade 
and Jensen, 2009), but also the comparatively high incidence of acquired brain injuries, 
developmental structural abnormalities and inborn errors of metabolisms in this age 
group.  
Acquired brain lesions: Epilepsy on the background of perinatally acquired brain lesions 
(e.g. haemorrhages, congenital infections, hypoxic-ischaemic encephalopathy) account for 
a large proportion of epilepsy-associated disease burden globally (World Health 
Organization, 2005). Patients with perinatally acquired brain lesions and epilepsy are also 
often affected by additional impairment and disability, such as the motor and cognitive 
impairments in the context of cerebral palsy (Ignjatovic, 2009).  
Structural abnormalities in brain development: Epileptogenic abnormalities in structural 
brain development range from those that are highly epileptogenic, usually presenting with 
devastating epilepsies in early childhood (e.g. polymicrogyria, tuberous sclerosis (Leventer 
et al., 2008), to those that may present with focal onset epilepsies later in life (e.g. focal 
cortical dysplasias (Kabat and Król, 2012)).  
Neurometabolic conditions: Seizures can be the manifestation of inborn errors of 
metabolism in infants and children. The mechanisms by which neurometabolic disorders 
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cause seizures ranges from resultant energy deficiency (e.g. Glucose transporter-1 
deficiency), neurotoxicity (e.g. organic acidurias), specific impairment of neuronal 
inhibition (e.g. pyridoxine dependent epilepsy) and many more (Dhamija et al., 2012; Lado 
et al., 2013).  
More recently, a range of autoimmune conditions have emerged that can cause seizures 
because of direct antibody mediated disruptions of neuronal circuits – most notable are 
the autoimmune encephalitides, such as NMDA-receptor encephalitis, or MOG-antibody 
encephalitis (Ogawa et al., 2017; Wandinger et al., 2011).  
As a group, epilepsies associated with structural or metabolic causes, despite being 
aetiologically diverse, have particular clinical significance because of their treatment 
implications:  
1) Primary prevention: Perinatally acquired brain lesions are often preventable with 
appropriate obstetric and neonatal care, making them the single biggest preventable 
cause of epilepsy (Newton and Garcia, 2012). 
2) Secondary prevention: For a number of inborn errors of metabolism, the neuronal 
dysfunction (and over time lasting brain damage) can be halted by circumventing the 
impaired metabolic pathway (e.g. ketogenic diet in GLUT-1 deficiency, (Kass et al., 
2016)). This can stop seizures and prevent further acquired brain damage.  
3) Effective treatment: Where epilepsy is the clear product of a structural brain lesion, or 
associated with the presence of neuronally-specific autoimmune antibodies, removing 
this underlying cause can lead to complete seizure freedom, and effectively cure a 
patient of their epilepsy (Spencer and Huh, 2008).   
2.2.1.2 Epileptic encephalopathies 
In some early onset epilepsy syndromes, it is believed that the burden of abnormal, 
epileptic activity in and of itself causes more widespread disruption of brain dysfunction 
and impacts on the development of patients. These syndromes are commonly referred to 
as epileptic encephalopathies, and sometimes (in reference to their peak incidence) as early 
infantile epileptic encephalopathies (EIEE).  
The EIEEs are characterised by (1) widespread and often pervasive electrographic 
paroxysmal abnormal activity, (2) mixed and multiple seizure types in individual patients, 
(3) and cognitive, behavioural and neurological deficits associated with the burden of EEG 
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abnormalities (Khan and Al Baradie, 2012). Many patients with EIEEs can be classified 
into recognisable syndromes that are clustered around typical ages of onset (cf. Table 2-1).  
One of the most common EIEEs is West syndrome. It is classically defined as the triad of 
infantile spasm (a particular seizure type), hypsarrhythmia (an interictal EEG abnormality 
pattern), and associated developmental delay or even regression with an onset in infancy 
(Pavone et al., 2013). West syndrome is closely associate with a set of genetic and 
neurodevelopmental syndromes, such as Down syndrome, tuberous sclerosis or Aicardi 
syndrome, but West syndrome is also recognised in children without any underlying, 
causative diagnosis.  
Where identified, the range of underlying causes may be either very focal lesions (Chugani 
et al., 2010), or widespread neurodevelopmental abnormalities as part of a genetic 
syndrome (Paciorkowski et al., 2011). Yet the age and developmental stage at which these 
underlying causes find their expression in the triad of signs and symptoms that defines 
West syndrome are very specific.  For the majority of patients this particular constellation 
of signs and symptoms does not start before the age of three months, and evolves by the 
age of two years (Kurokawa et al., 1980).  
Individual patients with a diagnosis of an EIEE are classically thought to transition 
between different age-specific phenotypes during their development, which often means 
that they will change diagnostic labels in terms of their electroclinical epilepsy syndromes. 
One classic example is the relationship between Ohtahara syndrome (an EIEE of the 
neonatal period), West syndrome and Lennox-Gastaut Syndrome (an epileptic 
encephalopathy of childhood). In one classic description of the natural history of patients 
with Ohtahara syndrome, a majority of surviving patients would go on to develop West 
syndrome and subsequently Lennox Gastaut syndrome.    
Taken together, this suggests that the individual diagnostic categories that have been 
established for the different age-of-onset epileptic encephalopathy syndromes, are not 
necessarily identifying aetiologically distinct pathologies. The diversity of underlying 
causes that can converge to the same EIEE phenotype suggests that the EIEE syndromes 
reflect a common pathway of how severe, and epileptogenic abnormalities in brain 
function can express themselves in the developing brain. Within certain limits, differences 
between clinical syndromes are more likely to result from the particular developmental 
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context in which the epileptogenic dysfunction unfolds than underlying aetiology 
differences between patients.    
2.2.1.3 Idiopathic/Genetic Generalised epilepsies (IGE / GGE) 
A contrasting group of epileptic syndromes that stands out from the ILAE classifications 
in Table 2-1 are ‘idiopathic’ (now termed ‘genetic’) generalised epilepsy syndromes of 
childhood and adolescence: Childhood absence epilepsy, epilepsy with myoclonic 
absences, juvenile absence epilepsy, juvenile myoclonic epilepsy, and epilepsy with 
generalised tonic-clonic seizures alone. These epilepsies are typically ‘isolated’ epilepsy 
syndromes – unlike the epileptic encephalopathies, they usually occur in patients without 
additional severe neurodevelopmental issues and are often effectively treatable with anti-
epileptic medication.  
This group of conditions has long been recognised to show a high heritability with a likely 
high presumed genetic burden (Berkovic et al., 1998). Yet despite the transformative effect 
of genomic technologies on epilepsy-gene identification in the EIEEs, the molecular and 
genetic basis for these ‘genetic’ generalised epilepsies have remained elusive to date.  
However, despite the lack of an age of ‘genetic generalised epilepsy gene discovery’, several 
insights have been made from genetic studies in these patient cohorts: 
 
• Copy number variations (duplications or deletions of segments of the genome) are 
more common in patients with GGEs than controls (a possible genetic risk factor 
burden shared with a range of neurodevelopmental syndromes) (Helbig et al., 2013; 
Mullen et al., 2013) 
• Multi-gene approaches reveal that some of the risk of developing GGE syndromes 
can be explained through mutations in a number of genes that share a physiological 
mechanism (e.g. GABA transmission) (May et al., 2018) 
• A recent review of genome-wide association studies revealed a single signal with 
genome-wide significance as risk allele for genetic generalised epilepsies near the 
vaccinia-related kinase 2 (VRK2) gene, and the Fanconi anaemia, 
complementation group L (FANCL) gene (International League Against Epilepsy 
Consortium on Complex Epilepsies, 2014). Interestingly, a nearby locus has 
previously been described as the location of a schizophrenia risk allele (Donnelly 
et al., 2012).     
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Having briefly reviewed the nosology of epilepsy from a clinical perspective, I will now 
turn to phenotyping in terms of dynamic in the setting of dynamical systems.  
2.2.2 A dynamic systems perspective on epilepsy and epileptic seizures 
As illustrated above, the term ‘epilepsy’ encompasses a broad range of distinct phenotypes, 
with an even greater range of sometimes overlapping genetic and pathophysiological 
mechanisms. How then can this multitude of mechanisms and phenotypes be recognised 
as a common entity (or indeed a group of related entities). Mathematics and theoretical 
physics may offer helpful perspectives here: In understanding the brain as a time varying, 
dynamical system, we can identify some general principles that emerge from the manifold 
molecular disruptions that appear to give rise to clinical epilepsy in patients.   
Mathematical dynamic systems can be defined through differential equations that define 
the evolution of the system states over time. Where there are non-trivial relationships (e.g. 
nonlinear relationships) between the system states, they become difficult to predict and 
can show non-intuitive relationships between changes in the parameters of the system, and 
the dynamic behaviour in time (Rabinovich et al., 2006).  
One of the key insights we can draw from these mathematical dynamical systems, is that 
the ‘switch’ between, e.g. noisy low-amplitude activity, and high amplitude regular 
oscillations as seen in the transition into an epileptic seizure, can be thought of in terms of 
‘bifurcations’ of a dynamical system. Bifurcations occur when a small, smooth change in a 
model parameter qualitatively changes the behaviour of the model. They can be classified 
according to the sort of changes that can be observed in the data on approaching and 
transitioning the bifurcation point (Izhikevich, 2007).  
This has become an attractive perspective for understanding and classifying epileptic 
seizures. The amplitude and frequency changes recorded in ictal EEG just before and just 
after the onset (or offset) of a seizure can be used to identify the kind of bifurcation that 
best captures the paroxysmal dynamics that occur (Jirsa et al., 2014).  
Figure 2.6 illustrates features of some of the different bifurcation types that can arise from 
just changing a single parameter in a dynamical system (Codimension-1 bifurcations). 
These vary in the signal changes that become visible as the bifurcation point is approached 
(e.g. gradual increase in amplitude in the supercritical Hopf bifurcation). And somewhat 
surprisingly, the vast majority of seizure onset- and offset patterns as observed on the EEG 
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can be classified as corresponding to a set of these mathematical forms – highlighting some 
universal and invariant properties of seizure dynamics (Friston, 2014). 
These descriptions of invariance and universality stand in stark contrast to both 
observations of phenotypic diversity at the whole-brain level (as highlighted in the sections 
above), and the particulars of interacting cellular dynamics and spatiotemporal 
 
Figure 2.6 – Codimension-1 bifurcation types. This figure illustrates the different 
bifurcations types that link fixed points (where the system does not change over time) and 
oscillatory regimes. In the oscillatory states, the system moves around a so-called limit cycle, 
a closed trajectory in state space that acts as an attractor.  
The phase flow columns illustrate the change of the dynamic landscape as relevant 
parameters of the system are changed. These are represented in a two-dimensional 
representation of the system’s state (e.g. excitatory, and inhibitory neuronal activity), with 
blue lines illustrating individual trajectory as the system evolves in time. Small circles 
indicate fixed points, large circles indicate limit cycles; solid lines are stable FP/LC, dashed 
lines are unstable FP/LC. The timeseries column illustrates how the bifurcation would appear 
if only one state is recorded over time. The remaining columns show amplitude-frequency 
behaviour, where λ signifies the distance from the critical transition point. The penultimate 
column indicates whether the FP is inside or outside the stable LC. The last column indicates 
the possible directions the bifurcation can be crossed – i.e. whether it is an onset bifurcation, 
offset bifurcation, or both.   
 
FLC – Fold Limit Cycle, FP – fixed point, LC – limit cycle, SH – saddle homoclinic bifurcation; 
SN – saddle node bifurcation; SNIC – saddle node on invariant circle bifurcation; subH – 
subcritical Hopf bifurcation, supH – supercritical Hopf bifurcation; 
 
[reproduced with permission from (Saggio et al., 2016)] 
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organisation of individual neurons during an epileptic seizure (Liou et al., 2018; Smith et 
al., 2016). Yet the particular perspective offered by these dynamical systems approaches 
may help us to organise our understanding of these multi-level system particularities along 
conceptually relevant categories. Similar approaches has already helped integrating 
observations at different spatial and temporal scales (Proix et al., 2018; Richardson, 2011).    
In the following chapters of this thesis, I will use a range of different computational models 
of neuronal function (discussed in more detail in Chapter 3), each of which (1) is a 
mathematical formulation of a dynamical system, and (2) describes biophysical properties 
of neuronal systems at a particular scale (e.g. neuronal membrane, single neuron, or 
neuronal population / circuit).  It is through the inherently universal representation of 
abnormal dynamics within the context of a dynamical system, that these models may help 
us to link apparently diverse underlying biological mechanisms into coherent categories 
of disease.  
2.3 Disruptions of cognitive function in adolescence: 
Lessons from schizophrenia 
Whilst some of the most severe neurological conditions emerge during the earliest 
developmental stages of infancy and childhood (as discussed for, e.g., the epileptic 
encephalopathies above), there is a separate group of conditions whose incidence peaks 
later in development: Many neuropsychiatric disorders, such as obsessive-compulsive 
disorder, mood disorders, and schizophrenia are diagnosed most commonly in older 
teenagers or in young adults. Despite this comparatively late onset, these conditions can 
significantly impact and alter a previously healthy young person’s life (Erskine et al., 2015), 
and are associated with significant morbidity and mortality (Boys et al., 2003; Patton et al., 
2009; Wittchen et al., 1998). 
Schizophrenia is a cardinal example of one such condition. The most commonly reported 
onset of symptoms is at approx. 20-25 years, depending on gender and cohort (Häfner et 
al., 1993; Sham et al., 1994). Prior to this the child or young person may have been 
developing normally, with no reported symptoms. Yet despite the apparently later onset, 
many cognitive processes are altered profoundly in patients: perception, decision making, 
social cognition are all impaired in patients with the diagnosis – often to the point where 
independent living becomes impossible and the patient may become a danger to himself 
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or others if left untreated (Porcelli et al., 2018; Strauss and Cohen, 2017; Takeda et al., 
2018). And even with the best currently available treatment, a diagnosis of schizophrenia 
is associated with a reduction in life expectancy of approximately 20 years (Laursen et al., 
2014).    
Like many epilepsies, schizophrenia has long been recognised as a heritable 
neurodevelopmental disorder with a likely high genetic burden (Cardno et al., 1999; 
Sullivan et al., 2003). Yet – and again like e.g. idiopathic/genetic generalised epilepsies – 
whilst many candidate and risk factor genes have been identified (Freedman et al., 1997; 
Greenwood et al., 2012; Schizophrenia Working Group of the Psychiatric Genomics 
Consortium, 2014), almost none of these insights about the genetic background have been 
translated into an immediate clinical benefit for patients yet.   
On the other hand, the combined insights from neuroscience and molecular genetics do 
give us biological insights into the development of different neuropsychiatric conditions, 
including schizophrenia. In the following section of this chapter, I discuss the particular 
vulnerabilities of the adolescent brain that may predispose patients to developing 
particular neuropsychiatric conditions in this crucial time period. I then illustrate how 
molecular and computational perspectives give us complementary insights into the 
pathophysiological mechanisms underlying the disorder.  
2.3.1 Adolescence as a sensitive period during brain development 
Many neuropsychiatric syndromes have their peak onset during adolescence (Paus et al., 
2008) – including substance abuse disorders, mood disorders, anxiety disorders, and 
schizophrenia (Figure 2.7). This particular developmental timescale suggests that the 
contemporaneous developmental changes in neurobiology confer particular 
vulnerabilities to disruptions in brain functions that manifest in neuropsychiatric 
conditions (as opposed to e.g. the early infantile epileptic encephalopathy, that seem to 
disrupt more fundamental neuronal processes that are established earlier in 
neurodevelopment).  
There are a broad range of key developmental changes occurring in the human brain 
around the time of puberty and later adolescence (Asato et al., 2010; Blakemore and 
Choudhury, 2006; Uhlhaas et al., 2009). The most widely accepted global brain changes 
during adolescence include synaptic pruning, and intracortical and white-matter tract 
myelination (cf. earlier sections of this chapter, Figure 2.1).  
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Figure 2.7 – Peak onset of different neuropsychiatric conditions in adolescence. Many 
neuropsychiatric disorders have their peak onset during adolescence.  
 
[Reproduced with permission from (Paus et al., 2008)] 
 
Evidence of a reduction of the number of synapses (i.e. synaptic pruning) after childhood 
has been provided by detailed, opportunistic studies on post-mortem human brain 
specimens (Huttenlocher and Dabholkar, 1997; Huttenlocher and de Courten, 1987). 
Quantitative experiments in non-human primates then confirmed that the loss of these 
synapses is likely accelerated around puberty (Bourgeois and Rakic, 1993). Furthermore, 
putative electrophysiological markers of intracortical connectivity (i.e. low-frequency 
band power during sleep on EEG, (Tononi and Cirelli, 2006)) also show their largest 
developmental change during adolescence and can be assessed across large, representative 
samples in normally developing human participants (Feinberg and Campbell, 2010). This 
developmental change in electrophysiological measures of cortical function also appears 
to be correlated with MRI-measurable, structural markers of cortical structural maturation 
during childhood and adolescence (Buchmann et al., 2011). 
In terms of neuronal function, there seems to be an optimum amount of intracortical 
‘connectedness’ for network-level computations. In a simple neural net trained to 
recognise words from phonetic input, pruning initially improves performance, before 
there is a decline in further performance (Figure 2.9). Notably in the case of ‘over-pruning’, 
the model starts ‘recognising’ words in periods of no input – a notion that is relevant for 
computational models of schizophrenia, suggesting that an ‘excess’ of certain brain 
changes can confer a behaviour consistent with e.g. a psychotic phenotype.   
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Figure 2.8 - Age of onset distribution in 
schizophrenia.  
This figure shows the age of onset of 
schizophrenia for male and female 
patients identified as part of a Swedish 
family study of schizophrenia.  
Both male and female patients show a 
peak incidence during adolescent brain 
development at around 15-25 years of 
age.  
 
[Figure adapted from (Sham et al. 
1994)] 
 
Whilst these general principles of synaptic pruning are observable across the whole brain, 
maturation does not unfold evenly across the cortex. Many of the structural measures of 
brain development in adolescence that we can derive through neuroimaging methods 
point towards protracted maturational profiles particular in higher order association 
cortices (Gogtay et al., 2004). Thus, adolescence may be a particularly sensitive period 
during brain development, during which higher order cognitive processes (that rely on the 
high-level association cortices) can be selectively impaired (Fuhrmann et al., 2015).  
 
 
Figure 2.9 – Effects of synaptic pruning on 
computational performance. The plot shows 
performance of neural net against gradual 
reductions of synaptic connectivity. This 
neural net recognises words from degraded 
phonetic input. Gradual ‘Darwinian’ 
pruning of synaptic connections (where the 
strongest synapses survive) initially increases 
performance, with a clear optimum at 
around 30% pruning.  
At higher rates of pruning, the performance 
drops, and the model starts increasingly 
recognising words even during periods of 
complete silence.  
 
[Figure reproduced with permission from 
(McGlashan and Hoffman, 2000)] 
Changes in cortical myelination can give quantitative insights into brain maturation 
during adolescence. When assessed with structural MRI across a broad adolescent age 
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range, Whitaker et al. have reported evidence of locally patterned changes in cortical 
thickness and intracortical myelination during adolescence. Interestingly, the topology of 
these structural markers of brain maturation was associated with regional expression of 
myelination-related genes, as well as schizophrenia risk genes (Whitaker et al., 2016).  
2.3.2 Features of schizophrenia 
Schizophrenia is a chronic psychiatric condition with a peak onset during adolescence 
(Figure 2.8). A clinical diagnosis made on the basis of a mixture of positive and negative 
psychiatric symptoms, summarised in Table 2-2. The diagnosis can be made based on 
symptoms present for a significant portion of at least a one month period (unless treatment 
is initiated earlier), and a significant portion of patients experience chronic ongoing 
symptoms throughout their lives (Lewis and Lieberman, 2000).  
Schizophrenia is related to a number of syndromes that share some symptomatology 
(particularly psychosis-related symptoms) but differ in their long-term outcomes and 
associated other psychiatric symptoms (such disorders include acute psychotic disorders, 
schizoaffective disorders, and schizophreniform disorders).  
Cohort studies of genetically at-risk individuals, and retrospective reviews of patient data 
revealed that clinically diagnostic symptoms can be preceded by more subtle abnormalities 
at a younger age, including infancy, and pre-diagnosis adolescence (Jones, 1997). Children 
who later developed schizophrenia were more likely to have abnormal gross motor 
development in infancy (Fish and Kendler, 2005), as well as more likely to have overt 
psychotic symptoms by the age of 11 (Fisher et al., 2013). 
Whilst positive symptoms (e.g. delusions, hallucinations, etc.) most commonly lead to 
diagnosis, the presence or absence of negative symptoms (e.g. social withdrawal, 
 
Table 2-2 - DSM-5 Criteria for the diagnosis of schizophrenia.  
[Adapted from: (Tandon et al., 2013)] 
 
 
Two or more of the following must be present for a significant portion of the time during 
a 1-month period (or less if sufficiently treated). At least one of these should include 
symptoms 1-3 
 
1) Delusions 
2) Hallucinations 
3) Disorganised speech 
4) Grossly disorganised or catatonic behaviour 
5) Negative symptoms (i.e. diminished emotional expression or avolition) 
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diminished emotional expression) is more predictive of future outcomes for individual 
patients (Fenton, 1991). Presence of significant negative symptoms indicates more severe 
disease of likely insidious onset with potentially longer periods of untreated 
symptomatology. Early treatment with antipsychotic medication appears to have a small 
but significant beneficial longer-term effect, but both recurrent positive and persistent 
negative symptoms are present in a majority of patients even >10 years after initial 
presentation (Hegelstad et al., 2012), irrespective of early treatment status. 
 
 
Figure 2.10 – Dendritic spine reduction in 
patients with schizophrenia. Golgi-stained 
widefield microscopy images are shown for 
dendritic processes of human post-mortem 
specimens from (A) a control subject, and 
(B-C) patients with schizophrenia, 
illustrating the reduction in the number of 
dendritic spines in patients.  
  
[Figure reproduced with permission from 
(Glantz and Lewis, 2000)] 
 
Whilst the psychiatric symptoms are diagnostic in schizophrenia, it has long been 
recognised that neurological signs, structural brain abnormalities and electrophysiological 
markers of dysfunction exist in patients. The most frequently reported neurological 
impairments include sensory dysfunction and motor coordination deficits (Schröder et al., 
1991).  
Structural brain imaging has further provided insights into potential anatomical correlates 
of schizophrenia. A number of studies showed that schizophrenia is associated with 
progressive volume loss, with the earliest involved brain areas consistently reported to be 
prefrontal cortex, temporal pole and mesial temporal lobe (DeLisi, 2008). Those brain 
areas showing the most severe volume loss are also affected by microscale changes in 
cellular organisation – including those indicative of reduced intracortical connectivity, 
such as reduced number of dendritic spines (Figure 2.10). 
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There is a number of well recognised electrophysiological markers frequently observed in 
patients with schizophrenia, even EEG recordings have not (yet) been included in routine 
clinical practice (Owens et al., 2016).  A number of these are changes in event-related 
potentials evoked during particular sensory paradigms (e.g. P50, P300, Mismatch 
Negativity /MMN), whilst changes in stimulus-induced gamma frequency power. 
Furthermore sleep spindles and slow waves during sleep have been reported to be reduced 
in patients with schizophrenia (D’Agostino et al., 2018). Specific electrophysiological 
markers have been the point of much theoretical discussion in regard to their underlying 
mechanisms, some of which will be reviewed in Chapter 7 of this thesis. Recent genetic and 
genome-wide association studies have aimed to relate these electrophysiological 
‘endophenotypes’ to risk alleles in schizophrenia and have identified a dosage effect – 
where increased schizophrenia risk allele burden is broadly associated with more severe 
electrophysiological deficits (Hall et al., 2015). 
Over the last couple of decades, some of these observations in schizophrenia have been re-
contextualised through insights gained from genetics. Amongst a range of studies applying 
different approaches, we have gained the following three key insights: 
 
• Population-wide common variants – such as specific catechol-O-methyltransferase 
(COMT – a catecholamine degrading enzyme) associated haplotypes – can be 
associated with an increased risk of developing schizophrenia (Shifman et al., 
2002).  
• Individually rare genetic variants (including copy number variations (Malhotra 
and Sebat, 2012)) account for a large proportion of the genetic risk in 
schizophrenia (Donnelly et al., 2012; Purcell et al., 2009; Walsh et al., 2008) – this 
is now believed to be a contributing factor to many common neurodevelopmental 
disorders (Gibson, 2012).  
• Genes affected by rare, de novo mutations that confer a high risk of schizophrenia 
disproportionally affect postsynaptic density formation, and more specifically the 
NMDA-receptor complex, and the activity-related cytoskeleton-associated 
protein (ARC) complex (Figure 2.11).  
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2.3.3 A computational neuroanatomy of schizophrenia 
The picture of schizophrenia that emerges is complex, as outlined above: Schizophrenia is 
associated with cardinal psychiatric symptomatology, as well as a wide range of associated 
neuroanatomical, neurophysiological and synaptic/genetic abnormalities. Several theories 
have been developed to bring together some of these apparently disparate features of the 
wider syndrome and relate them to one another.  
 
 
Figure 2.11 – Postsynaptic gene network affected by de novo mutations in schizophrenia. 
The figure indicates the roles of genes affected by de novo mutations in schizophrenia. 
Different functional groups are marked; red outlines indicate loss of function; black outlines 
indicate non-synonymous mutations.  
NMDAR – N-methyl-D-aspartate receptor; ARC – activity-related cytoskeleton-associated 
protein complex; FMRP – fragile X mental retardation protein.  
 
[Figure reproduced with permission from (Fromer et al., 2014)] 
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One such perspective is offered by the so called ‘dysconnection hypothesis’ (Friston et al., 
2016a) / ‘disconnection hypothesis’ (Friston, 1998; Weinberger, 1993). Crucially this 
hypothesis integrates observations from molecular genetics and pharmacology 
(principally the central role of NMDAR transmission and its modulation by 
neuromodulatory systems), and features of psychopathology and neurophysiology in 
schizophrenia.  The central proposition is that the physiological effects of abnormal 
modulations of NMDAR-mediated plasticity (e.g. the context sensitive modulation of gain 
in cortical pyramidal cells) cause impairments in local (i.e. intrinsic) and between-region 
(i.e. extrinsic) coupling, which in turn explain the related phenotypes.  
Providing evidence for this hypothesis critically rests on linking abnormal synaptic 
coupling and psychopathology. In order to make this link, there needs to be a mapping 
between the different components of cortical neuronal circuitry, and the specific normal 
and abnormal computations conducted that are completed by this circuitry. Predictive 
coding offers one framework in which this link is possible (Friston and Kiebel, 2009): 
According to this framework, higher cortical areas generate predictions of future sensory 
states and attempts to minimise the error between these predictions and actual sensory 
evidence that is encoded in prediction errors in lower cortical areas. This process requires 
the brain to learn a generative model of the world and infer the setup of this model from 
(degenerate) sensory input. This Bayesian account of normal cognitive function 
(particularly in reference to normal sensory processing) provides quantitative predictions 
of different types of signals used for processing: top-down/backward predictions, bottom-
up/forward prediction errors and a precision term that describes the uncertainty around 
them (Friston, 2012; Shipp, 2016). This Bayesian computation can be related directly to 
different aspects of neurobiology: the stereotyped, or ‘canonical’ connectivity between 
cortical layers and between cortical regions is believed to be closely associated with 
different processes and quantities in predictive coding. This link can be formalised through 
quantitative dynamic models of cortical circuitry that are formally related to simpler 
representations of neural population dynamics (which will be introduced in more detail in 
the following Chapter 3), but relate more closely to the presumed predictive coding 
processes in the human brain: The ‘canonical microcircuit’ (Bastos et al., 2012).  
This quantitative link between neurobiology and computational processes has allowed the 
testing of a range of hypotheses in regards to normal brain function (Bhatt et al., 2016; 
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Brown and Friston, 2013; Garrido et al., 2008), as well as dysfunction in human 
neurological and psychiatric disorders (Breakspear et al., 2015; Friston, 2005; Lawson et 
al., 2015; Ranlund et al., 2016).  
In specific regard to schizophrenia, the dysconnection hypothesis – contextualised 
through the predictive coding paradigm and its quantitative links between neurobiological 
processes and neuronal computation – has led to a number of key insights. First, the 
psychopathology observed in schizophrenia is consistent with an abnormal encoding of 
precision of the sensory evidence – i.e. because of abnormally high precision weighting of 
incoming sensory evidence, the brain is unable to discount random variations and 
considers everything as meaningful (Adams et al., 2013). Second there are a number of 
synaptic mechanisms that could result in the downstream failure to control the gain on 
cortical superficial pyramidal cells – which corresponds to the abnormally high precision 
in the predictive coding scheme. These synaptic mechanisms include NMDAR 
dysfunction, GABAergic abnormalities and excitation-inhibition imbalance, all of which 
have been described in schizophrenia (Friston et al., 2016a). Third, a range of macroscopic 
structural and functional connectivity measures indicates that there is indeed an apparent 
reduction in connectivity (Pettersson-Yeo et al., 2011), with the patterns broadly 
consistent with predictions made on the basis of the dysconnection hypothesis – indicating 
a particular disruption of prefrontal circuits,  where NMDAR hypofunction has long been 
implicated in schizophrenia phenotypes (Akbarian et al., 1996).  
2.4 Conclusion  
Considering the breadth of the topics discussed in this chapter, the above illustrations are 
not meant to represent a fully comprehensive manual on dysfunction in the developing 
brain. Rather, by focussing on laying out key stages in (particularly postnatal) human brain 
development, and temporally relating them to quite contrasting neurodevelopmental 
disorders – epilepsy, and schizophrenia – this chapter illustrates a number of insights and 
questions that the rest of this thesis will build on.  
Different neurodevelopmental disorders reveal distinct vulnerabilities of the developing 
brain. Both the epilepsies and schizophrenia carry significant morbidity for affected 
patients. The way in which they disrupt normal brain function appears to be associated 
with the particular vulnerabilities of the developmental stage in which they most 
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commonly emerge. For example, in the early infantile epileptic encephalopathies (EIEEs), 
the fundamental oscillatory activity of the brain is continuously disrupted to the extent 
that the implicit dysconnection causes global delay across all developmental domains. In 
contrast, whilst schizophrenia can be disabling, the cardinal symptoms are recognisable as 
affecting particular cognitive and affective domains and are associated with a relatively 
localised dysfunction (or dysconnection) in specific neuronal circuits. And crucially these 
circuits also appear to be the ones that undergo the biggest changes later in development, 
suggesting that adolescence is a neurobiologically predestined time of vulnerability for the 
development of schizophrenia. 
Molecular mechanisms reveal distinct but overlapping mechanisms in 
neurodevelopmental disorders. The examples discussed above highlight the diversity of 
causes in neurodevelopmental disorders. The disorders described in this chapter capture 
two ends of a likely spectrum: Whilst in the very early onset epilepsies, up to 75% of 
patients may have a single gene mutation detected by clinical testing (Oates et al., 2018), 
such single gene diagnostics play no role in schizophrenia to date. However, even at these 
two extremes of how molecular / genetic mechanisms are expressed in the individual, they 
also share key features in terms of their molecular pathologies.  
 
 
Figure 2.12 – Model of developmental brain dysfunction.  
 
[Reproduced with permission from (Moreno-De-Luca et al., 2013)] 
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The genetics of both epilepsy, and schizophrenia indicate that both could be considered 
‘synaptopathies’ – pathologies whose main mechanism is dysfunction at the synapse (Luo 
et al., 2018). In terms of the genetics underlying this functional disruptions, the study of 
neurodevelopmental disorders has revealed novel mechanisms of human disease 
inheritance (e.g. the surprising role of copy number variations in a broad range of 
neurodevelopmental disorders (Grayton et al., 2012; Magri et al., 2010; Mulley and 
Mefford, 2011). Lastly and in many ways surprisingly, disruptions of similar mechanisms 
apparently can produce different phenotypes within the broad set of neurodevelopmental 
disorders: NDMAR dysfunction is now a well described cause of both epileptic 
encephalopathies (Lemke et al., 2014; Lesca et al., 2013), and schizophrenia (Demontis et 
al., 2011). In fact autoimmune disruption of NMDAR transmission in NMDAR-antibody 
encephalitis (the focus of Chapter 6 of this thesis) causes both neuropsychiatric symptoms 
and epileptic seizures at different stages of the disease (Crisp et al., 2016; Wandinger et al., 
2011). In fact, the recent wave of discoveries indicating the shared molecular basis for a 
broad range of neurodevelopmental disorders has brought with it a revival of the idea that 
these conditions are differential expressions of mixed risk factors (Figure 2.12). 
Microscale mechanisms and phenotypic observations need to be linked to understand 
dysfunction in the developing brain. Both within the epilepsies, and for 
neurodevelopmental disorders more broadly, there is a gap between our understanding of 
molecular background, and the range of phenotypes observed. In the remainder of this 
thesis I outline with empirical examples, how quantitative models of neuronal function 
and dynamics may offer an approach to close this gap – both those reproducing dynamic 
signatures of epileptic seizures, and those recapitulating some of the computational deficits 
in schizophrenia. In most of neuronal dysfunction there is no one-to-one mapping 
between molecular determinants of neurobiology and system function as a whole. Using 
quantitative models to identify a set of key mechanisms that underpin specific aspects of a 
diverse set of phenotypes will mediate the mapping between molecular mechanisms and 
patient phenotypes and allow us to reduce the complexity of this challenge.  
An approach like this is necessary if we want to reconcile the phenotypic specificity of the 
neurodevelopmental disorders under consideration with the apparent continuum of 
genetic and molecular causes that underlie them.  In the following chapter, I indicate how 
specific sets of models can be utilised this approach. I then test a range of such approaches 
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across a number of model systems of neurodevelopmental disorders – ranging from 
heterologous expression systems to identify the dynamic effects of an epilepsy-related 
SCN1A-mutation (Chapter 4), to human pharmacological experiments reproducing key 
features of the psychopathology in schizophrenia (Chapter 7). 
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3 
 
 Computational modelling of neuronal 
dynamics § 
3.1 Empirical data for computational neurology 
3.1.1 EEG as quantitative measurements of whole-brain function 
The invention of electroencephalography (EEG) in the early 20th century facilitated a 
revolutionary insight into the dynamic behaviour of the human brain. For the first time, 
clinicians and researchers were able to examine direct evidence of brain function, in both 
normal human participants and patients with neurological conditions (Jung and Berger, 
1979). Clinically this new way of assessing brain function has had significant impact on 
our understanding of a number of neurological and psychiatric conditions, but none more 
so than epileptic seizure disorders.  
EEG measures potential differences across the scalp: through electrodes placed on different 
locations on the scalp surface, one can record sub-millisecond fluctuations in electric 
potentials that can be shown empirically to correspond to brain function. Electrical signals 
measured on the scalp depend on potential changes that are generated locally in the 
                                                        
§ Parts of this chapter have been published as part of the following book chapter:  
 
Rosch, R.E., Cooray, G., Friston, K.J. 2017. Dynamic causal modelling of dynamic dysfunction 
in NMDA-Receptor Antibody Encephalitis. In Erdí, P., et al. (eds.), Computational Neurology 
and Psychiatry. Springer Publishing, Cham, Switzerland.  
 
The review included here was conceived by me, Gerald Cooray and Karl Friston. All theoretical 
work and review of computational modelling included in this chapter was completed by 
myself.    
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cortical extracellular space by neuronal activity. Post-synaptic potentials and action 
potentials cause changes in permeability of neuronal membranes which allows for 
transmembrane flow of charges ions to and from the extracellular space. This space, 
however, is limited to only small inter-cellular clefts because of the high number of neuron-
to-neuron connections and a densely packed variety of glial cells. Glial cells therefore play 
an important role in regulating extra-neuronal ion concentrations and influence actively 
the distribution of charges ions across the extra-neuronal domains.  
 
Where changes in the extracellular potentials are spatially segregated, they will invoke an 
electromagnetic field along which current flows, i.e. a dipole. All of the excitable 
 
 
Figure 3.1 – Cortical contributors to the EEG signal. (A) Potentials as measured by EEG 
electrodes are generated by local dipoles that originate from spatially separate differences 
in extracellular potentials. These are generated for example through synaptic transmission 
as illustrated here. (B) A presynaptic neuron fires and causes local excitatory post synaptic 
potentials (EPSPs) and possible postsynaptic action potentials. These are associated with an 
extracellular ionic shift, leading to a locally more negative extracellular potential. This 
extracellular space is tightly regulated by astrocytes, which buffer and distribute ion 
concentration changes through a gap-junction coupled network. The difference between 
negatively charged membrane patches, and other parts of the membrane generates a 
dipole, along which microcurrents equilibrate the differences. These slower changes in 
dipoles along the postsynaptic membrane (rather than fast, self-limiting action potentials) 
are reflected in the composite potential measured at the scalp (top panel). The direction 
(positive or negative) of the surface potential depends on the direction of the dipole.  
 
[Figure adapted from (Speckmann and Elger, 2005)] 
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membranes that permit transmembrane currents contribute to this extracellular field, 
generating a composite, indirect measure of neuronal function. However, there are certain 
characteristics of neuronal potential changes  that cause it to have a higher impact on the 
electrical activity at the scalp: (1) proximity to the surface means less information is lost 
through volume conduction and noise effects, (2) signals with longer time constants (i.e. 
slower decay) such as post-synaptic potentials are more likely to summate over time and 
have sufficient synchrony to produce a large enough ‘populations shift’ to be measurable, 
(3) channel opening that does not generate a significant ionic current does not contribute 
much to the overall signal (e.g. GABA channels opening at rest, where the Cl- reversal 
potential is similar to the existing membrane potential, (Buzsáki et al., 2012)). These 
characteristics are best met by the dendrites of pyramidal cells: superficially located, these 
are long apical dendrites summating many post-synaptic potentials, a large proportion of 
which are excitatory (Figure 3.1).  
Whilst the concept that abnormal electrical activity causes epileptic seizures predates the 
invention of EEG, much of our current physiological understanding and clinical decision 
making is based on EEG recordings from patients suffering from epilepsy (Eadie and 
Bladin, 2001). Descriptions and analyses of EEG recordings have remained virtually 
unchanged since its original conception. Its clinical use largely rests on the description of 
visually recognisable features and their phenomenological categorisation, with the 
exception of some recently adopted advanced source localisation algorithms (Zschocke 
and Hansen, 2012). But relying just on these visually apparent pathological patterns does 
not capture the entire breadth of information that is available in an EEG recording.  
One of the main advantages of EEG (that is shared with magnetoencephalography, MEG) 
is its temporal resolution, which still remains unparalleled when it comes to investigating 
the human brain in-vivo. This results in rich datasets that capture interacting fluctuations 
of electric activity across frequencies that may be two or three orders of magnitude apart. 
Whilst surface EEG recorded non-invasively from the scalp has a limited spatial resolution, 
it does allow for the simultaneous recording of neuronal activity across almost the entirety 
of the cortical surface. Furthermore, the spatial resolution limitations can be addressed 
where clinically necessary by using invasive EEG recordings from neurosurgically placed 
electrodes.  
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Much of the information contained within these datasets is not accessible through visual 
inspection alone, but rather needs to be elicited utilising more quantitative analysis 
methods (Tong and Thakor, 2009). Applying such quantitative analysis methods has led 
to the description of a wide variety of novel electrophysiological findings. For example, 
analysing the correlation between the time series of individual EEG channels will yield a 
matrix of channel-to-channel correlation measures. These can be read as indicators of 
functional connectivity, with the results interpreted in a graph theory framework as 
functional network analysis (Bullmore and Sporns, 2009).  Another example can be found 
in the recent emergence of cross-frequency coupling as a potentially important mechanism 
for neuronal computation: Quantitative analysis of power at different EEG frequencies in 
humans has shown that amplitude fluctuations are measurably modulated and time-
locked to the phase of concurrent slower frequency oscillation, known as phase-amplitude 
cross-frequency coupling (Canolty and Knight, 2010).  
3.1.2 Microscale neurophysiological recordings 
Dynamic changes in permeability of neuronal membranes can be measured through a 
number of cellular neurophysiology techniques referred to collectively as patch-clamp 
recordings.  In principle the concept is based on two steps: (1) isolating small membrane 
compartments (i.e. a patch) from influences of surrounding ion concentrations by 
establishing a tight seal with a glass pipette; (2) enforcing specific electrical conditions, e.g. 
at a set voltage (known as voltage-clamp), mediated via the electrolyte in the clamping 
pipette (Kornreich, 2007). This set up, together with pharmacological regulation of specific 
channels or receptors allows the direct measurement of membrane permeability to specific 
ions under specified electrical conditions. The technique builds on classical voltage-clamp 
designs, where electrical properties are measured and clamped through a pair of intra- and 
extracellular microelectrodes (rather than the pipette). The novel pipette approach first 
established in 1976 (Neher and Sakmann, 1976), however, allows more experimental 
control, and resolves to the dynamics of even a single channel.  
Patch clamp experiments are usually performed in cell / tissue culture, with some 
successful applications of voltage-clamp paradigms on individual neurons in-vivo in 
animal models (Kitamura et al., 2008). This means that its use to make inference regarding 
human neuronal function is limited to a specific set of experimental designs:  
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Human pathology in animal or cell culture models: Where a causative gene mutation for 
a human condition is known, inference on the disease mechanism can sometimes be made 
by expressing the mutant gene product in an animal organism or cell line and assessing its 
functional effects in the model using patch clamp (the focus of Chapter 4 in this thesis). 
Examples of this include patch-clamp characterisation of gating abnormalities in epileptic 
conditions associated with calcium-sensitive potassium channels (Du et al., 2005). This 
approach makes strong assumptions regarding the monogenic cause underlying the 
respective conditions, and rests on reliably identified molecular causes.  
Biopsy-derived tissue culture: Access to neuronal tissue from human probands is rare, but 
possible in conditions where surgical treatment is an option, or from acute post-mortem 
specimens. Patch clamp techniques have been applied in cultured slices of tissue from such 
specimens, resected for temporal lobe epilepsy. Patch-clamp studies in sclerotic mesial 
temporal lobe tissue from human patients, for example, have identified abnormalities in 
potassium current dynamics in astrocytes (Schröder et al., 2000).  
Patient-derived induced pluripotent stem cells: One of the more recent advances has been 
the possibility to develop neuronal cultures directly from patient-derived stem cells. These 
carry the entire genetic make of specific patients and are therefore better models for 
complex gene-gene interactions. This approach has been applied for example to investigate 
human epilepsy causing mutations in the voltage-gated sodium channel gene, SCN1A and 
for the first time identify single cell mechanisms through which loss-of-function mutations 
could produce hyperexcitable cellular phenotypes (Chen et al., 2015).  
3.1.3 Molecular determinants of neuronal function 
Alongside advances in the detailed quantitative analysis of macroscopic EEG signals in 
health and disease, there has been an exponential increase in our understanding of the 
molecular, and to some extent cellular basis of many of the epilepsies and other 
neurodevelopmental conditions (Helbig et al., 2008; Thomas and Berkovic, 2014). 
Increasingly, knowledge of associated molecular abnormalities such as the presence of 
relevant gene mutations or specific autoantibodies against synaptic targets influences 
prognosis, clinical management, and specific treatment decisions for affected patients. 
Features of disease-associated molecular abnormalities have also led to a putative 
understanding of the pathophysiological mechanisms underlying different epileptic 
seizure disorders. For example, the frequency of mutations in ion channel genes has led to 
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the concept of epilepsies and other paroxysmal neurological disorders being 
channelopathies, i.e. disorders in neuronal ion channel function, which can be further 
investigated in appropriate animal model systems.  
However, with the increase in knowledge, new challenges arise. The availability and 
increased clinical use of testing for specific mutations and autoantibodies has quickly led 
to the realisation that even apparently specific molecular abnormalities are associated with 
a wide variety of disease constellations – both in terms of recognisable syndromes and 
diseases, and some less specific changes (McTague et al., 2018, 2016; C. F. Wright et al., 
2015) – in human patients. The same mutation in the voltage gated sodium channel gene 
SCN1A for example can cause a diverse selection of phenotypes within the same family: 
ranging from comparatively mild phenotypes consisting of childhood febrile seizures, to a 
severe epileptic disorder characterised by difficult to control frequent daily seizures 
associated with global developmental delay (Miller and Sotero de Menezes, 2014). 
Similarly, mutations in the GRIN2A gene, coding for a subunit of the N-methyl-D-
aspartate receptor (NMDAR) can cause a range of electroclinical syndromes, even within 
the same family (Lesca et al., 2013).  
With the advent of increased genetic and molecular diagnostics, we can thus now 
empirically identify the molecular context in which the paroxysmal neurological disorders 
unfold: The available diagnostic tools are focussing us on the persistent and detectable 
abnormalities at the microscale – such as genetic mutations – that allow for intermittent 
pathological dynamics to emerge at the whole brain scale.  
3.2 The explanatory gap 
3.2.1 Different scales in experimental neuroscience 
The different empirical perspectives illustrated above open an explanatory gap: On one 
side there is an increased understanding of the putative molecular and cellular causes of 
dynamic disorders of the brain; on the other there are macroscale measures of abnormal 
brain function that, whilst loosely associated with some microscale abnormalities do not 
allow a direct one-to-one mapping. Bridging this gap is likely to require an intermediate 
step – a conceptual bridge that can link information about molecular dysfunction with its 
expression in neuronal function at an intermediate level, the mescoscale, in order to 
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understand the emergence of phenotypic variability observed in human patients 
(Freeman, 2000a).  
In other areas within the neurosciences, similar approaches are emerging as a necessary 
step for linking observations at the microscale (e.g. cellular neuronal circuits) with the 
observation at the macroscale (e.g. organism behaviour). Whilst descriptions of the cellular 
circuitry may include too many particular details to understand their functional 
contributions to overall behaviour, evaluating only behaviour of the whole organism may 
 
  
Figure 3.2– Understanding epileptic dynamics at different scales. Different lines of evidence 
lead to descriptions of pathology on different scales. Clinical syndromes often rely on the 
description of recognisable phenotypes at the macroscale. Recent advances in 
understanding associated molecular abnormalities have improved our pathophysiological 
understanding of many diverse epilepsy and other neurodevelopmental syndromes, but 
robustly linking clinical phenotypes with microscale abnormalities has proven difficult. 
Including an intermediate consideration of network dynamics may aid both prediction and 
allow for addressing the inverse problem of inferring pathophysiology from whole-brain 
electrophysiological measure.  
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not sufficiently represent the complexity and the constraints of the underlying neuronal 
processes. Bridging this gap requires the identification of recurrent themes at an 
intermediate functional level – such as that of neuronal circuits – that may be implemented 
through differing neuronal circuits, but produce similar overall effects (Carandini, 2012).  
In the context of clinical neurology, a similar approach would suggest that in order to link 
putative molecular causes (microscale) with diverse disease phenotypes observed in 
patients (macroscale), the intermediate step needs to be considered: Dysfunction at the 
level of integrated, neuronal microcircuits (mesoscale, Figure 3.2). Linking molecular 
abnormalities to in-vivo neuronal dysfunction is now a standard component of identifying 
disease mechanisms in emerging genetics and autoimmune conditions (Pal and Helbig, 
2015). Attempts in relating macroscale findings to models of mesoscale neuronal dynamics 
have been less forthcoming but will be the focus of this chapter. An introduction of 
population models of neuronal function will be followed by an in-depth discussion of how 
such models can be used to make inference on the mechanisms underlying specific 
electrophysiological changes.  
3.2.2 Linking phenotype and pathophysiology: An ill-posed problem 
The functional validation of possible molecular causes of neurological disease is an 
essential step in any description of new pathophysiological mechanisms. A candidate 
genetic mutation that is epidemiologically linked with a specific phenotype may or may 
not play a causative role in the pathogenesis of the associated condition. In order to 
increase confidence that a direct biologically causative link exists, evidence that the 
molecular/cellular pathway affected is involved in neuronal function is considered a 
standard requirement (Quintáns et al., 2014). 
Providing this evidence usually relies on replicating the molecular abnormality in an 
experimental model organism or cellular system and evaluating the model for any 
resultant deficits, particularly regarding neuronal function. For example, to provide 
evidence for the direct pathogenicity of NMDAR-antibodies in the recently described 
NMDAR-antibody associated encephalitis (Dalmau et al., 2008), the antibody-rich patient 
cerebrospinal fluid was applied to murine hippocampal slices prepared for voltage-clamp 
recordings in order to measure the effects of antibody exposure on glutamate transmission. 
This provided evidence both for acute antagonism of NMDAR by the antibody, as well as 
chronic reduction of NMDAR associated with antibody exposure (Hughes et al., 2010).  
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Whilst this approach is powerful, and necessary in order to evaluate candidate molecular 
causes of neurological disorders in the context of neuronal function, several problems 
remain unsolved when relying on this approach alone:  
 
• Animal models for human disease: Model systems used to assess the pathological 
effects of molecular abnormalities are usually non-human organisms or tissues, 
leaving uncertainty as to whether similar effects would be evident in the human 
brain.  
• Emergent properties at different scales: There may be a gap between individual cell 
and small circuit abnormalities assessable in an experimental model system, and 
the inference drawn on larger networks and systems. These models are particularly 
prone to neglecting emergent properties at different scales (e.g. bistability of a 
network), and the effects of unknown modulators in the whole system that may 
enhance or suppress the observed microscale abnormality.  
• Human phenotypic variability: An unexpected result of the recent increase in 
molecular diagnoses in neurology is the discovery of large phenotypic variability 
even where a molecular cause has been identified and well characterised 
(Hildebrand et al., 2013). Functional investigations in homogeneous model 
systems alone do not address the mechanisms underlying phenotypic diversity.  
 
Issues of disease pathology in humans, understanding whole-organism, and delineating 
relevant categories within phenotypically diverse groups are essential for translating basic 
neuroscientific findings into clinically relevant advances. In order to start addressing these 
issues, the inverse problem has to be addressed: How do macroscale abnormalities relate 
to underlying pathophysiology? 
The EEG signal despite containing a lot of rich information is a poor measure of neuronal 
function at the cellular, or synaptic level: because of the spatial inaccuracies and the 
summation of many million individual neurons’ activity into a composite signal, there are 
an infinite number of possible neuronal constellations that could cause the same 
measurable EEG signatures. Attempting to relate this composite, diffuse signal to 
underlying neuronal dysfunction is thus an ill-posed problem, where no unique solution 
exists.  
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Ill-posed problems are common in neuroscience, both in terms of problems researchers 
encounter when investigating nervous systems (e.g. the source localisation problem for 
EEG signals (Friston et al., 2008)), and the problems that nervous systems themselves have 
to address (e.g. the feature binding problem (Di Lollo, 2012)). Pragmatically, these 
problems are not impossible to solve, as is evident in the successful application of source-
reconstruction algorithms in identifying epileptogenic brain areas for surgery (Lantz et al., 
2011), and the brain’s successful and reliable decoding of visual information (Kawato et 
al., 1993).  
With underdetermined ill-posed problems, providing constraints to the range of possible 
solutions is crucial (Friston, 2005b). Constraining the problem reduces the space of 
possible solutions and makes finding a possible, good solution more tractable. These 
constraints also help in keeping inverse solutions more interpretable and relevant to the 
scientific question at hand, where applied to inference on neurobiological data.  
One way to constrain such inverse problems in neuroscientific research is the use of 
computational models of neuronal populations as a mesoscale representation of neuronal 
dynamics. This casts the inverse problem of attempting to infer microscale causes of 
macroscopic phenomena into a more restricted problem: Assuming basic mechanisms of 
neuronal function and organisation are met (i.e. the neuronal model applies), which setup 
of the known circuitry could produce an observed effect (i.e. which specific set of model 
parameters can produce the observed macroscale response?).  
In the following sections, I discuss mesoscale models of neuronal function and how they 
can be used to link observable measurements of neuronal function across multiple 
different scales. I introduce the basic concepts underlying neuronal population modelling 
and focus on methods that will be applied in later chapters of this thesis.  
3.3 Biophysical models for empirical neuroscience  
Neuronal systems are highly nonlinear coupled systems (Werner, 2007). This means that 
predicting input-output relationships is challenging and often counterintuitive. One of the 
great strengths of computational models is that they can be used to explore input-output 
relationships systematically and help identify some of the otherwise difficult to anticipate 
effects produced by nonlinear interactions.  
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The pioneering work by Hodgkin and Huxley (Catterall et al., 2012; Hodgkin and Huxley, 
1952) produced one of the first such computational explanations for the observable 
behaviour of neuronal systems – and by some measures this remains the most successful 
approach to link empirical observations and underlying neurobiology through the use of 
computational models. Using empirical voltage clamp measurements from the giant squid 
axon, they elegantly developed a model of neuronal membrane dynamics based entirely on 
voltage dependent ion channels that could predict many patterns of neuronal behaviours 
observed empirically.  
Since then, a range of models have been developed across a multitude of different spatial 
and temporal scales. These range from models describing subcellular compartment 
dynamics to models describing the output of whole neuronal populations and networks. 
Because of the spatial scales of measurement, those models that represent whole neuronal 
populations are particularly informative when relating them EEG measurements.  
One of the earliest such models was the Wilson and Cowan neural mass model (Wilson 
and Cowan, 1972) – they describe the behaviour of a whole set of interconnected neurons 
not individually but as whole aggregates, based on similar approaches in particle physics. 
They also provide a justification for this method based, interestingly, not just on its 
computational tractability, but rather the conceptually different inference this approach 
enables: 
It is probably true that studies if primitive nervous systems should be 
focussed on individual nerve cells and their precise, genetically determined 
interaction with other cells […] [S]ince pattern recognition is in some 
sense a global process, it is unlikely that approaches which emphasize only 
local properties will provide much insight. Finally, it is at least a 
reasonable hypothesis that local interactions between nerve cells are 
largely random, but that this randomness gives rise to quite precise long-
range interactions.  
(Wilson and Cowan, 1972) 
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Using this approach, they arrive at a system of two ordinary differential equations, 
describing a neuronal oscillator consisting of two different populations, one excitatory, 
one inhibitory:  
    (3.1) 
   (3.2) 
 
This system describes two neuronal populations, whose current states ( , : proportion 
of cells in the population firing) influence each other through weighted connections (  
weights of population connections, see Figure 3.3 A. This coupling is mediated through a 
sigmoid activation function , which acts like a switch integrating all incoming synaptic 
influences and translating them into a postsynaptic state change within a defined dynamic 
range (i.e. 0-1). The sigmoid functions are population specific (and can therefore be 
parameterised independently) and are the source of non-linearity in the model.  
Even despite the extreme simplification of these models of neuronal function, a whole 
range of dynamic behaviours can be reproduced with WC-type models at the scale of 
neuronal populations or cortical patches (Heitmann et al., 2012; Meijer et al., 2015; Wang 
et al., 2014). Because of the coupled nonlinearities, however, ‘forward’ predictions of 
model behaviour given specific parameters is often non-intuitive and usually requires 
simulation of the model responses. Repeat simulations for varying parameter values can 
then be used to establish a link between model parameterisation and overall dynamic 
responses Figure 3.3 B.  
These parameter/response relationships can be exploited in order to make inference on 
model parameters underlying a given observation. Faced for example with noisy 
measurements of a population oscillation (Figure 3.3 C), one can use systematic variations 
of a model parameter to identify the specific parameter value that best fits the data (Figure 
3.3 D, illustrated for the stimulating current parameter P). However, even adding a single 
additional free parameter (e.g. the connection parameter c1) creates a complex model 
prediction error landscape that is much more difficult to optimise (Figure 3.3 E) – an 
important problem that I will return to later.  
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Figure 3.3 – The Wilson-Cowan neural mass model. (A) The model consists of one inhibitory 
and one excitatory neuronal population, coupled through synaptic connections of a specific 
connection strength (ci parameters). These can be excitatory (black) or inhibitory (red). The 
system receives external stimulating current input (P parameter) and acts as a neuronal 
oscillator. (B) The model generates particular oscillation patterns for different parameter 
constellations – this figure illustrates steady state oscillatory responses with decreasing 
values for the input parameter P. Excitatory populations are represented by the solid lines, 
inhibitory populations by the dashed lines. (C) Synthetic data illustrating a noisy 
measurement of neuronal population oscillation driven with P = 1.4. Oscillatory frequency 
alone can be used to derive the P-parameter from noisy measurements such as this: (D) 
Estimates of steady state oscillatory frequency can be derived from the model for a range 
of different values for P. Plotting the squared difference between estimated frequencies 
and that derived from the noisy synthetic signal, the P value that produces the minimal 
error can be identified. This approach identifies P = 1.4 as the value producing the minimal 
error (indicated by the red arrow). (E) If more than one parameter is allowed to vary (e.g. 
input P and self-excitation strength c1), the error landscape becomes more complex and 
error minimisation alone does not produce unambiguous results – the red arrow indicates 
the same parameter constellation identified in panel (D) of this figure. The model 
specifications were taken directly from the model’s original description (Wilson and Cowan, 
1972). Parameters for the modelling were taken from one of the known oscillatory states 
and unless otherwise stated were: c1 = 16, c2 = 12, c3 = 15, c4 = 3, P = 1.25 
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WC models allow for generation of complex dynamics that remain computationally 
tractable enough to explore different parameter compositions and attempt inference on 
parameter combinations producing a certain dynamic response. However, in the original 
formulation consisting of a single excitatory and inhibitory population they are limited in 
how well they can represent the range and complexity of cortical dynamics observed in the 
laminate cortex.  
A major extension of the WC model was introduced by Jansen and Rit (Jansen and Rit, 
1995) building on an extant literature of adaptations of WC-type models (Lopes da Silva 
et al., 1974). The Jansen and Rit (JR) model explicitly models dynamics of a local cortical 
circuit by ascribing different neuronal populations to specific cortical lamina and 
describing their dynamics in terms of differential equations. In this model, an additional 
excitatory neuronal population is added allowing separate parameterisation for two 
excitatory neuronal populations.  
   (3.3) 
   (3.4) 
    (3.5) 
    (3.6) 
  (3.7) 
    (3.8) 
This constellation of neuronal populations allows a diverse spectrum of frequency 
mixtures to be modelled, and is capable of producing a host of response dynamic also 
observed in empirical measurements of cortical potential fluctuations (Aburn et al., 2012; 
Goodfellow et al., 2012; Jansen and Rit, 1995). An additional benefit that emerges from the 
laminar specificity of the JR model is that it relates naturally to commonly available brain 
recordings in humans – specifically MEG and EEG. The electromagnetic activity 
measurable at the scalp is thought to mainly reflect postsynaptic currents in the apical 
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dendrites of populations of pyramidal cells (Lopes da Silva, 2010). These are explicitly 
modelled in the JR model, so that their selective contributions to EEG/MEG measurements 
can be separated from the activity of other cell populations. 
The laminar specificity and the wide range of physiological frequencies that can be 
modelled mean that JR-type models are commonly employed in computational 
neuroscience as models of cortical function. They currently form one of the model-based 
approaches for the analysis of large scale brain dynamics, such as the dynamic causal 
modelling (DCM) framework, which will be discussed in more detail later (David and 
Friston, 2003).  Because they aim to represent the biophysical connectivity patterns found 
in actual cortical microcircuits, their architecture is also congruent with computational 
motifs thought to be the basis of cortical processing (e.g. predictive coding, (Bastos et al., 
2012)). 
 
Figure 3.4 – The canonical microcircuit (CMC) model. (A) This extension of the Jansen-Rit 
model consists of four neuronal populations (left panel) mapping onto different cortical 
laminae (right panel). The middle panel shows the intrinsic excitatory (black) and inhibitory 
(red) connections contained in the model (for simplicity, recurrent self-inhibition present 
for each population is not shown here). (B) Two operators define the evolution of 
population dynamics: First, a synaptic kernel performs a linear transformation of 
presynaptic input into an average postsynaptic potential, dispersed over time (left panel). 
This is parameterised by synaptic gain parameters and averaged time constants. Second 
there is a nonlinear transformation of average membrane potential into population firing 
rates, described as a parameterised, population-specific sigmoid function (right panel).  
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Within the DCM framework, several extensions of existing neuronal models have been 
developed to address specific hypotheses regarding neuronal function (Moran et al., 2013). 
One of the extensions to the classical JR model employed in DCM is the so-called 
‘canonical microcircuit’, or CMC (Figure 3.4).   
The model consists of a simple extension of the differential equations given in equations 
Eq (3.3) to Eq (3.8). Using the mean-field approximation, the model can also be 
reconceptualised in terms of average membrane potentials and firing rates interacting 
through specific kernels that summarise the activity-dependent integration of input at the 
postsynaptic membrane, and the nonlinear transformation of all input into an output 
firing rate (Figure 3.4 B). 
 
 
Figure 3.5 – Changes in intrinsic connectivity produce characteristic spectral responses. Gradual 
changes to the recurrent self-inhibition gain parameter gi are introduced to a CMC model of 
the cortical column at around 1s, changing the intrinsic modulation from 0 to -0.5, 0.5, and 1.5 
respectively (left, middle, and right panels). These changes produce characteristic signatures in 
the spectral output, apparent in botht he time traces (top panels), and the spectral densities 
(bottom panels) with increases in self-inhibition leading to high power high frequency 
oscillations.  
 
Because the architecture of the CMC model represents neuroanatomical features of the 
cortex, most of the modelling parameters are neurophysiologically meaningful and thus 
easily interpretable. The model parameters can be directly manipulated to reproduce many 
different dynamic behaviours – increasing the degree of self-inhibition in superficial 
pyramidal cells for example will produce high frequency oscillations (Figure 3.5, 
(Papadopoulou et al., 2015)).  
Clearly the more intriguing question is whether inference on the model parameters can be 
made from empirical measurements, in order to identify which functional abnormality in 
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the microcircuitry produced an abnormal measurement. This problem usually has more 
than one possible solution – meaning that many different possible constellations of 
parameters may cause apparently identical measurements, particularly where only some 
of the system’s states are measurable, or observable (e.g. local field potentials), whilst many 
remain hidden (e.g. fluctuations of intracellular ion concentrations); i.e. the problem is ill-
posed. This becomes particularly problematic where many different parameters can be 
used to explain a limited set of observed states. Even for the WC models with very few free 
parameters, simple optimisation routines, as indicated in Figure 3.3, quickly become 
intractable with complex multidimensional error landscapes that cannot be 
comprehensively mapped. The flexibility afforded by the increased number of free 
parameters in the CMC model comes at the cost of increased complexity of the space of 
possible solutions, making it difficult to evaluate which one best explains observed 
behaviours.  
There are several possible approaches to addressing such ill-posed problems, many of 
which have been employed in the computational modelling of epileptic seizures and EEG 
abnormalities. In the following sections, I introduce a few of these approaches, with a focus 
on highlighting the genealogy of dynamic causal modelling, which will be one of the key 
methods employed in the remaining chapters of this thesis.  
3.4 Model inversions as applied to EEG abnormalities 
One of the most intuitive strategies to inversely link observed EEG features to changes in 
the parameters of an underlying generative model – i.e. to inverting models – is to 
systematically vary the parameters and evaluate how well the model simulations then fit 
the observed measurements. This can be done ‘by hand’, choosing individual parameter 
ranges independently of one another, and assessing the individual modelling outcomes 
(illustrated in Figure 3.3 (D-E) for the simple case of estimating input currents producing 
a specific frequency output in the WC model). Such an approach can be informative, even 
in complex models of laminar cortical connectivity (Du et al., 2012), but is limited to small 
numbers of varying parameters if comprehensive parameter mapping is attempted.  
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3.4.1 Optimisation algorithms  
Optimisation algorithms describe computational strategies to identify parameter 
constellations within a range of possible values that produce a model output that best 
matches the observed results. There is a large literature regarding competing optimisation 
methods in a whole host of different areas of science and engineering. Thus, in this section 
I focus on only a few algorithms applied in fitting neuronal models to EEG data.  
One of the most commonly applied group of algorithms are gradient descent (or ascent, 
depending on whether one is attempting to find minima or maxima of the function that is 
to be optimised) algorithms. The basic idea is that from a random starting point, in order 
to find a minimum, one could iteratively take steps following the direction of the steepest 
downward gradient until no more changes are made at each step, i.e. the algorithm 
converges. Because the local gradient is defined by the first derivative of the cost function 
(discussed further below), this cost function will have to be locally differentiable and 
smooth for gradient descent to be applicable. This approach is intuitive and easy to apply 
to a range of optimisation problems, such as seizure classification (Thomas et al., 2008), or 
to refine aspects of EEG source reconstruction (Hansen and Hansen, 2015).  
There are two major limitations to this approach, however, which apply to the problem at 
hand – namely inverting complex, multi-parameter neural mass models to fit EEG data:  
 
1. The gradient descent approach relies on the cost function to be smooth and 
continuous in order to be able to calculate the derivatives. Furthermore, in systems 
where there are unobserved variables in addition to unknown parameters that need 
to be inferred, calculating the derivatives directly is often not possible because of 
recursive dependencies between variables and parameters.  
2. The algorithm by design identified local optimum, not necessarily the global 
optimum. Where the cost function is complex and has multiple local extrema, the 
local optimum identified in this approach may be far from the global optimum 
possible in the parameter ranges. Yet this global optimum may remain ‘invisible’ 
to the algorithm 
 
There are several alternative optimisation algorithms that address these problems. Genetic 
algorithms for example resemble the process of natural selection by producing random 
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parameter variations and propagating the most ‘successful’ ones. After iteratively varying 
some of the parameters (introducing mutations) and then choosing the best variant 
(selection), the algorithm will converge to the best global solution, without requiring 
estimation of local gradients for its progression. This has been applied to fitting parameters 
of a detailed phenomenological model of individual EEG abnormalities in clinical EEG 
recordings, identifying patient-specific differences in the transition through parameter 
space (Nevado-Holgado et al., 2012). Similarly, algorithms such as particle swarm 
optimization or simulated annealing use direct search strategies that do not rely on 
knowledge of the gradients. These algorithms converge to a global maximum without 
getting stuck in local optima. A variety of these have been used in model based analyses of 
EEG signals (Gollas and Tetzlaff, 2005; Shirvany et al., 2012; van Dellen et al., 2012). 
These examples illustrate two broad classes of algorithms: (1) global direct search strategies 
that yield robust convergence to global optima, but come at a high computational cost, and 
(2) gradient descent algorithms that are more computationally efficient but may get stuck 
in local optima and not yield a global resolution. The balance of these competing 
limitations dictates which optimisation algorithm is the most appropriate in a given 
situation.  
When making inference on models with relatively few parameters, it is often possible to 
use one of the global algorithms for a model inversion, as the computational requirement 
for inverting a model of only a few parameters are often manageable. However, in models 
such as the CMC, where there are many free parameters that need to be fitted, the 
computational expense of these stochastic algorithms can be prohibitive and more efficient 
gradient descent algorithms are called upon. In this setting, prior constraints are used to 
ensure model inversion is less susceptible to arresting in local optima. Paradoxically the 
local minima problem can also be finessed by having many free parameters (as ‘escape 
routes’ are more likely to be present where there are many different dimensions of 
parameter space).  
The gradient descent approach can be further finessed to address some of the remaining 
problems: local linearization can be used to estimate gradient where the underlying cost 
function is expensive to calculate; expectation-maximisation (EM) algorithms can be 
employed to invert probabilistic models where not all variables are observed (Do and 
Batzoglou, 2008), hierarchical model inversion can help to avoid local extrema (Friston et 
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al., 2016). Each of these strategies is employed within the DCM framework – but all 
crucially hinge on the type of function that is being optimised – often referred to as the 
cost function, which will be discussed below. 
3.4.2 Cost Functions 
In order to apply optimisation routines and improve how well a model represents data, we 
need to define which measure should be optimised. Often the most intuitive approach is 
to calculate the difference between the numerical predictions of the squared errors between 
model prediction and empirical measurement. This approach has been successfully 
applied to EEG in a variety of ways (Babajani-Feremi and Soltanian-Zadeh, 2010; Sitnikova 
et al., 2008). 
If closeness of the model fits is the only criterion for the optimisation function, all free 
parameters within the models will be adjusted in order to produce the best model fit. 
Especially in models with many free parameters, this can lead to idiosyncratic results that 
resemble specific features of a given dataset, but show poor generalisability across 
different, similar datasets – a problem that has been termed overfitting. Seevral strategies 
can be employed to avoid overfitting and ensure generalisability of the modelling results.  
One such approach has emerged naturally from reformulating the cost function not in 
terms of an absolute error that needs to be reduced, but rather in terms of the Bayesian 
model evidence (also known as the marginal likelihood) that needs to be maximised. The 
evidence is simply the probability of getting some data under a model of how those data 
were caused. This is generally evaluated by trying to estimate the underlying parameters of 
a model. In more detail: within the Bayesian framework, one estimates the probability of a 
given parameterisation θ, given a set of observations, or data y, by assuming that these were 
produced from a model m as follows:  
   (3.9) 
   
This posterior probability is not easy to estimate directly, but various approaches can be 
used to approximate it. Variational Bayes is a generic approach to the analysis of posterior 
probability densities. In this approach, the free energy represents a bound on the log of the 
model evidence and can therefore be used in optimization routines to identify optima in the 
model evidence distribution (Friston et al., 2007). The (log-) evidence of marginal 
p(θ | y,m) = p( y |θ ,m)p(θ ,m)
p( y |m)
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likelihood is defined as follows (where D (||) denotes the Kulback-Leibler, or KL 
divergence – a measure of the difference between two probability distributions; y denotes 
data; m denotes the model; θ denotes a set of model parameters;  q(θ) denotes the variational 
density, i.e. the approximating posterior density that is being optimized. Thus,  – áln q(θ)ñq 
denotes the entropy and áL(θ)ñq denotes the expected energy; F denotes the free energy): 
 
   (3.10) 
   (3.11) 
 
The log evidence itself can be split into an accuracy and a complexity term, and thus 
automatically contains a penalty for overly complex models that are prone to overfitting. 
In the context of DCM, the complexity of the model is established on the basis of how far 
parameters deviate from their prior values. Therefore, maximising this Bayesian estimate 
of model evidence provides a compromise between goodness of model fit, and the 
generalisability of the model.  
Specifically, in regard to epilepsy there are further specific problems that need to be 
addressed: Often the change of parameters that vary with time are of interest (for example 
whilst trying to track network changes during the transition into a seizure). If no account 
were taken of the temporal contiguity between individual time steps, the already 
computationally expensive model inversion needs to be fully repeated at each time step, 
treating each window as independent sample.  
For dynamic systems, where there is a temporal dissociation between fast varying states 
and more slowly changes in underlying model parameters, this problem can be addressed 
through optimisation approaches that take into account the temporal dependencies between 
parameter values at preceding time points. One of the most successful of these approaches 
is the Kalman filter. This was originally developed for linear systems, but soon extended 
to nonlinear systems (Julier and Uhlmann, 2004). The Kalman approach has been used very 
successfully to estimate parameters underlying transitions into seizure state, where it has 
proven to benefit from its ability to estimate unobserved (hidden) states (Freestone et al., 
2014).  
A similar (and mathematically equivalent) approach can be implemented within the DCM 
framework, where each time step receives the preceding model inversion posteriors as prior 
expectations, resulting in evidence accumulation (also known as Bayesian belief updating) 
ln p( y |m) = F + D(q(θ ) || p(θ | y,m))
F = 〈L(θ )〉q − 〈lnq(θ )〉q
 76 
across all of the modelled temporal windows (Cooray et al., 2016). More recently, a generic 
approach to estimating parameters at two modelling levels has allowed to accommodate 
arbitrary relationships between individual model inversion steps in a computationally 
efficient way (parametric empirical Bayes, (Friston et al., 2016)).  
In summary, a Bayesian framework for the cost function allows incorporating constraints 
that can help solve the inverse problem when trying to fit neurobiological models to explain 
observations made in electrophysiological recordings. These constraints are formally 
incorporated as prior beliefs regarding certain parameters, which are specified as densities 
with an expected value, and an uncertainty measure around that value. The use of priors 
furthermore allows the model evidence to be cast directly in terms of a balance between 
model accuracy and model complexity, preventing overfitting of excessively complex 
models, ensuring higher generalisability of the models derived with this approach. 
Furthermore, several computationally efficient techniques are available to accommodate 
modelling of time series data. 
3.5 Models in clinical neurosciences. 
This chapter offers an introduction to using empirical electrophysiological data to inform 
the parameterisation of advanced mesoscale neuronal models. This approach is 
particularly suited to link conditions where long-lasting, or even permanent pathologies 
(such as a lesion, or a molecular abnormality) find their pathophysiological expression 
only transiently in abnormal neuronal dynamics. Either during discrete, paroxysmal 
events, such as in epilepsy, or from a transient expression at longer, developmental time 
scales.  
Linking macroscopic, and often transient observations – such as variably apparent clinical 
features, or EEG measurements – to underlying causes, even where they are understood in 
some detail remains far from intuitive. This is rooted in the nature of the system that the 
models are trying to describe – which due to the inherent nonlinearities does not respond 
with easily intuitable linear additive responses to perturbation and external influences. 
Whilst the discoveries of more and more specific molecular mechanisms underlying some 
neurological and neuropsychiatric conditions suggest converging pathological 
mechanisms, understanding how these mechanisms affect synaptic connectivity and 
normal neuronal function requires more work in linking underlying pathology and 
phenotypic expression – for example through the sort of modelling approaches introduced 
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here.  This gap in understanding – specifically how molecular abnormalities impact on 
whole brain phenotypes – limits our ability to make patient specific predictions and 
prognoses both based on the molecular cause of their disease, and on the 
neurophysiological measures (such as EEG) that clinicians routinely access.   
 
In this chapter I introduced mesoscale computational modelling as a possible link between 
molecular, or microstructural pathology and macroscale phenotypes. Exploiting recent 
advances in both neuronal models of cortical function, and the fitting of parameters to 
empirical data within the well-established dynamic causal modelling (DCM) framework 
allows for the testing of mechanistic hypotheses. The approach presented here allows 
researchers to directly address specific questions emerging from other disease models and 
evaluate whether evidence for similar mechanisms can be identified in human patients.  
These computational models can facilitate a thorough understanding of the dynamic 
effects of apparently static abnormalities within an organism. Whilst they are not set up to 
reproduce the complexity of whole organisms, they allow the mapping of changes in the 
model parameters and dynamic outputs of the model. They are therefore an ideal tool to 
further explore hypotheses derived from newly identified genetic mutations, other 
molecular causes, or animal models of specific conditions.  
The use of computational models should not be seen in isolation, but instead provides a 
novel and necessary perspective on existing scientific questions emerging from clinical 
neurosciences. When attempting to identify causative mechanisms for human 
neurological disorders, neither clinical observations, computational approaches, nor 
animal based studies alone will provide conclusive evidence in favour or against specific 
mechanisms.  Rather the strength of the evidence provided by the models (and in the 
remainder of this thesis) lies in the use of existing evidence across model systems and 
human patient observations to constrain computational analyses to address specific, 
competing hypotheses with quantitative information.  This ‘evidence accumulation’ is 
most productive, where all lines of evidence refer to related neurophysiological concepts 
(e.g. connection strengths, time constants, gain parameters). Indeed, one can foresee the 
application of dynamic causal modelling to data from animal models to provide a formal 
integration of animal and human measurements.  
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4 
 
 SCN1A-associated changes in neuronal 
excitability §  
4.1 Introduction 
A diagnosis of epilepsy is established when a patient shows continued susceptibility for 
recurrent epileptic seizures. Although in some patients this susceptibility is conferred by 
structural brain abnormalities (such as tumours, previous strokes, or congenital 
malformations), for a majority the suspected – or indeed the confirmed - cause is genetic 
(Thomas and Berkovic, 2014). 
Mutations in a wide variety of synaptically relevant genes – coding for ion channels, 
structural proteins, or regulatory proteins – have been implicated in epilepsy. For a 
number of these, a clear causative link has been established, which means that now several 
familial as well as apparently sporadic epilepsies can be explained by pathogenic mutations 
in synaptic genes (Spillane et al., 2016). Somewhat surprisingly, a large proportion of genes 
where direct causation could be established were identified not from common, familial 
                                                        
§ The work reported here has also been described in the following publication:  
 
Peters, C.*, Rosch, R.E.*, Hughes, E., Ruben, P.C. 2016. Temperature-dependent changes in 
neuronal dynamics in a patient with an SCN1A mutation and hyperthermia induced seizures. 
Sci Rep, 6:31879. *equal contribution.  
 
As part of this work, I proposed the study design, designed the experiments together with 
collaborators, independently performed the computational modelling and wrote the report. 
I was not directly involved in the patch-clamp recordings of the neuronal channels, which are 
reported here for completeness. 
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epilepsies (which have recently been reclassified as genetic generalised epilepsies as 
discussed in Chapter 2 in this thesis) (Helbig, 2015), but from epileptic encephalopathies 
(Mulley and Mefford, 2011) – sporadic severe epilepsies occurring mainly in childhood. 
Genomic diagnostics in patients with neonatal onset, severe epilepsies can have a 
diagnostic yield of up to 75% (Oates et al., 2018) - meaning that genomic testing can 
identify specific genetic mutations responsible for up to three quarters of patients with 
previously ‘idiopathic’ epilepsy in this age group.   
One of the first ion channel ‘epilepsy gene’ implicated in epilepsy was SCN1A which 
encodes the neuronal voltage-gated sodium channel NaV1.1. It was initially described in 
patients with Generalised Epilepsy with Febrile Seizures plus Type 2 (Escayg et al., 2000), 
but quickly became recognised as the cause for – and is indeed most strongly associated 
with – Dravet syndrome (DS). DS was previously described as severe myoclonic epilepsy 
of infancy (Claes et al., 2001), an early onset epileptic encephalopathy. The link between 
the two conditions was made because of the shared susceptibility to recurrent, prolonged 
febrile seizures; patients living with Dravet syndrome in particular experience seizures in 
response to increases in environmental temperatures such as hot baths or other hot 
environments (Wolff et al., 2006).  
 
Figure 4.1 – Schematic sodium channel topology. The figure shows the domain and segment 
structure of the mammalian voltage-gated sodium channel and its relationship to the neuronal cell 
membrane. Pore forming regions of each domain are shown in blue (segments S5 and S6), while the 
positively charged S4 segment S4 of the voltage-sensors are shown in yellow. Locations of fast 
inactivation particle (h-gate, linking Domains DIII and DIV) and the A1273V mutant (in segment S2 of 
Domain III) are also shown. 
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Mammalian voltage-gated sodium channels are comprised of 4 domains (DI to DIV), 
encoded by a single transcript. Each domain constrains 6 transmembrane segments (S1 to 
S6) (Noda et al., 1984). The segments S1 to S4 constitute the voltage sensors, whilst S5 and 
S6 form the channel’s central pore. The protein structure of the channel is shown in further 
detail in Figure 4.1 . Movement of the positively charged S4 segments towards the 
extracellular side of the membrane leads to opening of the channel pore and an influx of 
sodium (Chanda, 2002; Kontis et al., 1997). Following channel activation, the current 
ceases due to a process called fast inactivation: the linking segment between DIII and DIV 
moves to occlude the channel pore (illustrated as fast inactivation particle h in Figure 4.1) 
(West et al., 1992). Channel missense mutations which lead to channels with altered rates 
and voltage dependence of gating can impair electrical signalling at the synapse, and in the 
case of neuronal channels lead to different epilepsy syndromes.  
SCN1A mutations related to Dravet syndrome include severe disruptions of channel 
integrity (e.g. frameshift mutations, deletions) and, albeit less commonly, missense 
mutations leading to either channel impairment, or gain of function. The prevalence of 
complete loss-of-function mutations in clinical cohorts of patients with epilepsy is 
counterintuitively high (Zuberi et al., 2011) – voltage-gated sodium channels are integral 
to action potential generation and neuronal excitability, so the link between a loss of this 
excitability and an epilepsy phenotype is non-trivial. The paradoxical link between loss of 
sodium-channel mediated excitability and increased seizure susceptibility may be 
explained by the observation that NaV1.1 channels are predominantly found on 
GABAergic interneurons. Thus loss of function in NaV1.1 may cause overall cortical 
disinhibition, which itself would be permissive of epileptic seizure activity (Ogiwara et al., 
2007; Yu et al., 2006). This also explains the paradoxical exacerbation of seizures in 
response to sodium channel blocking antiepileptic drugs observed in many Dravet patients 
(Ceulemans et al., 2004).  
This NaV1.1 haploinsufficiency account of epileptogenesis in Dravet and associated 
epilepsies does not fully explain all clinical observations. A significant number of patients 
with gain of function mutations show severe epilepsy phenotypes considered more typical 
of deletion or frameshift mutations (Catterall et al., 2010; Scheffer, 2011; Zuberi et al., 
2011). Indeed, one of the recently described SCN1A mutations with the one of the most 
severe associated clinical phenotypes is a missense mutation resulting in a single 
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substituted amino acid (Sadleir et al., 2017).  Mapping possible direct mechanistic link s 
between sodium channel mutations and increased seizure susceptibility may help improve 
our understanding of genotype-phenotype correlations – and indeed has produced 
promising results for a separate group of neurodevelopmental disorders caused by 
mutations in the SCN2A gene (Ben-Shalom et al., 2017). Here I will show how integrating 
experimental measurements into a computational model can allow contextualisation of 
what effects mutation-related changes of channel biophysics may have on neuronal 
function. Using a clinical case with a novel SCN1A mutation as illustrative example, I will 
highlight how a single mutation may result in a mixture of effects at an in-silico neuronal 
model – thus deriving candidate mechanisms of epileptogenesis. This work, in future, may 
help categorise diverse sets of biophysical effects at the single channel into functionally 
relevant groups of mechanistically related phenotypes at the level of integrated neuronal 
circuits (Catterall et al., 2012; Strohman, 2002).  
Here I report on a patient with an early-onset, temperature-sensitive epilepsy phenotype 
and a not previously characterised de novo heterozygous SCN1A mutation (c.3818C>T, 
ClinVar Accession: RCV000180969.1) coding for an amino acid exchange in DIII S2 of the 
NaV1.1 channel (p.Ala1273Val; will be referred to as AV from here on). Using patch-clamp 
characterisation of channel properties, my collaborators on this project have identified 
dynamic, temperature-dependent differences from wild-type (WT) channels. I then 
integrate the empirical results into computational models of action potential dynamics at 
the membrane of a cortical neuron, specifying the functional effects of the mutation and 
describing a mechanism that can explain the temperature-sensitive epilepsy observed in 
this patient.   
4.2 Methods 
4.2.1 Patient selection 
The patient was identified by a clinical collaborator (Dr Elaine Hughes, King’s College 
Hospital) on the basis of their phenotype and previously uncharacterised SCN1A 
mutation. The patient’s mutation was identified through bidirectional Sanger sequencing 
by the West of Scotland Genetics Service laboratories as part of routine clinical workup. 
The use of genetic and clinical information for the study and all experimental protocols 
were approved by the UK National Research Ethics Service (NRES). Written consent was 
 83 
given by the patient’s parents prior to the experiments described below. Use of all clinical 
and genetic information was carried out in accordance with relevant guidelines (including 
university and hospital data protection guidelines as well as the principles laid out in the 
Good Clinical Practice framework).  
4.2.2 Bacterial transformations and mutagenesis 
All bacterial transformations for this project were performed by collaborators (Prof Peter 
Ruben and Dr Colin Peters, Simon Frasor University, Burnaby, Canada) in TOP10/P3 E. 
coli bacteria (Invitrogen). As SCN1A is known to spontaneously mutate in bacterial 
cultures, the entire length of the sodium channel was sequenced following every 
transformation. The original SCN1A DNA in the PCDM8 vector was generously provided 
by Dr Lori Isom (University of Michigan, Ann Arbor, USA). All transformants from the 
original SCN1A vector were found to express the T1967A and G6923T mutations 
(compared to NM_006920.4), which encode the V650E and A1969 mutants in NaV1.1, 
respectively. A QuikChange Lightning Mutagenesis kit (Agilent Technologies, USA) with 
primers shown in Table 4-1 was used to get the WT and mutant DNA.   
 
Table 4-1 – Primers used for mutagenesis for wild type, and pathological variant. 
 
 
A1967T 
 
 
5' – CACTGTGGATTGCAATGGTGTGGTTTCCTTGGTTGGTGGAC - 3' 
5' – GTCCACCAACCAAGGAAACCACACCATTGCAATCCACAGTG - 3' 
 
T5923G 
 
5' – CTGATCTGACCATGTCCACTGCAGCTTGTCCACCTTCC - 3' 
5' – GGAAGGTGGACAAGCTGCAGTGGACATGGTCAGATCAG - 3' 
 
C3818T 
 
5' – CTGGAAATGCTTCTAAAATGGGTGGTATATGGCTATCAAAC - 3'  
5' – GTTTGATAGCCATATACCACCCATTTTAGAAGCATTTCCAG – 3' 
 
 
4.2.3 Electrophysiology 
Chinese Hamster Ovary (CHO-K1) cells were acquired and used to measure channel 
biophysics in a heterologous expression system by the collaborators Prof Peter Ruben and 
Dr Colin Peters. CHO-K1 (Sigma-Aldrich, MO, USA) were grown in Ham’s F12 medium 
supplement with 10% Foetal Bovine Serum at 37ºC in 5% CO2. At about 24-48h prior to 
the experiment, cells were transfected with 1µg of the SCN1A, 1µg of the eGFP (enhanced 
green fluorescent protein), and 0.5µg of the β1 subunit using Polyfect transfection reagents 
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and associated protocols (Qiagen, Venlo, NL). At approximately 8-12h post transfection, 
the cells were plated on sterile glass coverslips.  
Whole cell patch clamp experiments were then performed at 32ºC, 37ºC (normal human 
body temperature), and 40ºC (febrile temperature) using borosilicate glass pipettes pulled 
with a P-1000 puller (Sutter Instruments, USA), dipped in dental wax and polished to a 
resistance of 1.0-1.5 MΩ. Extracellular solutions contained: NaCl (140mM), KCl (4mM), 
CaCl2 (2mM), MgCl2, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 
10mM), and Ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid (EGTA, 
10mM). Extracellular solutions and intracellular solutions were titrated to pH 7.4 with 
Caesium hydroxide (CsOH) solution.  
All experiments were performed using an EPC9 patch-clamp amplifier digitised using an 
ITC-16 interface (HEKA Elektronik, Lamprecht, Germany). For data collection and 
analyses, the Patchmaster/Fitmaster (HEKA Eletronik) and Igor Pro (Wavemetrics, USA) 
were used on an iMac (Apple Inc., USA). Temperature was maintained using a TC-10 
temperature controller (Degan Corporation, USA). The data were low-pass filtered at 
5kHz, and a P/4 leak subtraction procedure for all recordings was applied. The holding 
potential between protocols was set at -90mV.  
4.2.4 Pulse protocols and analysis 
Macroscopic currents were elicited with 20ms depolarizations to membrane potentials 
between -100mV and +60mV. Conductance was determined by dividing peak current by 
the experimentally observed reversal potential subtracted from the membrane potential. 
Normalised conductance plotted against voltage was fit by a single Boltzman equation. The 
decay of current was fitted by a single exponential equation to determine the time constant 
of open state inactivation at a given voltage.  
Steady state fast inactivation was measured as the proportion of current remaining in a test 
pulse of 0mV following 200ms pulses to voltages between -130mV. The normalised current 
plotted against voltage was fitted by a single Boltzman equation. The time course of fast 
inactivation recovery at -90mV was measured as the proportion of current after a 200ms 
depolarisation to 0mV and a recovery pulse of varying lengths to -90mV. The normalised 
current was plotted versus recovery time and fitted with a double exponential equation.  
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4.2.5 Statistical analysis 
I used a two-factor completely random design analysis of variance (ANOVA) to test first 
for evidence that the AV mutant has differential temperature sensitivity compared to the 
WT channel. The mutant effect was evaluated as a nominal independent variable and 
temperature as a continuous independent variable. The distribution of residuals from the 
statistical model were approximately normally distributed. In this analysis the interaction 
between temperature (continuous variable) vs. mutant (nominal variable), was used as a 
predictor variable. A significant difference in the interaction term was taken as evidence 
of a difference in temperature sensitivity between the AV mutant and WT channels. If this 
was not the case, the analysis was repeated without the interaction term to test for main 
effects of mutant and temperature. All statistical analyses were performed using the JMP 
software package (SAS Institute, USA). Statistical significance was evaluated at p < 0.05, 
and measurements of error are reported as standard error of the mean. Means, standard 
error of the mean and number of recordings for experimental data are reported in full in 
the Results section in Table 4-3. Inference drawn from the statistical tests are reported in 
the Results where appropriate.  
4.2.6 Computational modelling 
I modelled the mutation’s effects on action potential generation by implementing the 
empirically derived biophysical parameters of channel function in a Hodgkin Huxley (HH) 
model adapted specifically to fit the dynamics of responses seen in regular spiking cortical 
pyramidal cells (Pospischil et al., 2008).  The full model has been made publicly available 
online (https://github.com/roschkoenig/SCN1A_HodgkinHuxley) and custom code is 
included in the appendix to this thesis, section A.4. The online repository includes a 
detailed description of how to reproduce figures pertaining to the modelling results that is 
also included in the appendix of this thesis.  
The HH model estimates changes in membrane potential from non-linear, voltage-
dependent changes on ion-specific membrane conductances using the following set of 
differential equations, Eq. (4.1)-(4.10). 
 
    (4.1) C dVmdt = −gNam
3h(Vm − ENa )− gKn
4(Vm − EK )− gl (Vm − El )+ Istim
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   (4.2) 
   (4.3) 
   (4.4) 
   (4.5) 
   (4.6) 
   (4.7) 
   (4.8) 
   (4.9) 
   (4.10) 
 
These equations are a system of coupled ordinary differential equations, describing the 
changes of membrane voltage – Eq.(4.1) – and  ion channel gating parameters – Eq. (4.2)
over time. In this formulation, there are only two specified ion channels: voltage-gated 
potassium channels, and voltage-gated sodium channels. The latter of these is of particular 
interest, as I will use changes in the specifications of the voltage-gated sodium channels in 
order to implement the experimentally derived changes in gating parameters m and h in 
this computational model. This allows me to identify the effects of biophysical channel 
properties on dynamics at the neuronal membrane.  
At steady state, the gating parameters are described by Eq. (4.3) (Gurney, 2006). This 
represents a sigmoid function, which can also be parameterised using the generic 
Boltzmann formulation (Willms et al., 1999) as follows: 
dx
dt
=
x∞(V )− x
τ x (V )
x∞(V ) =
α x (V )
α x (V )+ βx (V )
τ x (V ) =
1
α x (V )+ βx (V )
, where x is m, n, or h
α n(V ) = −0.032*
V −Vt −15
exp(−
V −Vt −15
5
)−1
αm(V ) = −0.32*
V −Vt −13
exp(−
V −Vt −13
4
)−1
α h(V ) = 0.128*exp(−
V −Vt −17
18
)
βn(V ) = 0.5*exp(−
V −Vt −10
40
)
βm(V ) = 0.28*
V −Vt − 40
exp(
V −Vt − 40
5
)−1
βh(V ) =
4
1+ exp(−
V −Vt − 40
5
)
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    (4.11) 
Experimental measurements taken from voltage clamp experiments include measures of 
midpoints (V2x) and slope (sx) of conductance and fast inactivation of sodium channels, 
representative of steady state gating parameters m and h respectively, and thus speak 
naturally to the Boltzmann formulation of these gating parameters in the HH model. 
However, because the experimental design did not fully replicate physiological states in 
cortical neurons (as a heterologous expression model was used (CHO-K1 cell line), and 
non-physiological additives such as fluoride are used to stabilise cell membranes during 
the experimental procedure, I first normalised the empirical results to a formulation of the 
HH model that captures physiological cortical dynamics (Pospischil et al., 2008) using the 
following computational steps, which can also be identified in the custom code provided 
in the Appendix section A.4: 
 
1. Simulate cortical neurons using the parameterisation given in Pospischil et al. 2008 
2. Fit Boltzmann equation parameters to these simulations and derive midpoint 
voltages and slope of steady state gating parameters for the Pospischil 
parameterisation 
3. For the WT simulations at 37ºC, the parameters (V2m, sm, V2h, sh) were set to the 
baseline values identified from the HH model described in Pospischil et al. 2008 
4. For all remaining simulations, parameters were adjusted using the original 
parameterisation as baseline – preserving the absolute offset compared to WT 
(V2m, V2h), or the relative difference compared to the WT (sm, sh) 
5. An additional offset parameter was introduced for fast inactivation gating 
equations Eq (4.7) and Eq (4.10) to account for temperature-dependent differences 
in time constants (note that with the Boltzman formulation for equation 3, only 
time constants – Eq (4.4) – depend on equations Eq (4.5) - (4.10).  This is specified 
as follows:  
   (4.12) 
x∞(V ) =
1
1+ exp(
V −V2x
sx
)
α h(V ) = 0.128*exp(−
V −Vt −17 +Toffset
18
)
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   (4.13) 
This process yields four parametrisations of the same HH model, which represent different 
degrees of deviations from a standard model of regular spiking pyramidal cells. This 
normalisation was introduced to ensure that the experimental values are translated into 
physiologically plausible section of parameter space, whilst also preserving the relative 
differences in parameterisation between different experimental conditions. Parameter 
values used for capacitance, channel conductances and Nernst (reversal) potentials are 
summarised in Table 4-2 below.  
 
Parameter Units WT37 WT40 AV37 AV40 
C  µA/mm2 0.010 0.010 0.010 0.010 
gL  µS/cm
2 0.0205 0.0205 0.0205 0.0205 
gK mS/cm
2 5 5 5 5 
gNa  mS/cm
2 56 56 56 56 
EL  mV -70.3 -70.3 -70.3 -70.3 
EK  mV -90 -90 -90 -90 
ENa  mV 50 50 50 50 
Istim  µA/mm
2 0.20 0.20 0.20 0.20 
Vt  mV -55 -55 -55 -55 
sm  -  7.4 6.6 6.1 7.6 
sh - -4.0 -3.4 -3.4 3.8 
V2m mV -39.0 -32.5 -33.1 -29.1 
V2h mV -43.3 -45.2 -41.0 -31.6 
Toff mV 0 1.9 -2.4 -11.7 
 
Table 4-2 - Parameter values for the computational model in the four different conditions 
evaluated. All parameters were normalized to an existing model of cortical Hodgkin-Huxley dynamics, 
and empirical differences represented as appropriate shifts in the model parameters. Parameters that 
change between conditions are indicated in bold.  
 
Based on these model specification, I investigated the four conditions included in further 
analysis (i.e. WT at 37ºC and 40ºC; AV at 37ºC and 40ºC) in regards to their response to 
different levels of stimulation (included as the Istim parameter in Eq(4.1)). I first explored 
the changes of model dynamics qualitatively, observing the changing nature of responses 
at different input states, and then addressed this more comprehensively using systematic 
variations in the input currents in order to perform a bifurcation analysis, which is 
reported on in detail in the Results section.  
βh(V ) =
4
1+ exp(−
V −Vt − 40+Toffset
5
)
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Table 4-3 – Empirical parameters of biophysical channel properties. This table summarises 
key parameters derived from patch clamp experiments with wild type (WT) and A1273V 
mutant (AV) at three different temperatures. A – amplitude, G – conductance, SEM – 
standard error of the mean, t – time constant, z – apparent valence 
 
(A) Conductance G and steady state fast inactivation (SSFI): Boltzman parameters 
 
 WT at 32ºC AV at 32ºC 
parameter mean SEM N mean SEM N 
 G V½ (mV) -12.6 2.1 11 -16.4 1.9 8 
 G z 3.73 0.28 11 3.62 0.18 8 
 SSFI V½ (mV) -50.2 2.6 9 -58.9 1.6 9 
 SSFI z -4.07 0.30 9 -3.12 0.37 9 
  
WT at 37ºC 
 
AV at 37ºC 
parameter mean SEM N mean SEM N 
 G V½ (mV) -14.1 3.1 9 -12.0 1.5 5 
 G z 3.43 0.24 9 4.08 0.21 5 
 SSFI V½ (mV) -57.2 1.1 5 -54.8 3.7 5 
 SSFI z -3.14 0.11 5 -3.73 0.63 5 
  
WT at 40ºC 
 
AV at 40ºC 
parameter mean SEM N mean SEM N 
 G V½ (mV) -10.0 2.0 7 -4.2 2.0 11 
 G z 3.39 0.19 7 3.07 0.19 11 
 SSFI V½ (mV) -59.1 3.4 5 -45.5 3.1 6 
 SSFI z -3.79 0.17 5 -3.38 0.49 6 
 
(B) Activation: Time in ms to 50% maximal activation 
 
 WT at 32ºC AV at 32ºC 
membrane potential mean SEM N mean SEM N 
-20mV 0.303 0.011 11 0.304 0.016 9 
-10mV 0.290 0.010 12 0.300 0.013 9 
0mV 0.274 0.010 12 0.277 0.013 9 
10mV 0.256 0.011 12 0.261 0.013 9 
20mV 0.238 0.011 12 0.244 0.012 9 
30mV 0.224 0.010 12 0.228 0.013 8 
40mV 0.219 0.014 10 0.214 0.012 9 
50mV 0.211 0.013 10 0.210 0.013 9 
       
 WT at 37ºC AV at 37ºC 
membrane potential mean SEM N mean SEM N 
-20mV 0.269 0.057 9 0.267 0.011 5 
-10mV 0.250 0.008 9 0.266 0.008 5 
0mV 0.227 0.006 9 0.257 0.012 5 
10mV 0.211 0.005 9 0.237 0.012 5 
20mV 0.199 0.004 9 0.218 0.011 5 
30mV 0.191 0.004 9 0.204 0.010 5 
40mV 0.185 0.004 9 0.194 0.009 5 
50mV 0.181 0.006 6 0.187 0.008 5 
60mV 0.182 0.006 6 0.180 0.010 5 
  
WT at 40ºC 
 
AV at 40ºC 
membrane potential mean SEM N mean SEM N 
-20mV 0.260 0.023 4 0.263 0.009 9 
-10mV 0.261 0.019 7 0.270 0.010 10 
0mV 0.238 0.016 7 0.256 0.011 10 
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10mV 0.222 0.015 7 0.239 0.012 10 
20mV 0.206 0.013 7 0.225 0.010 10 
30mV 0.196 0.011 7 0.211 0.009 10 
40mV 0.189 0.010 7 0.200 0.005 10 
50mV 0.182 0.008 7 0.183 0.006 8 
60mV 0.181 0.013 6 0.186 0.007 8 
 
(C) Fast inactivation recovery curves: Double exponential fits 
 
 WT at 32ºC AV at 32ºC 
parameter mean SEM N mean SEM N 
 FIrec t1 (ms) 2.18 0.29 9 2.55 0.70 5 
 FIrec A1 0.597 0.030 9 0.508 0.046 5 
 FIrec t2 (ms) 97 20 9 125 34 5 
 FIrec A2 0.357 0.024 9 0.400 0.025 5 
  
WT at 37ºC 
 
AV at 37ºC 
parameter mean SEM N mean SEM N 
 FIrec t1 (ms) 1.62 0.44 5 1.42 0.23 5 
 FIrec A1 0.542 0.087 5 0.536 0.041 5 
 FIrec t2 (ms) 81 16 5 141 56 5 
 FIrec A2 0.418 0.022 5 0.337 0.023 5 
  
WT at 40ºC 
 
AV at 40ºC 
parameter mean SEM N mean SEM N 
 FIrec t1 (ms) 1.27 0.21 6 1.24 0.13 5 
 FIrec A1 0.396 0.030 6 0.623 0.033 5 
 FIrec t2 (ms) 72 22 6 138 57 5 
 FIrec A2 0.503 0.034 6 0.285 0.033 5 
 
(D) Open state fast inactivation time constants: Single exponential fit (t in ms) 
 
 WT at 32ºC AV at 32ºC 
membrane potential mean SEM N mean SEM N 
-10mV 0.641 0.097 12 0.571 0.104 7 
0mV 0.364 0.043 12 0.327 0.030 7 
10mV 0.256 0.026 12 0.246 0.028 7 
20mV 0.181 0.014 12 0.178 0.027 7 
30mV 0.163 0.015 12 0.176 0.028 6 
40mV 0.154 0.016 11 0.140 0.015 5 
  
WT at 37ºC 
 
AV at 37ºC 
parameter mean SEM N mean SEM N 
-10mV 0.369 0.040 6 0.809 0.102 5 
0mV 0.249 0.024 6 0.429 0.017 5 
10mV 0.181 0.017 6 0.273 0.013 5 
20mV 0.188 0.022 6 0.209 0.017 5 
30mV 0.168 0.023 6 0.165 0.026 5 
40mV 0.134 0.010 5 0.158 0.033 5 
  
WT at 40ºC 
 
AV at 40ºC 
parameter mean SEM N mean SEM N 
-10mV 0.494 0.100 7 0.686 0.117 9 
0mV 0.259 0.042 7 0.487 0.104 9 
10mV 0.170 0.026 7 0.245 0.037 9 
20mV 0.159 0.025 7 0.174 0.025 9 
30mV 0.127 0.016 7 0.150 0.014 9 
40mV 0.124 0.017 7 0.116 0.010 6 
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4.3 Results 
4.3.1 Clinical case report 
The child whose mutation is investigated here was highlighted by clinical collaborators due 
to their phenotype and miss-sense mutation in SCN1A. The child was first admitted to 
hospital at the age of 6 months with a brief, self-terminating febrile seizure with a right-
sided predominance in his twitching movements. He subsequently presented with 
prolonged recurrent seizures, both with and without fever. Some of these lasted 30 minutes 
or more. These seizures required emergency treatment with benzodiazepines, and one 
intensive care unit admission related to respiratory depression following treatment. After 
the intensive care admission, treatment with phenytoin was started, which reduced the 
duration of his seizures to less than 5 minutes at a time. Interestingly, a proportion of these 
seizures were apparently provoked by a hot bath, or whilst playing on a very warm 
environment.  
There was no evidence of focal neurological impairment after recovery from seizures 
during any of his hospital admissions, nor was any focal impairment reported by the 
parents.  He was born at term and had an uncomplicated perinatal course. There was no 
family history of epilepsy, neurodevelopmental or psychiatric conditions and he was the 
first child of non-consanguineous parents. No abnormalities were found on systemic 
examination, nor during extensive cardiology review – clinical examination, 
echocardiogram, and electrocardiogram were unremarkable.  
Because of the clinical phenotype he underwent genetic sequencing of the SCN1A gene at 
12 months of age. This showed a de novo heterozygous missense mutation (c.3818C>T) 
causing changes in a functionally significant and highly conserved region of the SCN1A 
protein (p.Ala1273Val – referred to as AV in this chapter). This genetic mutation together 
with the clinical context suggest a diagnosis of a seizure disorder within the wider Dravet 
syndrome (DS) spectrum.  
Following his genetic diagnosis, his treatment was changed to sodium valproate, which he 
tolerated well, and which has markedly reduced the number and duration of seizures. At 
the time of writing he continues to make age appropriate developmental progress, and only 
experiences a small number of seizures, mostly in the context of febrile illnesses.  
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4.3.2 Results from the patch-clamp recordings 
Data from patch-clamp recordings of both WT and AV channels expressed in CHO-K1 
cells and recorded at 32ºC (standard preparation), 37ºC (physiological temperature), and 
40ºC (febrile temperature) are reported in full in Table 4-3. I will discuss the result in terms 
of different aspects of sodium channel gating behaviour below.  
 
 
Figure 4.2 – Macroscopic NaV1.1 currents. Sample WT (a) and AV (b) currents elicited at potentials 
between -100mV and +50mV at 40ºC. Time to 50% maximal current is plotted versus voltage for WT 
and AV NaV1.1 channels at 37ºC (c) and 40ºC (d). Source data for all experimental conditions is also 
shown in Table 4-3 (B). 
 
4.3.2.1 NaV1.1 activation 
Sample macroscopic sodium currents from WT and AV channels are shown in Figure 4.2 
(a), and (b) respectively. There is no significant difference in the time to 50% maximal 
current between WT and AV channels (from -20mV to +60mV in 10mV intervals: p-values 
= 0.7681, 0.1564, 0.0803, 0.0896, 0.0749, 0.1743, 0.4456, 0.2645, 0.5020), nor is there a 
difference in temperature sensitivity (from -20mB to +60mV in 10mV intervals: p-values 
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= 0.8318, 0.8101, 0.3128, 0.3882, 0.3936, 0.4212, 0.3160, 0.5845, 0.2824). This is shown in 
Figure 4.2 (c), and (d).  
Increasing the temperature significantly accelerates the time to 50% maximal current at 
potentials between -20mV and +50mV in both WT and AV (from -20mV to +60mV in 
10mV intervals: p = 0.0006, 0.0046, 0.0047, 0.0061, 0.0077, 0.0127, 0.0149, 0.0215, 0.1239). 
There is also a significant difference in temperature sensitivity of the conductance-voltage 
relationship between WT and AV (p = 0.0235), as illustrated in Figure 4.3 (a) and (b). At 
37ºC the AV curve is depolarised by only 2.1mV compared to WT, whilst at 40ºC this 
difference is increased to 5.8mV.  
4.3.2.2 NaV1.1 fast inactivation  
There is a significant difference in the temperature sensitivity of the midpoint of steady-
state fast inactivation between WT and AV (p<0.0001), as illustrated in Figure 4.3 (c) and 
(d). At 37ºC the AV steady-state fast inactivation midpoint is depolarised by 1mV 
 
 
Figure 4.3 – Voltage dependence of NaV1.1 conductance and fast inactivation. Normalised 
conductance curves for WT and AV NaV1.1 channels (a) at 37ºC and (b) at 40ºC. Conductance was 
determined from macroscopic current recordings using Ohm’s law, corrected for the experimentally 
observed equilibrium potential. Normalised current during a test pulse following a 200ms pre-pulse is 
plotted versus pre-pulse potential for WT and AV NaV1.1 channels (c) at 37ºC and (d) at 40ºC.  
 94 
compared to WT (Figure 4.3 c). This difference increased to 14mV at 40ºC (Figure 4.3 d). 
The fast time constant of recovery is significantly accelerated by increases in temperature 
(p = 0.0028); whilst the slow time constant of recovery is not (p = 0.8631). Neither the fast 
nor slow time constant of recovery are altered by the mutation (p = 0.8229, 0.0828, 
respectively).  
There is a significant difference in the temperature sensitivity of the recovery component 
amplitudes in the AV mutant compared to WT (p = 0.0021). Increasing temperature 
decreases the fast component amplitude and increases the slow component amplitude in 
WT, whilst the opposite occurs in AV. The overall results are thus an increased recovery 
in AV channels at 40ºC compared to WT channels (Figure 4.4). Open state fast inactivation 
time constants are shown for WT and AV channels in Figure 4.4 (c) and (d) respectively. 
A significant mutant effect on fast inactivation onset only occurs at 0mV (from -10mV to 
+40mV in 10mV intervals: p = 0.1066, 0.0366, 0.0734, 0.6507, 0.4492, 0.5990) As I tested 
for effects at 6 voltages, and only found difference at a single voltage point, I concluded 
that AV has minimal impact on NaV1.1 fast inactivation onset.  
 
Figure 4.4 – Time course of fast inactivation. Open-state fast inactivation time constants are plotted 
versus voltage for WT and AV NaV1.1 (a) at 37ºC and (b) at 40ºC. Thje time course of fast inactivation 
recovery versus recovery is plotted for WT and AV NaV1.1 (c) at 37ºC, and (d) at 40ºC respectively. The 
double-pulse protocol used to measure fast inactivation recovery is shown in the inset of (a).  
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4.3.2.3 Cortical Neuron Modelling 
Results from the empirical measurement of channel function at different environmental 
temperatures was implemented in cortical neuronal models, representing WT and AV 
channels at 37 and 40ºC each. The cortical neuronal model was parameterised to 
specifically incorporate the observed shifts activation and fast inactivation through 
changes in gating parameters m and h (Figure 4.5 a-b), as well as the AV mutant effect in 
fast inactivation dynamics (Figure 4.5 c-d). Simulations with minimal input strengths (Istim 
= 0.2, Eq (4.1)) reveal little difference in firing frequency or amplitude between WT and 
AV as a result of these shifts in model parameters for either temperature condition Figure 
4.6 a).  
 
Figure 4.5 – Steady-state parameter changes implemented in a Hodgkin-Huxley model. Steady 
state values for different voltages were estimated for both the m and the h parameters based on values 
from cortical Hodgkin-Huxley type neuronal simulations. A Boltzman formulation of the steady state 
equation was then fitted to the estimates to derive baseline parameter values for the slopes (sm, sh) and 
half-peak voltages (V2m, V2h). Experimental results from the voltage clamp experiments were then 
translated into changes from these baseline parameters to produce steady state curves for (a) the WT 
and (b) the AV mutant gating parameters at different temperatures. Forward and revere rates of the 
fast inactivation gate (αh(V), βh(V)) were shifted along the voltage axis to correspond to the shifts in half-
peak voltage of steady-state fast inactivation. The resultant recovery time courses for fast inactivation 
are shown for WT and the mutant at 37ºC and 40ºC (c-d). 
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Simulations with high input currents (Istim = 45, Eq (4.1)) reveal a significant divergence in 
the dynamic behaviours of different model neurons. Although there is no response from 
the WT neurons at either temperature (due to depolarisation block), there is continued 
action potential firing in AV neurons at both temperatures, with higher amplitude firing 
at the febrile temperature condition at 40ºC.  
 
Figure 4.6 – Computational modelling of membrane dynamics. Experimental voltage clamp 
measurements for four experimental conditions (WT and AV at 37 and 40ºC) were 
implemented in a Hodgkin-Huxley model of cortical neurons and normalised to the WT 
measurements at 37ºC. (a) Simulations of the membrane response at different input current 
levels revealed absent action potential generation at high currents, even when the in-silico 
AV neuronal model continues to fire. (b) Bifurcation analysis shows differences in the 
transition from oscillation to fixed steady states at high input currents (i.e. depolarisation 
block), both qualitatively in terms of the bifurcation type, and quantitatively in terms of the 
input currents required to achieve depolarisation block. Of all experimental conditions 
modelled, AV neurons permit the highest input currents to elicit continuous action potentials.  
 
Model parameters: gL = 2.5*10-5S/cm2, EL = -70.3, gNa = 0.056 S/cm2, ENa = 50 –mV, gK = 0.005 
S/cm2, EK = -90 mV, Vt = -60 mV, Cm = 0.01 µF/mm2, (Pospischil et al., 2008).  
 
High input current: Istim = 45µA/mm2, low input current Istim = 0.2 µA/mm2. Remaining 
parameters were condition specific and defined as described in the Methods section. 
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The dynamic behaviour of neuronal oscillators are characterised by transitions between 
fixed steady states and oscillations (bifurcations) (Jirsa et al., 2014). Here I am comparing 
WT and AV in terms of the bifurcation behaviour identified along variations of the 
stimulating current magnitude. There is a shift of this oscillation offset bifurcation towards 
higher input current values, particularly at 40ºC (Figure 4.6 b). This means AB neurons in 
the hyperthermic condition continue to produce action potentials at very high input 
currents, where WT neurons will have already ceased firing. The model also shows 
differences in firing frequency, with slower firing in the AV neurons for any given input 
(Figure 4.7).  
4.4 Discussion 
This study highlights the value of characterising SCN1A variants at elevated temperatures 
both using a combination of empirical measurements and in-silico models. At the time of 
writing, only one previous study identified a temperature-sensitive loss-of-function 
mutant, R865G in the NaV1.1 channel (Volkers et al., 2013).  
 
Figure 4.7 – Action potential frequency at different input currents. Action potential 
frequency is shown for the adapted Hodgkin-Huxley models for each of the four 
experimental conditions included in the modelling (i.e. WT and AV at 37 and 40ºC 
respectively). Modelling for all conditions was performed in two directions (i.e. increasing 
and decreasing values for the input current with each successive simulation). This revealed 
hysteresis in the WT at 37ºC only (grey: successive increases in stimulation current; black: 
successive decreases in stimulation current). The plot shows the temperature-sensitive 
increase in stimulation tolerance across conditions also seen in the bifurcation analysis as 
shown in Figure 4.6. However, for any given stimulation current, the predicted action 
potential frequency is lower for the low temperature vs high temperature conditions.  
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R865G leads to primarily gain-of-function properties in channel gating at 37ºC with 
depolarisation of steady-state fast inactivation, hyperpolarisation of channel conductance 
and increased window current. At 40ºC the mutant also leads to a decrease in channel 
current during repetitive depolarisations. Most functional studies of sodium channel 
function in Dravet syndrome and related epileptic disorders has focussed on animal 
models of human SCN1A mutations (including fruit flies (Sun et al., 2012), zebrafish 
(Dinday and Baraban, 2015), and mice (Oakley et al., 2011)). These models are very flexible 
in that they can be used to investigate a range of genetic changes (including, e.g. 
heterozygous knockouts), and produce whole-organism phenotypes (including neuronal 
microcircuitry abnormalities, excitation-inhibition imbalance, and behavioural febrile 
seizure phenotypes) – giving both insights into whole-brain pathophysiological 
mechanisms and allowing targeted therapy development in-vivo. However, it is often not 
possible to fully characterise sodium channel gating parameters and their temperature 
dependence in these experimental models, where high quality temperature-specific 
electrophysiology is technically difficult or impossible to perform.  Furthermore, the 
isolated contributions of channel-, cell- and network-level abnormalities as possible routes 
from genotype to phenotype cannot be disentangled with whole-organism models alone 
but requires detailed insights from basic channel biophysics.  
Recently, models of patient-derived induced pluripotent stem cells (iPSCs) have also been 
developed. These suggest that patient derived pyramidal cells show evidence of 
hyperexcitability in isolation (i.e. even in the absence of faulty GABAergic control) (Liu et 
al., 2013). Building on this background this study further suggests that a single mutation 
can confer both temperature-sensitive gain-of-function (i.e. action potential generation at 
higher input currents) and loss-of-function (i.e. lower action potential frequency) in 
Dravet syndrome and related epileptic disorders.  
The A1273V (AV) mutant investigated here occurs in the domain III voltage-sensor, 
specifically near the intracellular side of S2. Movement of the DIII voltage-sensor is part 
of the activation of the sodium channel (Kontis et al., 1997). Furthermore, DIII may play 
a role in channel fast inactivation. Previous work suggests that the primary determinant of 
channel inactivation is the movement of DIV, S4 followed by the binding of the DIII-DIV 
linker to the intracellular side of the channel (Capes et al., 2013; West et al., 1992). 
However, as the movements of DIII are immobilised by channel inactivation, it may also 
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play a role in the binding of the DIII-DIV linker (Cha et al., 1999). Thus, mutants which 
impact the movement of DIII, S4 may affect both channel activation and fast inactivation.   
In the case of the AV mutant discussed here, the empirical work on biophysical channel 
properties shows destabilisation of both channel activation and fast inactivation at elevated 
temperatures. As the temperature is elevated to 40ºC, the WT channels show relatively 
little temperature dependence with shifts of +4.1 and -1.9mV in the conductance-voltage 
relationship and steady-state fast inactivation, respectively. In contrast, the AV mutant is 
shifted by +8.0 and +9.3mV in the conductance-voltage relationship and steady-state fast 
inactivation, respectively. These data suggest that the mutant DIII voltage sensing domain 
may be stabilised in the inward conformation. This stabilisation is unmasked at elevated 
temperatures. Crystal structures are not available for the voltage-sensing domains of 
mammalian sodium channels, limiting the ability to identify a molecular mechanism for 
the impacts of AV on NaV1.1. However, one hypothesis is that the presence of a bulkier 
valine near the intracellular side of the DIII voltage sensor impedes and slows the outward 
rate of DIII, S4. This slowing becomes more apparent at elevated temperatures when 
presumably the rates of the other three voltage sensors are accelerated. It is also possible 
that the mutant alters the balance of inward and outward rates of DIII, S4 – which in turn 
may lead to a decreased probability of activation at elevated temperatures. This may 
explain why at 40ºC a more depolarised voltage could be required to activate the DIII, S4 
– which in turn would depolarise the opening of the channel pore.  
The data reported here provide further support that DIII is part of the fast inactivation 
machinery in the channel. The WT channels undergo a small hyperpolarising shift in fast 
inactivation as temperature is increased from 37ºC to 40ºC (Table 4-3). This suggests that 
a destabilisation of the outward state in DIII, S4 can destabilise fast inactivation possibly 
through either decreased availability of a DIII binding site for the fast inactivation particle, 
or inter-domain interactions of the voltage sensor which have been previously shown 
(Chanda, 2004). In conjunction with the increased rate of channel recovery, the increased 
availability of sodium channels in the mutant at 40ºC may allow for higher neuronal firing 
rates, consistent with the decrease in depolarisation block in my models. I found evidence 
of an effect on the rate of open-state inactivation at only one voltage (0mV). As this was 
one of the least positive potentials at which I measured open state inactivation, I conclude 
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that at more depolarised voltages the mutant does not exert large effects on the rate of 
inactivation, but this may not be true at more negative voltages.  
The results show functional impairments of AV are temperature-specific, suggesting a 
direct link between the disease phenotype observed in the patient the mutation was 
identified in, and the genetic mutation itself at the level of channel function. My 
embedding these functional abnormalities at the channel level into a computational 
neuronal model suggests that, while low input stimulation leads to decreased action 
potential firing, the maximum stimulus current which results in oscillations is higher in 
the mutant at 40ºC.  
The modelling results are directly correlated to the empirical measurements. The 
decreased rate of action potential firing is consistent with an increased threshold for firing, 
which can be predicted from the depolarised conductance-voltage relationship (a loss-of-
function change) in the AV mutant channel. The lack of depolarisation block, in contrast, 
is consistent with the depolarisation in the fast inactivation relationship – a gain-of-
function leading to increased channel availability at a given resting membrane potential. 
Depolarisation block describes the observation that neurons stop responding at high levels 
of stimulation despite being depolarised beyond the firing threshold. There is evidence that 
it might play a role in seizure termination (Bragin et al., 1997; Ullah and Schiff, 2010). The 
difference in depolarisation block thresholds for the different models corresponds to the 
empirically measured changes in channel gating parameters: Specifically, in AV at 40ºC, 
both channel gates are shifted to more depolarised potentials, allowing oscillations to 
occur, where in the WT they would not.  
The model I implemented here also suggests that there are more subtle differences between 
WT and AV. In the WT, there are bistable bifurcations in which neurons that enter 
depolarisation block are subsequently more likely to remain at a fixed (i.e. blocked) steady 
state when stimulating currents decrease. In models incorporating the mutant channel 
dynamics, bifurcations are monostable: Neurons which enter depolarisation block return 
to oscillatory behaviour when stimulation falls even just below the bifurcation threshold. 
These findings suggest a pathophysiological mechanism in which neurons recover their 
excitability more readily after high frequency stimulation – allowing pathological 
participation in high activity states (such as epileptic seizures) to persist.  
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The change between different oscillation-offset bifurcation types occurs gradually and the 
bistability can be seen to collapse into a monostable bifurcation across the different 
conditions Figure 4.6 b.  This observation likely relates to interactions between dynamic 
behaviours of the different voltage-sensitive parameters in the full Hodgkin Huxley model 
(i.e. including other channel types than just sodium channels): Through changes in the 
sodium channel gating parameters, the bifurcation point may be shifted to a location in 
the combined space that does not allow for bistability. This dynamic behaviour is an 
emergent property of the system as a whole and would not have easily been predicted from 
the gating behaviour of sodium channels alone.  
Combining empirical measurements of impairments in molecular function with 
computational neuronal modelling integrates different scales of evidence. A similar 
approach identified novel pathological mechanisms resulting in abnormally increased 
persistent sodium currents through mutant channels in other SCN1A mutations (Kahlig 
et al., 2006). Computational models have helped identify a common mechanisms of 
epilepsy pathophysiology: apparently functionally different mutations affecting different 
sodium channels can result in neuronal hyperexcitability (Spampanato et al., 2004).  
This has implications for further improvements of antiepileptic drug choices in Dravet 
syndrome and related epileptic disorders. The clinical effectiveness of valproate in the 
patient reported here is in keeping with my results, and valproate’s effect on inducing use-
dependent limitations of fast action potential firing reported in the literature (McLean and 
Macdonald, 1986). However, valproate can have significant adverse effects and is not 
effective in all patients. Currently, sodium channel blockers such as carbamazepine are 
avoided in standard clinical practice because of frequent reports of associated paradoxical 
worsening seizures (Chiron and Dulac, 2011). Detailed knowledge of mutation locus and 
associated gating abnormalities may help stratify the risk of adverse effects and permit the 
addition of an anti-epileptic drug with direct sodium channel blocking action for some 
patients. One example is lidocaine, which is already used in some centres for the treatment 
of status epilepticus (Hattori et al., 2008). It may therefore be a valuable addition to 
treatment protocols specifically for patients with similar dynamic gating abnormalities in 
a high-frequency firing state (e.g. status epilepticus) and may warrant further detailed 
study in whole organism models of such SCN1A mutations. This study design allows for 
comprehensive assessment of the molecular functional effects of the mutation under 
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different, controlled experimental conditions. Describing the dynamic effects caused 
directly by the mutation through a computational model yielded a novel mechanism of 
seizure susceptibility for this epilepsy patient, consistent with his phenotype.  
Using such functional evaluations to achieve clinical improvements will require further 
study. Functional neurophysiological studies combined with computational modelling, as 
illustratred in this case, show that rich information can be derived about abnormal 
nueronla firing dynamics for individual patients. Conducting these experiments on a 
larger scale will confirm whether mechanisms observed in individual patients or will 
converge to common mechanisms that correlate to phenotypes – something that has 
already been pioneered in other voltage-gated sodium channel associated conditions (Ben-
Shalom et al., 2017). 
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5 
 
 Brain-wide synaptic changes during 
epileptic seizures in zebrafish §  
5.1 Introduction 
Epileptic seizures are transient disturbances in the brain’s electrical activity causing 
changes of patients’ behaviours or perceptions. Seizure have different causes, from gene 
mutations to acquired brain injuries, as discussed in chapter 2 of this thesis (Thomas and 
Berkovic, 2014). The effects of particular pathologies on neuronal dynamics have been 
studied using animal models, where different interventions (e.g. chemoconvulsant 
exposure) can be evaluated  in-vivo (Depaulis et al., 2015; Parker et al., 2011; Seo and 
Leitch, 2014). Zebrafish in particular have been of recent interest for epilepsy research 
because they (1) are a vertebrate organism, (2) allow the relatively quick introduction of 
genetic mutations (Dhindsa and Goldstein, 2015) and large-scale drug screening (Baraban 
et al., 2013; Griffin et al., 2017), and (3) allow recording of neuronal function at high 
resolution across distributed brain networks (Ahrens et al., 2013; Kibat et al., 2016). There 
are now several studies of epileptic seizure in zebrafish (Afrikanova et al., 2013; Hong et 
al., 2016; Meyer et al., 2016; Winter et al., 2008) and recent imaging studies have captured 
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network-wide changes in zebrafish activity during seizures (Turrini et al., 2017; Winter et 
al., 2017). However, a detailed mapping of how localised activity is integrated across the 
brain as a functional network during seizures is still missing.  
Insights into seizure dynamics have largely been derived from computational modelling of 
EEG and other electrophysiological signals (Jansen and Rit, 1995; Lopes da Silva et al., 
1974; Lytton, 2008). Using population models of neuronal activity allows the systematic 
description of the relationship between local brain circuit function and neuronal dynamics 
(Jirsa et al., 2014). Combining novel empirical data and in-silico models in this way has the 
potential to lead to an in-depth understanding of how specific disruptions at the 
microscale lead to whole-brain phenotypes recognisable as epilepsy.  
One strategy to combine computational modelling with imaging is dynamic causal 
modelling (DCM, (Friston et al., 2003)). Here, Bayesian model inversion is used to fit 
neuronal models to empirical data (as discussed in Chapter 3 of this thesis). This approach 
combines (1) widely-used neural mass models, and (2) Bayesian model inversion 
algorithms. It is formally related to existing work on neural mass models in epilepsy 
(Blenkinsop et al., 2012; Goodfellow et al., 2012; Kameneva et al., 2017; Wang et al., 2012); 
as well as Bayesian inference approaches (Lie and van Mierlo, 2017; Schiff and Sauer, 
2008). DCM has been widely applied to scalp EEG (Cooray et al., 2016), invasive recordings 
in patients (Papadopoulou et al., 2015), and invasive recordings from in-vivo animal 
models (Papadopoulou et al., 2017). 
Both EEG and LFP recordings are spatially sparse samples of distributed neuronal activity. 
Yet most modelling approaches assume measurable oscillations to represent homogeneous 
averages of population activity. Such averages can now be accessed more directly using 
light sheet microscopy, providing summaries of neuronal population activity that closely 
adhere to the modelling assumptions.  
In this chapter, I will model empirical recordings of epileptic seizures in zebrafish across 
spatial and temporal scales using hierarchical DCM analysis: Spatial scales range from 
regional microcircuit neural mass models (mesoscale) to dynamic whole-brain networks 
(macroscale). Neuronal states of the underlying biophysical models capture fast oscillatory 
neuronal dynamics (millisecond temporal scale), whilst slowly carrying model parameters 
capture the slow changes in dynamic behaviour that occur over time (seconds to minutes 
temporal scale). 
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Seizures in the in-vivo zebrafish larval model were induced with pentylenetetrazole (PTZ) 
in healthy larval zebrafish and recorded in-vivo with light sheet microscopy of a single slice 
through the zebrafish brain capturing five main bilateral brain regions. PTZ is a well-
characterised chemoconvulsant and acts as a GABA antagonist, thus disrupting inhibitory 
synaptic transmission. Acute seizures are believed to be associated with changes in (1) local 
microcircuit dynamics that allow for a (phase) transition between resting and seizure 
activity (Breakspear, 2005; Jirsa et al., 2014), and (2) changes in whole brain connectivity 
(Nehlig, 1998; Omidvarnia et al., 2017; Sinha et al., 2017). DCM allows concurrent testing 
of the following emerging hypotheses across these different spatial scales: (a) seizures lead 
to a measurable reorganisation of effective connectivity between regions (Burns et al., 
2014), (b) local excitation-inhibition imbalance explains associated regional spectral 
changes  (Netoff et al., 2004), (c) in addition to changes in connection strengths, seizures 
are also associated with changes in synaptic transmission dynamics (Papadopoulou et al., 
2017).  
5.2 Methods 
5.2.1 Zebrafish maintenance  
Zebrafish were maintained at 28.5ºC in a 14/10 light/dark cycle. The transgenic line that 
was used was Tg(elavl3bL:GCaMP6f) (Dunn et al., 2016). Sex of individual larval animal 
included in the study is not known. The work was approved by the local animal care and 
use committee (King’s College London) and was performed in accordance with the 
Animals (Scientific Procedures) Act, 1986; under license from the United Kingdom Home 
Office.  
5.2.2 Construction of light-sheet microscope 
The light-sheet design was based on that described in (Wolf et al., 2015). Briefly, excitation 
was provided by a 488nm laser (488 OBIS, Coherent) which was scanned over 800µm in 
the y-direction of the illumination plane by a galvanometer mirror (6215H/8315K, 
Cambridge Technology) creating an illumination sheet in the XY-plane. The sheet was 
associated with two pairs of scan and tube lenses, scanned along the z-axis using a second 
galvanometer mirror (6215H/8315K, Cambridge Technology) and focussed onto the 
specimen via a low NA illumination objective (5 x 0.16NA, Zeiss EC Plan-Neofluar). The 
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detection arm consisted of water immersion objective (20 x 1 NA, XLUMPlanFL, 
Olympus) mounted vertically onto a piezo nanopositioner (Piezosystem Jena MIPOS 500) 
allowing alignment of the focus plane with the light sheet. The fluorescence light was 
collected by a tube lens (150mm focal length, Thorslabs AC254-150-A) and passed through 
a notch filter (NF488-15, Thorlabs) to eliminate 488 nm photons. The image was formed 
on an sCMOS sensor (PCO.edge 4.2, PCO). The 20x magnification yielded a field of view 
of 0.8 x 0.8 mm2 with a pixel dimension of 0.39µm2. The detection arm and specimen 
chamber were mounted on two independent XY translation stages to allow precise 
alignment of the specimen, detection axis and light sheet.   
5.2.3 Imaging 
Nonanaesthetised Tg(elavl3b:GCaMP6f) larvae, 5 days post-fertilisation were immobilised 
in 2.5% low melting point agarose (Sigma-Aldrich) prepared in Danieau solution and 
mounted dorsal side up on a raised glass platform that was placed in a custom-made 
Danieau-filled chamber. Pentylenetetrazole (Sigma-Aldrich) was added to the Danieau-
filled chamber after 30 minutes of baseline imaging to a final concentration of 20mM. 
Functional time series were acquired at a rate of 20Hz, 4x4 pixel binning (1.6µm x 1.6µm 
resolution). In order to achieve the maximum temporal resolution in these recordings, 
they were restricted to a single plane, allowing for a sampling frequency of 20Hz. The light 
sheet displays a hyperbolic profile along the light propagation axis. The diffraction-limited 
minimum (z-dimension) thickness iof the light sheet (characterised by imaging 100nm 
diameter florescent beads) was ~2.5µm at the focal plane of the illumination objective. This 
value increases to ~9µm at a distance of 80µm from the waist. This yields single neuron 
resolution over a field of view of ≃160 x 1000µm centred on the midline of the larval fish 
– a region which contains the majority of neuronal cell bodies. At the extreme lateral 
margins of the fish the illumination sheet spans >1 neuronal cell body diameter and 
therefore does not provide single neuron solution in these regions.  
Time-series of the images were aligned to a Mean image in the functional imaging data for 
each fish (rigid body transformation as implemented in SPM12 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm12). Mean fluorescence traces were then 
extracted from ten anatomically defined regions of interest for further analyses. Analogous 
to other calcium-based connectivity in model organisms (Mann et al., 2017),  anatomical 
regions were selected according to well-defined landmarks corresponding to the following 
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regions in a publicly available standard zebrafish atlas (Z-Brain Atlas, 
https://engertlab.fas.harvard.edu/Z-Brain (Randlett et al., 2015)). Cross-sectional images 
from the atlas corresponding to the srtructures included below are provided in Figure 5.1. 
• Tectum: Tectum Stratum Periventriculare, Tectum Neuropil 
• Cerebellum: Cerebellum 
• Rostral Hindbrain: Rhombomere 2, Rhombomere 3 
• Mid Hindbrain: Rhombomere 4, Rhombomere 5, Rhombomere 6 
• Caudal Hindbrain / Rostral Spinal Cord: Rhombomere 7, Spinal Cord  
A 
 
B 
 
C 
 
D 
 
E 
 
 
Figure 5.1- Atlas regions corresponding to the anatomical segmentation. (A) ‘Tectum’ 
corresponds to Z-Brain regions Tectum Stratum Periventriculare and Tectum Neuropil. (B) 
‘Cerebellum’ corresponds to Z-Brain region Cerebellum. (C) ‘Rostral Hindbrain’ corresponds 
to Z-Brain regions Rhombomere 2 and Rhombomere 3. (D) ‘Mid Hindbrain’ corresponds to 
Z-Brain regions Rhombomere 4-6. (E) ‘Caudal Hindbrain / Rostral Spinal Cord’ corresponds 
to Z-Brain regions Rhombomere 7 and Spinal Cord. Images are taken from 
https://engertlab.fas.harvard.edu/Z-Brain [accessed 187/05/2018, all images at z = -90]. 
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5.2.4 Quantification and statistical analysis 
Analysis was performed using custom scripts written for Matlab, as well as dynamic causal 
modelling packages available as part of SPM. Custom code is available online 
(https://osf.io/q7kth/wiki/home/) and are included in the appendix in Section A.5. 
5.2.4.1 Estimation of spectral features 
Mean fluorescence traces from the regions of interest were treated as multichannel time 
series for subsequent analysis. Short segments derived from a sliding window (length: 60s, 
step size: 10s) were used to estimate time-varying changes in the spectral composition of 
the time series: For each step of the sliding window, the real component of the Fourier 
spectrum was calculated. A correlation matrix of region-specific mean Fourier amplitude 
across all time points was used to visualise slow fluctuations in distributed activity (Betzel 
et al., 2012; Rosch et al., 2018). To estimate between time-window correlation, I calculated 
a vector containing the average power of the 0-10Hz frequency band of all channels, 
separately for each time window. I then calculated the full correlation matrix of each such 
power-distribution vector with the vectors at each other time point, yielding a k x k 
correlation matrix, where k is the total number of time steps. Averages of the windowed 
Fourier spectra and the power correlation matrix across the studied animals are shown in 
the results section.  
5.2.4.2 Simulated calcium imaging traces 
To test the construct validity of the inversion approach, I used a neural mass model with 
known parameterisation to generate an LFP output, convolved this output with a calcium-
imaging kernel and inverted a DCM on those synthetic calcium-imaging traces to test 
whether the original parameterisation can be reconstructed.  
The model was a three-population neural mass model already implemented as standard as 
‘LFP’ model in the SPM12 model library (Moran et al., 2013). I generated 6 segments of 
LFP-like model output with linear variation of a single parameter (H1) with values ranging 
from -1 to +1. The convolution kernel was constructed from a fast, inverted quadratic rise 
lasting  of the form: . This is followed by an exponential decay 
function of the form:   . Both functions were normalised so that . 
tup = 250ms y(t) = 2t * tup − t
2
y(t) = e
− 1
1000
t y(tup ) = 1
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Parameters of these functions were chosen to approximate GCaMP6f dynamics reported 
elsewhere (Chen et al., 2013). 
5.2.4.3 Inversion of simulated calcium imaging traces 
Each individual synthetic calcium imaging trace was inverted using a DCM for cross-
spectral formulation with a single three-population neural mass model as the generative 
model (Moran et al., 2011a). The DCM analysis relies on spectral features, which are 
estimated using a multivariate autoregressive model that provides (complex) cross-
spectral densities for each time window separately. Each of these full cross spectra is then 
approximated during the Bayesian model inversion.  
Using a parametric empirical Bayes approach, I then compared the evidence for models 
where changes in a single one of the parameters explains the difference between segments 
(Friston et al., 2016; Rosch et al., 2017b). Parameter estimates for the winning parameter 
are then compared to the ‘ground truth’ parameter changes originally introduced into the 
generative model, therefore providing evidence for which parameter is changed, and how 
that parameter is changed to achieve the spectral changes contained in the time series.  
5.2.4.4 Dynamic causal modelling of empirical calcium imaging traces 
Baseline architecture: To characterise functional network architecture at rest in an initial 
step only. Baseline data were analysed using a DCM approach. Specifically, 4-minute 
segments prior to PTZ exposure were inverted using a single fully connected DCM 
containing 10 standard prior (‘LFP’ type) sources – comprising three neuronal populations 
each (Moran et al., 2013). DCM estimated parameter values for each of the directed, 
extrinsic (between region) coupling parameters, each of the intrinsic (within region) 
coupling parameters, regionally specific time constants, as well as a free energy 
approximation for the model evidence for the full model in each individual fish.  
Based on this full model inversion, smaller subsets of models were then compared using 
Bayesian model reduction, which allows Bayesian model selection for the network 
architecture that best explains the baseline data with computational efficiency (Friston et 
al., 2016). The model space was designed as a full factorial design around three main 
features: The presence or absence of homologous connections between bilateral brain 
regions (2 model families); the presence or absence of homologous connections between 
bilateral brain regions (2 model families); and the presence or absence of hub-like 
connections from one set of brain regions to all other regions (6 model families). Thus, the 
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model evidence was estimated across 2 x 2 x 6 = 24 model types and evaluated using family-
wise Bayesian model comparison across sections of this full model space to yield inference 
about hub-type connections (comparing 6 model families) and short-range connections 
(comparing 2 x 2 = 4 model families). The null model (Model 0) is a model where no 
between-region (i.e. extrinsic connectivity) exists and is included for completeness. In this 
model, each node is equipped with its own steady state input (a parameterised pink noise 
function), simulating background local activity, and has several free intrinsic connectivity 
parameters (local connection strengths H1-5, and time constants of local connectivity TE 
and TI). This model space was chosen to emulate some basic features of brain connectivity 
found across many species and systems, specifically rich-club organisation (modelled as 
hub-like connectivity), hierarchical message passing (modelled as forward/backward 
connections along neighbouring nodes), and typically seen homotopic connections 
between symmetrical structures.  
Seizure data inversion: Based on the dynamic network architecture identified in the step 
above, an additional DCM analysis was performed to identify slow fluctuations of synaptic 
parameters within this architecture that could explain seizure activity. For this, data were 
again divided into segments using a sliding window approach (60s, 50s steps) for each 
animal separately. DCMs with the architecture derived from the step above were inverted 
separately for each individual time window.  
I then constructed a second level model to estimate between-time window variations in 
parameters using a parametric empirical Bayesian approach (Friston et al., 2016; 
Papadopoulou et al., 2016a). This contained several temporal basis functions that in 
combination can explain a majority of possible parameter trajectories: (1) an ‘on/off’ tonic 
seizure effect step function with onset at PTZ injection; (2) a monophasic seizure effect 
function with onset at PTZ injection; (3) a linear increase with onset at PTZ injection; (4) 
a set of three discrete cosine basis functions to model parameter drifts at different temporal 
frequencies; (5) a set of three regressors modelling random between-fish effects.  
This approach provides estimates for how between-time window parameter changes can 
be modelled as a linear combination of the basis sets provided, as well as free energy 
estimate for the model evidence. I can thus perform Bayesian model reduction and 
selection at the second level, comparing competing model families where only subsets of 
parameters are free to vary between time windows, and thus select a subset of parameters 
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that best explain the observed changes over time. I broadly divided the model space of 
these between time-window (i.e. between individual DCM) effects into (a) models with 
variations in hierarchical coupling, (b) models with variations in hub coupling, and (c) 
models with variations in intrinsic synaptic coupling parameters. Family-wise Bayesian 
model selection was used to select relevant parameters, which were freed in a single model 
to provide parameter estimates at time windows with the estimated maximum PTZ effect.  
Forward modelling: To further explore the effects of specific parameter changes, the optic 
tectum with its hub-like position in the network was analysed further. Posterior parameter 
estimates for each time window derived from the PEB-DCM analysis above were grouped 
into time constant and connection strength changes. In order to allow a low dimensional 
projection of the multiple parameters of interest, I performed a principal component 
analysis separately on the intrinsic connectivity parameters (H1-5), and the time constant 
parameters (TE and TI). The first principal component of each of these categories was then 
used to project the parameter changes into a two-dimensional plane. Because the DCM 
provides a fully generative model, I can not only plot the parameter estimates, but also 
generate a predicted spectral output for each point across this plane, by adding the 
respective principal component values to the baseline parameterisation of the model and 
simulating its output. I then plotted the resultant low frequency (delta-range), and high 
frequency (gamma-range) power across the parameter space to indicate how movement in 
parameter space affects the spectral output.  
5.3 Results 
5.3.1 Simulations 
In the analysis presented here, I used electromagnetic neural mass models originally 
designed to explain data features observed in LFP recordings. First, I confirmed the 
construct validity of this approach – i.e. applying DCM for local field potentials to time 
traces derived from light sheet imaging – by applying the analysis to synthetic data, where 
the ‘ground truth’ is known. These were derived from a neural mass undergoing 
predefined parameter changes: Using a single ‘source’ consisting of three coupled neuronal 
populations, I generated noisy LFP-like data. These were then convolved with a composite 
exponential decay kernel modelling calcium probe dynamics (Chen et al., 2013). These 
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Figure 5.2 – Dynamic causal modelling of simulated calcium imaging time traces. (A) Left-
hand side time series show signal amplitude over time in arbitrary units. Calcium imaging 
dynamics were modelled by convolving LFP-traces (top) with calcium imaging kernel 
(middle), resulting in a calcium imaging (CAI) time trace (bottom). The CAI trace follows 
slow LFP dynamics whilst attenuating faster components of the transform of the original 
signal. Right hand side frequency plots show normalised log-amplituds derived from a 
Fourier transform of respective time series over a range of frequencies (1-50Hz). In 
frequency space, the convolution differentially scales low and high frequency components, 
but preserves most frequency features (B). LFP-like time-series plotted in arbitrary 
amplitude units over 10s. These are derived from a three-population neural mass model 
with increasing values of a single parameter, H1 – also shown in panel (C).  
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surrogate fluorescence time traces are then down sampled to the sampling frequency 
achieved in the single-slice light sheet imaging (20Hz). This linear convolution equates to  
a simple addition of the signals in (log) frequency space. Because of the simple frequency 
composition of the calcium imaging kernel, this linear transformation preserves much of 
the spectral features in the underlying LFP-like signal Figure 5.2 A.   
The variations in the single neural mass model parameter introduces spectral changes in 
both the surrogate LFP and fluorescence time traces Figure 5.2 B. I fitted a three-
population neural mass model (of the kind used to generate the synthetic LFP traces, 
Figure 5.2 C) separately to each of the fluorescence time traces. This yielded six separate 
dynamic causal models (DCMs), one each fitted to the six time series generated using 
variations in a single parameter as shown in Figure 5.2 D. Using a hierarchical parametric 
empirical Bayesian model, I then identified which parameter could best explain the 
differences in these DCMs (fitted to fluorescence signals). This approach successfully 
identified variations in the correct parameter (the intrinsic connectivity parameter H1) as 
the most likely cause for the differences in time series. Furthermore, the estimated 
between-DCM differences in H1 values also captured the direction of the linear change 
introduced in the original simulated LFP.  
5.3.2 Seizure recordings 
In order to elicit epileptic seizures, PTZ was infuse in the bath of n = 3 zebrafish larvae. 
Resultant seizure activity was recorded with light-sheet imaging utilising somatically 
expressed GCaMP6f genetically encoded calcium probes. Neural activity was recorded in-
vivo in agarose immobilised larvae capturing a single slice of the intact brain. The changes  
Example CAI traces after convolution are shown in darker colours. (C) A three-
population neural mass model is used for generating LFP traces and is subsequently 
fitted to the convolution-derived CAI traces. (D) Bayesian model comparison (Bayes 
factor 2.6) between repeated model inversions identifies correctly that differences 
between simulated CAI traces were caused by the effects of variations in the H1 
parameter on the synthetic LFP traces. The parameter values included in the generative 
model are shown in the bar chart. (E) The DCM analysis provides estimates of the 
generative model parameters (shown in the bar chart). These results correctly infer the 
increase of H1 across the six model inversions from the CAI traces. Parameter estimates 
are shown here with a Bayesian 95% confidence interval (grey bars). Whilst the group 
mean parameter value and the effect size are different, this inversion correctly identifies 
the linear increase in the parameter from the simulated CAI dataset.  
 
LFP – local field potential, CAI – calcium imaging, DCM – dynamic causal model, PEB – 
parametric empirical Bayes. 
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in activity within the whole imaged slice was readily apparent in the fluorescence images 
(Figure 5.3 A). The slice was divided into 5 bilateral regions of interest to extract 
fluorescence time series from the recording. These showed distinctive features consistent 
with highly correlated epileptic seizure activity (Figure 5.3 B).  Using a sliding window 
(length: 60s, step: 10s) I was able to estimate the time changing frequency content using a 
Fourier transform, which demonstrate a particular increase in low frequency power after 
PTZ infusion (Figure 5.3 C), with additional intermittent bursts of broadband activity 
 
Figure 5.3 – PTZ induced seizures recorded in the zebrafish larvae using light-sheet 
imaging. (A) This image shows heat maps of fluorescence in a single slice of the intact larval 
zebrafish brain in the xy plane at different time points during the experiment (also marked 
in panel (B)). Seizure activity at t2 is visually apparent as an overall increase in neuronal 
activity compared to the baseline state at t1. (B) Regionally averaged time traces of the 
fluorescence signal across 5 bilateral anatomically defined regions are shown for the whole 
duration of the experiment in a single animal (150 minutes). Seizures are readily apparent 
as an increase in generalised and apparently synchronous high amplitude activity. (C) 
Average Fourier power spectra across fish and across all brain regions are plotted against 
time for the duration of the experiment, using a sliding window estimator (length: 60s, step 
10s), with colours indicating log-power. The graph is the average over n=3 fish. (D) A 
correlation matrix showing correlation indices of the power-distribution patterns across 
different time points (delay-delay matrix). This reveals three distinct time periods, 
corresponding to baseline (<30min), ictal (30-70min) and late ictal (>70min) phases with 
distinct spectral signatures and temporal dynamics.   
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seen. Estimating correlations between the regional power-frequency distributions across 
different time windows reveals apparently distinct phases of PTZ induced seizures (Figure 
5.3 D): A baseline (pre-seizure) that is stable over time (0-30min), an initial ictal period 
that differs the most from the baseline state (30-70min) and a late ictal period where time  
 
Figure 5.4 – Network model architecture during interictal background activity. (A) Two 
aspects of a factorial model space are shown: extrinsic connectivity of putative network 
hubs (yielding 6 types of models), and short-range connections between neighbouring and 
homotopic nodes (yielding 4 different types of models); a total of 6 * 4 = 24 models were 
evaluated, where any one model combines one of the network hub connectivity 
architectures with a short-range connectivity setup. Bayesian model reduction was used to 
estimate the model evidence across this model space characterised by the presence, or 
absence of these defined sets of between-region reciprocal connections (neighbouring, 
homotopic, and hub connections). (B) For each model family (corresponding to the factorial 
model space), the free energy difference to the worst-performing model is shown. In DCM, 
the free energy difference is used to approximate model log-likelihood differences: 
Asterisks indicate the winning model family identified from Bayesian model selection. These 
results indicate that the model with neighbouring, and homotopic connections as well as 
the optic tectum with hub-like connectivity best explain the observed spontaneous activity 
at baseline. (C) Mapping of the ROIs for this analysis is illustrated as overlay on a single 
fluorescence image taken from one of the animals included in this study. Areas were 
identified based on visible neuroanatomical landmarks and correspond to the nodes of the 
same colour in the network representations of the model space.  
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periods of apparent similarity (i.e. high correlation) to the baseline are interrupted by 
intermittent different (i.e. low correlation) segments (70-150min).  
5.3.3 Functional network architecture at baseline 
I employed Bayesian model comparison to identify the effective connectivity network that 
best explains the observed baseline data. In brief, baseline activity was modelled as 
spontaneous activity arising from a coupled network of neuronal sources. Each source is 
made of up of a three-population neuronal microcircuit (excitatory and inhibitory 
interneuron populations) that is fitted to a cross-spectral density summary of the 
fluorescence signal at baseline. A single fully connected network was fitted to an average 
of the baseline activity by inverting a single fully connected dynamic causal model (DCM). 
Using Bayesian model reduction and Bayesian model selection I then compared models, 
where specific sets of between-region reciprocal effective connections were either present 
or absent. These sets of connections were (1) hub-like connectivity between any one region 
and all other regions; and (2) short range connections between neighbouring, and 
 
Figure 5.5 – Individual fish spectral changes during induced epileptic seizures. (A) Fourier 
spectra are shown for light sheet recordings of individual animal recording sessions. Using 
a sliding window (size 60s, step 10s), windowed estimates are made of the frequency 
composition of the mean time fluorescence time series across all regions and plotted over 
time with colour-coding indicating the (log) power at particular frequencies. Seizure onset 
is associated with frequency bursts, which become less frequent but more prolonged in the 
late ictal state. (B) Frequency power plots are shown for individual regions at preictal, early 
ictal and late ictal intervals for each fish. Colours indicate the brain region as indicated by 
the key. Individual fish show reproducible patterns of localised frequency power 
distribution changes at seizure onset – in the preictal state the caudal hindbrain / rostral 
spinal cord (CHbr/RSc) show highest overall activity; during early and late seizure activity in 
the rostral hindbrain (RHbr) has the highest broadband power.  
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homotopic brain regions (Figure 5.4 A). Bayesian model comparison across the reduced 
models in this model space provided evidence that the baseline configuration can best be 
described as a network of neighbouring connected nodes with the tectum acting as a 
network-wide hub (Figure 5.4 B).  Notably in this mesoscale modelling, such directed 
connectivity is understood to be the average influence one region has over another – this 
may be mediated monosynaptically or through additional (hidden) network nodes. In the 
model each source contains a simply parameterised steady state noise input function that 
is updated as part of the model inversion – therefore synchronous oscillations between 
different nodes could possibly be explained away during the inversion by fitting identical 
inout functions to each source. Where more complex models with specific connectivity 
patterns are identified as the most parsimonious explanations for the particular 
spontaneous activity, this suggests that not all aspects of the complex cross-spectral 
densities (which include phase differences between sources) can be explained by common 
input alone.  
5.3.4 Hierarchical dynamic models of seizure activity 
Using the model architecture identified above, I then fitted individual DCMs to the 
sequence of sliding window derived cross-spectral density summaries of the original data. 
Spectral changes were found to be consistent across the fish used for this study (Figure 
5.5). All seizure effects are subsequently assumed to arise from variations in the model 
parameters that are present in the baseline model architecture and are shared between 
individual fish. Thus, seizure activity may ‘switch off’ connections (through reduction of 
the particular parameter), or silence a node in the network (through increases in self-
inhibition), but no new connections or nodes are added to explain data features that arise 
during the seizure. At this stage (i.e. first level models), each time window is modelled as 
an independent DCM. The model fits show that these independently inverted models 
recreate the dynamic fluctuations of spectral composition observed during a seizure very 
well and thus provide a good representation of the original data features (Figure 5.6). 
Across all complex cross-spectra (for all time windows and all animals), the model fits 
explain 74.6% of the variance in the original data (R2 = 0.746). 
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Figure 5.6 - Group level effects of PTZ-induced seizures on synaptic coupling. (A) Here (1) 
an example fluorescence time trace from a single region, (2) an example eigenmode 
summary of the cross-spectral density changes over time observed across all region in a 
single fish (this is derived from a multivariate autoregressive model and constitutes the 
primary data features in DCM), and (3) the model fits of windowed DCMs to that same 
animal are shown. The middle and bottom panel both plot frequency power distribution 
across the time of the experiment, where the log-power for any given frequency is 
represented by colours corresponding to the same colourbar (range -4 to 2). DCMs fitted to 
these individual time windows capture the spectral changes measured well for the duration 
of the experiment. (B) Free energy approximation for the model-family evidence for 
reduced models where PTZ-induced changes were restricted to a subset of coupling 
parameters is shown. Bayesian model comparison at this second (between time-window) 
level was performed to compare reduced models with PTZ-induced changes in F forward, B 
backward, FB both, 0 or neither type of regional connectivity. Asterisks indicate the winning 
models.  
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Parametric empirical Bayes (PEB) can be employed to identify parameters across 
individual DCMs that vary systematically with specified experimental variables. In brief, 
PEB allows one to invert hierarchical models where, in this instance, the first level of the 
model corresponds to a sequence of time windows. The second level of the model then uses 
the posterior densities over the first level parameters to model changes (here fluctuations) 
in the first level parameters. I modelled PTZ induced changes in a mixture of four effects: 
(1) a simple model of PTZ bioavailability as first order pharmacokinetics with a maximum 
effect at 30 minutes, (2) a tonic effect switched on for the duration of the PTZ exposure, 
(3) a monotonically increasing effect representing the influence of prolonged seizure 
activity, (4) oscillatory effects at different slow frequencies represented by a set of discrete 
cosine transforms (Cooray et al., 2015). This approach provides a single model at the group 
level (i.e. across all time windows and all individual fish) and parameter changes are 
modelled as a mixture of experimental and random effects. The estimated mixture of 
parameter effects yielded consistent spectral changes across the individual fish used for the 
study (Figure 5.7). This type of modelling assumes that discrete oscillatory neuronal states 
(e.g. apparently distinct states during the seizure with very different neuronal signatures 
arise from mostly smooth fluctuations in the underlying parameters. This is indeed a 
Only changes in connections from other brain regions to the hub region show evidence 
of being modulated by the seizure activity. (C) Similarly, free energies for model families 
that allow for intrinsic connectivity parameter changes in none of the brain regions, 
single brain regions, or all brain regions are shown. The asterisk indicates the winning 
model. There was strong evidence for intrinsic connection changes in all brain regions. 
(D) Estimates of the PTZ-effect on DCM model parameters are shown, corresponding to 
the expected change relative to baseline that was induced by PTZ. Each dot represents 
a posterior density, centred around the expected value, and its size inversely correlated 
to the covariance (or uncertainty), i.e. the larger the dot, the more precise the estimate. 
Dots are colour-coded by region as shown in the legend. Lines indicate the median of 
the expected values with whiskers showing 25th and 75th centiles respectively – but note 
that individual parameter estimates are not random samples from an underlying 
distribution but themselves represent more or less precise model parameters fitted to 
the observed data.  
 
Model families (extrinsic): 0 – no extrinsic connectivity changes; F – extrinsic connectivity 
changes in forward connections only; B – extrinsic connectivity changes in backward 
connections only; FB – extrinsic connectivity changes in both forward and backward 
connections. Model families (intrinsic): 0 – no intrinsic connectivity changes; Tect – 
intrinsic connectivity changes only in the bilateral optic tectum; Crbl – intrinsic 
connectivity changes only in the bilateral cerebellum; RHbr – intrinsic connectivity 
changes only in the rostral hindbrain; MHbr – intrinsic connectivity changes only in the 
mid-hindbrain; CHbr/RSc – intrinsic connectivity changes only in the caudal 
hindbrain/rostral spinal cord; all – intrinsic connectivity changes across all areas.  
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feature of the types of models at the heart of dynamic causal modelling (i.e. neural mass 
models) and their nonlinear mapping between parameters and states.  
This has been exploited extensively in the past to link apparently sudden transitions in 
neuronal dynamics to slow synaptic or neurochemical changes that could cause them (Jirsa 
et al., 2014). These second level inversions also provide an estimate of the model evidence 
so that different models can be tested against each other.  
In the first instance, I compared models where only subsets of between region connections 
were allowed to vary between time points. Bayesian model comparison shows that only 
changes in the forward connections to the network hub (i.e. bilateral tectum) are required 
to explain the spectral changes during seizure activity (Figure 5.6 B). Model comparison 
was also used to test for PTZ-induced changes in the intrinsic coupling parameters in 
 
Figure 5.7 – Predicted full-spectrum power densities for individual fish. Graphs show the 
full spectral densities predicted by the fitted dynamic causal models derived from the 
hierarchical model inversion across all time windows and fish. Each graph shows time-
windowed power spectral density estimates for the optic tectum, with colours indicating 
the time-window (see colourbar). Each fish showed recognisable frequency peaks at 
approximately 20Hz, and 90Hz, which differ quantitatively between fish. Note that the high 
frequency peak is predicted to achieve its maximum just after PTZ injection for each of the 
fish.    
 
 
 121 
individual regions. There was strong evidence for an involvement of all measured brain 
regions. 
 
Figure 5.8 - Temporal evolution of intrinsic coupling parameter changes in the optic tectum 
throughout the seizure. (A) A single source 3-population model is shown, indicating the 
seven parameters that are fitted as part of the dynamic causal modelling: 5 intrinsic 
connectivity parameters (H1 – H3 excitatory connections, to H4 – H5 inhibitory connections), 
and 2 time constants (TI and TE). (B) A principal component analysis was performed 
separately across the posterior estimates of intrinsic connectivity, and time-constant 
parameters for the optic tectum across all time windows of the experiment.  The coefficients 
for the first principal component of intrinsic connections (left) and time constants (right) 
are shown here. (C) Using these two principal components, parameter estimates of intrinsic 
coupling within the optic tectum for each individual time window are projected onto a two-
dimensional parameter space. Each point of this projection is colour coded according to its 
time in the experiment from which the estimate was derived. In order to relate location in 
parameter space to spectral output at the optic tectum, for each point in this parameter 
space, I ran a dynamic causal model of the optic tectum in simulation mode to yield an yield 
an estimate of power spectral densities at that particular parameter combination. Here I 
map the predicted mean log-power in the delta- (black and white heat map) and gamma-
band (purple isoclines) respectively. Thus the figure shows the temporal evolution of 
intrinsic coupling parameter estimates within the optic tectum during the seizures on a map 
of the spectral energy for different frequency bands for the specific parameter 
combinations.  
Time points just after PTZ injection occupy the most extreme top-right corner of this 
parameter space. This indicates both slower inhibitory connectivity (time constant 
component) and stronger excitatory / weaker inhibitory connectivity (connectivity time 
constant component). These paramete changes are associated with high powers in both the 
gamma and the delta band.   
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Note that among the models where seizure activity only affects intrinsic connections of a 
single node, the tectum and rostral hind brain emerge as the most likely models – 
suggesting that variations in both have a particular impact on the seizure dynamics. The 
estimated parameter changes induced by PTZ were varied between different brain regions, 
but overall showed a relative reduction in excitatory time constants (suggesting faster 
responses), reduction in inhibitory intrinsic connections, and a reduction of the influence 
of other brain regions on the optic tectum (i.e. a reduction in forward connections; 
estimates of the time varying parameters shown here summarise effects at the assumed 
peak PTZ-effect time window early in the seizure, Figure 5.6 D). Most of the larger effects 
in terms of intrinsic model parameters affect the rostral hind brain and the optic tectum, 
with at times apparently opposing effects (e.g. opposing changes in excitatory time 
constant changes).  
Note that each value on the parameter plot (Figure 5.6 D) represents a posterior density 
that consists of both the estimated parameter value for the particular parameter and a 
posterior covariance that represents the uncertainty around that parameter estimate. In 
dynamic causal modelling, inferences are made via model comparison (i.e., log evidence 
or odds ratios provided). Thus, the plot shown in Figure 5.6 D provides a quantitative 
characterisation of the underlying effect sizes in terms of posterior densities, under the best 
model. The values show the effects and between-region differences (the scatter of the dots 
reflects precise and systemic inter-regional differences, not random effects). Whilst similar 
parameters are grouped in the scatter plot for visualisation purposes, they represent 
different aspects of the same model inversion and thus the optimal fit, given the data. As 
such their mean or median value is only informative to provide an intuition as to the 
overall direction of the effect. The intuition of how individual parameter changes relate to 
spectral output is characterised in more detail for one region (the optic tectum), below.  
In the next step, I quantified the temporal evolution of the parameter changes in one 
example region so as to map (smooth) parameter changes against associated changes in 
the spectra over time. For this, I collated all the parameters intrinsic to that region (i.e. 
intrinsic coupling parameters H and time constants T) and simulated the associated 
spectral output from a single three-population source. This was done for a range of 
different parameter values informed by the empirically-derived posterior parameter 
estimates from the PEB analysis above (Figure 5.8 A).   
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I then extracted parameter estimates for time constants and intrinsic connectivity within 
the right tectum over time across all components of the PEB model (i.e. tonic seizure 
effects, monophasic PTZ effect, prolonged seizure effect, discrete cosine transforms, 
random between-animal effects). In order to visualise the parameter changes over time, I 
derived a low-dimensional representation of the data: I extracted the first principal 
component of the posterior estimates of the intrinsic connectivity parameters, and the time 
constants across time windows (Figure 5.8 B). The first principal component of the time 
constant changes explains 70.9% of their variance; the principal component of the intrinsic 
connection changes explains 49.2% of their variance (which can be increased by including 
an additional component to 80.0%).  
 
Figure 5.9 – Three-dimensional projection of seizure trajectories. Analogous to Figure 5.8 C 
this figure shows a low-dimensional projection of the parameter values for each individual 
time window as estimated for the optic tectum. Here I am plotting an additional third 
dimension (the second component of the PCA over intrinsic connectivity strengths), 
revealing a clearer separation of the different seizure phases, indicating the transition from 
pre-ictal, to early seizure, to late seizure phases.  
 
 
 124 
Plotting each time window onto this reduced parameter space containing most of the 
variance in coupling parameters represents the seizure as a spiral path through parameter 
space. Because this parameter space specifies a fully generative model, I can apply 
parameter combinations at each point in the space to a microcircuit model and predict the 
spectral output. Here I show these predictions of log-delta band power as a heatmap, and 
log-gamma band power superimposed as isoclines (Figure 5.8 C). This forward modelling 
approach shows that during the seizure, the model enters a section of parameter space 
characterised by both high delta and high gamma power components, which is also seen 
in LFP recordings during seizures in zebrafish reported in previous studies (Baraban et al., 
2013). Adding a second intrinsic connectivity component further separates out the distinct 
seizure phases in a three-dimensional parameter space (Figure 5.9).  
5.4 Discussion 
Even well studies pharmacological interventions, such as PTZ show multi-scale effects 
across the nervous system (Baraban et al., 2005; Huang et al., 2001; Kalueff, 2007; Nehlig, 
1998). Thus, linking membrane-level changes with a whole brain seizure phenotype 
remains challenging. Here I combined zebrafish light-sheet imaging data during PTZ-
induced seizures with dynamic causal modelling in order to identify network-wide 
connectivity changes.   
5.4.1 Validity of DCM for calcium imaging traces of seizure activity 
Calcium imaging time series are highly correlated with concurrent LFP recordings (Chan 
et al., 2015). Whilst LFP generally allows measurement of neuronal population activity at 
a higher temporal resolution (including activity > 100Hz), calcium imaging is more limited 
due to both the sampling frequency (Keller et al., 2014), and the fluorescence decay 
dynamics of the calcium-sensitive probe (Chen et al., 2013).  
The predominant frequency components of both resting brain activity and seizure activity 
in the larval zebrafish brain are in the delta (<4Hz) and theta (4-8Hz) band (Afrikanova et 
al., 2013). Neuronal fluctuations in these frequency bands are largely preserved in calcium 
imaging, and apparent even at sampling frequencies as low as 20Hz,. The simulations here 
illustrate the construct validity of using neural mass models that generate 
electrophysiological responses to explain calcium imaging data: DCM allows correct causal 
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inference from calcium fluorescence time series to underlying coupling parameters. This 
approach provides deeper neurobiological insights than functional connectivity 
approaches alone. Furthermore, the hierarchical models I have applied here allow tracking 
of slowly varying model parameters (Papadopoulou et al., 2017), offering explanations for 
qualitatively very sudden changes in oscillatory behaviour (represented by the output of 
individual DCM models) emerging from gradual changes in model parameters 
(represented in across-DCM parameter changes estimated in the PEB approach).  
The DCM analysis of simulated data here only recovered the trend of the activity (not the 
actual value). I used a convolution kernel to simulate the effects of calcium imaging on a 
time series but inverted the models with a DCM that lacks such a kernel – therefore some 
difference in the results is anticipated. However, in the time resolved analysis of 
connectivity changes during a seizure, I was particularly interested in the relative change 
of model parameters over time more than the background setup (which I account for as 
an additional group-mean effect in the hierarchical modelling with PEB-DCM).  
This analysis harnesses specific advantages of regionally averaged calcium imaging: Light-
sheet microscopy samples in a spatially unbiased fashion, thus providing a closer 
approximation to the assumptions underlying neural mass models (Moran et al., 2013). 
Heuristically, this spatial averaging suppresses local fluctuations in the same way that 
averaging over time in event related potential studies (in electrophysiology) reveals 
dynamics that are conserved over multiple realisations. Furthermore, epileptic seizures are 
an emergent property at the level of neuronal populations, and computational models 
specifically addressing this ‘mesoscale’ may yield important insights about emergent 
population-wide features less readily apparent from microscale modelling of individual 
neurons (Kuhlmann et al., 2015). Furthermore, this analysis allows inferences to be linked 
back to established knowledge about the anatomical regions included in the study. 
However, I do not fully exploit the spatial resolution offered by the calcium imaging data, 
which will need to be addressed in the future with scalable custom approaches to modelling 
of individual neurons (Chen et al., 2018; Rahmati et al., 2016). One strategy to exploit the 
resolution of light sheet images is through definition of ‘regions’ based on microscale 
neuronal properties (e.g. correlated activity, distribution of neurotransmitter receptors 
(Lovett-Barron et al., 2017)) – whilst the same model inversion technology illustrated here 
remains applicable, the data features selected for DCM inversion would be informed by 
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the neuroanatomical and neurophysiological information in the light-sheet imaging data 
and thus exploit the spatial resolution available.  
5.4.2 Network organisation in the larval zebrafish brain 
DCM allows for the estimation of network coupling parameters that underlie and ‘cause’ 
features observable through neurophysiological recordings, within the constraints of the 
available data and the hypothesises model space. The first step of my analysis thus aims to 
explain the pre-ictal baseline fluctuations in 5 bilateral brain regions of the zebrafish brain 
through any one of the proposed model architectures. Both changes in the data used for 
further analysis (e.g. changes in the regional divisions, or extension beyond a single 
imaging plane) and changes in model space (e.g. inclusion of another possible hypothesis) 
may therefore impact on the inference drawn. However, both the data included in this 
study and the model space explored reflect the types of hypotheses I sought to explore.  
Early during zebrafish development, retinotectal connections develop and stereotyped but 
effective visuomotor behaviour is established (Meyer, 2006; Niell et al., 2004; Niell and 
Smith, 2005; Portugues and Engert, 2009). This is associated with distributed network 
activity involving information flow from the optic tectum to other brain areas. This 
visually-dominated early network activity is also apparent in the DCM analysis, where the 
tectum has been identified as a hub with widespread connectivity to the rest of the larval 
zebrafish brain from resting state light sheet recordings at baseline.  
This network organisation is modulated during seizure activity, where my modelling 
identifies a reduction of the effective forward connections from other brain areas to the 
optic tectum. This asymmetric shift in connectivity (with only forward, but not backward 
connections affected), may be indicative of a key role of the optic tectum – as a central 
network hub at baseline – in driving network-wide synchronisation during an epileptic 
seizure. The selective reduction in effective connectivity corresponds to previously 
reported seizure-related changes in functional connectivity estimated from human EEG 
recordings, where increased clustering during a seizure has been described (Schindler et 
al., 2008). 
Fluctuations in effective connectivity between regions is usually thought of as resulting 
from changes in direct synaptic connectivity (Nam et al., 2004). Where all connections 
towards a single brain region are involved, this may be due to (1) specific synaptic 
mechanisms affecting synaptic receptors at this particular region, or (2) changes in local 
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excitability. However, the asymmetric involvement of a single brain region – where only 
effective connectivity to (and not from) the optic tectum is reduced suggests that local 
microcircuitry changes may underlie the macroscale observable changes. The relationship 
between local and macroscale network changes in epilepsy in the context of hierarchically 
coupled brain areas is discussed elsewhere (Omidvarnia et al., 2017). This phenomenon 
has been formally described in other modelling work through a slow local permittivity 
variable that governs synchronisation between different brain regions and represents 
different slowly unfolding changes in local energy and metabolic milieu (Proix et al., 2014).  
5.4.3 Intrinsic coupling changes disrupt excitation-inhibition dynamics 
PTZ acts as an acute chemoconvulsant in a range of different model organisms, likely due 
to allosteric inhibition of GABA-A receptors (Huang et al., 2001). Previous work on a PTZ 
rat model showed dose-dependent regionally specific cellular activation (Nehlig, 1998), 
suggesting differential susceptibility of different brain regions to PTZ effects. Bayesian 
model comparison of seizures recorded from the zebrafish in this report indicate that PTZ-
induced changes of intrinsic neuronal population coupling were required in each of the 
brain regions. From the free energy distribution across models with different single regions 
affected by seizure changes, I found relatively high model evidence for models comprising 
seizure-related parameter changes in the optic tectum, or in the rostral hindbrain, 
suggesting that there is heterogeneity in the contribution of individual brain regions to the 
evidence for the winning model.  
PTZ-related seizure effects are modelled under the assumption that they arise from 
changes in the existing extrinsic (between-region) connections and intrinsic coupling 
parameters. I expected most of the interesting effects to occur on the coupling parameters 
within regions (as most of the PTZ effect will affect local inhibitory interneuron 
connectivity (Lee and Maguire, 2014)). Whilst epileptogenesis in the brain (i.e. developing 
the propensity for recurrent seizures) may require the establishment of novel, pathological 
connectivity, acute seizure activity most likely will not. Thus, this modelling approach has 
the ability to account for most neurobiologically plausible mechanisms underlying acute 
seizures.  
However, these effects varied widely between regions. This in part reflects different 
baseline configurations of the regional source models, which in turn required different 
shifts in coupling parameters. Yet, overall the PTZ-related changes are broadly consistent 
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with the current understanding of its effects at the neuronal membrane. Specifically, PTZ 
is expected to cause a relative decrease of inhibitory connectivity compared to excitatory 
connectivity; and preferential blockade of fast GABA-A (and not GABA-B) mediated 
transmission would be expected to cause an increase in the relative inhibitory transmission 
time constants (i.e. slowing down), compared to excitatory synaptic dynamics – both of 
these effects are observed in the parameters estimated across the whole brain slice here 
(noting that population-level time constants are likely a product of several convergent 
synaptic effects (Chaudhuri et al., 2014; Huang et al., 2001; Koch et al., 1996)). Left-right 
asymmetries in the intrinsic estimated connectivity in the optic tectum is most likely 
secondary to differences in light stimulation received by either eye during the imaging 
process and the light sheet excitation in the visible light range.  
Further exploration of individual parameter effects at a single brain region supports the 
notion that seizure dynamics in this recording are largely caused by two main effects: a 
relative disturbance in excitation / inhibition balance with increased excitation and 
decreased inhibition, and a reciprocal disturbance in the dynamics of excitatory and 
inhibitory connectivity with slower inhibition and faster excitation. Because I have fitted 
fully generative neural mass models, I can also make predictions about the spectral output 
caused by particular parameter combinations beyond the measured ≤10Hz frequency 
range. This approach reveals that particularly the time points where both connectivity and 
time constant effects changes reach their respective extremes, the typical seizure spectral 
output containing high amplitudes in both low (i.e. delta) and high (i.e. gamma) frequency 
components emerges. The addition of PTZ causes an increase in broadband activity, with 
particularly high predicted power in the gamma band early after PTZ administration, and 
more pronounced increases in slow frequency power as the seizures evolve. This is 
consistent with previous studies that have separately recorded LFP traces during seizures 
in zebrafish (Baraban et al., 2013; Turrini et al., 2017).  
Recurrent neuronal loops with a close balance of overall excitation and inhibition underlie 
spontaneous brain activity. The brain is believed to operate near a transitional state from 
which both subcritical, random dynamics and supercritical, ordered dynamics can emerge 
(i.e. self organised criticality (Rubinov et al., 2011)). Blocking of the largely GABA-A 
mediated local recurrent inhibition shifts this balance and allows ordered, seizure-like 
activity to occur (Shu et al., 2003). In my model the emergence of seizure dynamics 
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requires changes in both connection strengths and their temporal dynamics. Future 
research will address how different pathologies may converge on the mechanisms that 
underlie observable seizure dynamics.  
5.4.4 Limitations 
Like all Bayesian modelling approaches, DCM only provides estimates of the likelihood of 
individual models in direct comparison to a larger model space. As the model space 
evolves, and other plausible hypotheses are being tested, a new model may offer an overall 
better solution to the inverse problem. Furthermore, as our understanding about the 
underlying neurophysiology progresses, prior knowledge can be incorporated into the 
model inversion (quantitatively in terms of changes in the prior parameter expectations) 
and thereby nuance Bayesian model comparison.  
It is also worth noting that the DCM results are ‘true’ in that they represent the 
mathematically simplest approximation of a given dataset under specific assumptions – a 
more complex model may be biologically implemented but not emerge as the winning 
model because the added complexity is not required to explain the particular data features 
at hand.  
The approach presented here illustrates how light-sheet imaging in zebrafish larvae can 
offer an insight into the kind of mesoscale dynamics that are also observable (and of 
interest to the modelling communities) in electrophysiological recordings. The type of 
modelling and inversion scheme used here is flexible enough to ultimately accommodate 
data that contain some of the microscale information about the neuronal ensemble (e.g. 
by defining ‘regions’ through molecular markers present on individual neurons rather 
than gross anatomy), however this was beyond the scope of the current – proof of concept 
– study presented here. Furthermore, the imaging protocol here was optimised to capture 
widespread activity changes at high sampling frequencies (e.g. by only imaging a single 
plane), assuming that activity in this plane reflects the dynamics of the whole region, whilst 
excluding non-imaged regions (that are situated above or below the plane) from the 
analysis.  
Whilst only a small number of fish were included in this analysis, the effects at the level of 
the recordings are large and consistent between fish. For future studies on more subtle 
effects and observations (e.g. the topological organisation of spontaneous seizures), a 
higher number of fish is likely to be required.  
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5.4.5 Conclusion 
The analysis presented here illustrates the use of computational modelling to explain 
neuronal dynamics in the larval zebrafish brain during acutely induced seizures. This 
approach exploits the spatial independence of single plane in-vivo light-sheet recordings 
of brain regions and uses dynamic causal modelling to identify the mechanisms underlying 
seizure dynamics. The Bayesian model inversion scheme allows translating observations 
from whole-network novel light sheet imaging to the concepts and models used to explain 
electrophysiological abnormalities observed during seizures.  
Seizures in this model are associated with an asymmetric decoupling of the network hub, 
and changes in excitation/inhibition balance that crucially also involve temporal dynamics 
of excitatory and inhibitory synaptic transmission. Mapping the expected spectral changes 
along both the connection strength and time constant domains of the model within the 
pathophysiological range estimated from acute seizures allows me to delineate the 
independent contribution of changes in either type of parameter to the overall dynamics. 
This is the first step to establishing network-wide mechanisms that underlie seizures and 
may be targeted with novel treatments for epilepsy.  
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6 
 NMDA-receptor antibodies alter 
cortical microcircuit dynamics §  
6.1 Introduction 
The recent incorporation of novel molecular diagnostics into clinical practice has 
transformed our ability to identify specific molecular disruptions of synaptic functions as 
the cause for a diverse range of neurological disorders in patients (Crisp et al., 2016). For 
example, antibodies to N-methyl-D-aspartate receptors (NMDAR-Ab) have been 
identified as an important and treatable cause of autoimmune encephalitis (Dalmau et al., 
2007), with a particularly high incidence in children, who make up approximately 40% of 
patients. Patients with NMDAR-Ab encephalitis show a diverse range of associated 
symptoms; including behavioural changes, movement disorders and seizures (Florance et 
al., 2009; S. Wright et al., 2015a). Important aspects of the clinical presentation are 
electroencephalography (EEG) abnormalities, which have been reported in up to 90% of 
patients undergoing EG monitoring; between 20-60% of patients also have overt 
epileptiform discharges or electrographic seizures (Dalmau et al., 2008; Schmitt et al., 
                                                        
§ The work reported here has also been described in the following forthcoming publication:  
 
Rosch, R.E., Wright, S., Cooray, G., Papadopoulou, M., Goyal, S., Lim, M., Vincent, A., Upton, 
A.L., Baldeweg, T., Friston, K.J. 2018. NMDA-receptor antibodies alter cortical microcircuit 
dynamics. Proc Natl Acad Sci, in press. doi:10.1073/pnas.1804846115 
 
As part of this work, I proposed the computational analysis, independently performed the 
computational modelling, analysed clinical reports and EEG data, and wrote the manuscript. 
I was not directly involved in the acquisition of the rodent recordings, which are reported here 
for completeness. 
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2012). While there are EEG features that are thought to be relatively specific for NMDAR-
Ab encephalitis (e.g. extreme delta brush) (Schmitt et al., 2012), the more common EEG 
abnormalities are non-specific, with the more global abnormalities broadly associated with 
more severe disease (Gitiaux et al., 2013; Nosadini et al., 2015). 
At the whole organism level, NMDAR-Ab cause an increased seizure susceptibility: Passive 
transfer of patient immunoglobulin (IgG) containing NMDAR-Ab into a mouse model 
causes increased susceptibility to chemically induced seizures (S. Wright et al., 2015b).  
NMDAR-Ab directly affect glutamate transmission through reversible loss of NMDARs, 
resulting in a reduction of miniature excitatory post-synaptic currents (mEPSCs) in brain 
slices (Hughes et al., 2010; Moscato et al., 2014). NMDAR hypofunction is also a hallmark 
of psychiatric conditions, such as schizophrenia and acute psychosis (Cohen et al., 2015; 
Nakazawa et al., 2017) – whose clinical features resemble the neuropsychiatric and 
behavioural symptoms also seen in the early phases of NMDAR-Ab encephalitis.  
Linking NMDAR hypofunction at the cellular level and a predisposition to seizures at the 
systemic scale is challenging. In the simplified view of epileptic seizures as a consequence 
of excitation-inhibition imbalance (Pinto, 2005), one would expect NMDAR hypofunction 
to be associated with a reduction of excitation, thus a decrease in seizure susceptibility. 
Whilst NMDAR are ubiquitous across central synapses, there is differential expression of 
NMDAR in different neuronal populations (Baude et al., 1993; Landwehrmeyer et al., 
1995). Therefore, when considering integrated neuronal ensembles, changes in NMDAR 
function at the level of a single synapse may have a multitude of different emergent effects 
depending on the combined influence on both excitatory and inhibitory components of 
the neuronal circuit. In relation to NMDAR, observations in a range of experimental 
models motivate several mechanistic hypotheses explaining the effects of NMDAR 
hypofunction: These include (1) altered excitatory dynamics with a reduction in late 
excitatory post-synaptic potential components (Hughes et al., 2010); (2) secondary 
neurotoxicity, reducing the number of functional excitatory connections (Farber et al., 
2002); and (3) a reduction of cortical inhibitory interneuron activity (Homayoun and 
Moghaddam, 2007). Furthermore, paradoxical changes in excitatory and inhibitory 
transmission – resulting from maladaptive homeostatic changes – have been proposed as 
underlying NMDAR-Ab associated abnormalities at different temporal scales (Moscato et 
al., 2014).  
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Relating observations of pathological brain dynamics to these specific hypotheses is 
challenging. In a highly non-linear dynamic system, such as the brain, the link between 
synaptic abnormalities and whole brain responses is seldom intuitive or predictable. 
Neuronal systems are hierarchically structured and each observational scale constrained 
by larger scale processes, as well as interacting with emergent properties arising from 
smaller scales (Freeman, 2000b). Some of these multi-scale dynamics can be successfully 
captured in computational models of neuronal populations, which have been integrated 
into validated analytical frameworks, such as dynamic causal modelling (DCM) (Friston 
et al., 2003; Kiebel et al., 2009; Moran et al., 2011a).  
DCM rests on mesoscale neural mass models that capture the average behaviours of neural 
populations at roughly the scale of a cortical column – the model used here is 
representative of generic features of layered cortical architectures referred to as the 
canonical microcircuit or CMC (Moran et al., 2013). The parameters of the CMC (which 
describes features such as synaptic connection strengths and population response 
dynamics) can be fitted to macroscale neurophysiological recordings such as EEG or LFP 
recordings and competing models can be ranked according to their Bayesian model 
evidence.  
I have chosen this specific model here for two reasons: (1) The CMC directly builds on 
models that have a long history in linking neurobiology to the dynamics of EEG during 
epileptic seizures and other abnormal oscillatory activity in the cortex (Jansen and Rit, 
1995; Moran et al., 2013; Wilson and Cowan, 1972). These neural mass models (originally 
comprising 2 or 3 neuronal populations) constitute neuronal oscillators (i.e. reciprocally 
coupled inhibitory and excitatory populations), as well as incorporating some key inter-
laminar connectivity patterns observed across a range of different cortical areas (Gilbert 
and Wiesel, 1983; Jiang et al., 2015; Thomson, 2003). (2) The addition of a second 
pyramidal cell population in this particular model affords a greater diversity of neuronal 
dynamics. Crucially, this addition allows for a separation in time scales between superficial 
and deep neuronal oscillators, which recapitulates laminar-specific dynamics observed in 
empirical laminar recordings in experimental animals (Bastos et al., 2015). In addition to 
the microcircuit structure, the prior values for the parameters are based on empirical 
measurements accessible in the literature, where possible (Bastos et al., 2012).  
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The themes of cortical laminar organisation recapitulated in the CMC are conserved across 
many mammalian species (Harris and Shepherd, 2015). This underpins the use of these 
models in a range of different experimental systems, ranging from local field potential 
recordings in rodents to invasive recordings in non-human primates and EEG/MEG 
recordings in human subjects (Cooray et al., 2016; Papadopoulou et al., 2017; Pinotsis et 
al., 2014). In the study presented in this chapter, I exploit this by combining measurements 
from invasive recordings in a rodent model of NMDAR-Ab encephalitis and human 
patient EEG recordings at the level of CMC parameters.  
I report the results of a DCM analysis of (a) changes in spontaneous (resting state) activity 
in a subacute mouse model of NMDAR-Ab encephalitis, and (b) abnormal EEG paroxysms 
observed in a series of paediatric patients with established NMDAR-Ab encephalitis. I first 
model the NMDAR-Ab effect in the mouse model; using DCM to identify a minimal set 
of synaptic parameters required to produce the NMDAR-Ab effects on ongoing neuronal 
oscillations. Based on patient EEG data I then estimate fluctuations in the parameters that 
explain the patient recordings. I am especially interested here in how changes in the 
different neuronal coupling parameters in combination yield intermittent abnormalities 
typically recorded in patients. For this, I leverage experimental control (afforded by the 
animal model) to characterise spontaneous paroxysmal abnormalities (observed in patient 
recordings): Operationally I reproduce the parameter changes that best explain human 
EEG paroxysms in the in-silico models of experimental effects in mice. This allows me to 
identify the specific conditions that are necessary for EEG paroxysms to emerge. 
Understanding the neuronal context in which EEG abnormalities can appear may in future 
be used to improve targeted therapeutic approaches.  
6.2 Methods 
The analysis presented here uses DCM to infer the neurobiological parameters that 
underlie electrophysiological changes in patients with NDMAR-Ab encephalitis and a 
corresponding mouse model. Once these changes have been identified, I use the fully 
parameterised in-silico models in simulation mode to integrate the findings and explore 
hypotheses about how NMDAR-Ab induced changes in the neurobiology cause the EEG 
abnormalities observed in patients.  For this, the analysis was broadly divided into three 
stages – explained in detail below: (a) using DCM of LFP recordings in the mouse model 
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(exploiting the factorial experimental design), I estimate neuronal population coupling 
changes in the cortical microcolumn induced by NMDAR (Figure 6.1 A-D); (2) in a 
corresponding DCM analysis of spontaneous EEG paroxysms recorded in human patients, 
I estimate fluctuations in microcircuit coupling (Figure 6.2); and (3) I implement these 
patient EEG derived parameter fluctuations in the in-silico representations of 
microcircuits derived from control and NMDAR-Ab conditions in the mouse experiment. 
This allows us to investigate the dynamics of the microcircuits with and without NMDAR-
Ab effects, testing whether the association between certain model parameters shifts and 
paroxysmal spectral abnormalities (as observed in the human patients) depend on specific 
dynamic contexts (i.e. conditions in the mouse experiments) (Figure 6.1 E-H).  
6.2.1 Collection and classical analysis of mouse LFP 
The mouse model and associated procedures have been previously described (S. Wright et 
al., 2015b).  Briefly, plasma with NMDAR-Ab (Immunoglobulin G, IgG) was obtained with 
informed consent from three female NMDAR-Ab positive patients with neuropsychiatric 
features, movement disorder and reduced level of consciousness, samples were de-
identified before research use. Control IgG was purified from serum from two healthy 
individuals. C57BL/6 female mice aged 8-10 weeks were housed and examined according 
to ARRIVE guidelines and all analyses were performed with the observer blinded to 
injected antibody group.  
Wireless telemetry transmitters (subcutaneous transmitter A3028B-CC from Open Source 
Instruments Inc) were implanted in a subcutaneous pocket over the right flank. Two 
craniotomies were performed at 1mm lateral and 1mm caudal from bregma. Electrode 
screws were fixed into the drilled holes with dental cement. After a five-day monitored 
recovery period, eight microliters of purified IgG (patient, or control) was injected slowly 
into the left lateral ventricle through a single additional craniotomy made 1mm left lateral 
and 0.45mm caudal from bregma.  
Mice were housed in a Faraday cage during wireless LFP data collection. To test seizure 
susceptibility, 40mg/kg of PTZ was given intra-peritoneally and the mice were observed 
for 45 minutes following injection. The 45-minute time period immediately preceding 
PTZ injection was used as control segment.  
Raw LF data was analysed in Matlab. Sliding-window (30s windows, 15s steps) Fourier 
estimates of power over frequency were used to statistically compare the different 
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conditions. ANOVA over mean delta-band power (1-4Hz) was used to estimate the effects 
of the two main interventions (NMDAR-Ab, PTZ) and their interaction on LFP signal 
composition.  
6.2.2 Modelling cortical activity with the canonical microcircuit model 
For the purposes of this analysis, cortical activity is assumed to arise from a cortical 
microcolumn that consists of four coupled neuronal populations: Two main output 
populations (superficial and deep pyramidal cells), and local inhibitory and excitatory 
populations (inhibitory interneurons, and spiny stellate cells respectively). These 
populations are based both on established models of cortical function (Jansen and Rit, 
1995; Lopes da Silva, 1991), and empirically observed connectivity patterns (Bastos et al., 
2012; Schubert et al., 2003; Thomson, 2003). These populations are organised into two 
oscillator pairs: one superficial (consisting of superficial pyramidal cells and spiny stellate 
cells); and one deep (consisting of deep pyramidal cells, and inhibitory interneurons). This 
architecture recapitulates generic themes in cortical organisation, whilst allowing for a 
diverse range of dynamics enabled by the two coupled oscillator pairs (Moran et al., 2013).  
Intralaminar connectivity is largely represented within neuronal populations: Each 
population is parameterised by recurrent inhibitory self-connection parameters, 
population time constants, and a parameterised sigmoid function that models the 
dispersion of population responses (Marreiros et al., 2008). Interlaminar coupling is 
modelled explicitly through population-level connectivity between the different 
populations. Each oscillator pair has reciprocal excitatory and inhibitory connectivity. 
Note that indirect inhibition from superficial pyramidal cells to excitatory interneurons – 
mediates via assumed intralaminar inhibitory interneurons – is absorbed into a direct 
inhibitory connection in this model.  
6.2.3 DCM analysis of mouse LFPs 
Modelling of the mouse LFP recordings can be divided into the following steps (as 
summarised in Figure 6.1; dynamic causal modelling was performed using SPM12, an 
academic software package and analysis code as well as raw data are available online -
https://github.com/roschkoenig/NMDAR-Ab_Encephalitis - these require Matlab 2014b 
or later and SPM12 to run). Code is also included in the appendix section A.6. 
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Figure 6.1 – Modelling approach to mouse LFP recordings. Modelling was designed to 
extract relevant parameters (left hand panels), and then explore the effects of those on 
delta power (right hand panels). (A) For both pre- and post PTZ injections, 45 minutes of 
LFP recordings were extracted for each mouse. A sliding window was used to extract a 
sequence of time windows for further analysis. (B) Power spectral densities were estimated 
for each time window, which are the basis for the DCM model fit. (C) Single-source DCMs 
comprising a single CMC model were fitted to each time window separately. (D) Using a 
parametric empirical Bayesian approach to fit a second level between-DCM general linear 
model I extracted parameter variations explained by specific experimental effects and 
updated first level DCM parameters.  
(E) From the updated first level DCMs, I extracted all parameters and summarised them in 
two principal components over time constants and connection strengths, retaining the first 
component summaries of the fitted DCMs. (F) Starting from the baseline model 
specification, I applied the reduced (i.e. first principal component) summaries of the 
parameter changes to simulating cross spectral outputs of the neural populations, yielding 
a map of delta-power across the ensuing two-dimensional parameter space. (G) I then 
applied quantitative parameter changes observed in patient EEGs (summarised as their first 
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1) Inversion of separate single-source DCM for each time window (performed on group-
average data) 
2) Second level (PEB) model to explain parameter changes over time, based on 
experimental interventions 
3) Forward modelling to explore effects of parameter changes on specific output 
measures (e.g. delta power) 
 
Individual time windows were assumed to be relatively stationary within the 20s sliding 
time window in line with previous DCM analyses of EEG seizure activity (Cooray et al., 
2016; Papadopoulou et al., 2017). Each time window was modelled as originating from a 
single cortical source comprising four coupled neuronal populations (i.e. a single cortical 
column modelled as single CMC). DCM employs a standard variational Laplace scheme 
to fit the parameters of a specified neural mass model to empirical data (Friston et al., 
2003), whilst also providing a (free energy) measure of the Bayesian model evidence. The 
combination of posterior parameter estimates and free energy subsequently allows for 
computationally efficient modelling of group effects across individual DCMs, further 
exploited with the PEB analysis (Friston et al., 2016).  
A second level model (PEB) was used to estimate parameter changes associated with the 
experimental modulations. Specifically, each time window was associated with a numerical 
value representing the absence or presence of NMDAR-Ab (0 or 1), the estimated PTZ 
concentration (range 0 to 1, modelled as first order kinetics after intraperitoneal injection), 
and an interaction term (range -1 to 1). PEB employs Bayesian model reduction based on 
the specified model parameters, effectively modelling between-window changes in 
parameters as a mixture of random effects and systematic modulation of each parameter 
by the main effects provided in the PEB models specification. Thus, inversion at the second 
(between-window) level provides posterior parameter estimates for first level model 
parameters (i.e. neuronal physiology) that are associated with second level parameters (i.e. 
experimental modulation) across the whole series of individual DCMs.  
principal component) to the control, and NMDAR-Ab baseline model specifications in-silico 
to explore the effects of parametric fluctuations on spectral output. (H) To further illustrate 
the effects of parametric fluctuations, I applied an inverse Fourier transform to generate 
substitute time series – illustrating the nature of the changes in a time trace.  
 
 139 
Comparison between models is based on the free energy approximation of the Bayesian 
model evidence. I use a Bayesian model reduction approach that is computationally 
efficient and provides model evidence estimates for a range of different models that differ 
in terms of the parameters that are free to vary to explain between-window variation in the 
PEB analysis (Friston et al., 2018; Friston et al., 2016). This approach provides a ranking 
of how well different combinations of free parameters explain a given dataset (here 
consisting of between-window changes in power spectral densities) and allows me to 
identify the most parsimonious model for the observed EEG, or LFP effects. Note that 
models with the highest evidence are those that generalise; in virtue of the fact that model 
evidence is the difference between accuracy and complexity.  
The DCMs are fully specified models of spontaneous neuronal activity and can therefore 
be used to explore individual parametric effects on overall spectral output. Here, I utilise 
the parameter estimates derived as the group mean in the PEB analysis as baseline. I then 
extract the first principal component of the time constant, and connection strength 
variations across all individual time window DCMs (Figure 6.1 E). This provides a 
summary of covarying changes in parameters that explain most of the variance across 
 
Figure 6.2 – DCM analysis approach for patient EEG recordings. (A) Visual analysis was 
performed to identify segments of artefact free background EEG, as well as visually 
apparent paroxysms of abnormal activity (which were further separated into isolated and 
rhythmic abnormal activity). (B) This activity was source localised using an IID approach. 
Subsequent modelling was performed using a virtual electrode estimate of LFP activity at 
the identified source (bottom of this panel). (C) Single source DCMs comprising a single CMC 
were fitted separately to power spectral density averages of background, and paroxysmal 
activities (D) PEB was employed to reduce within subject differences between individual 
DCMs to specific subsets of parameters. The model space was designed to distinguish 
between sets of models where time constant, inhibitory connections, excitatory 
connections, or modulatory connections explained variations among conditions. (D) A 
random effects Bayesian model comparison between these alternative PEB models helped 
identify which parameters best explain the fluctuations across the whole group of subjects.  
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samples. I then systematically vary the contribution of each of these two components in 
300 discrete steps each around the baseline estimates. This yields 300 * 300 = 90,000 
parameterisations for a single source DCM, and for each of these the spectral output can 
be estimated. I can then use these estimates to visualise scalar output measures (e.g. log 
mean delta band power) across a section of this two-dimensional parameter space (Figure 
6.1 F). This combines the benefits of fitting generative models to empirical data, and 
exploring the effects of specific parameters on model output through forward modelling 
(Lytton, 2008; Wendling et al., 2002).  
In the last step, I implement the microcircuit parameter fluctuations estimated from 
paroxysmal EEGs in patients in different conditions of the in-silico mouse model. 
Specifically, I  
 
1) Estimate parameter changes that underlie paroxysmal EEG responses in patients 
(discussed in further detail below)  
2) Take the first principal component of the variations of time constants across all 
participants and EEG states to capture most of the variance of the time constant 
changes 
3) Implement corresponding parameter changes across the range estimated from human 
EEG in mouse-derived in-silico microcircuit models 
 
This allows me to simulate the kind of spectral changes that would be induced if the mouse-
derived in-silico microcircuits experienced the same (spontaneous) fluctuations in model 
parameters that I estimated from observed human EEG paroxysms. I then use an inverse 
Fourier analysis to illustrate the sort of paroxysmal responses that would be expected based 
on the spectral prediction under specific parameter combinations (Figure 6.1 H).  
6.2.4 Patient selection and EEG recording 
Patients were selected from routine clinical service at a tertiary paediatric specialist 
hospital that is a regional referral centre for patients with presumed autoimmune 
encephalitis. Patients were selected based on (1) symptoms consistent with autoimmune 
encephalitis, (2) positive laboratory testing for NMDAR-Ab at some point during their 
clinical course, (3) availability of routine clinical EEG recording during the acute phase of 
their illness, (4) presence of visually apparent EEG abnormalities. Anonymised clinical 
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information was provided by the patients’ care team with written, informed consent 
provided by the patients’ legal guardians. All patients met the Graus criteria for a clinical 
diagnosis of NMDAR-Ab encephalitis (Graus et al., 2016). Use of anonymised data was 
approved by the UK Health Regulatory Authority (Appendix A.1-A.3). 
All EEGs used in this analysis were standard clinical recordings (21 electrodes, 
international 10-20 electrode layout, 30-minute recording time, 256 Hz sampling 
frequency, 1-70 Hz digital Butterworth bandpass filter). EEGs were visually analysed by 
two clinicians with expertise in EEG interpretation (myself, and clinical collaborator 
Gerald Cooray), identifying paroxysmal abnormalities, as well as segments of artefact free 
awake background EEG that were used for further analysis.  
6.2.5 DCM analysis of patient EEG paroxysms 
EEG analysis was designed to identify mechanisms underlying the frequently observed 
paroxysmal abnormalities in patients with NMDAR-Ab encephalitis. The purpose of this 
modelling approach is to identify a small set of parameters that can explain the transition 
between background activity and EEG paroxysms for each individual patient. The analysis 
can broadly be summarised as follows (also shown in Figure 6.2).  
 
1) Visual identification of paroxysmal and background EEG activity source localisation 
and ‘virtual electrode’ source wave form extraction 
2) Fitting of single source DCM to each ‘virtual electrode’ summary of paroxysmal and 
background data 
3) Inversion of hierarchical (PEB) model explaining all within-subject parameter changes 
that lead to different EEG patterns and Bayesian model comparison between sets of 
reduced models at the group level (random effects analysis) 
 
Patients were selected on the basis of the availability of clinical EEG with reported dynamic 
abnormalities (ranging from evidence of mild encephalopathy to overt epileptiform 
activity). EEGs were reviewed by two clinicians with EEG experience (RER, GC) and 
segments containing normal awake background, as well as paroxysmal abnormalities 
(isolated slow waves, intermittent rhythmic slow activity, and overt epileptiform activity) 
identified. 
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Paroxysmal activity was averaged across visually identified 2s windows and source 
localised using an IID (independent and identically distributed) approach in SPM12 
(Litvak et al., 2011). At the cortical location with maximal activity, a single virtual electrode 
trace was extracted for each of the paroxysmal and background activity windows and used 
for further DCM analysis (Cooray et al., 2016).  
This ‘virtual LFP’ activity was modelled using a single CMC source. An average of all 
paroxysm time windows, and all background time windows was inverted separately, 
producing 2-3 fully specified DCMs per subject. These were subsequently combined into 
a single hierarchical (PEB) model for each patient, in which only a subset of specific 
parameters was allowed to vary. A model space was created at the level of these second 
level models where either time constants, inhibitory between population connections, 
excitatory between population connections, or inhibitory self-modulatory connections 
were allowed to vary to explain the difference between paroxysms, and background 
activity. 
 
Figure 6.3 – NMDAR-Ab alter the spectral composition of resting state activity following 
PTZ. Average Fourier spectra of LFP recordings of endogenous activity in mice are shown 
(A) In control animals, PTZ injections cause a small decrease in low frequency power. (B) In 
NMDAR-Ab positive IgG treated animals, PTZ causes a profound increase in low frequency 
power, which is also visible as high power slow waves in segments; largely without overt 
epileptiform activity (examples shown). Average Fourier spectra across animals are shown 
for 45-minute recordings pre- and post-PTZ injections, shading indicates the 95% 
confidence interval. Insets show Fourier spectra for a broadband frequency range. Example 
5s LFP segments are also shown for individual animals pre- and post-PTZ injections.   
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Figure 6.4 – Synergistic changes in synaptic coupling explain the effects of PTZ and NMDAR-
Ab. (A,B) DCMs were fitted to sliding window power spectral density summaries of LFP 
recordings separately for control, and NMDAR-Ab positive animals. Top panels show the 
observed power spectra over time, with model fits shown in the lower panels. (C) A second 
level general linear model was used to estimate parameter changes associated with 
NMDAR-Ab exposure, PTZ, and their interaction. The regressors for the three main effects 
are shown. (D) These experimental effects are associated with parameter changes across all 
populations of the canonical microcircuit (CMC) neural mass model. The left panel illustrates 
the population-specific synaptic time constants that parameterise the temporal dynamics of 
post-synaptic responses within that population. The right panel indicates the connections 
between populations, which are excitatory / inhibitory connections between populations, 
or self-inhibitory connections. The centre panel shows how each of the parameters is 
modulated by each of the experimental effects. The strongest effects are caused by PTZ, 
with the biggest associated changes in sp and ss time constants and excitatory connection 
strength 4. These changes are further potentiated by NMDAR-Ab exposure. Error bars 
indicate Bayesian 95% confidence intervals.  
 
sp: superficial pyramidal cells, ss: spiny stellate cells, ii: inhibitory interneurons, dp: deep 
pyramidal cells.  
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Random effects Bayesian model comparison across these second level models uses the 
approximation to model evidence from the variational Laplace model inversion (i.e. the 
free energy) to compare the evidence for any given model parameterisation, given the 
empirical data (Kiebel et al., 2009).  
6.3 Results 
6.3.1 NMDAR-Ab alter the dynamic response to acute chemoconvulsants in 
mice 
Cortical dysfunction associated with NMDAR-Ab was tested in C57BL/6 mice using a two-
by-two design. This design tested for the effects of NMDAR-Ab (delivered via 
intracerebroventricular injection), the acute chemoconvulsant pentylenetetrazol (PTZ, 
delivered via a later intraperitoneal injection), and their interaction. LFPs were recorded 
wirelessly in freely behaving animals and 45 minutes of recordings pre- and post-PTZ 
injection of 8 NMDAR-Ab positive and 5 control animals were included for the analysis 
reported here.  
Antibodies alone caused a moderate suppression of the LFP signal across low frequency 
bands (delta and theta range) in the NDMAR-Ab positive mice. However, additional 
exposure to PTZ revealed a marked difference between NMDAR-Ab positive and control 
mice, with a large increase of low frequency (delta-band, 1-4Hz) power in the antibody 
positive treated mice only (Figure 6.3). Analysis of variance (ANOVA) revealed a 
significant main effect of NMDAR-Ab on log-delta-band power [F(1,4601) = 9.67; p = 
0.002]; and a significant interaction between NMDAR-Ab and PTZ exposure [F(1,4061) = 
85.05; p < 0.001]. A PTZ-induced increase in paroxysmal fast activity consistent with 
epileptic seizures was observed in the NMDAR-Ab positive IgG treated mice  compared to 
 
Table 6-1 – Free parameters fitted by the DCM 
 τ1 (superficial pyramidal cell time constant) g1 (sp to ss inhibition) τ2 (spiny stellate time constant) g2 (ii to ss inhibition) τ3 (inhibitory interneuron time constant) g3 (ii to ip inhibition) τ4 (deep pyramidal cell time constant) g4 (ss to sp excitation) 
 g5 (ss to ii excitation) 
 g6 (dp to ii excitation) 
 g7 (sp self-modulation) 
 g8 (ss self-modulation) 
 g9 (ii self-modulation) 
 g10 (dp self-modulation) 
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control animals, which has previously been reported elsewhere (S. Wright et al., 2015b), 
but this did not produce a spectral difference in the frequency bands analysed here. An 
example of induced, non-epileptiform slow activity is seen in the bottom panel of Figure 
6.3 B. These slow wave cortical dynamic abnormalities were further analysed in the 
dynamic causal modelling approach reported below.  
6.3.2 NMDAR-Ab potentiate PTZ-induced effects in cortical microcircuitry in 
mice 
To explain the observed differences in spontaneous activity, a hierarchical dynamic causal 
model was used to infer parameter changes associated with the experimental variables over 
time (i.e. NMDAR-Ab exposure, PTZ infusion, and an Antibody-PTZ interaction). In 
brief, a sliding window (length = 30s, step size = 15s) was used to estimate the mean power 
spectra over successive time points. Each time window was then modelled as the steady 
tate output of a canonical microcircuit (CMC) model (Moran et al., 2013) with – for the 
duration of a single time window – fixed synaptic parameters. By repeating this analysis 
over windows, I identified fluctuations in synaptic parameters that corresponded to the 
experimental interventions. Across windows, the evolution of spectral patterns was 
captured well for all experimental conditions (Figure 6.4 A,B). To infer experimental 
effects on DCM parameters, the sequence of parameter estimates was then modelled using 
a parametric empirical Bayesian (PEB) approach (Friston et al., 2016b). Here, slow 
fluctuations of cortical coupling were modelled as between-window changes in the 
synaptic parameters estimated within-window (see (Papadopoulou et al., 2017) for a 
worked example). I included three main experimental effects of interest: (a) NMDAR-Ab, 
(b) PTZ, and (c) an NMDAR-Ab x PTZ interaction term (Figure 6.4 C).  
The neuronal parameters that affect the spectral composition of spontaneous neuronal 
activity correspond roughly to the mechanistic hypotheses outlined above: (1) time 
constants of the neuronal populations τ describe the dynamics of neuronal population 
responses; (2) excitatory coupling parameters ge describe the strength of excitatory 
between-population connections; (3) inhibitory coupling parameters gi represent the 
strength of inhibitory between-population connections, whilst modulatory coupling 
parameters gm represent the strength of inhibitory self-connections (Moran et al., 2013) 
(Table 6-1).  
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Spectral changes associated with NMDAR-Ab, PTZ exposure and the interaction were 
each explained by several corresponding parameter changes. The biggest effects were 
associated with PTZ exposure, with a decrease in the superficial pyramidal cell population 
time constant (i.e. a faster return to baseline after perturbation), an increase in the spiny 
 
Figure 6.5 – NMDAR-Ab push the neuronal ensemble into high delta-band power regions 
of reduced parameter space. Parameter variations between time windows are projected 
onto the first principal component of (A) time constant changes consisting predominantly 
of superficial pyramidal cell, and spiny stellate cell changes, and (B) of connectivity strength 
changes consisting predominantly of spiny stellate to superficial pyramidal cell coupling 
changes. (C) Across this parameter space, simulations can predict spectral densities, of which 
log-mean delta power is shown here as background colouring (with selected centile 
isoclines also plotted). Individual time windows across the four conditions are then 
projected into the same reduced parameter space, showing an accumulation of NMDAR-Ab 
positive, post-PTZ time window estimates in high delta-ranges. (D) The distribution of time 
windows in parameter space is further illustrated with smoothed heat maps of parameter 
combination occurrence frequencies over the same section of parameter space for control 
animals (left) and NMDAR-Ab positive animals (right). Estimates in NMDAR-Ab positive 
animals cross the 75th centile more frequently than in controls.  
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stellate population time constant (i.e. a slower return to baseline after perturbation), and 
an increase in the excitatory connectivity from spiny stellate to superficial pyramidal cells. 
Notably those changes were further potentiated by NMDAR-Ab and the NMDAR-Ab x 
PTZ interaction (Figure 6.4 D).  
6.3.3 Shifts in synaptic dynamics underlie emergence of low frequency 
power in mice 
I further investigated the effect of changes in synaptic parameters on the main spectral data 
feature of interest (i.e. delta-band power). For this, I first performed a principal component 
analysis over the slow (between time-window) parameter fluctuations separately for time 
constants and connection strengths, retaining the first principal component of each 
(Figure 6.5 A,B). This analysis showed that most of the variance over time can be explained 
by fluctuations in a small subset of parameters; specifically, the time constants of 
superficial pyramidal and spiny stellate cells, and the excitatory coupling between them (as 
is also apparent in the analysis or second level model parameters shown in Figure 6.4).  
I use these two components to project synaptic parameter estimates at each time window 
onto the two dimensions explaining most of the variance (i.e. one time constant 
component, and one connection strength component). To characterise different locations 
in this parameter space – in terms of the neuronal dynamics generated by the parameters 
– I used the mean delta band power of the predicted power spectral density. This functional 
characterisation of parameter space is shown (in log-scale) with a colour code, and as 
isoclines indicating mean delta-band power centiles across the parameter space considered 
(Figure 6.5 C). Whilst there is variation in delta-band power associated with both the time 
constant (x-axis) and the connection strength (y-axis) parameters, the time constants have 
the greatest effect on delta power: The difference between controls and NMDAR-Ab 
positive animals in the delta band power post-PTZ is largely conferred by shifting the time 
constant component, causing it to cross the 75th delta-band power centile much more 
frequently than in controls (Figure 6.5 D). This differential effect of PTZ can be seen by 
comparing the orange and purple scatter plot marks in Figure 6.5 C.  
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6.3.4 EEG paroxysms in patients are caused by fluctuations in synaptic 
dynamics 
To identify which synaptic parameters cause paroxysmal EEG abnormalities commonly 
observed in NMDAR-Ab encephalitis, I used the above CMC model to perform a DCM 
analysis of 8 paediatric cases of NMDAR-Ab encephalitis, for whom EEG recordings were 
available and contained visually apparent EEG paroxysms. Briefly, routine visual EEG 
analysis was performed to identify paroxysmal abnormalities by two EEG-trained 
clinicians (RER, GC, see Table 6-2 for clinical details). For each patient, 2s time windows 
containing spontaneous activity, short isolated paroxysms, or rhythmic/ongoing 
epileptiform activity were extracted and used for further analysis (Figure 6.6 A). 
Cortical source estimation for the paroxysmal EEG activity was performed and ‘virtual 
electrode’ responses extracted from the most active sources (Boly et al., 2012). For each 
patient, DCMs were independently fitted to power spectral density averages of each 
available condition (e.g. background, short paroxysms, ongoing rhythmic activity (Figure 
6.6 B). Individually fitted DCMs (with near perfect model fits, Figure 6.6 C) were 
subsequently combined in (within-patient) between-condition hierarchical (PEB) models 
that explained the condition specific differences with changes in synaptic time constants 
(τ), between-population inhibitory connections (gi), between-population excitatory 
connections (ge), or within population modulatory connections (gm). Across participants, 
Table 6-2 – EEG features of NMDAR-Ab Encephalitis patients. Patients were selected from routine 
clinical service based on paroxysms identified on clinical EEG recordings 
ID Sex Age 
(years) 
EEG background EEG paroxysms 
N001 M 2 Normal Isolated slow waves 
 
N002 F 15 Normal Intermittent rhythmic slow, regional left 
frontal 
N003 F 9 Diffusely 
continuous slow  
Intermittent rhythmic slow, generalised, 
maximum bifrontal 
N004 F 1 Normal Runs of spike and wave complexes, 
generalised; Isolated sharp waves 
N005 F 3 Diffusely 
continuous slow  
Intermittent slow, generalised, maximum 
bifrontal 
N007 F 10 Diffusely 
continuous slow 
Intermittent slow, generalised 
N008 F 14 Diffusely 
continuous slow 
Near continuous spike and wave complexes 
in sleep, generalised, max R frontal (ESES) 
N009 F 11 Diffuse continuous 
slow 
Intermittent slow, generalised, maximum 
bifrontal 
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models explaining spectral differences as arising from differences in time constants offer 
the best explanation of the virtual electrode data (with an exceedance probability of >95%,  
Figure 6.6 D).  
 
 
 
 
Figure 6.6 – EEG paroxysms in NMDAR-Ab encephalitis patients are best explained as time 
constant fluctuations. (A) For each individual patient, 2s time windows containing 
spontaneous activity, short EEG paroxysms and where available longer rhythmic EEG activity 
were extracted. (B) These were source localised and ‘virtual electrode’ time traces extracted 
at the estimated cortical source. Normalised power spectral density averages across all time 
windows were then fitted using separate DCMs for each condition. (C) The normalised 
spectral output of fitted DCMs show near perfect overlap with the observed spectral 
densities, illustrating that the fits provide good explanations for the observed (spectral) 
data features. (D) I then used Bayesian model reduction to test which subset of parameters 
best explains the differences between the different EEG states across the whole group: For 
each individual, between-condition effects were estimated in a number of reduced 
(parametric empirical Bayesian) models that different only in which parameters were free 
to explain the between-window spectral variations. Of these parametric empirical Bayesian 
summaries of individual participants, models explaining the spectral changes with 
fluctuations in time constants have an exceedance probability of > 95%.  
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Figure 6.7 – NMDAR-Ab sensitise the microcircuit to intrinsic fluctuations in time constants. 
Here, I apply a summary component of the time constant fluctuations estimated from 
human patients to a cortical microcircuit model derived from the control mice (left), and 
the NMDAR-Ab positive mice (right). (A-B) The same fluctuations cause spectral outputs 
containing much higher relative delta power in the model estimated from NMDAR-Ab 
positive mice. (C) This figure shows log of mean delta power for a range of smoothly 
increasing time constant fluctuations. In the low parameter range (-2.5 to -1.5 of the time 
constant principal component contribution) there is a large jump in delta power, suggesting 
that there are two distinct dynamic states separated by small differences in parameter 
values. (D) Example reconstructions of time series for parameter values at two very close 
parameter values (p1 and p2) are shown for control and NMDAR-Ab positive models. The 
sudden increase in delta power is visible as paroxysmal change in the time series in the 
NMDAR-Ab positive context, whilst the control time series appears continuous. This sudden 
change in dynamics with a small change in parameter space is known as a phase transition.  
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6.3.5 NMDAR-Ab alter the response to intrinsic fluctuations in synaptic 
dynamics 
The DCM of human data provides an estimate of the brain-state-specific changes in 
synaptic parameters: From the Bayesian model comparison of a set of reduced models, it 
emerged that the differences in EEG states in human patients are best explained through 
variations in neuronal population time constants. I extracted DCM parameter estimates of 
these time-constant changes for each patient, yielding a set of time constant parameters 
that explain the transition from background to paroxysmal EEG states for each participant 
individually. From this matrix of time constants (4 time constants in 8 participants with 2-
3 EEG states), I extracted the first principal component, and applied them to the control, 
and the NMDAR-Ab positive mouse-derived CMC models. Conceptually I am thus 
enforcing the same degree of time constant fluctuations estimated from the patient models 
to the in-silico microcircuits derived from the mouse empirical experiments. 
The differences between the parameter estimated from the control and NMDAR-Ab 
positive model result in qualitatively different spectral outputs; even when applying the 
same time constant changes. Overall, the NMDAR-Ab positive context results in higher 
delta-band power and less high frequency power (Figure 6.7 A-B). Crucially, delta power 
was higher in the NMDAR-Ab positive model across a wide range of time constant 
fluctuations (Figure 6.7 C). Furthermore, small changes in the synaptic parameters 
identified with the patient data cause large changes in delta power in – and only in – the 
NMDAR-Ab positive model. This is manifest as low frequency paroxysmal activity when 
the synaptic parameters change slightly in the NMDAR-Ab positive model, but not the 
control (Figure 6.7 D). Technically, this abrupt change in dynamics with a small change in 
parameters is known as a phase transition; suggesting that antibody-positive effects on 
synaptic coupling move the network towards a critical regime in which small fluctuations 
in synaptic time constants produce qualitatively different dynamics (i.e. paroxysmal EEG 
abnormalities).  
6.4 Discussion 
This study reveals common synaptic mechanisms underlying a range of 
electrophysiological disturbances associated with NMDAR-Ab in a mouse model, and in 
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paediatric patients: NMDAR-Ab cause a shift in cortical synaptic parameters that is 
associated with an increase in low frequency oscillations and which predisposes to the slow 
wave paroxysms seen in clinical EEG recordings.  
6.4.1 NMDAR-Ab are associated with high-amplitude low-frequency 
discharges 
NMDAR-Ab cause changes in the spectral composition of resting state LFP of the mouse 
strain tested. These differences are further revealed on additional exposure to PTZ, with a 
large PTZ-induced increase in mean delta power in the presence of NMDAR-Ab. This 
increase is largely due to intermittent rhythmic slowing without concurrent epileptic 
spikes. Previous analysis of seizure events shows that NMDAR-Ab also lower the seizure 
threshold (S. Wright et al., 2015b), but seizure events fall largely outside the frequency 
spectrum analysed here. These observations are in keeping with clinically reported EEG 
features: i.e. background slowing with or without additional slow wave paroxysms.  
In mouse models of NMDAR-hypofunction, normal NMDAR function in parvalbumin 
(inhibitory) interneurons is required for gamma rhythm induction (Carlén et al., 2012).  
Furthermore, persistent NMDAR-hypofunction confers an increase of resting gamma 
power, with a concurrent reduction in stimulus-induced gamma oscillations (Gandal et 
al., 2012). In the mouse model presented here, I did not see such a change in gamma 
frequency power, which may reflect the modelled disease stage: Patients with NMDAR-Ab 
encephalitis progress through distinct stages of their disorders – initially presenting with 
neuropsychiatric symptoms before developing a more severe encephalopathic syndrome 
associated with slowing of the EEG (Irani et al., 2010). The findings of this study most 
closely relate to this second stage, and thus may relate to a pathophysiology distinct from 
‘neuropsychiatric’ NMDAR hypofunction: Early on during the course of the disease, 
antibody effects may be limited to the inhibitory interneuronal system (Nakazawa et al., 
2017). However, during the encephalopathic stages (including the emergence of 
paroxysmal EEG abnormalities and epileptic seizures), there may be more wide-ranging 
effects across cell-types that is partly recapitulated in the mouse model.  
An increase in the power of slow frequency components in an EEG or LFP recording is 
thought to be associated with increased synchronisation of local cortical firing, itself 
regulated by interacting cortical and subcortical systems (e.g. thalamocortical loops 
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(Steriade et al., 1993), brain stem monoamine arousal systems (Krishnan et al., 2016), and 
intrinsic cortical effects such as astrocytic regulation of synaptic function (Fellin et al., 
2012)). Firing synchrony can occur physiologically (e.g. during sleep), can be associated 
with non-specific cortical dysfunction (e.g. in the context of an encephalopathy), or be a 
component of epileptic discharges (apparent in slow-wave components in spike-wave 
discharges) (Beenhakker and Huguenard, 2009).  
Synchrony by definition is an emergent feature of population dynamics, rather than a 
property of any single neuron, but an increase in cortical synchrony may arise from a whole 
range of different coupling changes at the synaptic level. Many of these can be captured in 
mesoscale models of neuronal ensembles (Lopes da Silva et al., 1974). The DCM approach 
uses this mesoscale perspective to identify changes that are underlying the emergence of 
hypersynchronous slow wave activity in the presence of NMDAR-Ab.  
6.4.2 NMDAR-Ab cause laminar specific changes in cortical dynamics 
DCM rests on neural mass modelling of coupled neuronal oscillators that are described 
using specific synaptic parameters (e.g. connection strengths, time constants, see Table 
6-1) and that broadly resemble the laminar structure of mammalian cortex. The neural 
mass model of a single electromagnetic source contains two pairs of coupled neuronal 
oscillators that support slower (deep oscillator: deep pyramidal cells and inhibitory 
interneurons) and faster (superficial oscillator: superficial pyramidal cells and spiny 
stellate cells) activity (Bastos et al., 2015). These popuilations model the dynamics of an 
integrated cortical column. Individual parameters exert highly non-linear effects on the 
system’s output. The parameterisation of these models is rooted in biophysical properties 
of individual neurons but describe average characteristics of populations of functionally 
related neurons; i.e. composite properties emerging from the features of individual cells.  
At this mescosale, PTZ and NMDAR-Ab produce synergistic effects that result in excessive 
synchrony not seen in other experimental conditions. My results suggest that increases in 
low frequency power can be explained by a combination of: (1) an increase in superficial 
cortical excitatory coupling, largely associated with PTZ exposure, and (2) opposing 
changes in the dynamics of the superficial oscillator pair (spiny stellate and superficial 
pyramidal cells, Figure 6.5). 
The changes in synaptic dynamics align time constants in a gradient along the CMC 
coupling chain, with the slowest time constants in the deep pyramidal cells, and fastest 
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time constants in the superficial pyramidal cells – and gradual steps between. This reduces 
the stepwise difference in time constants along the CMC chain compared to the standard 
CMC configuration. This parameterisation allows a dominant frequency to resonate 
across – and recruit – the whole column, thus producing the high amplitude slow 
frequency patterns observed. Thus interestingly, slow wave activity appears to be under 
control of the faster, superficial oscillator pair in the CMC model, with both NMDAR-Ab 
and PTZ having profound and relatively specific effects on their dynamics. This is in 
keeping with observations from invasive recordings of sloe wave activity in human patients 
with epilepsy, which implicate superficial cortical coupling in the regulation of slow wave 
sleep activity (Csercsa et al., 2010). 
6.4.3 Different molecular changes show converging effects at the neuronal 
population level 
The synaptic parameters of the CMC model employed in DCM are population summaries 
of a variety of cellular effects, encompassing emergent properties and multiple 
nonlinearities (Schmidt et al., 2014). Time constants at the population level are essentially 
descriptions of post-synaptic integration affected by multiple factors, such as background 
firing frequency, membrane conductance, intra- and extracellular ion composition, and 
the dynamics of receptor types present in the membrane to name but a few (Koch et al., 
1996). Connection strengths at the population level summarise the effect one population 
has over another and may include effects mediated via subpopulations within (e.g. self-
connections are modelled as direct connectivity but represent local intralaminar inhibitory 
interneuronal inhibition).  Because a number of different effects may converge on the same 
population parameters – and individual molecular effects may only be expressed in certain 
conditions – the link between molecular change and population parameters is nontrivial.  
The approach presented here deliberately collapses much of the diversity of cortical 
physiology into mathematical descriptions that have specifically been developed to capture 
the sort of abnormal responses observable in EEG. This offers the opportunity to integrate 
findings from diverse sets of recordings into a common mathematical framework 
describing ongoing cortical dynamics.  
Exposure to NMDAR-Ab has been reported to cause a number of changes in the 
postsynaptic glutamate response, including a reduction in overall postsynaptic potentials, 
 155 
a reduction in late postsynaptic currents, and a faster return to baseline after stimulation 
(Hughes et al., 2010; Moscato et al., 2014). In intact neuronal circuits, NMDAR exert 
differential control over excitatory and inhibitory populations, leaving the populations 
differentially affected by NMDAR-blockade (Moreau and Kullmann, 2013).     
PTZ is believed to act as an antagonist to γ-Aminobutyric acid type A (GABA-A) receptors 
by directly blocking ionophores (Kalueff, 2007). GABA-A receptors are fast inhibitory 
receptors with a wide-spread, region and cell-type specific set of post-synaptic effects (Lee 
and Maguire, 2014). These include inhibitory post-synaptic potentials, but also inhibition 
of dendritic excitatory post synaptic potentials via extrasynaptic GABA-A receptors, which 
is particularly pronounced at the cortical pyramidal cells (Paulus and Rothwell, 2016). In 
some neuronal cell types and at certain developmental stages GABA-A can cause 
excitatory post synaptic potentials (Song et al., 2011), and GABA transmission can exert 
direct or indirect control over excitatory NMDAR-dependent synaptic transmission 
(Kapur et al., 1997).  
With this range of different cellular effects, it is unlikely one can capture the breadth if 
NMDAR-Ab and PTZ related effects in a small subset of population model parameters. 
However, the effects on delta-band power specifically can be reproduced well with a. few 
principal components; comprising largely just two main effects: (1) decreasing the time 
constants of superficial pyramidal cells relative to excitatory spiny stellate cells, and (2) 
increasing the excitatory coupling between spiny stellate and superficial pyramidal cells.  
There are a number pf possible and convergent changes at the molecular level associated 
with NMDAR-Ab and PTZ exposure that could explain these population level effects. The 
time constant changes in superficial pyramidal cells may result from being switched 
towards (faster) AMPA mediated excitatory inputs (due to the NMDAR-Ab mediated 
internalisation of NMDAR) and a change in membrane conductivity (due to PTZ-
mediated blocking of extrasynaptic GABA-A receptors). The change in excitatory 
connection, on the other hand is consistent with a disinhibition of excitatory EPSPs under 
GABA-A blockade with PTZ (i.e. a reduction of so-called shunting inhibition) (Paulus and 
Rothwell, 2016). Furthermore, different inhibitory interneuron populations – 
characterised by different molecular markers, morphology and functional integration – 
show distinct, and at times opposing overall effects on cortical dynamics (Muñoz et al., 
2017). Thus, features of neuronal dynamics that in my models appear as changes in 
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excitatory coupling at the population level, may result from subpopulation-specific 
changes in cortical (dis)inhibition.  
Experimental methods to link detailed cell-type specific cortical physiology and 
population dynamics exist in experimental animals (Krook-Magnuson et al., 2013), but 
cannot be accessed directly in patient EEGs. By focussing on the mesoscale description 
here – whilst enforcing a simplified representation of cortical dynamics – I can describe 
the systemic effects of NMDAR antibodies in recordings from the mouse model as well as 
in patient EEGs. The increasingly detailed characterisation of mouse cortex circuitry 
 
Figure 6.8 – Sensitivity analysis for canonical microcircuit models fitted to control and 
NMDAR-Ab positive mouse recordings. This figure shoes the effects of modulations of 
individual model parameters in the in-silico models fitted to LFP recorded from control mice, 
and NMDAR-Ab respectively. For each plot a single parameter was varied in small steps from 
values of -1.8 (purple) to 1.8 (green). The left-hand side two columns show time constant 
variations, the right-hand side fur columns show variations in individual connection 
strengths. These plots highlight a few key parameters that sensitively affect power spectra 
when varied in different conditions.  
Notably spiny stellate time constants reproduce closely the phase transition also observed 
when implementing the empirical parameter variations observed in human patients. Note 
the spiny stellate to superficial pyramidal excitatory connection increases overall spectral 
output, as also indicated in the simulations in Figure 3 of the main report.  
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provides an important focus for progressively refining these sorts of models in future 
studies.  
Each of these changes at the molecular level (approximated through the population model 
parameters) has nonlinear effect on neuronal responses. Thus, like in other complex 
systems, even small fluctuations in the parameters induced by only a relative shift in the 
balance of e.g. AMPAR and NDMAR mediated transmission can have profound effects on 
the activity of the dynamics of the whole circuit. These effects can be quantified using a 
sensitivity analysis, i.e. quantifying how changes in model parameters produce distinct 
spectral responses, as shown in Figure 6.8.  
6.4.4 NMDAR-Ab sensitise the cortical column to spontaneous paroxysmal 
EEG abnormalities 
In the patients with NDMAR-Ab encephalitis there is no experimental control over 
NMDAR-Ab exposure. Furthermore, the sample of patients is heterogeneous – 
representative of clinical practice (e.g. age, gender, timing of EEG, timing of initial 
diagnosis in relation to symptom onset, etc.). Yet these patients show a diverse range of 
paroxysmal, short-term changes in EEG dynamic patterns that are visually apparent, 
allowing me to probe spontaneous fluctuations of DCM parameters that may underlie 
discrete pathological brain states.  
Patient-specific modelling as facilitated by DCM allows inference on patient-specific 
parameters in a generic model of the cortical column. Thus, applying DCM analysis to this 
diverse sample, one can access two types of results: (1) Qualitative: Identify the types of 
parameters whose changes underlie the dynamic abnormalities seen in EEG; (2) 
Quantitative: Establish the numerical range of parameter fluctuations that can be applied 
to other specified DCMs.  
Consistently across patients, models with changes in time constants best explained the 
observed transitions between background activity and paroxysms. Furthermore, I 
summarised these parameter changes along a single (principal component) axis. I used this 
component to enforce similar fluctuations in the fully specified DCMs derived from the 
mouse model analysis; asking whether the baseline context (i.e. the parameterisation 
derived from NMDAR-Ab positive or control animals) alters the effect of parameter 
changes of the type and magnitude estimated from human patients.  
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Indeed, the dynamic responses of the two types of models are very different: In the context 
of NMDAR-Ab, overall greater delta-band power is observed, and there are regimes of 
parameter space that contain boundaries between very different dynamic states (Jirsa et 
al., 2014). This structural instability underwrites phase transitions of the sort seen in 
seizure activity or other EEG state transitions. In the control parametrisation, the same 
changes have a much less pronounced effect, and do not induce overt slow wave 
paroxysms. In short, it appears that paroxysmal EEG activity in patients may be best 
explained by normal fluctuations in synaptic time constants that occur in an abnormal 
regime of synaptic parameter space.   
In the human patients I relied on EEG recordings that were obtained in the absence of 
external experimental control; effectively using the modelling to describe the kinds of 
neuronal coupling changes that cause spectral shifts in the EEG as observed during short 
term paroxysms. Furthermore, dynamic features observable in EEG are averages of larger 
scale network activity than e.g. the LFP recordings in mice. However, the insight the that 
spectral shift induced by changes in these parameters depends on NMDAR-Ab was only 
afforded through the experimentally constrained DCMs estimated from the animal model. 
The translation between species and modalities is afforded by explicit generative neuronal 
models that relate data features to underlying neuronal population activity: In the case of 
human EEGs, I first extract local cortical time series using a ‘virtual electrode’, i.e. a 
beamformer source reconstruction algorithm, before fitting mesoscopic neuronal 
population models using DCM; in the case of LFP recordings in mice, I can use DCM 
directly to explain the recorded LFPs (with the observation model consisting of a single 
scalar gain parameter). Crucially these generative models then allow for neurobiologically 
relevant features (i.e. the changes in connection strength and synaptic dynamics) to be 
translated at the same mesoscopic scales.  
Overall these findings provide integrative evidence from human patients and a mouse 
model of NMDAR-Ab encephalitis suggesting that (a) NMDAR-Ab cause 
electrophysiological abnormalities via a small number of synaptic changes, which may lend 
themselves to targeted therapeutic interventions; e.g. by exploiting laminar and/or cell-
type specific effects of transcranial current stimulation (Rahman et al., 2013). And (2) 
paroxysmal abnormalities can be explained by persistent baseline changes that render 
cortical microcircuitry particularly sensitive to (potentially normal) fluctuations in 
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synaptic coupling. Future research may reveal whether similar approaches have diagnostic 
value when performed on patient EEGs alone (Symmonds et al., 2018).  
6.4.5 Limitations  
The modelling approach presented here allows unique insights into possible mechanisms 
underlying empirically observed phenomena. Although DCM has been applied to a wide 
variety of neurophysiological studies – and its validity has been assessed repeatedly (Kiebel 
et al., 2009; Moran et al., 2011a) – there are certain limitations to the approach I have 
adopted for this study.  
First, the modelling can only be applied to existing data – this places restrictions on study 
design (e.g. pre-NMDAR-Ab EEGs are not usually available from patients) and limit the 
approach to a subset of testable hypotheses. Second, like all inference, DCM is based on 
specific assumptions regarding the underlying neuronal architecture – all activity 
presented here is presumed to emerge from microcircuitry consistent with CMC models, 
and only given this assumption can I estimate the parameters and provide evidence for or 
against specific model parameterisations.  
Most importantly, I have reduced a complex brain-wide pathology of interacting systems 
to changes in a cortical microcircuit. Thus, I are ignoring interactions between different 
cortical regions, as well as the influence of subcortical structures, such as thalamus and 
brain stem, which (especially in the context of encephalopathy and slow wave 
abnormalities) will exert a powerful influence over cortical states. Although these effects 
can be accommodated in the model as random effects, they are not modelled explicitly.  
The approach here – by design – focusses not on single cell dynamics, but treats cortical 
patches as integrated units, which correspond to the mesoscale dynamics observable in 
EEG (Freeman, 2000b). My computational modelling of cortical microcircuits aims to link 
some of these observed dynamics with the themes that have emerged from detailed micro-
anatomy and neurophysiology at the microscale and are implicated in NMDAR-related 
pathology. However, I am not attempting to make inference about single neurons. The 
models are describing the ‘net’ effect of NMDAR-Ab on integrated circuits of neuronal 
populations: Future studies should allow us to model how these effects emerge from single 
neuron interactions. Furthermore, I note that many of the ‘canonical’ models of cortical 
circuitry (including ours) have focussed on excitatory population coupling, and in the 
future may benefit from incorporating some of the more recent themes that have been 
 160 
identified in the connectivity patterns of inhibitory interneuronal populations (Pfeffer et 
al., 2013). This study aimed to answer specific questions driven by observations in a 
particular pathology related to NMDAR-Ab. Whilst the models and results as presented 
here are appropriate for this focus, there are many observations related to abnormal 
NMDAR-function not currently captured in the model here. I hope that future research 
will integrate across different such experiments and observations and expect that 
generative models like the one presented here will help in this ongoing work.  
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 Selective prefrontal disinhibition 
under NMDA receptor blockade §  
7.1 Introduction 
N-methyl-D-aspartate receptor (NMDAR) hypofunction is considered one of the primary 
causes of schizophrenia (Friston et al., 2016; Krystal, 1994), which itself is associated with 
a number of electrophysiological brain abnormalities (Näätänen and Kähkönen, 2009; 
Uhlhaas and Singer, 2010). NMDAR antagonism, e.g. with ketamine, can reproduce a set 
of symptoms and electrophysiological features of schizophrenia (Guo et al., 2009; Javitt et 
al., 1996; Nakazawa et al., 2017), including a reduction in auditory mismatch negativity 
(MMN) observed in patients (Ranlund et al., 2016; Umbricht et al., 2000; Umbricht and 
Krljes, 2005; Wynn et al., 2010). MMNs are difference waves of event-related potentials 
(ERPs) to an unexpected deviant stimulus and repeated standard stimuli (Cheour et al., 
2000; Todd et al., 2014). One theory of the underlying perceptual inference is formalised 
in the predictive coding framework (Friston and Kiebel, 2009; Schröger et al., 2014): Based 
on Helmholtz’s notion that the brain attempts to infer the causes of sensations (Dayan et 
al., 1995; Friston, 2005), predictive coding proposes that the brain generates predictions of 
                                                        
§ The work reported here has also been described in the following forthcoming publication:  
 
Rosch, R.E., Auksztulewicz, R., Leung, P.D., Friston, K.J., Baldeweg, T. 2018. Selective prefrontal 
disinhibition in a roving auditory oddball paradigm under N-Methyl-D-Aspartate receptor 
blockade. Biol Psychiat CNNI, in press. doi: 10.1016/j.bpsc.2018.07.003 
 
As part of this work, I proposed the computational analysis, independently performed the 
computational modelling, and wrote the manuscript. I was not directly involved in the 
acquisition of the recordings, which are reported here for completeness. 
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sensory input. When sensation deviates from these predictions, prediction error signals 
are generated, and passed along the sensory hierarchy. Evidence from different sensory 
domains and species suggests that this provides a good explanation of MMN-type 
responses (Wacongne et al., 2012; Ylinen et al., 2016). However, there is limited evidence 
on how the underlying mechanisms are affected by NMDAR transmission and its 
blockade.  
Computational models offer a bridge between putative synaptic mechanisms, and 
electrophysiological and psychopathological features of disease phenotypes (Anticevic et 
al., 2012; Moran et al., 2011b). Dynamic causal modelling is one such approach: Here 
neural mass models of cortical microcircuitry are fitted to ERP data (Friston et al., 2003; 
Kiebel et al., 2009), an approach widely applied to auditory MMN paradigms  (Garrido et 
al., 2009a; Phillips et al., 2015), including in patients with schizophrenia (Dima et al., 2012), 
patients with psychosis (Ranlund et al., 2016), and healthy volunteers exposed to ketamine 
(Schmidt et al., 2013).  
Here I apply novel DCM techniques to data from a double-blind placebo-controlled study 
of the effects of ketamine on the auditory MMN. I employ a single hierarchical model to 
identify (1) within-session coupling changes explaining ERPs to deviants and standard 
stimuli (modelling MMN and repetition suppression effects respectively); and (2) group-
wise between-session coupling differences induced by ketamine. Previous DCM studies 
have focussed on synaptic changes plausibly affected by sensory input directly. My 
approach here accommodates more fundamental effects of ketamine on neuronal circuits; 
e.g. on excitation/inhibition balance within cortical microcircuits, on intrinsic timescales 
of cortical areas, or on postsynaptic gain. I exploit the biophysically detailed microcircuit 
models implemented in DCM, linking neurobiological insights and theoretical accounts 
of sensory processing in the brain (Bastos et al., 2012). This, I use DCM to identify intrinsic 
(within-source), or extrinsic (between-source) synaptic connection changes induced by 
oddball stimuli, and how these changes were contextualised by altered neurobiology 
during the administration of ketamine.    
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7.2 Methods 
7.2.1 Subjects 
The study team recruited N=18 male volunteers (Table 7-1) through university 
advertisements. Subjects gave fully informed, written consent prior to participation, and 
were compensated. The study was approved by the University of Lübeck Research Ethics 
Committee. Participants completed a psychiatric questionnaire (SCL-90-R®) and routine 
clinical examination (including ECG, auscultation, and blood pressure measurements). 
Subjects with pre-existing conditions, a family history of psychotic illness or epilepsy, 
regular medication and subjects who were left handed, smoked, or were recreational drug 
users were excluded. Participants were invited for two sessions >3 weeks apart (placebo, 
and ketamine arms).  
 
ID 
 
 
Dose  (mg/kg/h) 
 
Age  (years) 
 
Gender 
A 0.250 23 Male 
C 0.250 21 Male 
E 0.250 23 Male 
G 0.083 22 Male 
I 0.083 22 Male 
J 0.250 22 Male 
K 0.083 23 Male 
M 0.083 26 Male 
N 0.083 22 Male 
O 0.083 24 Male 
P 0.083 25 Male 
R 0.083 22 Male 
T 0.083 22 Male 
U 0.083 22 Male 
W 0.083 25 Male 
X 0.250 21 Male 
Y 0.250 25 Male 
Z 0.083 23 Male 
 
Table 7-1 - Study subject details  
 
This was a randomised, placebo-controlled, double-blind cross-over experiment: 
Participants were randomly assigned to either ketamine- or placebo-first groups (9 in each 
group). Subjects and supervising researchers were blinded to session conditions (N.B., 
psychotomimetic effects of ketamine may reveal session conditions to participants). 
Ketamine, or the saline placebo were infused continuously over 2.5 hours, with ERP 
recording commencing at 1.5h post onset (Feld et al., 2013; Gais et al., 2008). An initially 
used higher ketamine dose was poorly tolerated by some participants, who suffered from 
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nausea, vomiting and some degree of disorientation. Because of this, the concentration of 
the infusion was reduced from 0.250 to 0.083 mg/kg/h for subsequent data collection, as 
detailed in the subject specification table (Table 7-1). 
7.2.2 Stimuli and ERP recording 
ERPs were recorded using 20 electrodes (10-20 EASYCAP system, www.easycap.de; 
Compumedics Neuroscan© amplifier, sampling frequency 500Hz). Pure tones were 
presented in pseudorandom sequences: Sounds of the same frequency were repeated 2-36 
times, before a frequency change (i.e., roving oddball paradigm). Sounds were presented 
at 80dB, with frequencies between 700-1200Hz (in 50Hz steps), and an inter-stimulus 
interval of 400ms, tones were 25ms in duration (Haenschel, 2005). Subjects were given an 
incidental reading task, and were instructed to ignore the sounds.  
Data were analysed in average referential montage, bandpass-filtered (range 0.1-80Hz) and 
divided into -100ms to 300ms peristimulus epochs. In the roving paradigm, tones change 
from deviants (i.e. first in sequence) to standard stimuli through increasing repetitions. 
Average ERPs were calculated to capture the average waveforms of the 1st (deviant, D1; 
average 228 trials per participant), 2nd, 6th, and 36th (standards S2, S6, and S36; average of 
76 (S36) to 209 (S2) trials per participant) presentation in a sequence. Baseline correction 
was performed based on the -100 to 0ms peristimulus time interval (D1), the 250 to 300ms 
interval (S2), or both (S6, S36) in order to avoid large P3a components at the end of D1, 
and the beginning of S2 epochs.  
7.2.3 Experimental design and statistical analysis 
The experiment was designed to determine within-session effects of stimulus repetition 
and deviance, as well as between-session effects of ketamine in a crossover design. Within-
sessions, I compared ERPs to standard tones after short (2 tones), and long (36 tones) 
sequences, as well as ERPs after 36 tones, and the deviant ERP (1st tone) using Bonferroni 
corrected t-tests for time-point by time-point differences. To evaluate between session 
group effects of ketamine vs placebo, I compared peak amplitude of the mean difference 
between the standard and deviant ERPs (i.e. mismatch negativity) with a t-test.  
7.2.3.1 Dynamic causal modelling 
Further detailed analysis using cortical source estimates of population output was 
performed using dynamic causal modelling (DCM). My analysis was based on low-density 
 165 
EEG recordings (20 electrodes in the 10-20 electrodes system), resembling EEG recordings 
routinely used in the clinic. These data were sufficient for the purposes of this study, 
because the aim of the study was not to identify the functional architecture of the auditory 
mismatch response, which has been the focus of previous studies (Auksztulewicz and 
Friston, 2016; Garrido et al., 2009b). Rather, I wanted to infer the effects of ketamine on 
the neurobiology of an established MMN network. My models reflect this question, 
focussing on variations in model parameters as the explanation for the ERP differences. 
Prior knowledge about source locations was included in the DCM inversion as prior, 
enabling me to finesse the source reconstruction problem using low-density EEG data and 
thereby drill down specifically on the ketamine effects. I applied hierarchical (parametric 
empirical) Bayesian modelling to identify group effects across DCMs fitted to single 
subjects. This analysis was conducted using the free academic software SPM12 
(http://www.fil.ion.ucl.ac.uk/spm/, Litvak et al. 2011), and custom code available online 
(doi.org/10.5281/zenodo.570595) – which is also included in the appendix of this thesis in 
section A.7.  
Identifying prior parameter distributions from grand mean ERP inversions: In order to 
produce the best fits at the single-subject level, a DCM was fitted to grand mean ERPs as 
detailed below (Garrido et al., 2009a, 2009b). A standard electromagnetic forward model 
based on a boundary element method (BEM) standard head model in MNI spac 
implemented in SPM12 was used to calculate lead-fields and reconstruct source ERP 
waveforms at six cortical locations (Garrido et al., 2008; Phillips et al., 2015): bilateral 
primary auditory cortex (A1), bilateral superior temporal gyrus (STG), and bilateral 
inferior frontal gyrus (IFG) with MNI coordinates: ltA1 [-42, -22, 7], rtA1 [46, -14, 8], 
ltSTG [-61, -32, 8], rtSTG [59, -25, 8], ltIFG [-46, 20, 8], rtIFG [46, 20, 8]. 
Differences between ERPs were modelled as arising from extrinsic (between cortical 
regions), or intrinsic (within cortical regions) synaptic coupling changes. I modelled the 
effect of deviance and repetition as coupling changes (i.e. short-term plasticity) that are 
summarised as linear mixture of two temporal basis functions (Figure 7-1 A). This yields 
three types of coupling: (1) Subject specific connectivity conserved across repetitions (A 
parameters); (2) repetition-dependent changes in connectivity greatest for the deviant and 
subsequently decreasing (B parameters of the monophasic decay); and (3) repetition- 
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Figure 7-1 – Two-level hierarchical DCM model space. DCM represents cortical sensory 
processing as a network of (extrinsically) coupled cortical sources, each of which contains 
(intrinsically) coupled neuronal populations. Each population is modelled as a neural mass 
with characteristic synaptic time constants. The free parameters of this model include: 
extrinsic coupling parameters between cortical sources (average coupling: A parameters; 
condition-specific modulation B parameters); and intrinsic coupling parameters between 
neuronal populations within a source (population time constants: τ parameters; coupling 
strengths: g parameters; activity dependent modulation of recurrent self-connections: M 
parameters; and condition-specific modulation of activity dependent coupling: N 
parameters).  
(A) Effects of repetition were modelled as condition-specific modulations of 
forward/backward extrinsic connections (B parameters) and intrinsic modulatory gain 
parameters (N parameters) in a coupled network of six cortical sources. The relative 
contribution of these parameters to each of the ERPs modelled here (i.e. D1, S2, S6, S36) is 
estimated using two temporal basis functions: a monophasic decay (where the contribution 
is maximal for the deviant stimulus D1), and a phasic change in connectivity (where the 
response is maximal at the standard stimulus S2), as shown in the right panels. (B) Ketamine 
effects were modelled at the second level, i.e. as group-level differences in DCM parameters 
between conditions that were conserved over subjects. The left panel illustrates the 
parameters in the canonical microcircuit representation of each source used in this DCM. 
My analysis addressed the following question: Which combination of parameter changes 
between placebo and ketamine conditions best explains the ketamine effect observed 
across the whole group? The model space is divided into models where ketamine affects 
combinations of extrinsic coupling parameters (right top panel), vs those where ketamine 
affects only combinations of intrinsic coupling parameters (right bottom panel).  
 
A1 – primary auditory cortex; STG – superior temporal gyrus, IFG – inferior frontal gyrus; 
Extrinsic connectivity parameters: AFWD – extrinsic forward coupling; ABWD – extrinsic 
backward coupling; BFWD, BBWD – condition specific modulations of extrinsic connections; 
Intrinsic connectivity parameters: g1-3 – intrinsic coupling; τ – time constants; M – modulatory 
self-connections; N – condition specific effects on modulatory connections 
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dependent changes in connectivity that peak with the first standard tone S2 (i.e. B 
parameters for the phasic temporal basis function). 
The linear mixture of both types of temporal basis function – weighted by their respective 
B parameters – reproduces the estimated connectivity changes across the four conditions 
(i.e. repetitions) allowing for a range of different types of plasticity over time (Garrido et 
al., 2009b), The model inversion provides both a measure for the model evidence, and 
posterior densities of these model parameters, identifying their estimated values and a 
certainty measure around those estimates. Parameter estimates of this grand mean 
inversion were then used as priors for single-subject DCMs.  
Individual model inversion and Bayesian model reduction to identify repetition effects: 
Whole-scalp ERPs for each subject were extracted separately for placebo and the ketamine 
conditions, resulting in 36 separate sessions (18 subjects, 2 conditions) for DCM analysis. 
For each DCM, the full 6-region network was equipped with grand-mean derived priors 
and inverted, yielding 36 individually parameterised DCMs.  
To test whether the effects of deviance (Garrido et al., 2009a) and the effect of repetition 
(Garrido et al., 2009b) replicate existing findings in the literature, I performed Bayesian 
model reduction. This identifies the best subset of DCM parameter changes that could 
explain the observed ERP responses: Based on inverted ‘full’ DCMs, I can estimate model-
evidence for a number of reduced DCMs, in which some parameters do not allow 
condition-specific variations (Friston et al., 2015; Kiebel et al., 2009; Litvak et al., 2015).  I 
then compared the models in which repetition modulated only a subset of network 
connections along three classes of models – (1) models in which forward connections 
change, vs models in which they do not; (2) models where backward connections change, 
vs those where they do not; and (3) models in which intrinsic modulatory gain parameters 
change, vs those where they do not (Garrido et al., 2009a; Phillips et al., 2015). This 
furnishes a combination of 2 * 2 * 2 = 8 models: 4 types of differences in between-source 
connectivity modulation; 2 types of differences in their within-source connectivity 
modulation (Figure 7-1 A). As each subject had a high model evidence for the same 
(winning) model (see Results section below), within-session effects across the group were 
summarised using Bayesian parameter averages.  
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Parametric empirical Bayes and ketamine effects: To estimate systematic variations in 
model parameters caused by ketamine, I used a parametric empirical Bayesian (PEB) 
approach. In brief, PEB allows the Bayesian estimation of a general linear model explaining 
effects across DCMs at the level of model parameters. This second level model can be 
equipped with different regressors (across all sessions and subjects), with the inversion 
providing parameter estimates for these between-DCM effects (Friston et al., 2016).  
Here I use PEB to (1) perform Bayesian model comparison across reduced models, and (2) 
quantify the parameter changes in the winning model where a subset of DCM parameters 
explains the ketamine effect.  Regressors comprised (a) an effect of ketamine (0 for placebo, 
 
Figure 7-2 – Ketamine causes a reduction in the mismatch negativity. (A) ERPs are shown 
for repetitions of a sound within the roving oddball paradigm. The first exposure to a sound 
within a sequence, D1, provokes a typical deviance response at the Fz electrode. ERPs for 
three different repetitions, S2, S6, and S36 show increasing positivity with a peak at 
approximately 120ms. The bold red lines indicate time points for which the S36 and D1 are 
significantly different across the whole group (i.e. the effect of deviance, p < 0.05, 
Bonferroni-corrected for multiple comparisons); bold green lines indicate time points for 
which S36 and S2 are significantly different (i.e. the effect of repetition, p < 0.05, Bonferroni 
corrected for multiple comparisons; differences only evaluated for the 0 – 300ms 
peristimulus interval). Ketamine reduces both the duration of the deviance and repetition 
effects. (B) Difference waveforms (i.e. mismatch negativity; plotted negative up) at Fz are 
shown for D1 – S36. The peak amplitude at around 150ms is significantly larger for the 
placebo condition compared to ketamine. (C) The panels show the difference between D1 
and either S2, S6, or S36 respectively. These are plotted across time (y-axis), and channels 
(x-axis, arranged from left to right). For each standard-deviant pair, there is a ketamine-
related reduction in mismatch responses. 
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1 for low dose ketamine, 2 for high dose ketamine; the two sessions from each individual 
subject were thus modelled as either 0-1, or 0-2, thus preserving differential effect sizes of 
ketamine across participants), (b) the group mean and (c) random subjects, or block 
effects. The parameters included time constants (t1-4 parameterising the temporal 
dispersion of postsynaptic responses), intrinsic connectivity parameters (g1-3 
parameterising cortical microcircuit connection strengths), modulatory gain parameters  
 
 
Figure 7-3 – Repetition effects. (A) ERPs to the 1st (Deviant, D1), 2nd, 6th, and 36th (Standards, 
S2, S6, S36) presentation of a sound within a sequence were modelled in subject-specific 
DCMs. The first principal eigenmode of the prediction in sensor space (bold colours), and 
the corresponding mode of the empirical scalp data (light colours) are shown for each 
individual. These suggest a good fit for the main components of the ERP waves. (B) Bayesian 
model comparison was performed to compared models in which the repetition effect was 
monophasic, phasic, or both, and included modulations of forward F, backward B, or 
intrinsic I connections and their combinations.  The winning model across the group was 
the full model, where monophasic and phasic repetition effects impact on forward, 
backward and intrinsic connections. (C) Bayesian parameter averages for this full model 
across all subjects show changes in connection strength across repetitions for forward, 
backward and intrinsic modulatory connections. Error bars indicate 95% Bayesian 
confidence intervals.  
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(M, N parameterising modulations of superficial pyramidal cell gain), and extrinsic 
connectivity parameters (A, B parameterising connection strengths between cortical 
sources). 
This model space addressed two classes of hypotheses: (a) ketamine affects extrinsic 
connections between sources (A and B parameters), and (b) ketamine modulates intrinsic 
properties within sources (M, N, g, and t parameters). I allowed for both a non-specific 
(main) effect of ketamine on coupling (M, A, g, t parameters) – and interaction effects 
specifically on plasticity (N, B parameters). I used Bayesian model reduction to compare 
the evidence for these (second-level) models, yielding approximate log-evidence for these 
second level models and estimates of the ketamine-induced parameter changes (with 
ayesian 95% confidence intervals). Finally, in order to further characterise these effects, I 
used parameter estimates in simulation mode (i.e. in a forward model based on the grand 
mean DCM across all participants) to visualise their impact on source space ERPs.  
7.3 Results 
7.3.1 Sensor space results 
ERPs contain averaged responses to tones of different frequencies at fixed positions within 
a sequence. Grand mean ERPs at the frontocentral (Fz) electrode for D1, S2, S6, and S36 
are shown for placebo and ketamine conditions (Figure 7-2 A). Deviance ERPs (to D1) 
constitute an early negative response (at MMN latency, approximately 150ms) and later 
positivity (P3a, approx. 250ms) that differs significantly from ERPs to standard tones 
(deviance effect). ERPs to S2, S6, S36 show the build-up of a positive ‘memory trace’ at 
around 120ms with significant differences between S2 and S36 indicated in Figure 7-2 A 
(repetition effect).  
Ketamine reduced the period during which there was a significant deviance effect (i.e. D1 
– S36 ERPs under placebo: 112ms, under ketamine: 90ms); as well as the repetition effect  
 (i.e. S36 – S2 ERPs under placebo: 120ms, under ketamine: 98ms). The MMN is attenuated 
by ketamine (paired t-test, t(17) = 1.85; p = 0.04) but not P3a (t(17) = 1.10: p > 0.05, Figure 
7-2 B). The attenuation is also apparent across the whole scalp when plotting all channels.  
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Figure 7-4 – Ketamine causes frontal lobe disinhibition. (A) Using PEB, 14 alternative second-
level models were considered, explaining differences between ketamine and placebo with 
changes in combinations of parameters. Bayesian model reduction shows that the model with 
changes in intrinsic connection parameters (𝑔) best explains the effects of ketamine on the 
ERPs. (B) Estimated parameter changes with Bayesian 95% confidence intervals (top), and 
posterior probability of the parameter being affected by ketamine (bottom) are shown. 
Significant changes were only observed in a subset of 𝑔 parameters, with the largest effects 
estimated for inhibitory interneuron (ii) connections to spiny stellate (ss) cells. In the bilateral 
STG, there was an increase in ii inhibition on ss, while in the bilateral IFG there is a ketamine-
induced disinhibition of ss. (C) Simulated effects of opposing changes in ii to ss inhibition at 
different hierarchical levels are shown in source space. Each graph shows superficial pyramidal 
cell (sp) activity in different regions for the 0 – 300ms poststimulus interval with concurrent, 
but opposite modulation of parameter the ii to ss inhibition: In the STG the (log-scaled) 
connection strength is increased from 0 to 2, whilst in the IFG the strength is decreased from 0 to −2. This modulation causes an attenuation and increase in latency in the IFG response, 
with concurrent attenuation of early STG responses and a decrease in the latency of the 
response. (D) Neuronal state space plots show the relationship between sp and ss activity for 
different hierarchical levels and for increasing changes to the ii to ss inhibition. There is 
minimal effect on the A1. For STG, the parameter changes induce a reduction in ss response 
amplitude compared to sp and an overall shift towards more negative population output. In 
the IFG there is an inverse reduction of sp response amplitude compared to ss.  
 
Intrinsic connectivity parameters: g1-3 – intrinsic coupling; τ – time constants; M – 
modulatory self-connections; N – condition specific effects on modulatory connections 
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7.3.2 Effects of repetition on connectivity  
Repetition effects were modelled as changes in connectivity of the cortical auditory 
network comprising three bilateral sources. This plasticity is captures in a linear mixture 
of two temporal basis functions (Figure 7-1 A): a monophasic decay and a phasic effect 
across repetitions. The combination of both effects on extrinsic and intrinsic coupling 
constitute the full model (model FBi in Figure 7-1 A; see Figure 7-3 A for subject specific 
model fits). A set of reduced models was compared using Bayesian model reduction. 
These comprised each of the models in Figure 7-1 A, paired with either one, or both of the 
temporal basis functions, resulting in a total of 8 * 3 = 24 models. Bayesian model 
comparison provides decisive evidence for the full model (i.e. FBi with both monophasic 
and phasic effects) at the group level (Figure 7-1 B) and for each individual subject.  
Bayesian parameter averages for forward connections, backward connections, and 
modulatory self-connections (shown here for A1) are shown in Figure 7-3 C, indicating 
distinct time courses of changes for different types of connections. Overall, extrinsic 
connectivity was reduced across repetitions: Biggest reductions were seen earlier in 
forward compared to backward connections. Modulatory gain parameters are reduced 
initially (D1 to S2) before increasing (S2 to S36). The combination of these parameters best 
explains the observed ERP changes with repetition.  
7.3.3 Effects of ketamine on model parameters 
I then combined DCMs for each subject and session in a single PEB model to identify 
between-session parameter changes induced by ketamine. Initially, I used Bayesian model 
reduction at this second level to compare reduced models that contained ketamine-related 
variation in only a subset of coupling parameters (Figure 7-4 A). This allowed me to 
identify the simplest models with greatest explanatory power: In my hypothesis space I 
allow for complex interactions between ketamine and the effects of repetition suppression 
on the network (through the selection of model parameters available to explain the 
ketamine effect). For example, the N parameters of the DCMs encode repetition-induced 
changes in cortical self-modulation. The second level (PEB) model space included models 
in which the ketamine effect could be explained through changes in these N parameters; 
e.g. ketamine could attenuate changes in self-modulation during repeated exposure to the 
same sound. However, the parameters encoding these effects were redundant and 
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eliminated after Bayesian model reduction. A better explanation for the ketamine effect on 
the MMN was instead a repetition-invariant change in cortical microcircuitry encoded in 
the g parameters.  
An inspection of the winning second-level model revealed that of these g parameters, only 
a subset is affected by ketamine (Figure 7-4 B).  The biggest effect size is seen in g3, which 
represents the strength of inhibition supplied by inhibitory interneurons to excitatory 
spiny stellate cells. This parameter is modulated in opposite direction in the lower areas of 
the hierarchy (increased in right primary auditory cortex A1, left and right superior 
temporal gyrus STG; decreased in left and right inferior frontal gyrus IFG).  
To simulate the (highly nonlinear) effects of these parameter changes on observed ERPs, I 
implemented a forward model based on the grand mean DCM inversion from the earlier 
stages of this analysis. This simulation gradually increased g3 in bilateral STG, while 
decreasing the same parameter in bilateral IFG. The effects of these reciprocal changes in 
source space ERPs are shown in Figure 7-4 C. This analysis reveals an attenuation and 
small increase in latency in the IFG response that resembles the observed changes in the 
mismatch negativity response at the Fz electrode in Figure 7-2 B. The responses at STG 
level are overall reduced in amplitude with a decrease in response latency (also previously 
reported empirically, (Umbricht et al., 2000)) .  
Further analysis of the relationship between excitatory interneurons (here modelled as 
spiny stellate cells) and the superficial pyramidal cells is shown in Figure 7-4 D. Plotted in 
terms of estimated neuronal responses, these graphs represent the evolution of population 
responses during the deviance ERPs in neuronal state space, starting from and returning 
to baseline. These plots show the relative impact of g3 parameter changes on the different 
neuronal populations. In IFG, where interneuron inhibition on spiny stellate cells is 
reduced, this plot reveals a decrease in superficial pyramidal cell amplitude with relative 
preservation of spiny stellate cell activity. Conversely, in STG where g3 is increased, the 
amplitude of spiny stellate cells is relatively decreased compared to superficial pyramidal 
cells.  
7.4 Discussion 
In this study, I identified region-specific changes in cortical microcircuits induced by 
ketamine during an auditory oddball paradigm. The approach presented, provides a 
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unifying hierarchical model explaining network-wide short-term sensory learning effects, 
mismatch effects and the effects of NMDAR-blockade with ketamine. I focussed on 
auditory ERPs – but mismatch responses are known to be attenuated by ketamine in other 
modalities (Schwertner et al., 2018). Furthermore, my results indicate that ketamine affects 
background (i.e. condition-invariant) cortical circuitry. These findings may thus represent 
generic aspects of how predictive coding is affected by ketamine, rather than domain-
specific features of decoding the auditory environment.  
7.4.1 Computational modelling links whole-brain observations with synaptic 
mechanisms 
Mesoscale neuronal models can reproduce various normal (Bhattacharya et al., 2016; Bond 
et al., 2014), and abnormal (Jirsa et al., 2014; Wendling et al., 2016) brain responses, 
explaining complex sets of observations, such as ERP data (Moran et al., 2011b). I used this 
approach to compare a range of possible ketamine effects on auditory ERPs.  
My results suggest that (1) acute NMDAR blockade effects can be explained by a small set 
of key parameters and (2) the parameters identified are consistent with a wealth of pervious 
related, but methodologically distinct studies. The non-trivial link between MMN changes 
and intrinsic inhibition within frontal microcircuits could not have been made without 
explicit computational modelling of EEG generators. With this approach I provide 
evidence for a localised and cell-type specific role of NMDAR hypofunction in psychotic 
pathophysiology in a placebo-controlled human experiment, with clear parallels in studies 
of schizophrenia and acute psychosis in patients (Geyer et al., 2001; Jentsch and Roth, 
1999).  
7.4.2 Deviance responses are caused by network-wide connectivity changes 
Competing theories regarding the origin of the MMN can be summarised as (1) the neural 
adaptation hypothesis, according to which the MMN is explained by ‘bottom-up’ 
dishabituation (Jaaskelainen et al., 2004); and (2) the model adjustment hypothesis, 
according to which MMNs represent an error detection signal prompting predictive model 
updating (Näätänen and Winkler, 1999). Here I replicate findings from previous studies 
pertaining to the neurobiological implementation of these putative mechanisms. In this 
study,  assume the same cortical sources previously identified and replicated in a number 
of auditory oddball EEG and MEG studies (Auksztulewicz and Friston, 2015; G.K. Cooray 
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et al., 2015; Garrido et al., 2009a; Phillips et al., 2015). This allowed me to focus on 
processing dynamics rather than network topology. The placebo results support previous 
DCM studies of the MMN showing that both neural adaptation and model adjustment are 
required to explain the phenomenon, as it requires changes in both intrinsic modulatory 
gain and extrinsic cortical coupling. This is in keeping with a predictive coding account of 
MMN generation. According to the predictive coding framework, sensory predictions are 
passed downstream along the sensory processing hierarchy. When they mismatch sensory 
evidence, a prediction error signal is evoked, which passes back up the cortical hierarchy 
(modulating extrinsic connectivity), whilst also causing adjustment of the intrinsic gain in 
primary sensory cortex (modulating intrinsic connectivity) (Friston, 2005b; Wacongne et 
al., 2012).   
7.4.3 Sensory learning causes distinct patterns of change for different 
coupling parameters 
In the roving oddball paradigm, deviant sounds are repeated until they become the new 
standard, no longer eliciting deviance responses. Previous DCM studies identified distinct 
temporal patterns in associated coupling changes: Using short auditory sequences, 
Garrido et al. (Garrido et al., 2009b) identified a clear difference in extrinsic connections, 
which were consistently reduced with each repetition; and intrinsic connections, which 
showed an initial phasic decrease before slowly increasing with repetition.  
These findings are replicated independently here: extrinsic connectivity decreases with 
repetition, whilst intrinsic connectivity parameters show only a brief phasic decrease. 
There is also a temporal dissociation between forward and backward connections: while 
forward connection strengths quickly return to their baseline value, backward connection 
strengths remain higher for longer. This asymmetry in the time course of forward and 
backward plasticity may reflect more general differences in temporal dynamics at different 
points along the cortical hierarchy. Primate cortical areas are hierarchically ordered in 
their neuronal timescales (Chaudhuri et al., 2014; John D Murray et al., 2014). The 
resultant hierarchically segregated tracking of fast and slow changes at different level of 
the hierarchy may support efficient representation of complex sensory input (Kiebel et al., 
2008a). My findings add further support for this hierarchical separation in time scales. 
After the deviant, short transient increases of forward connections reflect novel sensory 
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information (encoded in prediction errors) in lower cortical areas. More persistent 
changes in backward connections in contrast encode the preceding sensory context (i.e. 
the recent occurrence of the deviant), which persist for a number of repetitions.  
7.4.4 NMDAR blockade has regionally specific effects on intrinsic 
connectivity 
NMDARs are prevalent in the supragranular cortical layers, suggesting particular 
relevance of NMDAR transmission to backward connections in the cortical hierarchy, as 
they target superficial layers (Rosier et al., 1993). However, NMDAR are unevenly 
distributed across cortical interneuron subtypes, indicating that the overall effects of 
systematic NMDAR-blockade may be better represented in regionally-specific intrinsic 
coupling changes (excitatory, or inhibitory), corresponding to localised sub-population 
effects, rather than intrinsic coupling (Moreau and Kullmann, 2013). 
In this study, changes in a limited set of regional intrinsic connections best explain the 
ketamine effects, with strongest effects in a single connection type: inhibitory interneurons 
to spiny stellate interneurons. This is one of the links between fast-oscillating superficial 
and slow-oscillating deep neuronal oscillators of cortical microcircuits (Bastos et al., 2015). 
This effect is region specific: Ketamine causes a decrease in inhibitory interneuron to spiny 
stellate inhibition in STG, but an increase in IFG, indicating a relative disinhibition of the 
IFG. My findings contain within them a replication of Schmidt et al. (Schmidt et al., 2013), 
who considered a subset of model parameters for the ketamine effect. They identified a 
single forward connection as the ketamine-induced change in connectivity during a roving 
oddball paradigm. However, in this more comprehensive model space the regionally 
distinctive disinhibition proves a more parsimonious explanation of ketamine effects. This 
is furthermore in keeping with previous DCM studies of ketamine in other model 
organisms also implicating prefrontal regions (Moran et al., 2015; Muthukumaraswamy et 
al., 2015), as well as an MMN study in people with psychosis and their relatives (Ranlund 
et al., 2016). 
Functionally, the ketamine-related reduction in prefrontal inhibition results in a 
constitutive increase in prefrontal excitability, or gain. Dysfunctions on gain control have 
been put forward as explanations for aberrant sensory processing underlying 
hallucinations (Friston, 2005a), explaining hallucinations as a failure to encode sensory 
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uncertainty. Several clinical features of disorders characterised by psychotic symptoms, 
including attenuated mismatch negativity, can be explained through hierarchical failures 
in precision encoding, as discussed in detail in Adams et al (Adams et al., 2013).  
Interestingly, cell-type specific knock-outs of NMDAR on inhibitory interneurons are 
already used in animal models of schizophrenia (Bygrave et al., 2016; Nakazawa et al., 
2017). Invasive recordings in prefrontal cortex of such mouse models suggest that the 
overall effect of NMDAR-transmission is an inhibitory drive (Homayoun and 
Moghaddam, 2007). Detailed examination of the role of NMDAR-blockade on gamma 
oscillations (known to be abnormal in schizophrenia), also showed the effect to be 
mediated through inhibitory interneurons (Carlén et al., 2012). Although – by design – my 
study focussed on evoked and not oscillatory responses, it is worth noting the convergence 
on inhibitory dysfunction in these optogenetic mouse models, and in other EEG studies in 
human subjects (e.g. (Carlén et al., 2012; Homayoun and Moghaddam, 2007; Umbricht et 
al., 2000)). The regional specificity of the effects described here at the source level is 
furthermore mirrored by a literature on topographically specific impairments in 
schizophrenia (Baldeweg et al., 2002; Baldeweg and Hirsch, 2015). Prefrontal inhibitory 
interneuron dysfunction has also emerged as a potential mechanism underlying other 
features of schizophrenia (Cohen et al., 2015; Lewis et al., 2005), further supported by 
computational models of prefrontal cortex function (John D. Murray et al., 2014).  
The focus of this study was to relate pharmacological perturbation of brain function with 
measurable ERP modulations. The results concerning the localisable effects of NMDAR-
blockade have clear implications for NMDAR-focussed hypotheses of schizophrenia. 
Whilst previous studies have shown a link between MMN measures of abnormal 
physiology in schizophrenia and psychopathology (Umbricht et al., 2002), I have not 
specifically addressed psychopathology in the test subjects here. Previous studies have 
shown that MMN features (Thiebes et al., 2017) or MMN-derived DCM parameters 
(Schmidt et al., 2013) during ketamine exposure correlate with different aspects of 
psychopathology, which is clearly an important area of future research.  
7.4.5 Limitations 
This study uses complex dynamic causal models on low-density EEG, limiting robust 
source localisation without prior assumptions. Here, I am assuming cortical sources to be 
located at previously identified MNI coordinates (Auksztulewicz and Friston, 2015; G.K. 
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Cooray et al., 2015; Garrido et al., 2008; Phillips et al., 2015), focussing on exploring 
processing dynamics rather than MMN topology.  
Bayesian model selection – as used in this study – can only provide relative evidence of 
models that are actually included in the model space. A more parsimonious explanation of 
the data may exist, but I cannot comment on alternative hypotheses that are not included 
explicitly. I chose the model space carefully, based on the MMN literature to (a) 
accommodate previous findings on repetition suppression and (b) test specific hypotheses 
about the effects of ketamine in this setting. In short, I cannot draw conclusions about 
whether other models may offer better explanations for the data, however, I can argue that 
the model space offers a broad repertoire that includes most neurobiologically plausible 
hypotheses currently entertained in the literature. Secondly, because of side effects for 
some of the participants, the dose of ketamine had to be adjusted for subsequent subject. 
This additional variation is explicitly accommodated in the model (as a parametrically 
modulated regressor in the parametric empirical Bayesian analysis), thus allowing 
integration of two distinct ketamine doses compared to placebo. Furthermore, drug level 
monitoring was not included in the study design, thus some inter-subject variability may 
be accounted for by differences in drug metabolism and excretion. However, the statistical 
modelling used in my analysis accommodates the ensuing random (between-subject) 
effects.  
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 Conclusion 
In this thesis, I have provided an illustration of the use of a range of computational models 
to draw neurobiological conclusions from model systems and datasets focussed on 
neurodevelopmental disorders. I have specifically focussed the research projects on 
examples where a single molecular (genetic, autoimmune, or pharmacological) 
mechanism has profound effects on neuronal dynamics. With this approach, I have 
obtained neurobiological insights that are specific to the neurodevelopmental condition 
that is being modelled in the particular experiment (discussed in more detail in Chapters 
4-7), which I summarise briefly below.  
8.1 Summary of main findings 
• Chapter 4: Temperature-dependent gating abnormalities in an epilepsy-associated 
voltage-gated sodium channel variant confers a mixed loss-of-function, and a gain-
of-function effect in an in-silico model of cortical neurons. 
• Chapter 4: These gating abnormalities allows neurons carrying the mutant channel 
to continue firing at abnormally high input levels – a possible mechanism 
underlying the temperature-dependent seizure susceptibility this mutation confers 
in patients. 
• Chapter 5: Dynamic causal modelling of synaptic coupling in PTZ-induced 
seizures in zebrafish larvae reveals that global synchronisation of brain-wide 
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activity can be explained largely by local, regional-specific changes in synaptic 
coupling. 
• Chapter 5: The synaptic changes during seizures in zebrafish evolve cyclically over 
time, associated with specific spectral profiles at different time points in the seizure  
• Chapter 6: In paediatric patients with NMDAR-Ab encephalitis, paroxysmal EEG 
abnormalities can be modelled with just a few key parameters describing the 
dynamics of intracortical synaptic coupling. 
• Chapter 6: In a corresponding mouse model of NMDAR-Ab encephalitis, exposure 
to the antibodies sensitise the cortical circuitry to abnormal slow-wave paroxysms 
in response to additional chemoconvulsant exposure. 
• Chapter 6: In-silico simulations reveals that small fluctuation of synaptic coupling 
cross a phase transition in the NMDAR-Ab model, but not the control.  
• Chapter 7: NMDAR blockade with ketamine causes a reduction of MMN 
amplitude in healthy subjects in a placebo-controlled experiment  
• Chapter 7: Network modelling of the ketamine effect reveals that it is best explained 
through selective prefrontal disinhibition  
 
In addition to these main findings related to the specific neurobiological question posed 
within each of the empirical chapter of this thesis, these studies also provide some more 
general insights both in terms of the neurobiological basis of some of these 
neurodevelopmental disorders, and the use of computational models to link microscale 
pathomechanisms with macroscale phenotypic observations. It is these general principles 
that I will discuss in the following sections.  
8.2 Multiscale pathophysiology in neurodevelopmental 
disorders 
As indicated in Chapters 1 and 2 of this thesis, current genomic and molecular biology 
technologies have had a revolutionary impact on our understanding of the molecular basis 
of neurodevelopmental disorders. Yet from these technological advances, questions arise 
regarding the relationship between individual patient phenotypes and the underlying 
molecular disorder. In Chapters 4-7, I have used examples of empirical datasets that record 
phenotypic abnormalities associated with a well-defined molecular disruption. This 
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allowed me to explore what contribution models can make to our understanding of 
different phenotypic features associated with the particular molecular abnormality at 
hand. Across these worked examples, certain common themes about the neurobiology of 
some of these neurodevelopmental conditions emerge, which are discussed below.  
8.2.1 Phenotypes are emergent features of complex neuronal systems  
Biological systems – particularly neuronal systems – have long been recognised to be 
complex: Their components interact, often in non-linear ways and produce difficult to 
predict behaviours. Furthermore, “[c]omplex systems [...] display properties, often called 
“emergent properties”, that are not demonstrated by their individual parts and cannot be 
predicted even with full understanding of the parts alone” (Aderem, 2005). 
I have shown evidence of such emergent properties on a number of different scales – the 
changes in the neuronal firing behaviour of a simulated neuronal membrane equipped 
with the sodium channel dynamics of variant NaV1.1 channels, coded for by a pathological 
SCN1A mutation (Chapter 4); the mostly local changes to neuronal population dynamics 
that give rise to global synchronous oscillatory bursts during PTZ-induced seizures in 
zebrafish larvae (Chapter 5); the unexpected sensitivity to small fluctuations in time 
constant parameters identified in the in-silico model of a cortical microcircuit exposed to 
NMDAR-Ab (Chapter 6).  
Each of these was associated with features that is classically described as part of a patient 
phenotype: heat-induced seizures, abnormal slow wave paroxysms, abnormally 
synchronous activity on the EEG. Each of these would have been impossible to intuitively 
predict from just an analysis of the components of the system alone – either computational 
quantitative simulations, or model inversions allowed me to link the molecular 
abnormalities to the phenotypic observations. With all these features in mind, phenotypes 
appear as emergent features from disruptions at the molecular scale.  
This has conceptual and practical implications in our approach to understanding the 
pathophysiology of complex neurodevelopmental disorders. First, we cannot understand 
the biology of a disease process with reductive approaches focussing at a single scale alone. 
Given the complexity of biological systems, and the number of factors we cannot 
experimentally control, we need to constrain our inference by integrating observations at 
several explanatory levels (Hood and Tian, 2012). In order to effectively do this, we need 
as high quality data about patient phenotypes as we have on patients’ molecular biology 
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(e.g. genotypes) (Helbig and Lindhout, 2017). Where the specific phenotypic features can 
be paired with models of the underlying neurobiology this multilevel approach may not 
only improve our understanding of existing associations between diseases and specific 
molecular disruptions (Stephan et al., 2016), but also help us in establishing new such 
associations.  
8.2.2 Single-effect disruptions at the cellular scale can have wide-spread and 
diverse effects on integrated neuronal systems 
The aim of my work presented in this thesis was to utilise well established links between 
molecular disruption, and neurological/psychiatric disorders to illustrate the validity, and 
benefit of using specific computational modelling approaches. There is some evidence that 
such computational modelling approaches can identify underlying molecular pathologies 
from whole brain data with some specificity (Gilbert et al., 2016; Symmonds et al., 2018). 
Yet the picture that emerges from the studies I present in this thesis suggests a more 
complex picture: For example, NMDA-receptor disruption in models of NMDAR-Ab 
encephalitis produced broad changes in both the strength and the temporal dispersion of 
inhibitory as well as excitatory synaptic coupling, an effect further potentiated by the 
addition of the chemoconvulsant PTZ (Chapter 6); in contrast, in the ketamine model of 
acute psychosis, NMDA-receptor hypofunction was best described as a locally specific 
disinhibition in the prefrontal cortex (Chapter 7).    
There are many differences in terms of the hypotheses tested, the experimental design, the 
model system, and the computational modelling approach between the different 
experiments in this thesis. However, one general observations across the different studies 
included in this thesis is the following: Even for interventions where the molecular effect 
is relatively well characterised at the molecular, or single-cell level (e.g. NMDAR 
antibodies), the models of integrated neuronal populations employed here often identify 
more than just a single effect type as underlying the phenotypic features under 
investigation. 
In some ways this is unsurprising – NMDA receptor blockade for example blocks a single 
receptor-type but depending on (1) the relative distribution of NMDA/AMPA receptors, 
(2) the baseline NMDAR-mediated drive of inhibitory interneurons, and (3) the amount 
of synaptic and extra-synaptic NMDAR transmission, the net effect of NMDAR-blockade 
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on an integrated network can be very different. But the observation again highlights the 
context-dependence of even ‘simple’ disruptions in molecular processes – speaking to the 
phenotypic diversity that seem to be associated with overlapping risk factors across patient 
cohorts with different neurodevelopmental disorders.  
Evidence of such context-dependence is already being identified through genetic methods 
(e.g. CACNA1G as modulator of epilepsy risk in a mouse model of SCN1A-associated 
Dravet syndrome). Hypotheses about what type of context changes a specific molecular 
process might be most sensitive to can be generated in-silico by exploring the stability of 
the dynamical systems that are being modelled (cf. Chapter 4, and Chapter 5 of this thesis). 
8.3 Modelling dynamic neuronal pathologies 
In the different projects that constitute the empirical component of this thesis, I rely on a 
range of different modelling approaches – ranging from models of neuronal membrane, 
to cortical microcircuit, and whole-brain network models. Whilst the specific conclusions 
arising from these approaches are discussed in Chapters 4-7, I will discuss some insights 
that span multiple of the experiments below. 
8.3.1 Quantitative models link smooth parameter changes to apparently 
distinct states 
The kind of models used in this thesis (Hodgkin-Huxley type conductance models of 
neuronal membranes, Chapter 4; convolution-based neural mass models, Chapters 5-7) 
are based on ordinary differential equations that describe the flow of interacting systems 
in time. All of them contain a nonlinear mapping between input and the neuronal states – 
with the convolution-based models being more weakly nonlinear than the conductance 
based models. This combination – a coupled dynamical system with a nonlinearity is 
sufficient to generate a whole range of dynamic behaviours, many of which are illustrated 
in the thesis: the difference between fixed point and oscillatory states in Chapter 4, the 
critical transition identified in the NMDAR-Ab in-silico simulations in Chapter 6, and 
even the complex changes a local disinhibition produced in the models of an auditory 
processing network in Chapter 7.  
The simple nonlinear mapping between neuronal model parameters and neuronal 
dynamic states has wide ranging implications: Depending on the precise parameterisation 
 184 
of the model, small fluctuations in parameters may have a drastic effect on the neuronal 
states, whereas under different parameter combinations, even large changes in model 
parameters may have very limited effects on neuronal oscillatory outputs that are being 
modelled (most comprehensively discussed in Chapter 6 of this thesis). This feature of 
dynamical systems bears a deep relationship to how we understand brain dynamics to date. 
For example, even quite drastic changes in EEG dynamics – such as the appearance of a 
posterior dominant rhythm, or the change between qualitatively very distinct sleep stages 
– can appear very suddenly without drastic changes to synaptic parameters. From the 
dynamical systems approach illustrated throughout this thesis, we can conclude that the 
same qualitative neurobiology (i.e. the same model architecture, with the same types of 
parameters at play) can support very distinct appearing states through gradual changes 
such as neuromodulation (i.e. small changes in the parameters of the model system).  
Whilst the nonlinearities in these neuronal models (particularly in the case of the 
conductance models) make model inversion challenging, the insight that dynamical 
systems can produce distinctive states from (neurobiologically plausible) smooth 
transitions in parameters makes them an appropriate model for these neurobiological 
questions. This insight in itself is not new (Breakspear, 2005; Phillips and Robinson, 2007), 
the meaningful results provided by linking these modelling approaches to quantitative 
data of human pathophysiology makes this a promising avenue of further research.   
8.3.2 Modelling neuronal dynamics across multiple temporal scales 
In the model-based inference presented here, I was interested in how pathological 
processes (such as a genetic mutation, or antibodies against particular neuronal surface 
targets) entrain the dynamical system and relate to observable, quantitative features in the 
associated phenotypes (such as particular EEG patterns). The principal assumption in this 
modelling approach is that disruptions in the molecular neurobiology cause persistent 
changes in the parameters of the model (e.g. the excitatory coupling between different 
neuronal populations), which in turn makes certain neuronal states (e.g. specific 
oscillatory patterns) more or less likely to occur. This is illustrated e.g. by Chapter 7 of this 
thesis, where the experimental factors (standard vs. deviant sound; placebo vs. ketamine 
condition) are represented as discrete modulations of the network model parameters. 
In contrast, for some other experimental designs (e.g. the PTZ exposure as an experimental 
factor in Chapters 5 and 6), the system parameters are not organised into discrete 
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conditions, but rather change slowly over time – giving rise to transient excursions into 
abnormal dynamic regimes, such as seizure activity. Elsewhere such processes – fast 
changing neuronal states that are constrained by a slowly changing synaptic parameters – 
is modelled through an adiabatic separation of time scales of multiple neuronal states, i.e. 
the slowly changing process is so slow that within short time windows they can be assumed 
to be stationary (Jirsa et al., 2014). 
Such models with separate dynamics in their neuronal states can provide in-depth insights 
into the dynamic regimes that the model can operate under through simulations (Jirsa et 
al., 2017; Petkoski et al., 2016), but they are challenging to invert based on empirical data, 
because long recordings (and many data points) would have to be inverted in a single 
model inversion, tracking multiple types of neuronal states – quickly making such model 
inversions computationally intractable (although some processes, such as Kalman filters 
can alleviate some of the computational constraints (Schiff and Sauer, 2008)).  
An alternative approach developed by my collaborators and me is the complete separation 
of fast and slow states into (1) neuronal states (included in a steady state dynamical model), 
constrained by (2) parameters that fluctuate slowly over successive epochs or time-
windows. This approach has been particularly useful when modelling seizure activity 
(Papadopoulou et al., 2017), or where the experimental design includes time varying 
interventions (such a PTZ injection with known pharmacokinetics). This has been made 
possible by recent developments in the computationally efficient Bayesian inversion of 
hierarchically structured dynamic causal models, originally designed for group studies 
(Friston et al., 2015).  
This approach is useful not only in the application shown in the applications reviewed in 
this thesis (Chapter 5, Chapter 6), but also more broadly for research in 
neurodevelopmental disorders. For the purposes of this thesis, I have not specifically 
investigated the developmental aspects of neurodevelopmental disorder – clearly, studies 
over longitudinal datasets will be invaluable for deriving an account of how synaptic 
coupling underlying, e.g. particular EEG phenomena, changes in development and 
diverges between disease groups. The computational approach that allowed me to track 
slow synaptic variations across the duration of a single experiment can be used on those 
datasets to identify age-specific and longitudinal effects. With the current establishment of 
large, developmental, public multimodal EEG and phenotyping datasets for patients with 
 186 
neurodevelopmental disorders and healthy controls (Di Martino et al., 2017; Langer et al., 
2017), methods that can comprehensively capture dynamic changes across computational 
models of neuronal dynamics will be essential for future research into the neurobiological 
basis of neurodevelopmental disorders.  
8.4 Future directions  
The empirical work presented in the chapters of this thesis covered a broad range of 
computational models (Hodgkin-Huxley models of the neuronal membrane, neural mass 
models of single microcircuits, and network models of whole brain function); a diversity 
of data of neuronal function (local field potentials, light-sheet calcium imaging, EEG); and 
a broad range of models pertinent to different neurodevelopmental conditions (early 
infantile epilepsies, NMDA receptor antibody encephalitis, acute psychosis and 
schizophrenia). There is therefore a huge number of possible directions into which this 
work could continue in the future, a selection of which I will outline here.  
8.4.1 Translational neuroscience through computational models 
Animal models and other model systems are essential to improving our understanding of 
neurodevelopmental disorders, and in fact were incorporated in Chapter 4, 5, and 6 of this 
thesis. Yet many observations from the animal models do not translate easily into human 
studies, or even clinical practice. This may relate to neurobiological differences between 
the model systems that do not allow for easy interpretation of shared phenotypic features 
– e.g. a synaptic change that could cause epileptic seizures in human patients may have no 
easily detectable ictal phenotype in an animal model.  
Computational models can act as a bridge between clinical observations and 
experimentally controlled data that other disease models can yield. With the work 
illustrated in this thesis, I have but scratched the surface of the potential of quantitatively 
exploring the effects of human disease-causing mutations. For early infantile epilepsies 
alone, we now routinely sequence >100 genes per patient attending the clinic (Oates et al., 
2018; Trump et al., 2016) – each of which with likely more than one reported pathogenic 
mutation.  
Characterising a broader range of such genetic mutations in conjunction with associated 
animal models may offer a better mapping between human and animal model phenotypes 
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– as computational models may show that data features that appear quite different in 
calcium imaging in zebrafish, and in EEG recordings in human patients may in fact be 
caused by similar synaptic mechanism revealed by computational models such those 
considered in this thesis. Identifying such shared mechanisms between human patients 
and animal models is a necessary first step when testing possible future new therapies and 
the focus of ongoing future research.  
8.4.2 Quantitative models of mechanistic phenotypes in patients 
The chapters concerning the analysis of human EEG data (Chapters 5, 6) showcase the 
amount of additional information contained in non-invasive, quantitative recordings of 
human brain function. Classically analysis of clinical EEG has focussed on visual feature 
detection and qualitative reporting of abnormalities (e.g. the presence or absence of 
epileptiform activity), there is scope to utilise routine clinical EEG recordings in more 
model-based investigations.  
Bayesian model inference strategies (such as dynamic causal modelling) allow the 
quantitative link of EEG phenotypes and biophysically plausible models of neuronal 
(dys)function. Especially where there are particular informed hypotheses that may explain 
particular epileptic phenotypes (e.g. an interneuron-specific disruption in patients with 
SCN1A (Favero et al., 2018)), we can provide evidence for the explanatory potential of such 
hypotheses directly from human EEG data. Taken together with other lines of evidence – 
this approach may help us distinguish epiphenomena from actual pathophysiology, and 
target interventions appropriately to markers of pathophysiological mechanisms.  
8.4.3 Building predictive models for therapeutic interventions 
Ultimately one of the aims of translational neuroscience, and the neuroscience of human 
disorders is to inform novel strategies for the treatment of human conditions.  Yet whilst 
there are a multitude of possible interventions that show promise from pre-clinical animal 
and disease model trials (Griffin et al., 2017), translation to wide-spread human use 
remains challenging – in part because it is challenging a priori to identify from all 
promising strategies those that are most likely to work and prioritise them for clinical 
studies.  
Using computational models that (1) explain phenotypic features across different disease 
models through identifying a shared pathomechanisms and (2) can generate predictions 
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of how the system responds after intervention may offer a promising novel approach to 
this problem. There is some evidence, for example, that computational models of 
epileptogenic networks can help predict the outcome following epilepsy surgery (Sinha et 
al., 2017; Taylor et al., 2018). Such models have the promise to allow us to use inexpensive 
in-silico simulations to prioritise those most promising (more expensive and time-
consuming) in-vivo experiments, when developing novel therapies.   
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1. INTRODUCTION  
 
Genetic and other molecular diagnostics have revolutionised our understanding of many 
neurological conditions in childhood, including many different paediatric epilepsy syndromes. 
Based on these findings, many conditions can now be understood as disturbances in synaptic 
function caused by specific molecular alterations in channel and other synaptic proteins. However, 
how problems with individual molecular at the neuronal membrane translate to abnormal brain 
function is still poorly understood. This study aims to improve this understanding by using in silico, 
computational modelling of brain dynamics to link patients’ phenotypes with underlying neuronal 
abnormalities. 
 
 
2. BACKGROUND  
 
Computational modelling already has an established role in furthering our understand of 
mechanisms underlying different types of epilepsy (Lytton, 2008). In the context of epilepsies with 
a known molecular cause, computational models offer two conceptually complementary 
approaches: Models can be used in a bottom up approach, predicting the dynamic dysfunction 
caused by molecular abnormalities the whole neuron, or microcircuit (Peters et al., 2016); 
Alternatively, in a top-down approach, modelling of EEG recordings at the level of integrated 
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neuronal assemblies can help identify specific changes in microcircuitry associated with known 
molecular abnormalities (Gilbert et al., 2016).  
 
The results from these complementary approaches can then be used in two different ways: (1) They 
can outline a mechanism linking molecular abnormalities with whole-brain phenotypes in a single 
mechanistic understanding of the condition (Kopell et al., 2014), (2) They may support more 
neurobiologically relevant classification of patients into different categories (Brodersen et al., 2011), 
(3) They may in the future be used to predict treatment outcomes for individual patients (Sinha et 
al., 2017). 
 
Recent advances in computational modelling (Friston et al., 2015), and molecular diagnostics 
(Møller et al., 2015) have set the context in which this proposed study now can take place: There 
are now established cohorts of patients with shared molecular causes for their neurological 
condition (e.g. genetic mutations, neuronal antibodies); and computational modelling of the 
molecular and microcircuit basis of neuronal dynamics allows us to identify shared abnormalities 
between patients. 
 
 
3. AIM(S) OF STUDY 
 
The aim of this study is to identify possible mechanisms that underlie disorders in neuronal function 
in paediatric patients with known molecular abnormalities. In order to address this overall aim, the 
study will address the following objectives 
 
4. OBJECTIVES   
 
1) Collate anonymised, basic clinical information on cohorts of patients with disturbance 
of neuronal function and shared molecular abnormality (e.g. identified gene mutation, 
identified antibody to neuronal surface molecule). 
2) Bottom-up Modelling: Predicting dynamic consequences of genetic mutations at the 
neuronal membrane and neuronal microcircuits (e.g. from miss-sense mutations identified 
in single genes) 
3) Top-down Modelling: Identifying network disturbances underlying specific EEG features 
observed in patients with known molecular talk (e.g. dynamic EEG abnormalities in patients 
with antibodies to NMDA-receptor abnormalities) 
 
 
5. HYPOTHESIS  
 
5b. Primary Hypothesis 
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H1) Similar molecular disturbances cause similar disturbances in neuronal function, as estimated 
from computational models of neuronal populations 
 
 
5b. Secondary Hypotheses 
  
H2) Computational models of molecular disturbance at the ‘microscale’ can predict the 
abnormalities identified from computational models of the EEG ‘macroscale’  
 
H3) Model parameters may be used to distinguish different patient groups in a machine learning 
classification appraoch 
 
 
6. STUDY DESIGN  
 
This study is a retrospective, observational cohort study, applying quantitative analysis to clinical 
data, such as single gene sequencing results and clinical EEG recordings.  
 
 
7. STUDY SETTING/LOCATION 
 
The study will be conducted from 01/06/2017 – 01/06/2020, and data collation will include historical 
records of patients identified prior to the study date. The study will be conducted at approximately 
4 investigative sites across England, and Ireland. Collation will stop when approximately 50 subjects 
across all cohorts have been identified.    
 
Study sites will include: Great Ormond Street Hospital NHS Foundation Trust, London, UK; Evelina 
London Children’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK; King’s 
College Hospital NHS Foundation Trust, London, UK; Children’s University Hospital, Dublin, 
Ireland.  
 
 
8. STUDY POPULATION  
 
The study will collate several distinct cohorts with identified molecular abnormalities according to 
the inclusion and exclusion criteria below. Broadly selection will be based on identified molecular 
causes for the patients’ neurological conditions (i.e. genetic testing results, identification of neuronal 
surface antibodies, etc).  
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9. ELIGIBILITY CRITERIA 
 
9a. Inclusion criteria  
 
1) Paediatric patients: Age of clinical symptom onset 0 – 16 years  
2) Abnormal EEG recordings on record and accessible at one of the study sites 
3) Laboratory confirmed clinical diagnosis of one of  
a. SCN1A – mutation associated epilepsy  
b. NMDA-receptor antibody associated encephalitis 
c. GRIN2A – mutation associated epilepsy 
d. Tuberous sclerosis 
e. Other genetic, or autoimmune epileptic or encephalopathic conditions of childhood 
with confirmed molecular cause 
 
9b. Exclusion criteria 
 
1) Laboratory results of molecular diagnostics not available 
 
 
10. STUDY OUTCOMES 
 
10a. Primary Outcome 
 
The primary outcome measure will be statistical evidence for shared parameter abnormalities 
between patients with the same molecular abnormalities, estimated from the computational models 
and using a Bayesian analysis framework (where a Bayes factor > 3 will be considered strong 
evidence)  
 
10b. Secondary Outcome(s) 
 
The modelling will also provide more quantitative outcome measures regarding the types of 
dynamic abnormalities seen in patient cohorts (corresponding to seizure susceptibility, or instability 
of certain dynamic states)  
 
 
11. STUDY PROCEDURES  
 
The study procedures are limited to review of existing medical records and will not require access 
to any biological specimens or patient identifiers by the research team. 
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11a. Recruitment of participants 
 
Cases will be ascertained and summarised by treating clinicians. All analyses will be completed on 
anonymised case summaries only. Cases will be identified from routine clinical service by the 
clinicians responsible for clinical care (including but not limited to paediatric epileptologists, 
paediatricians, clinical neurophysiologists, clinical geneticist) in accordance with the inclusion and 
exclusion criteria outlined above. Cases can be included from clinical cohorts, historical records in 
existing research databases, and clinical databases held in the respective departments. 
 
11b. Study procedure  
 
Basic demographic information and case histories will be summarised from the clinical notes 
(including electronic patient records, clinic letters, etc). EEG recordings will be copied in 
electronically from the recording EEG department. Genetic and antibody diagnostics will be derived 
from the clinical notes, or directly from the performing laboratory and summarised.  
 
11c. Measurement tools used  
 
Clinical case will be included in anonymised and summarised form. The variables included in the 
case summaries will include the following domains 
 
 
Basic Demographics 
 
 
EEG  
 
Molecular Diagnostics 
 
Clinical History 
Age at symptom onset Background EEG 
(description) 
 
Diagnostic summary Diagnostic Label  
Gender Interictal abnormalities 
(description) 
 
Identified abnormality (e.g. 
gene mutation, antibody titre) 
 
Current and past 
medication and other 
treatments  
Ethnicity  Ictal abnormalities 
(description) 
 
Time between symptom onset 
and diagnostic test 
 
Past medical history 
(including related 
conditions) 
 Electroclinical diagnostic 
label 
 
 Family history of related 
conditions 
 
 
11d. Safety considerations/Patient safety  
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All data will be stored in compliance with UCL and national regulations. Specifically all effort will be 
made to maintain anonymity of the patients: 
 
1) No patient identifiers will be accessed by the research team 
2) No patient identifiers will be stored with the anonymised clinical record 
3) All electronic data will be stored in anonymised form on encrypted hard drive, or fully 
secured and compliant electronic databases hosted by UCL (Harris et al., 2009) 
 
Clinical records (i.e. source documents) will only be accessed by the clinicians directly involved with 
the patients’ care. Clinical summaries, and test results will be anonymised associated with unique 
study IDs that are used to link clinical data and EEG records; those anonymised summaries are 
transferred to the research team.  
Anonymous records will be kept as paper case forms in a securely locked cupboard on UCL 
premises, and/or will be stored electronically on a fully data-protection regulation compliant 
database, hosted on UCL servers (Harris et al., 2009). EEG data will be anonymised and then 
transferred on an encrypted hard drive from the study site to a UCL based desktop computer, where 
they will be stored in encrypted files on a desktop computer. Backups of the encrypted files will 
occur regularly (every day) on the institutional server, but only the research team will have access 
to the decryption key, and thus only the research team will have access to the anonymised EEG 
data for quantitative analysis.  
Anonymised data will be stored for 15 years post-publication date of any publications arising from 
this research on UCL premises and UCL electronic database systems before they will be destroyed.  
11e. Data monitoring  
 
The principal investigators will regularly review the progress of the study, and alert the Sponsor, 
and clinical study sites of any problems with data collection, data safety or irregularities. 
 
11f. Data protection arrangements 
 
All data collection and storage will be fully compliant with local and national regulation. Data will be 
collected on paper pro-forma, or directly recorded into an electronic database hosted by UCL 
servers (with write-only access granted to local study partners). Paper forms will be transferred 
through recorded mail to the UCL address of the chief investigator, and transferred onto the 
electronic database there. Paper forms will then be shredded and disposed of in confidential waste 
bins.  
The database will be located on encrypted servers hosted within the UCL Institute of Neurology, 
which will be backed up regularly. Data will be stored for 15 years, after which it will be destroyed.  
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12. STATISTICAL CONSIDERATIONS AND DATA ANALYSIS 
 
12a. Sample size and statistical power 
 
12b. Statistical methods 
 
Data will be analysing by developing data-informed individualised models of (1) whole-brain 
dysfunction based on EEG recordings, and (2) molecular dysfunction based on molecular 
diagnostic results.  
 
EEG Modelling 
 
EEG recordings will be analysed in the following stages: 
 
1) Routine preprocessing, including bandpass filtering (0.1 – 70Hz) 
2) Visual inspection to identify paroxysmal abnormalities and pertinent EEG features (e.g. 
intermittent rhythmic slowing, epileptiform discharges, etc). 
3) Calculating cross spectral density summaries of EEG signals across different types of EEG 
features for windowed segments of EEG 
4) Within individuals: Applying dynamic causal modelling approach to explain transitions 
between different EEG features as fluctuations in synaptic connectivity parameters (Kiebel 
et al., 2008b) 
5) Between individuals: Applying a parametric empirical Bayesian approach to identify shared 
parameter alterations between patients with the same molecular conditions (Friston et al., 
2016b) 
 
This approach will provide a summary of shared changes in computational model microcircuitry that 
underlies a range of EEG abnormalities between patients. Analysis of statistical significance will be 
based on Bayesian model comparison with a Bayes factor of >3 considered strong evidence 
(Stephan et al., 2010).  We will aim to include approximately 10 patients for group analyses in each 
cohort (5 cohorts)  
 
Modelling of Receptor Function 
 
In those patients where mutations affect an ion channel (e.g. SCN1A), computational models will 
be used to predict functional outcomes of the channel alteration at the level of the neuron, or a 
neuronal ensemble. This analysis will be performed in the following states: 
 
1) Use of the PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) online mutation effect 
prediction tools to predict likely pathogenicity and impact of individual mutations on 
channel function 
2) Where available, retrieve existing molecular characterisation parameters of specific 
mutation (Peters et al., 2016) 
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3) Integrate abnormalities in model of neuronal membrane (e.g. Hodgkin Huxley model), or 
neuronal ensembles (e.g. conduction-based neural mass models) to predict mutation 
effects 
4) Compare predictions with findings reported in EEG recordings and where possible with 
computational modelling analysis above.  
 
This approach will provide qualitative insights into different ranges of dynamic behaviour associated 
with specific receptor abnormalities (Jirsa et al., 2014) and may be used to classify disease related 
mutations according to the degree of functional abnormalities induced. These will be used to infer 
common, or convergent mechanisms of dysfunction arising from different patient mutations in the 
same gene. We will aim to include approximately 20 patients in total for this part of the analysis.  
    
 
 
13. ETHICAL CONSIDERATIONS  
 
This study will be conducted in full conformance with the principles of the “Declaration of Helsinki”, 
Good Clinical Practice and within the laws and regulations of the countries in which the research is 
conducted.  
 
No study is completely risk free, but in this retrospective data review study, the risk is limited only 
to a breach in confidentiality, which as this study involves genetic results may involve risks to people 
other than the patient him- or herself (i.e. related family members).  
 
The study of breaching confidentiality will be minimised as stated above by  
 
1) Case ascertainment by treating clinicians,  
2) Minimal data collection  
3) Only anonymised data kept in research database / files  
 
In principle, some of the genetic sequencing information may identify the patients (as they constitute 
a rare diagnosis), however the risk for breach of confidentiality based on the genetic sequencing 
information is considered minimal: Cases will be congregated in cohorts of at least 10 or more 
patients with similar mutations (e.g. missense mutations in SCN1A gene). The more detailed 
information regarding specific sequence alterations are usually not known to patients or people not 
directly involved with the patients clinical care related to the condition: Thus revealing this specific 
mutation information will only infer a minimal risk of confidentiality breach (i.e. reveal patient identity 
to the clinical team already involved in their care).  
Furthermore, we will not access any genomic data (e.g. SNP array, whole exome sequencing, 
whole genome sequencing) that may reveal patient identities and other clinical information not in 
the remit of this current study.  
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No clinical analysis of the data will be performed, and therefore the incidental discovery of 
actionable clinical information is extremely unlikely. However, should unexpected clinical 
information be identified, we will report this back to the clinical teams for further action.  
 
Whilst there are no direct benefits to the patients included in this study, there may be future benefits 
arising from this work improving future diagnostic, prognostic and treatment approaches to cohorts 
of patients with similar conditions.  
 
Overall, we conclude that this study infers only a minimal risk to the patients, with the potential for 
indirect future benefits to the patient cohorts in question. We feel that the benefit here outweighs 
the risks for individual patients.   
 
Consent  
 
This study is investigating rare neurological conditions of childhood and as such will require 
inclusion of historical patient records on patients that may not currently be actively followed-up by 
the contributing clinical departments. The study would therefore not feasibly be possible if informed 
consent was required for each participating. Thus we request a waiver of consent and assent (for 
paediatric patients) as justified below 
 
Waiver of Consent  
 
This study requires a waiver of consent requirements because: 
 
1) The study will pose no more than minimal risk to the subjects 
2) Waiver right will not adversely affect the rights and welfare of the subjects 
3) The research could not practicably be carried out without the consent waiver 
 
Waiver of Assent 
 
This study requires a waiver of assent requirements for paediatric patients because: 
 
1) The study will pose no more than minimal risk to the subjects 
2) Waiver right will not adversely affect the rights and welfare of the subjects 
3) The research could not practicably be carried out without the assent waiver 
4)  
 
14. OUTCOMES AND SIGNIFICANCE 
 
It may be of value to reiterate the potential benefits of answering the research question and 
conducting the project. This section restates the justification for the study in terms of the anticipated 
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results. It may be important to specify the implications of the potential results and how the results 
of this study may inform future research or policy makers. 
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A.3  Local trust approval for use of patient data 
A.3.1  Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS 
Foundation Trust 
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A.3.2  Great Ormond Street Hospital NHS Foundation Trust 
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A.4  Modelling dynamic abnormalities caused by an 
SCN1A mutation – custom code 
The Matlab scripts shown here implement a Hodgkin-Huxley type neuronal model with 
parameterisation derived directly from experimental voltage clamp results. They 
correspond to chapter 4 of this thesis.  
Below is a short summary of the code (included in the README file for the online 
repository), followed with excerpts of the custom code written for the analysis. The code 
can be downloaded and run in full from an online repository accessible here: 
https://github.com/roschkoenig/SCN1A_HodgkinHuxley  
A.4.1  README description of code function 
A.4.1.1  Fitting Boltzmann Equations and Plotting Steady-State Parameters 
steady_state_curves 
 
In the first instance, Boltzmann equations were fitted to an existing formulation of the 
Hodgkin Huxley Model that describes the dynamics at the membrane of a mammalian 
cortical neuron. The first component of the script steady_state_curves fits the 
Boltzmann equations. This formulation is taken as the baseline for all further modelling - 
i.e. the wildtype at 37ºC is modelled as this baseline parameter composition.  
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Remaining empirical values are represented as absolute (voltage parameters), or relative 
(slope parameters) deviations from the baseline in the model. The steady states that this 
produces for the sodium channel gating parameters are plotted in the second half of 
the steady_state_curves script. 
 
A.4.1.2  Virtual Voltage Clamp to Assess for Fast Inactivation 
cort_fastinactivation.m 
 
 
This function evaluates model dynamics by performing a 'virtual voltage clamp' 
experiments for the four parameterisations of the model (i.e. baseline, wild type sodium 
channels at 40ºC, SCN1A mutation at 37 and 40ºC). This consists of voltage clamp (i.e. 
 239 
specific voltages being enforced on the model), delivering paired voltage pulses with 
increasing inter-pulse intervals. Changes in sodium conductance are estimated in a 
reduced Hodgkin Huxley Model implemented in cort_hh_fastinactivation.m. Current 
peaks resulting from these paired stimuli are estimated and plotted for each of the 
individual parameterisations of the model in the figure. 
 
A.4.1.3  Running Models Under Different Conditions 
cort_variable_hh_eval 
 
This script calls cort_variable_hh.m and uses Matlab ODE solver to integrate the model 
and plot the time course. The parameters are derived from a baseline model of cortical 
dynamics with experimental values implemented in terms of their deviations from those 
baseline parameters. 
 
A.4.1.4  Evaluation of Model Bifurcations 
cort_bifurcation.m 
 
 
This routine calls cort_variable_hh.m and to run simulations of the cortical Hodgkin 
Huxley model across the four different parameterisations (i.e. baseline, wild type sodium 
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channels at 40ºC, SCN1A mutation at 37 and 40ºC). The model is estimated to steady state, 
and final state values from one simulation are used as initial values for the next simulation. 
This simulation is performed repeatedly across increasing, and then decreasing values of 
the input current Parameter Istim. The steady state values of each model run are then plotted 
as bifurcation plots, separately for the four parameterisations of the model. 
A.4.2  Custom Routines 
A.4.2.1  steady_state_curves 
% Simulate data from cortical parameterisation of HH 
%=======================================================================
=== 
% This routine will simulate datapoints for the cortical parameterisation 
% of the HH model according to Traub (1991) and fit the parameters of the 
% steady state / voltage clamp formulation to these data in order to find 
% the baseline for the further modelling steps 
%  
% This script is the basis for Figure 5a and c in the publication below: 
%  
% Peters C, Rosch RE, Hughes E, Ruben P (2016) Temperature-dependent  
% changes in neuronal dynamics in a patient with an SCN1A mutation and  
% hyperthermia induced seizures 
  
% 
% Setting up the HH equations 
%-----------------------------------------------------------------------
--- 
clear all 
syms a_m b_m a_h b_h V m_inf(V) h_inf(V) t_m(V) t_h(V) 
V_t = -65; 
  
a_m = -0.32 * ( V - V_t - 13 ) / (exp(-(V - V_t - 13) / 4) - 1); 
a_h = 0.128 * exp( -( V - V_t - 17 )/18 ); 
b_m = 0.28 * ( V - V_t - 40 ) / ( exp( (V - V_t - 40)/5 )-1 ); 
b_h = 4 / ( 1 + exp( -(V-V_t-40)/5 ) ); 
  
m_inf(V) = a_m / (a_m + b_m); 
h_inf(V) = a_h / (a_h + b_h); 
  
t_m(V) = 1/(a_m + b_m); 
t_h(V) = 1/(a_h + b_h); 
  
% Calculating simulated datapoints 
%-----------------------------------------------------------------------
--- 
i = 0; 
for V = -80:3:20 
    i = i+1; 
    hh_cort(1,i) = V; 
    hh_cort(2,i) = m_inf(V); 
    hh_cort(3,i) = t_m(V); 
    hh_cort(4,i) = h_inf(V); 
    hh_cort(5,i) = t_h(V); 
end 
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% Fitting steady state formulation to simulated datapoints 
%-----------------------------------------------------------------------
--- 
clear V 
  
V = hh_cort(1,:); 
m = hh_cort(2,:); 
h = hh_cort(4,:); 
  
F_m   = @(x_m,xdata_m) 1 ./ (1 + exp(-(xdata_m-x_m(1))./x_m(2))); 
F_h   = @(x_h,xdata_h) 1 ./ (1 + exp((xdata_h-x_h(1))./x_h(2))); 
x0  = [-12,3]; 
[x_m, resnorm, ~, exitflag, output] = lsqcurvefit(F_m,x0,V,m); 
[x_h, resnorm, ~, exitflag, output] = lsqcurvefit(F_h,x0,V,h); 
  
% Plotting the estimated and simulated steady state curves 
%-----------------------------------------------------------------------
--- 
for V = -80:3:20 
    i = i+1; 
    estimated(1,i) = V; 
    estimated(2,i) = F_m(x_m,V); 
    estimated(4,i) = F_h(x_h,V); 
end 
  
figure(1) 
subplot(3,1,1) 
    plot(estimated(1,:),estimated(2,:),'ro'); hold on 
    plot(hh_cort(1,:), hh_cort(2,:), 'r'); 
    plot(estimated(1,:),estimated(4,:),'bo'); hold on 
    plot(hh_cort(1,:), hh_cort(4,:), 'b'); 
  
  
% Plotting steady state curves for different experimental values 
%=======================================================================
=== 
% This routine will take the experimentally derived voltage clamp values 
% and plot the respective steady state curves for the different gating 
% parameters of the Hodgkin Huxley Model 
  
  
% Choosing parmeterisation 
%-----------------------------------------------------------------------
--- 
n_exp = {'WT37','WT40','AV37','AV40'}; 
exp_parameters = 1:4; % 1 = WT37 (norm), 2 = WT40, 3 = AV37, 3 = AV40; 
  
  
for e = exp_parameters 
% Set according to literature 
%-----------------------------------------------------------------------
--- 
params(1) = 0.010;      % C         HH 
params(2) = 0.0000205;  % g_L       Posposchil 2008, Fig 2 
params(3) = 5;          % g_K       Traub 1991 
params(4) = 56;         % g_Na      Posposchil 2008, Fig 2 
params(5) = -90;        % E_K       Traub 1991 
params(6) = -70.3;      % E_L       Posposchil 2008, Fig 2 
params(7) = 50;         % E_Na      Traub 1991 
params(8) = .2;         % I_stim    HH 
params(11) = -55;       % V_t       arbitrary (guided by Posposchil) 
 242 
  
  
% Set according to experimental values (with WT37 as baseline) 
%-----------------------------------------------------------------------
--- 
switch e 
    case 1  % standard HH formulation (WT37) 
        temperature = 37 + 273;        
        dV2_m   = 0; 
        dV2_h   = 0; 
        t_off   = 0; 
        m_z     =  3.6089; 
        h_z     = -6.6210; 
         
    case 2  % Experimental parameters for WT40 
        temperature = 40 + 273; 
        dV2_m   =  6.49; 
        dV2_h   = -1.9;    
        t_off   = 1.9; 
        m_z     =  2.43*3.6089/2.14;     
        h_z     = -3.79*6.6210/3.14; 
         
    case 3  % Experimental parameters for AV37 
        temperature = 37 + 273; 
        dV2_m   =  5.94; 
        dV2_h   =  2.4;  
        t_off   = -2.4; 
        m_z     =  2.58*3.6089/2.14;     
        h_z     = -3.73*6.6210/3.14; 
         
    case 4  % Experimental parameters for AV40 
        temperature = 40 + 273; 
        dV2_m   = 9.93; 
        dV2_h   = 11.7; 
        t_off   = -11.7; 
        m_z     = 2.1*3.6089/2.14;     
        h_z     = -3.38*6.6210/3.14;       
end 
  
s_m         = (0.0863 * temperature)/m_z; 
s_h         = -(0.0863 * temperature)/h_z; 
  
params(9) = x_m(1) + dV2_m; % V_2m, baseline estimated above 
params(10) = s_m;           % s_m 
  
params(12) = x_h(1) + dV2_h; % V_2h, baseline estimated above 
params(13) = -s_h;          % s_h 
params(14) = t_off;    
 
%-----------------------------------------------------------------------
--- 
  
syms x1 
m_inf = (1 / (1 + exp(-(x1-params(9))/s_m))); 
h_inf = 1 / (1 + exp(-(x1-params(12))/-s_h)); 
  
figure(1); 
if rem(e,2) == 0, col = 'r'; else col = 'k'; end 
if e <= 2 
    subplot(3,1,2) 
    h = ezplot(h_inf, [-80 20]); hold on 
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    g = ezplot(m_inf, [-80 20]); hold on 
    set(h, 'Color', col); 
    set(g, 'Color', col); 
    legend({'WT37 h','WT37 m','WT40 h','WT40 m'}); 
    title('WT channel'); 
else 
    subplot(3,1,3) 
    h = ezplot(h_inf, [-80 20]); hold on 
    g = ezplot(m_inf, [-80 20]); hold on 
    set(h, 'Color', col); 
    set(g, 'Color', col); 
    legend({'AV37 h','AV37 m','AV40 h','AV40 m'}); 
    title('AV mutation'); 
end 
  
dis = figure(1); 
set(dis, 'Position', [100 100 400 700]); 
end 
 
%=======================================================================
=== 
%=======================================================================
=== 
 
A.4.2.2  cort_fastinactivation 
%% Conducting a virtual experiment estimating fast inactivation 
%=======================================================================
=== 
% The appropriateness of the model is evaluated by conducting virtual 
% voltage clamp experiments in order to evaluate whether the model 
predicts 
% real empirical measures.  
% The routine below performs an two-pulse voltage clamp experiment aimed 
to 
% evaluate the dynamics of fast inactivation. A reduced set of HH equations 
% only including sodium channel function is probed with a specific set of 
% paired input pulses with increasing inter-pulse intervals. Short 
% intervals leave little time for inactivation to recover, and therefore 
% diminish model output. 
% The model performs the experiment across a range of inter-pulse 
intervals 
% and plots the maximally achieved pulse amplitude of the second pulse 
for 
% a wild type sodium channel (baseline), as well as a specific SCN1A 
% mutation causing epilepsy.  
% 
% The routine produces a figure that was the basis for Figure 5b and d in  
% the publication below: 
%  
% Peters C, Rosch RE, Hughes E, Ruben P (2016) Temperature-dependent  
% changes in neuronal dynamics in a patient with an SCN1A mutation and  
% hyperthermia induced seizures (under review) 
  
% Housekeeping 
%=======================================================================
=== 
clear all 
clf 
count = 1; 
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% Manual parameters 
%=======================================================================
=== 
% Define manually the name of the experiments and which experimental 
% parameters are going to be modelled in this evaluation 
  
% Choose experiments to be modelled 
%-----------------------------------------------------------------------
--- 
n_exp           = {'WT37','WT40','AV37','AV40'}; 
exp_parameters  = [1 2 3 4];        % 1 = WT37 (norm), 2 = WT40, 3 = AV37, 
3 = AV40; 
plot_phase      = 0; 
I_stim          = 0;                % I_stim    HH value = 0.200 nA 
  
% Set parameters (currently done according to literature 
%-----------------------------------------------------------------------
--- 
params(1) = 0.010;      % C         HH 
params(2) = 0.0000205;  % g_L       Pospischil 2008, Fig 2 
params(3) = 5;          % g_K       Traub 1991 
params(4) = 56;         % g_Na      Pospischil 2008, Fig 2 
params(5) = -90;        % E_K       Traub 1991 
params(6) = -70.3;      % E_L       Pospischil 2008, Fig 2 
params(7) = 50;         % E_Na      Traub 1991 
params(11) = -60;       % V_t       arbitrary (guided by Posposchil) 
params(8) = I_stim;   
  
for e = 1:4; %exp_parameters 
   
% Parameters defined according to experimental values (with WT37 as 
baseline) 
%=======================================================================
=== 
switch e 
    case 1  % standard HH formulation (WT37) 
    %-------------------------------------------------------------------
--- 
        temperature = 37 + 273;        
        dV2_m   = 0;        % normalised to 0 
        dV2_h   = 0;        % normalised to 0 
        t_off   = 0;        % normalised to 0 
        m_z     =  3.6089;  % normalised to cortical neuron values 
        h_z     = -6.6210;  % normalised to cortical neuron values 
         
    case 2  % Experimental parameters for WT40 
    %-------------------------------------------------------------------
--- 
        temperature = 40 + 273; 
        dV2_m   =  6.49;    % absolute difference to WT37 
        dV2_h   = -1.9;     % absolute difference to WT37 
        t_off   = 1.9;      % absolute difference to WT37 
        m_z     =  2.43*3.6089/2.14;    % relative difference to WT37 
        h_z     = -3.79*6.6210/3.14;    % relative difference to WT37 
         
    case 3  % Experimental parameters for AV37 
    %-------------------------------------------------------------------
--- 
        temperature = 37 + 273; 
        dV2_m   =  5.94;    % absolute difference to WT37 
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        dV2_h   =  2.4;     % absolute difference to WT37 
        t_off   = -2.4;     % absolute difference to WT37 
        m_z     =  2.58*3.6089/2.14;    % relative difference to WT37      
        h_z     = -3.73*6.6210/3.14;    % relative difference to WT37 
         
    case 4  % Experimental parameters for AV40 
    %-------------------------------------------------------------------
--- 
        temperature = 40 + 273; 
        dV2_m   = 9.93;     % absolute difference to WT37 
        dV2_h   = 11.7;     % absolute difference to WT37 
        t_off   = -11.7;    % absolute difference to WT37 
        m_z     = 2.1*3.6089/2.14;      % relative difference to WT37  
        h_z     = -3.38*6.6210/3.14;    % relative difference to WT37     
end 
  
% Calculate model parameters from values given above 
%-----------------------------------------------------------------------
--- 
s_m         = (0.0863 * temperature)/m_z;   % slope derived from m_z 
s_h         = -(0.0863 * temperature)/h_z;  % slope derived from h_z 
  
params(9)   = -39.0 + dV2_m;    % difference from standard cortical neuron 
params(10)  = s_m;            
params(12)  = -43.2 + dV2_h;    % difference from standard cortical neuron 
params(13)  = s_h;     
  
params(14) = t_off;          
  
  
g_Na        = params(4); 
E_Na        = params(7); 
x_ini       = [0 0 0 0]; 
  
% Run Model 
%=======================================================================
=== 
rec_t(1) = 0.1;      % recovery time in miliseconds 
for r = 1:10 
p1          = [100 200]; 
p2          = [0 10] + [p1(2) + rec_t(r)]; 
t_range     = [0 p2(2)+100]; 
  
options     = odeset('InitialStep',0.005,'MaxStep',t_range(2)/1000); 
[t,x]       = ode45(@(t,x)cort_hh_fastinactivation(t,x,params, p1, 
p2),t_range,x_ini,options); 
  
% Estimate currents for each time point 
%-----------------------------------------------------------------------
--- 
% Estimate actual currents from model output (sodium channel conductance)  
% and the set voltages as per voltage clamp experimental design 
  
for s = 1:length(t) 
     
    if t(s) < p1(1), vol(s) = -130;                      % Initial cond 
    elseif t(s) > p1(1) && t(s) < p1(2), vol(s) = 0;     % Pulse 1 
    elseif t(s) > p2(1) && t(s) < p2(2), vol(s) = 0;     % Pulse 2  
    else vol(s) = -90;                                   % Recovery Time 
    end 
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    x(s,3) = (-g_Na * x(s,1)^3 * x(s,2) * (vol(s) - E_Na));     
end 
  
% Estimate current peak after second pulse 
%-----------------------------------------------------------------------
--- 
count = 1; 
for i = 1:length(t) 
    if t(i) > p2(1) && t(i) < (p2(1) + 10) 
        ind(count) = i; 
        count = count+1; 
    end 
end 
  
[val loc]    = findpeaks(x(ind,3)); 
IR(e,r,1)    = rec_t(r); 
IR(e,r,2)    = max(val); 
  
rec_t(r+1)   = rec_t(r) * 2; 
end 
clear rec_t p1 p2 ind 
end 
  
subplot(2,1,1) 
plot(log(IR(1,:,1)), IR(1,:,2)/max(IR(1,:,2)), 'ks-'); hold on 
plot(log(IR(3,:,1)), IR(3,:,2)/max(IR(3,:,2)), 'ks:') 
title('37 degrees'); 
legend({'WT', 'AV'}); 
  
subplot(2,1,2) 
plot(log(IR(2,:,1)), IR(2,:,2)/max(IR(2,:,2)), 'rs-'); hold on 
plot(log(IR(4,:,1)), IR(4,:,2)/max(IR(4,:,2)), 'rs:') 
title('40 degrees'); 
legend({'WT', 'AV'}); 
 
%=======================================================================
=== 
%=======================================================================
=== 
 
A.4.2.3  cort_variable_hh.m 
 
%% Calculate and Plot Bifurcations for cortical HH model 
%=======================================================================
=== 
% This routine will simulate a Hodgkin-Huxley model adapted to capture 
% dynamics of cortical neurons for different parameterisations: the 
% wildtype sodium channels at 37, and 40 degrees; an SCN1A mutation 
causing 
% epilepsy at 37, and 40 degrees; and all of these at two different input 
% current strengths.  
% 
% The routine produces a figure that was the basis for Figure 6A in the 
% publication below: 
%  
% Peters C, Rosch RE, Hughes E, Ruben P (2016) Temperature-dependent  
% changes in neuronal dynamics in a patient with an SCN1A mutation and  
% hyperthermia induced seizures (under review) 
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% Housekeeping 
%-----------------------------------------------------------------------
--- 
clear all 
clf 
count = 1; 
  
% Manual parameters 
%=======================================================================
=== 
% Define manually the name of the experiments and which experimental 
% parameters are going to be modelled in this evaluation 
  
% Choose experiments to be modelled 
%-----------------------------------------------------------------------
--- 
n_exp           = {'WT37','WT40','AV37','AV40'}; 
exp_parameters  = [1 2 3 4];  % 1 = WT37 (norm), 2 = WT40, 3 = AV37, 3 = 
AV40; 
plot_phase      = 0; 
I_stim          = [0.2 45];         % I_stim    HH value = 0.200 nA 
direction       = [1 -1];           % 1 = forward, -1 = backward 
forward         = 0:2:90;           % defines range of I_stim parameter 
  
% Set parameters (currently done according to literature 
%-----------------------------------------------------------------------
--- 
params(1) = 0.010;      % C         HH 
params(2) = 0.0000205;  % g_L       Pospischil 2008, Fig 2 
params(3) = 5;          % g_K       Traub 1991 
params(4) = 56;         % g_Na      Pospischil 2008, Fig 2 
params(5) = -90;        % E_K       Traub 1991 
params(6) = -70.3;      % E_L       Pospischil 2008, Fig 2 
params(7) = 50;         % E_Na      Traub 1991 
params(11) = -60;       % V_t       arbitrary (guided by Posposchil)  
  
for e = 1:4; %exp_parameters 
   
% Parameters defined according to experimental values (with WT37 as 
baseline) 
%=======================================================================
=== 
switch e 
    case 1  % standard HH formulation (WT37) 
    %-------------------------------------------------------------------
--- 
        temperature = 37 + 273;        
        dV2_m   = 0;        % normalised to 0 
        dV2_h   = 0;        % normalised to 0 
        t_off   = 0;        % normalised to 0 
        m_z     =  3.6089;  % normalised to cortical neuron values 
        h_z     = -6.6210;  % normalised to cortical neuron values 
         
    case 2  % Experimental parameters for WT40 
    %-------------------------------------------------------------------
--- 
        temperature = 40 + 273; 
        dV2_m   =  6.49;    % absolute difference to WT37 
        dV2_h   = -1.9;     % absolute difference to WT37 
        t_off   = 1.9;      % absolute difference to WT37 
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        m_z     =  2.43*3.6089/2.14;    % relative difference to WT37 
        h_z     = -3.79*6.6210/3.14;    % relative difference to WT37 
         
    case 3  % Experimental parameters for AV37 
    %-------------------------------------------------------------------
--- 
        temperature = 37 + 273; 
        dV2_m   =  5.94;    % absolute difference to WT37 
        dV2_h   =  2.4;     % absolute difference to WT37 
        t_off   = -2.4;     % absolute difference to WT37 
        m_z     =  2.58*3.6089/2.14;    % relative difference to WT37      
        h_z     = -3.73*6.6210/3.14;    % relative difference to WT37 
         
    case 4  % Experimental parameters for AV40 
    %-------------------------------------------------------------------
--- 
        temperature = 40 + 273; 
        dV2_m   = 9.93;     % absolute difference to WT37 
        dV2_h   = 11.7;     % absolute difference to WT37 
        t_off   = -11.7;    % absolute difference to WT37 
        m_z     = 2.1*3.6089/2.14;      % relative difference to WT37  
        h_z     = -3.38*6.6210/3.14;    % relative difference to WT37     
end 
  
% Calculate model parameters from values given above 
%-----------------------------------------------------------------------
--- 
s_m         = (0.0863 * temperature)/m_z;   % slope derived from m_z 
s_h         = -(0.0863 * temperature)/h_z;  % slope derived from h_z 
  
params(9)   = -39.0 + dV2_m;    % difference from standard cortical neuron 
params(10)  = s_m;            
params(12)  = -43.2 + dV2_h;    % difference from standard cortical neuron 
params(13)  = s_h;     
  
params(14) = t_off;          
  
  
for i = 1:2;  
% Run Model 
%=======================================================================
=== 
params(8)   = I_stim(i); 
options     = odeset('InitialStep',0.005,'MaxStep',0.05); 
t_range     = [0 50]; 
x_ini       = [0 0 0 0]; 
[t,x]       = 
ode45(@(t,x)cort_variable_hh(t,x,params),t_range,x_ini,options); 
  
% Plot time courses 
% ----------------------------------------------------------------------
---- 
Figure1     = figure(1);  
xplot = linspace(1,length(t),5000); 
xplot = floor(xplot); 
  
if e <= 2,  sp_no = 0; 
else        sp_no = 2;  
end 
  
if rem(e,2) == 0,   col = 'r';  
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else                col = 'k'; 
end 
  
subplot(1,4,sp_no+i);   
    plot(t(xplot),x(xplot,1), col); hold on 
    title(n_exp{e}); 
    axis([0,20,-100,100]); 
    set(gca, 'XTickLabel', [], 'Box', 'off'); 
    xlabel('time'); 
    if count > 1 
        set(gca, 'YTickLabel', []); 
    else 
        ylabel('Membrane voltage in mV');   
    end 
     
set(Figure1, 'Position', [100 100 1000 350]);   
subplot(1,4,1), title('WT low stimulation'); 
subplot(1,4,2), title('WT high stimulation'); 
subplot(1,4,3), title('AV low stimulation'); 
subplot(1,4,4), title('WT high stimulation'); legend({'37', '40'}); 
end 
  
end 
 
 
A.4.2.4  cort_bifurcation 
%% Calculate and Plot Bifurcations for cortical HH model 
%=======================================================================
=== 
% This routine will recursively simulate steady state responses of a HH 
% model adapted to resemble cortical neuronal function, for wild type 
% sodium channels, and parameters derived from an epilepsy causing SCN1A 
% mutation. Simulations will be performed at a range of input currents 
% (defined as 'forward' variable below), with steady state values of one 
% parameter step acting as initial conditions for the next parameter step. 
% This is performed in two directions (forward and backward) in order to 
% plot a bifurcation diagram of action potential generation.  
% 
% The routine produces a figure that was the basis for Figure 6 in the 
% publication below: 
%  
% Peters C, Rosch RE, Hughes E, Ruben P (2016) Temperature-dependent  
% changes in neuronal dynamics in a patient with an SCN1A mutation and  
% hyperthermia induced seizures (under review) 
  
  
% Manual definitions 
%-----------------------------------------------------------------------
--- 
direction       = [1 -1];           % 1 = forward, -1 = backward 
forward         = 0:1:90;           % defines range of I_stim parameter 
n_exp           = {'WT37','WT40','AV37','AV40'}; 
exp_parameters  = [1 2 3 4];        % 1 = WT37 (norm), 2 = WT40, 3 = AV37, 
3 = AV40; 
count_e         = 1; 
  
for e = exp_parameters 
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% Parameters defined according to experimental values (with WT37 as 
baseline) 
%=======================================================================
=== 
switch e 
    case 1  % standard HH formulation (WT37) 
    %-------------------------------------------------------------------
--- 
        temperature = 37 + 273;        
        dV2_m   = 0;        % normalised to 0 
        dV2_h   = 0;        % normalised to 0 
        t_off   = 0;        % normalised to 0 
        m_z     =  3.6089;  % normalised to cortical neuron values 
        h_z     = -6.6210;  % normalised to cortical neuron values 
         
    case 2  % Experimental parameters for WT40 
    %-------------------------------------------------------------------
--- 
        temperature = 40 + 273; 
        dV2_m   =  6.49;    % absolute difference to WT37 
        dV2_h   = -1.9;     % absolute difference to WT37 
        t_off   = 1.9;      % absolute difference to WT37 
        m_z     =  2.43*3.6089/2.14;    % relative difference to WT37 
        h_z     = -3.79*6.6210/3.14;    % relative difference to WT37 
         
    case 3  % Experimental parameters for AV37 
    %-------------------------------------------------------------------
--- 
        temperature = 37 + 273; 
        dV2_m   =  5.94;    % absolute difference to WT37 
        dV2_h   =  2.4;     % absolute difference to WT37 
        t_off   = -2.4;     % absolute difference to WT37 
        m_z     =  2.58*3.6089/2.14;    % relative difference to WT37      
        h_z     = -3.73*6.6210/3.14;    % relative difference to WT37 
         
    case 4  % Experimental parameters for AV40 
    %-------------------------------------------------------------------
--- 
        temperature = 40 + 273; 
        dV2_m   = 9.93;     % absolute difference to WT37 
        dV2_h   = 11.7;     % absolute difference to WT37 
        t_off   = -11.7;    % absolute difference to WT37 
        m_z     = 2.1*3.6089/2.14;      % relative difference to WT37  
        h_z     = -3.38*6.6210/3.14;    % relative difference to WT37     
end 
  
% Calculate model parameters from values given above 
%-----------------------------------------------------------------------
--- 
s_m         = (0.0863 * temperature)/m_z;   % slope derived from m_z 
s_h         = -(0.0863 * temperature)/h_z;  % slope derived from h_z 
  
params(9)   = -39.0 + dV2_m;    % difference from standard cortical neuron 
params(10)  = s_m;            
params(12)  = -43.2 + dV2_h;    % difference from standard cortical neuron 
params(13)  = s_h;     
  
params(14) = t_off;     
     
for d = direction 
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% Use variables 
%-----------------------------------------------------------------------
--- 
i   = 0;                % counts number of model runs 
cyc = length(exp_parameters); 
  
if d == 1  
    steps = forward; 
    disp('Forward'); 
else 
    steps = flip(forward); 
    disp('Back'); 
end 
  
% Run model to steady state from random initial 
%-----------------------------------------------------------------------
--- 
options     = odeset('InitialStep',0.0025,'MaxStep',0.05); 
t_range     = [0 100]; 
x_ini       = [0 0 0 0]; 
[t,x]       = 
ode45(@(t,x)cort_variable_hh(t,x,params),t_range,x_ini,options); 
  
% Run model iteratively across parameterspace 
%-----------------------------------------------------------------------
--- 
for para = steps;  
     
    disp(length(steps)-i) 
    params(8) = para; 
    i = i+1; 
  
    bif(1,i)    = para; 
    options     = odeset('InitialStep',0.0025,'MaxStep',0.05); 
    t_range     = [0 100]; 
    x_ini       = x(end,:); 
    [t,x]       = 
ode45(@(t,x)cort_variable_hh(t,x,params),t_range,x_ini,options);  
     
    bif(2,i) = max(x(floor(3/5*end):end,1)); 
    bif(3,i) = min(x(floor(3/5*end):end,1)); 
     
    if bif(2,i)-bif(3,i)>0.5    
        [pks,locs] = findpeaks(x(floor(4/5*end):end)); 
        bif(4,i) = 1/mean(diff(t(locs))); 
    else 
        bif(4,i) = 0; 
    end 
end 
  
% Draw figures: Top panel - bifurcation diagram, bottom panel - frequency 
%=======================================================================
=== 
figure(2); 
set(gcf, 'Position', [100 200 1200 300]); 
hold on 
subplot(3,cyc,[count_e cyc+count_e]) 
  
% Bifurcation diagram 
%-----------------------------------------------------------------------
--- 
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for i = 1:length(bif(1,:)); 
    if bif(2,i)-bif(3,i)<0.5     
        if d == 1 
            scatter(bif(1,i), bif(2,i),'k.'); hold on 
        else 
            scatter(bif(1,i), bif(2,i),'r.'); hold on 
        end 
    else  
        if d == 1  
            scatter(bif(1,i), bif(2,i), 10, 'ko'); hold on 
            scatter(bif(1,i), bif(3,i), 10, 'kx');  
        else 
            scatter(bif(1,i), bif(2,i), 10, 'ro'); hold on 
            scatter(bif(1,i), bif(3,i), 10, 'rx'); 
        end 
    end 
end 
  
ylabel('Membrane potential (mV)'); 
switch e  
    case 1, title('WT at 37 degrees'); 
    case 2, title('WT at 40 degrees'); 
    case 3, title('AV at 37 degrees'); 
    case 4, title('AV at 40 degrees'); 
end 
  
% Frequency  
%-----------------------------------------------------------------------
--- 
subplot(3,cyc,2*cyc+count_e) 
if d == 1                             
    plot(bif(1,:),bif(4,:), 'k'); 
    xlabel('Input Current'); 
    ylabel('Frequency'); 
else  
    plot(bif(1,:),bif(4,:), 'r'); 
    xlabel('Input Current'); 
    ylabel('Frequency'); 
end 
  
end     % from for loop over directions 
count_e = count_e+1; 
clear x t x_ini bif 
end     % from loop over experimental conditions 
 
A.4.2.5  cort_variable_hh 
 
function dxdt = cort_variable_hh(t,x,params) 
dxdt=zeros(4,1); 
  
% Constant values 
%-----------------------------------------------------------------------
--- 
C       = params(1);  
g_L     = params(2);  
g_K     = params(3);  
g_Na    = params(4);  
E_K     = params(5);  
E_L     = params(6);  
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E_Na    = params(7);  
  
I_stim  = params(8); 
  
V_2m    = params(9); 
s_m     = params(10); 
V_t     = params(11); 
  
V_2h    = params(12); 
s_h     = params(13); 
t_off     = params(14); 
  
% Parameter equations 
%=======================================================================
=== 
% Opening probabilities  
%-----------------------------------------------------------------------
--- 
aV_n = -0.032 * ( x(1) - V_t - 15 ) / ( exp( -(x(1)-V_t-15)/5)-1 ); 
aV_m = -0.32 * ( x(1) - V_t - 13 ) / (exp(-(x(1) - V_t - 13) / 4) - 1); 
aV_h = 0.128 * exp( -( x(1) - V_t - 17 + t_off )/18 ); 
  
% Closing probabilities 
%-----------------------------------------------------------------------
--- 
bV_n = 0.5 * exp( -(x(1) - V_t - 10)/40); 
bV_m = 0.28 * ( x(1) - V_t - 40 ) / ( exp( (x(1) - V_t - 40)/5 )-1 ); 
bV_h = 4 / ( 1 + exp( -(x(1)-V_t-40+t_off)/5 ) ); 
  
% Steady state values 
%-----------------------------------------------------------------------
--- 
m_inf = 1 / (1 + exp(-(x(1)-V_2m)/s_m)); 
h_inf = 1 / (1 + exp(-(x(1)-V_2h)/-s_h)); 
t_h   = 1/(aV_h + bV_h); 
t_m   = 1/(aV_m + bV_m); 
  
% Differential equations 
%----------------------------------------------------------------------- 
% dxdt(1) = V 
% dxdt(2) = n potassium channel activation gate 
% dxdt(3) = m sodium channel activation gate 
% dxdt(4) = h sodium channel inactivation gate 
  
dxdt(1) = ( -g_Na * x(3)^3 * x(4) * (x(1) - E_Na)  ... 
            -g_K * x(2)^4 * (x(1) - E_K)  ... 
            -g_L * (x(1) - E_L) + I_stim ) / C;   
         
dxdt(2) = aV_n * (1-x(2)) - bV_n * x(2);    % n 
dxdt(3) = (m_inf - x(3)) / t_m;             % m 
dxdt(4) = (h_inf - x(4)) / t_h;             % h 
  
end  
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A.5  Analysing light-sheet imaging data of acute epileptic 
seizures in zebrafish 
The Matlab scripts below show were custom written and used to perform the analysis of 
light-sheet recordings of epileptic seizures discussed in chapter 7 of this thesis. Below there 
is a short summary of the package content and script segments for the key analysis scripts. 
The code can be downloaded in full from an online repository accessible here: 
https://github.com/roschkoenig/Zebrafish_Seizures  
A.5.1  README description of code function  
The analysis is done by way of a number of custom routines, that in conjunction can be 
used to reproduce the findings from chapter 7. Below is a summary of what each of the 
routines does. Broadly, the code is trying to accomplish the following 5 objectives: 
1. Identify induced network-wide changes in neuronal activity in ‘sensor space’ – i.e. 
directly from the measured signals 
2. Use simulations to test whether DCM can resurrect neuronal parameters from 
calcium imaging signals 
3. Use DCM and Bayesian model comparison to identify a parsimonious baseline 
network architecture 
4. Use a time-windowed, hierarchical DCM to identify slow changes in neuronal 
parameters induced by the induced seizures 
5. Simulate the effects of the indentified parameter changes to identify their effects on 
the network 
The different steps will be discussed in more detail below. 
 
A.5.1.1  Visualise sensor space changes in neuronal dynamics using a sliding window 
zf_seizureexplore 
This code performs a sliding window analysis of the regionally averaged light sheet 
microscopy data. The code will look for the original data files (stored in 'Data' in the 
repository, and called something like this single_plane_ROI_MEAN_TRACES.mat). The 
code will then take 60s time windows in 10s steps to estimate time changing fourier spectra 
of the calcium signal and plot these (if specified). This function is also used to generate the 
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SPM files (called MEEG objects) that will be required for the later analysis and are stored 
in the 'Matlab Files' folder. 
 
The windowed spectral estimates are also used to estimate a power dynamics correlation 
matrix (see discussion of the methods in (Rosch et al., 2018)) - for which the average across 
all fish is plotted as output. This matrix shows the correlation of each time window's 
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channel-resolved frequency-power spectra with each other time window. The leading 
diagonal of the matrix is therefore always = 1 (i.e. fully correlated), and time periods where 
the overall output remains relatively static appear as blocks on the dynamics matrix. The 
function's output is shown above. 
A.5.1.2  Simulate dynamic causal modelling based on calcium traces  
zf_calciumsim 
This code illustrates how parameter changes that correspond to underlying synaptic 
changes can be retrieved from both neurophysiological recordings, and calcium imaging 
data. For this, we are first simulating some LFP data, and illustrating a convolution with a 
kernel that resembles the temporal dynamics of a GCaMP6f probe (also used in the 
experimental paradigm). The results are shown below and will be given as putput from this 
code – they show the LFP, the calcium kernel, and calcium imaging time series both in the 
temporal domain (left) and the frequency domain (right).  
Temporal Domain Frequency Domain 
 
Top to bottom: Calcium kernel; example LFP; 
convolved calcium time series 
 
Top to bottom: LFP spectral density; 
Calcium kernel spectral density; resultant 
calcium time series spectral density 
 
 
 
The code witll then generate a number of time series with a known set of neuronal 
parameters, where one of the parameters is varied across the different repeated 
simulations. These are then used as the basis to estimate the underlying neuronal 
parameter changes. For each of the (calcium-) time series, we will invert a single-node 
DCM for cross-spectral densities. Using a Parametric empirical Bayesian approach, we will 
 257 
then identify the single parameter disturbance that best explains the differences between 
these individual time traces.  
 
This will yield both a free energy approximation of the model evidence for a any individual 
parameter to explain the observed effect (top panel of the figure below); and posterior 
estimates of the parameter change that best explains the transitions between the different 
time series. In this case the correct parameter was identified from the PEB analysis (i.e. the 
one that was manipulated to simulate the origin al LFP traces; bottom panel of the figure 
below). 
 
A.5.1.3  Set up and invert baseline DCM 
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zf_dcm (time intensive step) 
In the next step, we are using DCM to infer the model architecture that best explains the 
cross-spectral density summaries of baseline network activity. For the DCM we are loading 
baseline data for each animal and set up model architecture and inversion parameters:  
DCM.options.analysis = 'CSD';       % cross-spectral density 
DCM.options.model    = 'LFP';       % three-population model 
DCM.options.spatial  = 'LFP';       % virtual electrode input 
 
This section defines the basic features of the model inversion – here we are analysing 
ongoing neuronal oscillatory activity using cross-spectral densities (CSD). We are 
assuming a basic structure that is currently described as the ‘LFP’ model – a three 
population summary of microcircuitry, consisting of a single main (excitatory) output 
population and one inhibitory and one excitatory interneuronal population respectively.  
This is all analysed, treating the signal as direct neuronal recordings (i.e. as local field 
potentials – LFP – as the spatial model).  
 
A.5.1.4  Use Bayesian model reduction to make inference on model architecture at 
baseline 
zf_bmr 
Based on the full model inversion for the baseline model performed at the preceding step, 
this function now fills the remainder of the parameter estimates and approximates the 
model evidence across the model space using Bayesian model reduction, or BMR. This 
routine will set up a new DCM structure for each of the investigated models, then load the 
already inverted full DCM from the step above. Using the free energy approximation for 
the model evidence, this will then allow Bayesioan model comparison, which the code will 
present as family-wise comparison as shown below.  
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A.5.1.5  Set up (sliding window) files for DCM analysis  
(This is a very time intensive step, and will need setting up within your local infrastructure 
with zf_slide; and zf_slide_for_cluster) 
Based on the winning model architecture selected from the baseline model inversion 
performed in the previous two steps, we now invert DCMs for each individual time step 
separately – the idea here is that over a short time period (i.e. 60s), a network of neural 
mass models is fitted to an assumed stationary oscillatory signal. By doing this with 
overlapping windows separated by only short time steps, we will be able to track the slow 
parameter changes that underlie the transition between different neuronal states – such as 
here, the baseline and the induced seizure state.  
The version included in the code here will specify the model for each time window and 
invert them in a single loop (over many days). The zf_slide_for_cluster version will 
specify the DCM structure needed for inversion, but not actually invert the DCMs. This 
will need to be done on a computing cluster with Matlab installed, where a custom 
inversion function (zf_spm_dcm_fit) should be called.  
 
A.5.1.6  Using parametric empirical Bayes to make inference across time windows 
zf_peb 
As we are interested in the changes of DCM parameters over time (i.e. between-DCM 
parameter changes), we can use parametric empirical Bayes (PEB) to specifically estimate 
between DCM effects that correspond to particular trajectories. For PEB we will specify a 
model space at the second (between-DCM) level that describes possible trajectories, and 
in the inversion we will identify the most parsimonious combination of effects of this 
second-level general linear model on DCM parameters to explain the data.  
Specifically in this instance the code will first load the DCMs that were inverted at the 
previous step. It will then define the types of between-DCM effects that we are looking 
forms in terms of a second level design matrix in the variable ‘X’. For the purposes of this 
analysis, individual fish are treated as repeat measurements. We can visualise the design 
matrix by typing in imgagesc(X) and should get the following output, where each row is a 
DCM / time window and each column is an experimental effect or regressor.  
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Similarly to the Bayesian model reduction performed above to identify a simpler baseline 
architecture, we can then use a similar approach to define a set of models to compare at 
the second level – i.e. which of the model parameters affected by the changes observed 
during seizure activity offer the most parsimonious explanation of across-time-window 
effects. We can then perform Bayesian model comparison between these reduced models, 
and plot the second level parameter estimates.  
Extrinisc parameters Intrinsic Parameters 
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A.5.1.7  Simulate neuronal responses across parameter space 
zf_simulate 
Once we have identified a simple representation of consistent parameter changes across 
fish and time windows, we want to explore what effect those specific parameters have on 
the neuronal output. Because the DCM / PEB approach yields fully generative models that 
will produce predictions of neuronal oscillatory activity (in the shape of cross-spectral 
densities), we can simulate the effects of specific parameter changes.  
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This is illustrated in the paper using a single brain region as an example. For this we first 
use a low-dimensional representation of the data (through a principal component analysis 
of the windowed parameter estimates) and project each time window onto this low 
dimensional representation. Having mapped out the space of the maximum variance, we 
can then simulate output spectra at each point, plotting the landscape of low-frequency 
power, but also high frequency powere components not originally included in the data (as 
this is a simulation).  
 
A.5.1.8  Edits of SPM12 functions called by the routines above 
• zf_spm_dcm_csd_data – adapted to allow for smaller frequency bins (standard limit: 
1Hz) 
• zf_spm_dcm_csd – adapted to call zf_spm_dcm_csd_data 
• zf_spm_dcm_fit – adapted to call zf_spm_dcm_csd_csd 
• zf_spm_dcm_csd – adapted to use log-scales of cross-spectral densities 
• zf_spm_rand_power_law – use additional scheme to generate random power law 
dynamics  
 
A.5.2  Custom Routines 
A.5.2.1  zf_seizureexplore  
% This code performs a sliding window analysis on the seizure data in 
order 
% to visualise power distribution dynamics across the recording duration 
%-----------------------------------------------------------------------
--- 
  
clear all 
  
sliding  = 1; 
plotting = 1; 
saveplot = 0; 
  
extrctBL = 0; 
make_spm = 0; 
  
% Housekeeping 
%=======================================================================
=== 
fs          = filesep; 
D           = zf_housekeeping; 
Fbase       = D.Fbase; 
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Forig       = D.Forig; 
Fanalysis   = D.Fanalysis; 
lbl         = D.lbl; 
subs        = D.subs; 
scount = 0; 
  
  
for sub = subs 
scount = scount + 1 
     
Fsub        = [Fanalysis fs 'Data Files' fs sub{:}]; 
  
  
switch sub{:} 
    case 'S1', load([Forig fs 'single_plane_ROI_MEAN_TRACES']); 
    case 'S2', load([Forig fs 'single_plane_s2_ROI_MEAN_TRACES']); 
    case 'S3', load([Forig fs 'single_plane_s3_ROI_MEAN_TRACES']); 
end 
  
Z = ROI_MEAN_TRACES.data; 
  
clear fullc fullt 
Fs      = 20; 
win     = 60 * Fs; 
stp     = 10 * Fs; 
l       = length(Z); 
fstps   = win; 
i       = 0; 
  
if sliding 
for s = 1:stp:l-win 
    i               = i+1 
    w               = Z(s:s+win, :); 
    tfullt          = fft(w, fstps); 
    fullt(i,:,:)   = abs(tfullt(1:floor(end/2),:)); 
    ft(i, :)        = mean(squeeze(fullt(i,:,:)), 1); 
     
    fullc       = corr(w); 
    halfc       = tril(fullc, -1); 
    v           = halfc(find(halfc)); 
    co(i, :)    = v; 
end 
  
ccor{scount} = corr(co'); 
cpow{scount} = corr(abs(ft)'); 
end 
  
% Plot spectral changes before and during seizure 
%=======================================================================
=== 
% if plotting,  
alft(scount,:,:) = mean(log(fullt),3); 
     
figure(scount) 
  
cs = flip(cbrewer('div', 'RdGy', 100)); 
colormap(cs); 
frq_axis = linspace(1, Fs, fstps / 2); 
set(gcf, 'Color', 'w'); 
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subplot(3,3,1:6) 
    imagesc(mean(log(fullt),3)', [0 14]); hold on 
    title('Log frequency-power over time', 'fontsize', 12, 'fontweight', 
'bold'); 
    set(gca, 'YDir', 'normal'); 
    seg = floor(size(fullt,1)/6); 
  
cp = cbrewer('qual', 'Paired', 10); 
  
subplot(3,3,7) 
    for i = 1:10 
        plot(frq_axis, log(squeeze(mean(fullt(50:150,:,i),1))), 'Color', 
cp(i,:)); hold on 
    end 
    title('Pre PTZ average spectral distribution', 'fontsize', 12, 
'fontweight', 'bold'); 
    ylim([4 14]); 
    ylabel('Power'); 
    xlabel('Frequency'); 
  
subplot(3,3,8) 
    for i = 1:10 
        plot(frq_axis, log(squeeze(mean(fullt(300:400,:,i),1))), 
'Color', cp(i,:)); hold on 
    end 
    title('Early seizure spectra', 'fontsize', 12, 'fontweight', 
'bold'); 
    ylim([4 14]); 
    ylabel('Power'); 
    xlabel('Frequency'); 
     
subplot(3,3,9) 
    for i = 1:10 
        plot(frq_axis, log(squeeze(mean(fullt(500:600,:,i),1))), 
'Color', cp(i,:)); hold on 
    end 
    title('Late seizure spectra', 'fontsize', 12, 'fontweight', 'bold'); 
    ylim([4 14]); 
    ylabel('Power'); 
    xlabel('Frequency'); 
    legend(lbl); 
     
end 
  
figure(4)  
imagesc(squeeze(mean(alft,1))', [4 14]);  
set(gca, 'Ydir', 'normal'); 
colormap(cs); 
  
%% Generate SPM Files 
%=======================================================================
=== 
if make_spm 
tim_ax  = linspace(0, ((l / Fs)-1)/60, l); 
i       = 0; 
ftdata  = []; 
  
% Sliding window to separate out time windows 
%-----------------------------------------------------------------------
--- 
for s = 1:stp:l-win 
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    i   = i+1; 
    dw  = Z(s:s+win, :)'; 
    tw  = tim_ax(1:win); 
    conds{i} = num2str(tim_ax(s)); 
     
    ftdata.trial{i}     = dw; 
    ftdata.time{i}      = tw; 
end 
  
lbl = {'RTect'; 'LTect'; 'RCrbl'; 'LCrbl'; 'RRHbr'; 'LRHbr'; 'RCHbr'; 
'LCHbr'; 'RRSpC'; 'LRSpC'}; 
ftdata.label = lbl; 
ftdata.label = ftdata.label(:); 
  
winstr  = num2str(floor(win/Fs)); 
stpstr  = num2str(floor(stp/Fs)); 
  
D = spm_eeg_ft2spm(ftdata, [Fsub fs 'Z_' winstr 'by' stpstr]); 
D = type(D, 'single');  
for c = 1:length(conds) 
    D = conditions(D, c, conds{c}); 
end; 
  
S = []; 
S.task = 'defaulteegsens'; 
S.D = D; 
D = spm_eeg_prep(S); 
  
save(D); 
end 
  
  
%% Generate SPM Files 
%=======================================================================
=== 
if extrctBL 
     
l       = 4800; 
tim_ax  = linspace(0, ((l / Fs)-1)/60, l); 
ftdata  = []; 
  
  
% Extract time window 
%-----------------------------------------------------------------------
--- 
dw = Z(1:l,:)'; 
tw = tim_ax; 
  
conds{1} = 'Baseline'; 
     
ftdata.trial{1}     = dw; 
ftdata.time{1}      = tw; 
  
lbl = {'RTect'; 'LTect'; 'RCrbl'; 'LCrbl'; 'RRHbr'; 'LRHbr'; 'RCHbr'; 
'LCHbr'; 'RRSpC'; 'LRSpC'}; 
ftdata.label = lbl; 
ftdata.label = ftdata.label(:); 
  
D = spm_eeg_ft2spm(ftdata, [Fsub fs 'Baseline_data']); 
D = type(D, 'single');  
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for c = 1:length(conds) 
    D = conditions(D, c, conds{c}); 
end; 
  
S = []; 
S.task = 'defaulteegsens'; 
S.D = D; 
D = spm_eeg_prep(S); 
  
save(D); 
end 
  
  
end 
%% 
cols = flip(cbrewer('div', 'Spectral', 100)); 
colormap(cols) 
  
subplot(3,4,1), imagesc(cpow{1}); axis square 
subplot(3,4,5), imagesc(cpow{2}); axis square 
subplot(3,4,9), imagesc(cpow{3}); axis square 
  
mcpow = zeros(size(cpow{1},1), size(cpow{1},2)); 
for cc = 1:length(cpow), mcpow = mcpow + cpow{cc}; end 
mcpow = mcpow ./ length(cpow); 
  
subplot(3,4,[2:4, 6:8, 10:12]); 
imagesc(mcpow) 
axis square 
  
%% Plot Power dynamics and do statistics 
%-----------------------------------------------------------------------
--- 
r1 = 1:240;    r2 = 241:400;   r3 = 401:800; 
  
d{1} = [cpow{1}(1,r1), cpow{2}(1,r1), cpow{3}(1,r1)]; 
d{2} = [cpow{1}(1,r2), cpow{2}(1,r2), cpow{3}(1,r2)]; 
d{3} = [cpow{1}(1,r3), cpow{2}(1,r3), cpow{3}(1,r3)]; 
  
for dd = 1:length(d) 
    c{dd} = ones(1,length(d{dd})); 
end 
  
zf_dotplot(d, {'Baseline', 'Seizure', 'Prolonged Seizure'}, 1, c, 0.1); 
set(gcf, 'Color', 'w'); 
title('Power distribution correlations', 'fontsize', 12, 'fontweight', 
'bold'); 
ylabel('Correlation with first time window'); 
 
A.5.2.2  zf_calciumsim 
 
%% Housekeeping 
%=======================================================================
=== 
D           = zf_housekeeping(1); 
fs          = filesep; 
  
Fbase       = D.Fbase; 
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Fscripts    = D.Fscripts; 
Fanalysis   = D.Fanalysis; 
Fdata       = [Fanalysis fs 'Data Files' fs 'Synth']; 
Fdcm        = [Fanalysis fs 'DCM' fs 'Synth']; 
  
spm('defaults', 'EEG'); 
addpath(Fscripts); 
params = []; 
  
if ~isempty(params) 
    k = params.k; 
    H = params.H; 
    latency = params.latency; 
else  
    k = 1/1000;   % Inverse time constant 
    H = 1;        % Maximum height 
    latency = 250; 
end 
  
  
%% Set up convolution kernel 
%=======================================================================
=== 
clear cal ca 
  
for ms = 1:10000 
    ca(ms) = H * exp(-k*ms); 
end 
  
[val ind]   = max(ca); 
uprise      = flip( (latency-1)^2 - [0:latency-1].^2 ); 
uprise      = uprise / max(uprise) * val; 
cal = [uprise, ca]; 
ca  = cal(1:length(ca)); 
  
% Illustrate convolution kernel using spiking 
% ----------------------------------------------------------------------
---- 
figure(1), clf 
  
subplot(3,1,1), plot(ca); 
rng('default') 
  
Hz          = 1:50; 
dt          = .001; 
N           = 10000; 
  
nsd         = [1./Hz]'; 
lfp         = real(zf_spm_rand_power_law(nsd,Hz,dt,N)); 
  
fc          = degtorad(360); 
csrange     = linspace(0,fc,length(lfp)); 
mdt         = -cos(csrange) + 1; 
intmt       = lfp .* mdt' + lfp; 
  
subplot(3,1,2), plot(intmt); 
con = conv(intmt, ca); 
subplot(3,1,3), plot(con(1:N)); 
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%% Model specification 
%=======================================================================
=== 
range   = linspace(-1, 1, 6); 
par     = 'H(1)'; 
  
sP = range; 
rng('default') 
  
% number of regions in simulated seizure activity and model 
specification 
%-----------------------------------------------------------------------
--- 
Nc  = 1;                                   % number of channels 
Ns  = 1;                                   % number of sources 
options.spatial  = 'LFP'; 
options.model    = 'LFP'; 
options.analysis = 'CSD'; 
M.dipfit.model   = options.model; 
M.dipfit.type    = options.spatial; 
M.dipfit.Nc      = Nc; 
M.dipfit.Ns      = Ns; 
M.Hz             = 0.5:0.5:60; 
  
% get associated priors 
%-----------------------------------------------------------------------
--- 
A      = {0 0 0}; 
B      = {}; 
C      = 1; 
pE     = spm_dcm_neural_priors(A,B,C,options.model); 
pE     = spm_L_priors(M.dipfit,pE); 
pE     = spm_ssr_priors(pE); 
[x,f]  = spm_dcm_x_neural(pE,options.model); 
  
  
% suppress channel noise (assuming many trials would be averaged) 
%-----------------------------------------------------------------------
--- 
pE.a   = [ 0; 0];                  % log amplitude and f^(-a) exponent 
pE.b   = [-2; 0];                  % log amplitude and f^(-a) exponent 
pE.c   = [-2; 0];                  % log amplitude and f^(-a) exponent 
  
% number of hidden states and endogenous inputs 
%-----------------------------------------------------------------------
--- 
nx     = length(spm_vec(x)); 
nu     = size(pE.C,2); 
  
% create LFP model 
%=======================================================================
=== 
M.f    = f; 
M.g    = 'spm_gx_erp'; 
M.x    = x; 
M.n    = nx; 
M.pE   = pE; 
M.m    = nu; 
M.l    = Nc; 
M.u    = sparse(Ns,1); 
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P      = pE; 
  
U.dt  = 1/500; 
N     = 10/U.dt; 
M.p   = 8; 
M.dt  = U.dt; 
  
  
clear nsd noise timsr convr 
for t = 1:length(sP) 
     
% Generate time series from predicted spectral densities 
%-----------------------------------------------------------------------
--- 
switch par  
    case 'T(1)', P.T(1) = sP(t);  
    case 'T(2)', P.T(2) = sP(t);  
    case 'H(1)', P.H(1) = sP(t);  
    case 'H(2)', P.H(2) = sP(t);  
    case 'H(3)', P.H(3) = sP(t);  
    case 'H(4)', P.H(4) = sP(t);  
    case 'H(5)', P.H(5) = sP(t); 
end 
  
nsd         = [1./M.Hz]'; 
noise(t,:)  = real(zf_spm_rand_power_law(nsd,M.Hz,U.dt,N)); 
noise(t,:)  = noise(t,:) / max(noise(t,:)) / 100; 
  
psd         = spm_csd_mtf(P,M,U);  
timsr(t,:)  = real(zf_spm_rand_power_law(psd{1},M.Hz,U.dt,N)); 
timsr(t,:)  = timsr(t,:)/ max(timsr(t,:)) + noise(t,:); 
  
tonvr       = conv(timsr(t,:), ca); 
convr(t,:)  = tonvr(1:length(timsr(t,:))); 
  
mar    = spm_mar(timsr(t,:)', M.p); 
mar    = spm_mar_spectra(mar,M.Hz,1/U.dt); 
csd    = mar.P; 
clear mar 
  
mar = spm_mar(convr(t,:)', M.p); 
mar = spm_mar_spectra(mar, M.Hz, 1/U.dt); 
ssd = mar.P; 
  
end 
  
timsr = timsr/max(max(timsr)); 
convr = convr/max(max(convr)); 
  
figure(2); clf; 
for i = 1:size(timsr,1)     
subplot(length(sP), 1, i),  
    plot(timsr(i,:), 'k'); hold on 
    plot(convr(i,:), 'r');  
     
subplot(length(sP), 1, 1),  
    title('Simulated neuronal time series with calcium convolution'); 
end 
     
% Make MEEG object with the time series 
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%=======================================================================
=== 
Fs = 1/U.dt; 
ns = size(timsr,2); 
nt = size(timsr,1); 
  
ftdata.fsample  = Fs; 
ftdata.label    = {'SynC'}; 
timaxis         = linspace(0, ns*U.dt, ns); 
  
for s = 1:nt 
    ftdata.trial{s} = timsr(s,:); 
    ftdata.time{s}  = timaxis;  
    conds{s}        = ['LFP_' num2str(s)]; 
     
    ftdata.trial{nt + s}    = convr(s,:); 
    ftdata.time{nt + s}     = timaxis; 
    conds{nt+s}             = ['CAI_' num2str(s)]; 
end 
  
cfg.resamplefs = 20; 
cfg.detrend    = 'yes'; 
cfg.demean     = 'yes'; 
cfg.feedback   = 'textbar'; 
  
ftdata = ft_resampledata(cfg, ftdata); 
  
D = spm_eeg_ft2spm(ftdata, [Fdata fs 'syn.mat']); 
D = type(D, 'single');  
for c = 1:length(conds) 
    D = conditions(D, c, conds{c}); 
end 
  
S       = []; 
S.task  = 'defaulteegsens'; 
S.D     = D; 
D       = spm_eeg_prep(S); 
save(D); 
  
Fs20Time = ftdata.time{1}*1000; 
  
% Set up DCM structure and invert  
%=======================================================================
=== 
DCM = [];                           % create DCM struct  
DCM.options.analysis = 'CSD';       % cross-spectral density  
DCM.options.model    = 'LFP';       %  
DCM.options.spatial  = 'LFP';        % virtual electrode input     
DCM.options.Tdcm     = [Fs20Time(1) Fs20Time(end)];   % 1-30k ms  
DCM.options.Fdcm     = [0.5 10]; 
DCM.options.D        = 1;           % frequency bin, 1 = no downsampling 
  
DCM.options.Nmodes   = 8;           % cosine reduction components used  
DCM.options.han      = 0;           % no hanning  
  
  
DCM.Sname           = {'SynC'}; 
DCM.Hz              = DCM.options.Fdcm(1):0.5:DCM.options.Fdcm(2); 
DCM.xY.Dfile        = [Fdata fs 'syn.mat']; 
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DCM.A{1}        = 0; 
DCM.A{2}        = 0; 
DCM.A{3}        = 1; 
DCM.B           = {}; 
DCM.C           = sparse(length(DCM.A{1}),0);  
  
% Define spatial inversion model (simple LFP) 
%-----------------------------------------------------------------------
--- 
DCM.M.dipfit.Nm    = DCM.options.Nmodes; 
DCM.M.dipfit.model = DCM.options.model; 
DCM.M.dipfit.type  = DCM.options.spatial; 
DCM.M.dipfit.Nc    = 1; 
DCM.M.dipfit.Ns    = 1; 
  
% Get priors 
%-----------------------------------------------------------------------
--- 
[pE,pC]  = spm_dcm_neural_priors(DCM.A,DCM.B,DCM.C,DCM.options.model); 
[pE,pC]  = spm_L_priors(DCM.M.dipfit,pE,pC); 
[pE,pC]  = spm_ssr_priors(pE,pC); 
DCM.pE   = pE; 
DCM.pC   = pC; 
  
% Run CAI 
%-----------------------------------------------------------------------
--- 
for c = nt+1:length(conds) 
    DCM.name = [Fdcm fs 'SynC_' conds{c}]; 
    DCM.options.trials  = [c]; 
    SYN{c} = zf_spm_dcm_fit(DCM); 
end 
  
for i = 1:(length(SYN)/2) 
    CAI{i} = SYN{i+(length(SYN)/2)}{1}; 
end 
  
% PEB to identify group mean 
%=======================================================================
=== 
clear M; 
  
% Set second level model parameters 
%-----------------------------------------------------------------------
--- 
M.hE  = 0; 
M.hC  = 1/16; 
M.bE  = spm_vec(CAI{2}.M.pE); 
M.bC  = diag(spm_vec(CAI{2}.M.pC)); 
  
M.X(:,1) = ones(1,length(CAI)); 
M.Q      = 'all'; 
  
% Run PEB 
%-----------------------------------------------------------------------
--- 
CEB      = spm_dcm_peb(CAI', M, 'all'); 
  
  
% Rerun first level with new group means 
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%=======================================================================
=== 
% Equip first level DCM with new group mean priors 
%-----------------------------------------------------------------------
--- 
[pE,pC]  = spm_dcm_neural_priors(DCM.A,DCM.B,DCM.C,DCM.options.model); 
[pE,pC]  = spm_L_priors(DCM.M.dipfit,pE,pC); 
[pE,pC]  = spm_ssr_priors(pE,pC); 
  
vE              = spm_vec(pE); 
vE(CEB.Pind)    = vE(CEB.Pind) + CEB.Ep(:,1); 
pE              = spm_unvec(vE, pE); 
DCM.M.pE   = pE; 
DCM.M.pC   = pC; 
  
clear CEB M CAI 
  
% Run DCMs 
%-----------------------------------------------------------------------
--- 
for c = nt+1:length(conds) 
    DCM.name = [Fdcm fs 'SynC_' conds{c}]; 
    DCM.options.trials  = [c]; 
    SYN{c} = zf_spm_dcm_fit(DCM); 
end 
  
for i = 1:(length(SYN)/2) 
    CAI{i} = SYN{i+(length(SYN)/2)}{1}; 
end 
  
  
%% Run PEB for difference between conditions 
%=======================================================================
=== 
clear M 
  
%  Define model space in terms of parameters allowed to vary 
%-----------------------------------------------------------------------
--- 
field = {'T(1)', 'T(2)', 'H(1)', 'H(2)', 'H(3)', 'H(4)', 'H(5)'}; 
M.X(:,1) = ones(1,length(CAI)); 
M.X(:,2) = [1:length(CAI)] - length(CAI)/2; 
  
M.Q     = 'all'; 
  
for i = 1:length(field) 
    [CEB{i} RCM{i}]  = spm_dcm_peb(CAI',M, field{i}); 
    CF(i,1) = CEB{i}.F; 
end 
  
[score winner] = max(CF); 
  
BMC.CF  = CF; 
BMC.CEB = CEB{winner}; 
BMC.CAI = CAI; 
  
for r = 1:length(RCM{winner}) 
    Ep(r) = RCM{winner}{r}.Ep.H(1); 
    Cps   = diag(RCM{winner}{r}.Cp); 
    Cps   = spm_unvec(Cps, RCM{winner}{r}.Ep); 
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    Cp(r) = Cps.H(1); 
end 
  
figure 
subplot(2,1,1), bar(BMC.CF - min(BMC.CF)) 
subplot(2,1,2), spm_plot_ci(Ep', Cp') 
  
  
%% Plot convolution in frequency domain 
%=======================================================================
=== 
  
lfp = timsr(1,:); 
  
ftl = abs(fft(lfp)); fl = ceil(length(ftl)/2);  
ftl = ftl(1:fl); 
ftl = smoothts(ftl, 'g', 50, 6); 
  
fraxis = linspace(1/10, 250, fl); 
  
dscal = cal(1:2:end); 
tftc = abs(fft(dscal)); fl = ceil(length(tftc)/2); 
tftc = tftc(1:fl); 
ftc  = zeros(1,length(ftl)); 
ftc(1:length(tftc)) = tftc; 
ftc     = ftc(1:length(ftl)); 
  
subplot(3,1,1), plot(fraxis, log(ftl));  xlim([0 20]); 
subplot(3,1,2), plot(fraxis, log(ftc));  xlim([0 20]); 
subplot(3,1,3), plot(fraxis, log(ftl .* ftc));    xlim([0 20]); 
 
A.5.2.3  zf_dcm 
for sub = {'S1', 'S2', 'S3'}; 
%% Housekeeping 
%-----------------------------------------------------------------------
--- 
clear DCM 
fs          = filesep; 
Fbase       = '/Users/roschkoenig/Dropbox/Research/Friston Lab/1608 
Zebrafish';  
Fscripts    = [Fbase fs 'Scripts']; 
Fanalysis   = [Fbase fs 'Matlab Files']; 
Fdata       = [Fanalysis fs 'Data Files']; 
Forig       = [Fbase fs 'Data']; 
Fdcm        = [Fanalysis fs 'DCM' fs sub{:}]; 
datafile    = [Fdata fs sub{:} fs 'Baseline_data']; 
spm('defaults', 'EEG'); 
addpath(Fscripts); 
  
load([Forig fs 'single_plane_ROI_MEAN_TRACES']); 
Z = ROI_MEAN_TRACES.data; 
l = length(Z); 
  
Fs          = 20; 
fstps       = 200; 
frq_ax      = linspace(1, Fs, fstps / 2); 
tim_ax      = linspace(0, ((l / Fs)-1)/60, l); 
win         = 60*Fs;  
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stp         = 10*Fs; 
windows     = 1:stp:l-win; 
lbl = {'RTect'; 'LTect'; 'RCrbl'; 'LCrbl'; 'RRHbr'; 'LRHbr'; 'RCHbr'; 
'LCHbr'; 'RRSpC'; 'LRSpC'}; 
  
%% Set up DCM structure and invert baselne 
%=======================================================================
=== 
Amod = zf_modelspace; 
  
DCM = [];                           % create DCM struct  
DCM.options.analysis = 'CSD';       % cross-spectral density  
DCM.options.model    = 'LFP';       % structure cannonical microcircuit 
(for now) 
DCM.options.spatial  = 'LFP';        % virtual electrode input     
DCM.options.Tdcm     = [tim_ax(1) tim_ax(end)];   % 1-30k ms  
  
DCM.options.Fdcm    = [frq_ax(1) frq_ax(end)];      % frequency range   
DCM.options.Rft     = 5;            % delay  
DCM.options.onset   = 64;           % time delays between sources    
DCM.options.dur     = 16;           % time dur   
DCM.options.D       = 0.2;          % frequncy bin, 1 = no downsampling 
  
DCM.options.Nmodes  = 8;            % cosine reduction components used  
DCM.options.han     = 0;            % no hanning  
  
DCM.options.lock    = 0;            % lock the trial-specific effects   
DCM.options.multiC  = 0;            % multichannel effects   
DCM.options.location = 0;           % optmise location  
DCM.options.symmetry = 0;           % symmeterical dipoles 
  
DCM.Sname           = lbl; 
DCM.M.Hz            = frq_ax; 
DCM.xY.Dfile        = datafile; 
  
for a = 1:3 
    DCM.A{a}    = Amod{end}.A{a}; 
end 
DCM.B           = {}; 
DCM.C           = sparse(length(DCM.A{1}),0);  
  
DCM.M.dipfit.Nm    = DCM.options.Nmodes; 
DCM.M.dipfit.model = DCM.options.model; 
DCM.M.dipfit.type  = DCM.options.spatial; 
DCM.M.dipfit.Nc    = 10; 
DCM.M.dipfit.Ns    = 10; 
  
[pE,pC]  = spm_dcm_neural_priors(DCM.A,DCM.B,DCM.C,DCM.options.model); 
[pE,pC]  = spm_L_priors(DCM.M.dipfit,pE,pC); 
[pE,pC]  = spm_ssr_priors(pE,pC); 
DCM.pE   = pE; 
DCM.pC   = pC; 
  
DCM.name = [Fdcm fs 'Full_BLN']; 
DCM.options.trials  = [1]; 
BLN = spm_dcm_fit(DCM); 
end 
 
A.5.2.4  zf_bmr 
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%% Housekeeping 
%=======================================================================
=== 
fs          = filesep; 
D           = zf_housekeeping; 
  
Fbase       = D.Fbase; 
Fscripts    = D.Fscripts; 
Fanalysis   = D.Fanalysis; 
Forig       = D.Forig; 
sub         = D.subs; 
  
% Set up Bayesian Model Reduction across models of interest 
%=======================================================================
=== 
% Set up BMR structure 
%-----------------------------------------------------------------------
--- 
clear P 
Amod = zf_modelspace; 
  
% Collate all models in single matrix of models 
%-----------------------------------------------------------------------
--- 
for s = 1:length(sub) 
clear DCM  
Fdcm    = [Fanalysis fs 'DCM' fs sub{s}];  
load([Fdcm fs 'Full_BLN.mat']); 
FCM     = DCM; 
DCM     = rmfield(DCM, 'Ep'); 
DCM     = rmfield(DCM, 'Cp'); 
  
for m = 1:(length(Amod)-1) 
    for a = 1:3 
        DCM.pE.A{a} = Amod{m}.A{a}; 
        DCM.pC.A{a} = DCM.pE.A{a} .* FCM.pC.A{a}; 
        DCM.M.pE    = DCM.pE; 
        DCM.M.pC    = DCM.pC; 
    end 
    DCM.name    = Amod{m}.name; 
    P{s,m}      = DCM; 
end 
  
% Add full model to model matrix 
%-----------------------------------------------------------------------
--- 
P{s,length(Amod)} = FCM; 
  
end 
  
% Run Bayesian model reduction 
%=======================================================================
=== 
[BLCM BLMC BLMA] = spm_dcm_bmr(P); 
  
% Extract free energies 
%-----------------------------------------------------------------------
--- 
clear F Fs 
for b = 1:length(BLMC) 
    F(b,:) = BLMC(b).F; 
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end 
  
% Extract model names 
%-----------------------------------------------------------------------
--- 
for m = 1:length(Amod) 
    mlab{m} = Amod{m}.name; 
end 
  
%% Family wise comparison - draw figures 
%=======================================================================
=== 
% Define families 
%-----------------------------------------------------------------------
--- 
Flr = F(1:6) + F(7:12) + F(13:18) + F(19:24); 
Fsr = F(1:6:24) + F(2:6:24) + F(3:6:24) + F(4:6:24) + F(5:6:24) + 
F(6:6:24); 
  
figure(2) 
set(gcf, 'color', 'w'); 
colormap gray 
  
% Plot Hub connection BMC 
%-----------------------------------------------------------------------
--- 
subplot(2,1,2),  
    % Plot 
    bar(Flr - min(Flr)); 
     
    % Titles and legends 
    title('Evidence for hub connections', 'FontSize', 12, 'FontWeight', 
'bold'); 
    set(gca, 'XTick', 1:6); 
    set(gca, 'XTickLabel', {'None', 'Tec', 'Cbl', 'RHb', 'CHb', 'RSC'}); 
     
    % Settings 
%     axis square 
    box off 
     
% Plot Hub connection BMC 
%-----------------------------------------------------------------------
---     
subplot(2,1,1),  
  
    % Plot 
    bar(Fsr - min(Fsr)); 
     
    % Titles and Legends 
    title('Evidence for short range connections', 'FontSize', 12, 
'FontWeight', 'bold'); 
    set(gca, 'XTick', 1:4); 
    set(gca, 'XTickLabel', {'None', 'Homol.', 'Neigh.', 'Both'}) 
     
    % Settings 
    box off 
 
A.5.2.6  zf_slide 
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%% Manual Definitions 
%=======================================================================
=== 
wins = 60; 
stps = 10; 
  
% Housekeeping 
%-----------------------------------------------------------------------
--- 
clear DCM 
fs          = filesep; 
if strcmp('PCWIN64', computer);  
    Fbase = 'C:\Users\rrosch\Dropbox\Research\Friston Lab\1608 
Zebrafish'; 
else 
    Fbase = '/Users/roschkoenig/Dropbox/Research/Friston Lab/1608 
Zebrafish'; 
end 
  
Fscripts    = [Fbase fs 'Scripts']; 
Fanalysis   = [Fbase fs 'Matlab Files']; 
Fdata       = [Fanalysis fs 'Data Files']; 
Forig       = [Fbase fs 'Data']; 
Fdcm        = [Fanalysis fs 'DCM']; 
datafile    = [Fdata fs 'Z_180by90.mat']; 
spm('defaults', 'EEG'); 
addpath(Fscripts); 
  
load([Forig fs 'single_plane_ROI_MEAN_TRACES']); 
Z = ROI_MEAN_TRACES.data; 
l = length(Z); 
clear Z; 
  
load([Fdata fs 'Z_' num2str(wins) 'by' num2str(stps) '.mat']); 
Ntrials     = length(D.trials); 
clear D; 
  
Fs          = 20; 
fstps       = 200; 
frq_ax      = linspace(1, Fs, fstps / 2); 
tim_ax      = linspace(0, ((l / Fs)-1)/60, l); 
win         = wins*Fs;  
stp         = stps*Fs; 
windows     = 1:stp:l-win; 
lbl = {'RTect'; 'LTect'; 'RCrbl'; 'LCrbl'; 'RRHbr'; 'LRHbr'; 'RCHbr'; 
'LCHbr'; 'RRSpC'; 'LRSpC'}; 
  
%% Set up DCM structure 
%=======================================================================
=== 
Amod = zf_modelspace; 
  
DCM = [];                           % create DCM struct  
DCM.options.analysis = 'CSD';       % cross-spectral density  
DCM.options.model    = 'LFP';       % structure cannonical microcircuit 
(for now) 
DCM.options.spatial  = 'LFP';        % virtual electrode input     
DCM.options.Tdcm     = [tim_ax(1) tim_ax(end)];   % 1-30k ms  
DCM.option.DATA      = []; 
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DCM.options.Fdcm    = [frq_ax(1) frq_ax(end)];      % frequency range   
DCM.options.Rft     = 5;            % delay  
DCM.options.onset   = 64;           % time delays between sources    
DCM.options.dur     = 16;           % time dur   
DCM.options.D       = 0.2;          % frequncy bin, 1 = no downsampling 
  
DCM.options.Nmodes  = 8;            % cosine reduction components used  
DCM.options.han     = 0;            % no hanning  
  
DCM.options.lock    = 0;            % lock the trial-specific effects   
DCM.options.multiC  = 0;            % multichannel effects   
DCM.options.location = 0;           % optmise location  
DCM.options.symmetry = 0;           % symmeterical dipoles 
  
DCM.Sname           = lbl; 
DCM.M.Hz            = frq_ax; 
DCM.xY.Dfile        = datafile; 
DCM.xY.Hz           = frq_ax; 
  
for a = 1:3 
    DCM.A{a}    = Amod{4}.A{a};     % Tectum Hub Model 
end 
DCM.B           = {}; 
DCM.C           = sparse(length(DCM.A{1}),0);  
  
DCM.M.dipfit.Nm    = DCM.options.Nmodes; 
DCM.M.dipfit.model = DCM.options.model; 
DCM.M.dipfit.type  = DCM.options.spatial; 
DCM.M.dipfit.Nc    = 10; 
DCM.M.dipfit.Ns    = 10; 
  
[pE,pC]  = spm_dcm_neural_priors(DCM.A,DCM.B,DCM.C,DCM.options.model); 
[pE,pC]  = spm_L_priors(DCM.M.dipfit,pE,pC); 
[pE,pC]  = spm_ssr_priors(pE,pC); 
DCM.pE   = pE; 
DCM.pC   = pC; 
  
for s = 1 :Ntrials 
    if s < 10, ns = ['00' num2str(s)];  
    elseif s < 100, ns = ['0' num2str(s)]; 
    else ns = num2str(s);  
    end 
    DCM.options.trials  = [s]; 
    DCM = spm_dcm_fit(DCM); 
end 
 
 
A.5.2.7  zf_peb 
%% Housekeeping 
%=======================================================================
=== 
% Generic Housekeeping 
%-----------------------------------------------------------------------
--- 
clear all 
fs          = filesep; 
D           = zf_housekeeping; 
Fbase       = D.Fbase; 
Fscripts    = D.Fscripts; 
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Forig       = D.Forig; 
Fanalysis   = D.Fanalysis; 
  
sub         = D.subs; 
Fs          = D.Fs; 
win         = D.win; 
stp         = D.stp; 
lbl         = D.lbl; 
frq_ax      = D.frq_ax; 
endtime     = D.endtime; 
  
i   = 0; 
clear DCM 
  
for s = 1:length(sub) 
  
% Subject specific housekeeping 
%-----------------------------------------------------------------------
--- 
Fdata       = [Fanalysis fs sub{s} 'Data Files']; 
Fdcm        = [Fanalysis fs 'DCM' fs sub{s}]; 
Finv        = [Fanalysis fs 'Cluster Files' fs sub{s} fs 'Inverted 
DCMs']; 
datafile    = [Fdata fs 'Z_60by10.mat']; 
  
  
% Load DCMs  
%=======================================================================
=== 
files = cellstr(spm_select('FPList', Finv, 'DCM_*')); 
for f = 5:5:892 
    i = i + 1; 
    TCM = load(files{f}); 
    DCM{i} = TCM.DCM{1}; 
    clear TCM; 
end 
end 
  
DCM = DCM'; 
  
%% Set up PEB model 
%=======================================================================
=== 
% Make second level model space 
%=======================================================================
=== 
ldcm    = length(DCM)/3; 
tim_ax  = linspace(0, endtime, ldcm); 
ti      = find(tim_ax > 30); 
  
% PTZ time curves 
%-----------------------------------------------------------------------
--- 
clear ptz 
  
k = 1/30;           % Inverse time constant 
H = 1 * 1/0.37;     % Maximum height 
i = 0; 
ptz_t   = []; 
  
for w = (tim_ax(tim_ax > 30))-30 
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    i = i+1; 
    ptz(ti(i)) = H*k*w * exp(-k*w); 
end 
  
% Tonic effect 
%-----------------------------------------------------------------------
--- 
tnc = zeros(1,ldcm); 
tnc(ti) = ones(1,length(ti)); 
  
% Prolonged seizure effect 
%-----------------------------------------------------------------------
--- 
plg = zeros(1,ldcm); 
plg(ti) = linspace(0,1,length(ti)); 
  
% Direct cosine transforms 
%-----------------------------------------------------------------------
--- 
dct = spm_dctmtx(1,4,linspace(0, 5, ldcm)); 
dct = dct(:,2:end)' ./ max(max(dct)); 
  
% Static effects 
%-----------------------------------------------------------------------
--- 
stc = ones(1,ldcm); 
  
% Empty filler 
%-----------------------------------------------------------------------
--- 
emp = zeros(1,ldcm); 
  
% Run PEB 
%=======================================================================
=== 
clear X Xnames M PEB RCM BMA 
X       = [ tnc, tnc, tnc; ...  
            ptz, ptz, ptz; ... 
            plg, plg, plg; ... 
            dct, dct, dct; 
            stc, emp, emp; ... 
            emp, stc, emp; ... 
            emp, emp, stc]'; 
Xnames  = {'Tonic', 'Monophasic', 'Prolonged', 'DCT1', 'DCT2', 'DCT2', 
'S1', 'S2', 'S3'}; 
M.X         = X; 
M.Xnames    = Xnames; 
  
imagesc(X); 
[PEB RCM] = spm_dcm_peb(DCM, M, {'A', 'H', 'T'}); 
  
%% Create reduced model space at second level 
%=======================================================================
=== 
clear T H 
  
% Intrinsic effects 
%=======================================================================
=== 
for t = 1:7, T{t} = zeros(10,2); H{t} = zeros(10,5); end 
for f = 1:5 
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    idx     = [1:2]+(f-1)*2; 
    T{f+1}(idx,:)   = DCM{1}.pC.T(idx,:); 
    H{f+1}(idx,:)   = DCM{1}.pC.H(idx,:);     
end 
T{7}      = DCM{1}.pC.T;        H{7}    = DCM{1}.pC.H; 
  
% Extrinsic effects 
%=======================================================================
=== 
Amod = zf_modelspace; 
clear Hom Nei Hub hub nei extr 
  
% Homologue lateral connectivity 
%-----------------------------------------------------------------------
--- 
Hom{1} = Amod{1}.A;                             % none 
  
% Neighbouring forward/backward connectivity 
%-----------------------------------------------------------------------
--- 
empt    = zeros(length(Amod{1}.A{1})); 
neimat  = zeros(length(Amod{1}.A{1})); 
  
for m = 3:length(neimat) 
    neimat(m, m-2) = 1; 
    neimat(m-2, m) = 1; 
end 
  
Nei{1} = Amod{1}.A;                             % none 
Nei{2} = Amod{1}.A;                             % forward 
    Nei{2}{1} = empt + triu(neimat);                  
Nei{3} = Amod{1}.A;                             % backward 
    Nei{3}{2} = empt + tril(neimat); 
Nei{4} = Amod{1}.A;                             % forward and backward 
    Nei{4}{1} = Nei{2}{1}; 
    Nei{4}{2} = Nei{3}{2}; 
  
% Optic Tectum hub forward/backward connectivity 
%-----------------------------------------------------------------------
--- 
Hub{1} = Amod{1}.A;                             % none 
Hub{2} = Amod{1}.A;                             % forward 
    Hub{2}{1} = Amod{2}.A{1}; 
Hub{3} = Amod{1}.A;                             % backward 
    Hub{3}{2} = Amod{2}.A{2}; 
Hub{4} = Amod{1}.A;                             % forward and backward 
    Hub{4}{1} = Hub{2}{1}; 
    Hub{4}{2} = Hub{3}{2}; 
  
% Assemble into 4 * 4 = 32 model space 
%-----------------------------------------------------------------------
--- 
count = 0; 
h     = 1; 
for n = 1:length(Nei) 
for b = 1:length(Hub) 
    count = count+1; 
    ext{count}.A{1} = Nei{n}{1} + Hub{b}{1}; 
    ext{count}.A{2} = Nei{n}{2} + Hub{b}{2}; 
    ext{count}.A{3} = Hom{h}{3}; 
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    hub(count) = b; 
    nei(count) = n; 
end 
end 
  
% PEB BMC for Extrinsic Connections 
%=======================================================================
=== 
% Assemble model matrix 
%-----------------------------------------------------------------------
--- 
clear MOD 
  
for tw = 1:length(DCM)  
    count = 0;  
  
    for i = length(T) 
    for e = 1:length(ext) 
        count = count+1; 
        MOD{tw,count} = DCM{tw}; 
  
        MOD{tw,count}.M.pC.A     = ext{e}.A; 
        MOD{tw,count}.M.pC.T     = T{i}; 
        MOD{tw,count}.M.pC.H     = H{i}; 
    end 
    end 
end 
  
% Run PEB for Extrinsic Connections 
%-----------------------------------------------------------------------
--- 
PMA     = spm_dcm_peb_bmc(PEB, MOD(1,:)); 
  
% Family Wise Comparison - Extrinsic Connections 
%=======================================================================
=== 
figure 
F = sum(PMA.F,2); 
for ni = 1:length(Nei) 
    n(ni) = sum(F(find(nei == ni))); 
end 
sn  = sort(n); 
dFn = sn(end) - sn(end-1); 
  
for hi = 1:length(Hub) 
    h(hi) = sum(F(find(hub == hi))); 
end 
sh  = sort(h); 
dFh = sh(end) - sh(end-1); 
  
% Plot family-wise comparison for free energies  
%-----------------------------------------------------------------------
--- 
set(gcf, 'Color', 'w'); 
  
subplot(1,2,1) 
bar(n - min(n)) 
     
    % Labels and Fonts 
    title('Extrinsic coupling of hierarchy', 'FontSize', 12, 
'FontWeight', 'bold'); 
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    set(gca, 'XTick', [1 2 3 4], 'XTickLabel', {'Nil', 'Forward', 
'Backward', 'Forward/Backward'}); 
    xlabel(['dF = ' num2str(dFn,2)], 'FontWeight', 'bold'); 
     
    % Plotting Parameters 
    axis square 
    colormap gray 
  
subplot(1,2,2) 
bar(h - min(h)) 
     
    % Labels and Fonts 
    title('Extrinsic coupling of hub region', 'FontSize', 12, 
'FontWeight', 'bold'); 
    set(gca, 'XTick', [1 2 3 4], 'XTickLabel', {'Nil', 'Forward', 
'Backward', 'Forward/Backward'}); 
    xlabel(['dF = ' num2str(dFh, 4)], 'FontWeight', 'bold'); 
     
    % Plotting Parameters 
    axis square 
    colormap gray 
     
     
%% PEB BMC for Intrinsic connections 
%=======================================================================
=== 
% Assemble model matrix 
%-----------------------------------------------------------------------
--- 
clear MOD t F 
  
for tw = 1:length(DCM)  
    count = 0; 
    for i = 1:length(T) 
    for e = length(ext) 
        count = count+1; 
         
        MOD{tw,count} = DCM{tw}; 
         
        MOD{tw,count}.M.pC.A     = ext{e}.A; 
        MOD{tw,count}.M.pC.T     = T{i}; 
        MOD{tw,count}.M.pC.H     = H{i}; 
         
        int(count) = i; 
    end 
    end 
end 
  
% Run PEB for Intrinsic Connections 
%-----------------------------------------------------------------------
--- 
[PMA]   = spm_dcm_peb_bmc(PEB, MOD(1,:)); 
  
% Family Wise Comparison - Intrinsic Connections 
%=======================================================================
=== 
clear t ti  
F   = sum(PMA.F,2); 
st  = sort(F); 
dFn = st(end) - st(end-1); 
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% Plot family-wise comparison for free energies  
%-----------------------------------------------------------------------
--- 
figure 
bar(F - min(F)) 
set(gcf, 'Color', 'w'); 
  
% Labels and Fonts 
title('Intrinsic Parameters', 'FontSize', 12, 'FontWeight', 'bold'); 
set(gca, 'XTick', [1 2 3 4 5 6 7], 'XTickLabel', {'Nil', 'Tect', 'Crbl', 
'RHBr', 'CHBr', 'RSC', 'all'}); 
xlabel(['dF = ' num2str(dFn,4)], 'FontWeight', 'bold'); 
  
% Plotting Parameters 
axis square 
colormap gray 
  
%% Generate winning model average within model families 
%=======================================================================
=== 
clear M 
Xnames      = {'Tonic', 'Monophasic', 'Prolonged', 'DCT1', 'DCT2', 
'DCT2', 'S1', 'S2', 'S3'}; 
M.X         = X; 
M.Xnames    = Xnames; 
  
Fhub        = { 'A{1}(1,3)', 'A{1}(1,4)', 'A{1}(1,5)', 'A{1}(1,6)', 
'A{1}(1,7)', 'A{1}(1,8)', 'A{1}(1,9)', 'A{1}(1,10)', ... 
                'A{1}(2,4)', 'A{1}(2,5)', 'A{1}(2,6)', 'A{1}(2,7)', 
'A{1}(2,8)', 'A{1}(2,9)', 'A{1}(2,10)'}; 
  
[PEB, RCM]  = spm_dcm_peb(DCM, M, {'H', 'T', Fhub{:}}); 
[PMA]       = spm_dcm_peb_bmc(PEB); 
  
%% Extract and plot Parameters 
%=======================================================================
=== 
clear PEB PMA RCM 
  
% Load outputs of PEB analysis 
%-----------------------------------------------------------------------
--- 
Fpeb        = [Fanalysis fs 'PEB']; 
load([Fpeb fs 'PEB']); 
load([Fpeb fs 'PMA']); 
  
Rlist  = cellstr(spm_select('FPList', Fpeb, '^R')); 
for r = 1:length(Rlist) 
    load(Rlist{r}); 
    RCM{r}  = rcm; 
    clear rcm 
end 
  
%% Define time window to plot 
%-----------------------------------------------------------------------
--- 
clear xEp xCp Te Ti He Hi Aa Ep Cp c d  
X         = PEB.M.X; 
[val loc] = max(diff(PEB.M.X(:,2)));      % Maximum acute effect 
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G         = PEB; 
for i = 1:2 
    Np      = length(G.Pnames); 
    Ep(:,i) = G.Ep( [1:Np] + (i-1)*Np ) * X(loc,i); 
    Cps     = diag(G.Cp); 
    Cp(:,i) = Cps( [1:Np] + (i-1)*Np ); 
end 
  
xCp     = sum(Cp,2); 
xEp     = sum(Ep,2);  xEp = exp(xEp);   
  
Te      = zeros(1,Np);  Ti  = zeros(1,Np); 
He      = zeros(1,Np);  Hi  = zeros(1,Np); 
Aa      = zeros(1,Np); 
  
for p = 1:Np 
    if ~isempty(regexp(PEB.Pnames{p}, 'T.*,1)')), Te(p) = 1;    end 
    if ~isempty(regexp(PEB.Pnames{p}, 'T.*,2)')), Ti(p) = 1;    end   
    if ~isempty(regexp(PEB.Pnames{p}, 'H.*,[1 2 3])')), He(p) = 1;  end   
    if ~isempty(regexp(PEB.Pnames{p}, 'H.*,[4,5])')), Hi(p) = 1;    end  
    if ~isempty(regexp(PEB.Pnames{p}, 'A.*')), Aa(p) = 1;    end  
end 
  
Te = find(Te);  Ti = find(Ti); 
He = find(He);  Hi = find(Hi); 
Aa = find(Aa); 
  
clear cols colblock 
colblock = cbrewer('qual', 'Paired', 10); 
  
d{1} = xEp(Te)';     lab{1} = 'Te';  c{1} = xCp(Te)'; cols{1} = 
[colblock]; 
d{2} = xEp(Ti)';     lab{2} = 'Ti';  c{2} = xCp(Ti)'; cols{2} = 
[colblock]; 
d{3} = xEp(He)';     lab{3} = 'He';  c{3} = xCp(He)'; cols{3} = 
[colblock; colblock; colblock]; 
d{4} = xEp(Hi)';     lab{4} = 'Hi';  c{4} = xCp(Hi)'; cols{4} = 
[colblock; colblock]; 
d{5} = xEp(Aa)';     lab{5} = 'A';   c{5} = xCp(Aa)'; cols{5} = []; 
  
for a = 1:length(Aa) 
    dgt         = str2double(PEB.Pnames{Aa(a)}(end-1)); 
    if dgt == 0, dgt = 10; end 
    cols{5}     = [cols{5}; colblock(dgt,:)]; 
end 
  
figure 
zf_dotplot(d, lab, 1, c, cols); 
 
A.5.2.8 zf_simulate 
% Generic Housekeeping 
%-----------------------------------------------------------------------
--- 
clear all 
fs          = filesep; 
D           = zf_housekeeping; 
Fbase       = D.Fbase; 
Fscripts    = D.Fscripts; 
Forig       = D.Forig; 
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Fanalysis   = D.Fanalysis; 
Fpeb        = [Fanalysis fs 'PEB']; 
  
sub         = D.subs; 
Fs          = D.Fs; 
win         = D.win; 
stp         = D.stp; 
lbl         = D.lbl; 
frq_ax      = D.frq_ax; 
endtime     = D.endtime; 
  
% Load outputs of PEB analysis 
%-----------------------------------------------------------------------
--- 
Rlist  = cellstr(spm_select('FPList', Fpeb, '^R')); 
for r = 1:length(Rlist) 
    load(Rlist{r}); 
    RCM{r}  = rcm; 
    clear rcm 
end 
  
load([Fpeb fs 'PEB']); 
load([Fpeb fs 'PMA']); 
  
%% Principal component analysis 
%-----------------------------------------------------------------------
--- 
Np  = length(PEB.Pnames); 
Nw  = length(PEB.Snames); 
Ep  = [PEB.Ep(:,1:9) * PEB.M.X(:,1:9)']'; 
  
T = [];         H = []; 
for p = 1:Np 
    if ~isempty(regexp(PEB.Pnames{p}, ['T(.*[2],[1 2])'])),         T(p) 
= 1;    end 
    if ~isempty(regexp(PEB.Pnames{p}, ['H(.*[2],[1 2 3 4 5])'])),   H(p) 
= 1;    end   
end 
T = find(T);    H = find(H); 
colblock = flip(cbrewer('div', 'Spectral', Nw/3)); 
cols     = [colblock; colblock; colblock]; 
  
[Tcf Tsc Tlat Tt2 Texp]     = pca(Ep(:,T), 'Algorithm', 'eig'); 
[Hcf Hsc Hlat Ht2 Hexp]     = pca(Ep(:,H), 'Algorithm', 'eig'); 
  
clear CA 
  
CA.Tcf      = Tcf;          CA.Hcf      = Hcf; 
CA.Tsc      = Tsc;          CA.Hsc      = Hsc; 
  
scatter(Tsc(:,1), Hsc(:,1), 80, cols, 'filled') 
xlabel('T component'); 
ylabel('H component'); 
  
figure 
scatter3(Tsc(:,1), Hsc(:,1), Hsc(:,2), 80, cols, 'filled'); 
xlabel('First component of time constants'); 
ylabel('First component of connectivity parameters'); 
zlabel('Second component of connectivity parameters'); 
  
%% Model single node output 
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%=======================================================================
=== 
frq_ax      = D.frq_ax; 
BCM.A{1}    = 0; 
BCM.A{2}    = 0; 
BCM.A{3}    = 1; 
BCM.B       = {}; 
BCM.C       = sparse(length(BCM.A{1}),0); 
  
BCM.options.model    = 'LFP'; 
  
BCM.M.dipfit.Nm    = 8; 
BCM.M.dipfit.model = BCM.options.model; 
BCM.M.dipfit.type  = 'LFP'; 
BCM.M.dipfit.Nc    = 1; 
BCM.M.dipfit.Ns    = 1; 
  
frqsim      = .5:.5:50; 
BCM.M.Hz    = frqsim; 
BCM.M.f     = 'spm_fx_lfp'; 
BCM.M.g     = 'spm_gx_erp'; 
BCM.M.l     = BCM.M.dipfit.Nm; 
BCM.M.x     = zeros(1,13); 
BCM.M.u     = 0; 
BCM.xU.X    = zeros(1,0); 
  
[pE,pC]  = spm_dcm_neural_priors(BCM.A,BCM.B,BCM.C,BCM.options.model); 
[pE,pC]  = spm_L_priors(BCM.M.dipfit,pE,pC); 
[pE,pC]  = spm_ssr_priors(pE,pC); 
  
% Setup baseline  
%-----------------------------------------------------------------------
---- 
Ep  = PEB.Ep(:,7); 
Np  = length(PEB.Pnames); 
  
% clear T H 
% for p = 1:Np 
%     if ~isempty(regexp(PEB.Pnames{p}, ['T.*[2],[1 2])'])),          
T(p) = 1;    end 
%     if ~isempty(regexp(PEB.Pnames{p}, ['H.*[2],[1 2 3 4 5])'])),  H(p) 
= 1;    end   
% end 
% T   = find(T);  
% H   = find(H); 
  
Sp  = pE; 
Sp.T    = Ep(T)'; 
Sp.H    = Ep(H)'; 
  
%  
% mnSc  = -50;    
% mxSc  = 30;     
  
steps = 100; 
grad1  = linspace(-.5,.5,steps); 
grad2  = linspace(-1,1,steps); 
dim1  = grad1 .* CA.Tcf(:,1); 
dim2  = grad2 .* CA.Hcf(:,1); 
  
clear CSD POW 
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for d1 = 1:size(dim1,2)-1 
for d2 = 1:size(dim2,2) 
    pS      = Sp; 
    ti      = [1 2]; 
    hi      = [1 2 3 4 5]; 
    pS.T    = pS.T + dim1(ti,d1); 
    pS.H    = pS.H + dim2(hi,d2); 
     
    csd         = spm_csd_mtf(pS, BCM.M, BCM.xU); 
    CSD(d1,d2,:)= abs(csd{1}(:,1,1));  
    POW(d1,d2)  = mean(CSD(d1,d2,1:8)); 
end 
end 
  
%% 
for d1 = 1:size(dim1,2)-1 
for d2 = 1:size(dim2,2) 
    POW(d1,d2)  = mean(CSD(d1,d2,find(frqsim >= 25)));     
end 
end 
subplot(2,1,1) 
contour(grad1(1:end-1), grad2, log(POW)', [-3 -2 -1 0 1]); 
title('Log gamma power in parameter space'); 
colormap gray, axis square 
colorbar; 
set(gca, 'YDir', 'normal'); 
  
for d1 = 1:size(dim1,2)-1 
for d2 = 1:size(dim2,2) 
    POW(d1,d2)  = mean(CSD(d1,d2,find(frqsim <= 4)));     
end 
end 
  
subplot(2,1,2) 
imagesc(grad1(1:end-1), grad2, log(POW)'); hold on 
title('Log delta power in parameter space') 
colormap gray, axis square 
colorbar 
set(gca, 'YDir', 'normal'); 
  
scatter(Tsc(:,1), Hsc(:,1), 80, cols, 'filled') 
xlabel('T component'); 
ylabel('H component'); 
  
  
  
%% Plot individual fish predictions of parameter changes over time 
%-----------------------------------------------------------------------
--- 
for d1 = 1:length(Tsc(:,1)) 
    Ti(d1) = nearest(grad1, Tsc(d1,1));   % T dimension 
end 
  
for d2 = 1:length(Hsc(:,1)) 
    Hi(d2) = nearest(grad2, Hsc(d2,1));   % T dimension 
end 
  
ss = 1:floor(length(Ti) / 3);     % indices for single subject 
for s = 1:3 
subplot(1,3,s) 
    Tplot = Ti(ss + (s-1)*ss(end)); 
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    Hplot = Hi(ss + (s-1)*ss(end)); 
    for t = 1:length(Tplot) 
        csd     = squeeze(log(CSD(Tplot(t), Hplot(t), :))); 
        plot(csd, 'color', cols(t,:)); hold on 
    end 
    ylim([-5 1]); 
end 
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A.6  DCM analysis of NMDAR-Ab effects in patients and a 
mouse model of NMDAR-Ab encephalitis 
A.6.1  README description of code function 
The matlab scripts shown here implement the analysis discussed in detail in chapter 5 of 
this thesis – using invasive electrophysiological recordings in a mouse model of NMDAR-
Ab encephalitis, as well as EEG recordings in human patients, the analysis applies DCM to 
extract neural mass model descriptions of the NMDAR-Ab induced abnormalities.  
The full code and data for this project have been made publicly available in an open science 
repository that can be found online here: https://www.doi.org/10.17605/OSF.IO/YXKWD 
A.6.2  Custom functions 
A.6.2.1  mab_dcm 
%% mab_dcm 
%=======================================================================
=== 
% This routine implements and runs DCMs on the windowed spectral single 
% channel data  
  
D           = mab_housekeeping; 
Fbase       = D.Fbase;     
Fscripts    = D.Fscripts;   
Fanalysis   = D.Fanalysis;  
Fdcm        = D.Fdcm; 
mind        = D.mind; 
fs          = filesep; 
clear D 
  
%% Model specification 
%=======================================================================
=== 
rng('default') 
clear DCM SLIDE 
  
DCM.xY.Dfile    = [Fanalysis fs 'LFP_MEEG']; 
LFP             = spm_eeg_load(DCM.xY.Dfile); 
Fs              = fsample(LFP); 
smpls           = size(LFP,2); 
timax           = linspace(0, smpls/Fs, smpls); 
LFP_conds       = condlist(LFP); 
  
for c = 1:length(LFP_conds) 
disp(['Currently at ' num2str(c) ' of ' num2str(length(LFP_conds)) ' 
windows']); 
  
% Set up DCM details 
%-----------------------------------------------------------------------
--- 
DCM.options.analysis    = 'CSD';    % cross-spectral density  
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DCM.options.model       = 'CMC';    % structure cannonical microcircuit 
(for now) 
DCM.options.spatial     = 'LFP';    % virtual electrode input    
DCM.options.Tdcm        = [timax(1) timax(end)] * 1000;     % time in ms 
  
DCM.options.Fdcm    = [1 60];       % frequency range   
DCM.options.D       = 1;            % frequency bin, 1 = no downsampling 
DCM.options.Nmodes  = 8;            % cosine reduction components used  
DCM.options.han     = 0;            % no hanning  
DCM.options.trials  = c;            % index of ERPs within file 
  
DCM.Sname           = chanlabels(LFP); 
DCM.M.Hz            = 
DCM.options.Fdcm(1):DCM.options.D:DCM.options.Fdcm(2); 
DCM.xY.Hz           = DCM.M.Hz; 
  
% Create DCM Struct and specify DCM.options  
%-----------------------------------------------------------------------
--- 
DCM.A       = {1 1 1}; 
DCM.B       = {}; 
DCM.C       = sparse(length(DCM.A{1}),0); 
  
% Reorganise model parameters in specific structure 
%=======================================================================
=== 
DCM.M.dipfit.Nm     = DCM.options.Nmodes; 
DCM.M.dipfit.model  = DCM.options.model; 
DCM.M.dipfit.type   = DCM.options.spatial; 
  
DCM.M.dipfit.Nc     = size(LFP,1); 
DCM.M.dipfit.Ns     = length(DCM.A{1}); 
DCM.name            = [Fdcm fs 'DCM_' LFP_conds{DCM.options.trials} 
'.mat']; 
  
SLIDE{c}            = mab_spm_dcm_csd(DCM); 
SLIDE{c}.xY.R       = diag(SLIDE{c}.xY.R); 
save([Fanalysis fs 'DCM_All'], 'SLIDE'); 
end 
 
A.6.2.2  mab_peb 
%% mab_peb 
%=======================================================================
=== 
% This routine loads the inverted individual time window DCMs and 
performs 
% parametric empirical Bayesian analyiss 
  
clear all 
  
% Housekeeping 
%=======================================================================
=== 
D           = mab_housekeeping; 
fs          = filesep; 
Fbase       = D.Fbase; 
Fscripts    = D.Fscripts; 
Fdcm        = D.Fdcm; 
Fanalysis   = D.Fanalysis; 
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mind        = D.mind; 
Tplot       = D.Tplot;      Tlabel      = D.Tlabel; 
Gplot       = D.Gplot;      Glabel      = D.Glabel; 
  
load([Fanalysis fs 'DCM_All.mat']); 
LFP = spm_eeg_load([Fanalysis fs 'LFP_MEEG']); 
clear D 
  
% PEB Analysis 
%=======================================================================
=== 
% Make second level model space 
%-----------------------------------------------------------------------
--- 
clear M ptz atb itx 
k = 1/10;           % Inverse time constant 
H = 1 * 1/0.37;     % Maximum height 
i       = 0; 
ptz_t   = []; 
  
% PTZ time curves 
%-----------------------------------------------------------------------
--- 
seg     = 1:fix(length(SLIDE)/4); 
tim_ax  = linspace(0, 60, length(seg)); 
  
for w = tim_ax 
    i = i+1; 
    ptz_t(i) = H*k*w * exp(-k*w); 
end 
  
ptz(seg) = zeros(1,length(seg)); 
ptz(seg + seg(end)) = ptz_t; 
ptz     = [ptz, ptz]; 
  
% Antibody definitions 
%-----------------------------------------------------------------------
--- 
atb     = zeros(1, 2*seg(end)); 
atb_2   = ones(1, 2*seg(end)); 
atb     = [atb, atb_2]; 
  
% Interaction modelling  
%-----------------------------------------------------------------------
--- 
for i = 1:length(atb),  
    if ptz(i) == 0, 
        itx(i) = 0; 
    else 
        if atb(i) > 0 
            itx(i) = ptz(i); 
        else 
            itx(i) = -ptz(i); 
        end 
    end 
end 
  
clist   = condlist(LFP); 
for c = 1:length(clist) 
    uscores = find(clist{c} == '_'); 
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    for u = uscores, clist{c}(u) = ' '; end 
end 
  
subplot(3,1,1), plot(atb); title('Main effect of Antibody'); 
subplot(3,1,2), plot(ptz); title('Main effect of PTZ'); 
subplot(3,1,3), plot(itx); title('Interaction'); 
set(gca, 'XTick', 1:seg(end):length(SLIDE)) 
set(gca, 'XTickLabel', clist(1:seg(end):length(SLIDE))); 
  
% Run PEB 
%-----------------------------------------------------------------------
--- 
FCM         = SLIDE'; 
X           = [atb; ptz; itx; ones(1,length(atb)); ]'; 
Xnames      = {'Antibody', 'PTZ', 'Interaction', 'Static'}; 
  
M.X         = X; 
M.Xnames    = Xnames; 
M.Q         = 'all'; 
  
% The model space below yields the full model as winning 
%=======================================================================
=== 
% Time constant parameters mab_spm_fx_cmc 
%-----------------------------------------------------------------------
--- 
% G(:,1)  ss -> ss (-ve self)  4    MOD 
% G(:,2)  sp -> ss (-ve rec )  4    INH 
% G(:,3)  ii -> ss (-ve rec )  4    INH 
% G(:,4)  ii -> ii (-ve self)  4    MOD 
% G(:,5)  ss -> ii (+ve rec )  4    EXC 
% G(:,6)  dp -> ii (+ve rec )  2    EXC 
% G(:,7)  sp -> sp (-ve self)  4    MOD 
% G(:,8)  ss -> sp (+ve rec )  4    EXC 
% G(:,9)  ii -> dp (-ve rec )  2    INH 
% G(:,10) dp -> dp (-ve self)  1    MOD 
%  
% The order in the DCM structure is as follows 
% j     = [7 2 3 4 5 6 8 9 10 1]; 
% i.e.     M I I M E E E I M  M 
% new   =  1 2 3 4 5 6 7 8 9 10 
  
fields{1}   = {'T(1)', 'T(2)', 'T(3)', 'T(4)'};     % time constants 
fields{2}   = {'G(2)', 'G(3)', 'G(8)'};             % inh connections 
fields{3}   = {'G(5)', 'G(6)', 'G(7)'};             % exc connections 
fields{4}   = {'G(1)', 'G(4)', 'G(9)', 'G(10)'};    % mod connections 
fields{5}   = {fields{1}{:}, fields{2}{:}};         % time and inh 
fields{6}   = {fields{1}{:}, fields{3}{:}};         % time and exc 
fields{7}   = {fields{1}{:}, fields{4}{:}};         % time and mod 
fields{8}   = {fields{1}{:}, fields{2}{:}, fields{4}{:}};   % time, inh, 
and mod 
fields{9}   = {fields{1}{:}, fields{2}{:}, fields{3}{:}};   % time, inh, 
and exc 
fields{10}   = {fields{2}{:}, fields{3}{:}};         % inh and exc 
fields{11}   = {fields{2}{:}, fields{4}{:}};         % inh and mod 
fields{12}  = {fields{3}{:}, fields{4}{:}};         % exc and mod 
fields{13}  = {fields{2}{:}, fields{3}{:}, fields{4}{:}}; % all coupling 
fields{14}  = {fields{1}{:}, fields{2}{:}, fields{3}{:}, fields{4}{:}}; 
% all  
  
labels  = { 't', 'g_i', 'g_e', 'g_m', ... 
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            't, g_i', 't, g_e', 't, g_m', 't, g_i, g_m', 't, g_i, g_e', 
... 
            'g_i, g_e', 'g_i, g_m', 'g_e, g_m', 'g_{all}', 'all'}; 
%  
% % Run PEB across reduced second level model space 
% 
%=======================================================================
=== 
% for f = 1:length(fields) 
%     [PEB, RCM]  = spm_dcm_peb(FCM, M, fields{f}); 
%     P(f).PEB = PEB; 
%     P(f).F   = PEB.F; 
%     F(f) = PEB.F; 
% end 
% save([Fdcm fs 'PEB.mat'], 'P'); 
%  
% % Calculate the Free energy difference between winning and second 
model 
% %---------------------------------------------------------------------
----- 
% [Fstd Fstg] = sort(F, 'descend'); 
% dF          = Fstd(1) - Fstd(2); 
%  
% % Plot Bayesian model comparison over second level model space 
% %---------------------------------------------------------------------
----- 
% subplot(2,1,1), bar(F - min(F));          title(['Free Energy, dF = ' 
num2str(dF)]); 
% subplot(2,1,2), bar(spm_softmax(F'));     title('Posterior 
Probability'); 
  
% Bayesian model reduction over winning PEB (full model) 
%-----------------------------------------------------------------------
--- 
  
[PEB RCM]   = spm_dcm_peb(FCM, M, fields{end}); 
BMA         = spm_dcm_peb_bmc(PEB); 
FEB.BMA     = BMA; 
FEB.RCM     = RCM; 
FEB.PEB     = PEB; 
  
save([Fdcm fs 'Full Empirical Bayes.mat'], 'FEB'); 
  
%% Plot DCM outputs 
%=======================================================================
=== 
load([Fdcm fs 'Full Empirical Bayes']); 
RCM     = FEB.RCM; 
  
% Extract predicted and observed spectra 
%-----------------------------------------------------------------------
--- 
for r = 1:length(RCM) 
    pre(:,r) = log(abs(RCM{r}.Hc{1})); 
    obs(:,r) = log(abs(RCM{r}.xY.y{1})); 
end 
  
% Define plotting ranges 
%-----------------------------------------------------------------------
--- 
cbar    = [-2.8 1]; 
yrange  = [2 15]; 
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fqaxis  = RCM{1}.M.Hz; 
tmaxis  = linspace(-45, 45, length(RCM)/2); 
  
first   = 1:length(RCM)/2; 
second  = first + length(RCM)/2; 
  
subplot(2,2,1) 
    imagesc(tmaxis, fqaxis, obs(:,first), cbar); 
    ylim(yrange); 
    set(gca, 'ydir', 'normal'); 
    title('Control, observed'); 
  
subplot(2,2,2) 
    imagesc(tmaxis, fqaxis, obs(:,second), cbar); 
    ylim(yrange); 
    set(gca, 'ydir', 'normal'); 
    title('Patient, observed'); 
  
subplot(2,2,3) 
    imagesc(tmaxis, fqaxis, pre(:, first), cbar); 
    ylim(yrange); 
    set(gca, 'ydir', 'normal'); 
    title('Control, predicted'); 
  
subplot(2,2,4) 
    imagesc(tmaxis, fqaxis, pre(:, second), cbar); 
    ylim(yrange); 
    set(gca, 'ydir', 'normal'); 
    title('Patient, predicted'); 
  
cmap = flip(cbrewer('div', 'Spectral', 100)); 
colormap(cmap); 
  
%% Plot individual Parameter Values 
%-----------------------------------------------------------------------
--- 
Np      = length(FEB.BMA.Pnames); 
ploti   = [Tplot, Gplot+length(Tplot)]; 
  
Ep = reshape(FEB.BMA.Ep, [Np,4]); 
Cp = reshape(diag(FEB.BMA.Cp), [Np,4]); 
  
for e = 1:3 
    subplot(3,1,e) 
    spm_plot_ci(Ep(ploti,e), Cp(ploti,e)); 
    ylim([-1 2]); 
end 
set(gca, 'XTick', 1:Np, 'XTickLabel', {Tlabel{:}, Glabel{:}}); 
 
A.6.2.3  mab_parameterspace 
% mab_parameterspace 
clear all 
  
% Housekeeping 
%=======================================================================
=== 
D           = mab_housekeeping; 
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fs          = filesep; 
Fbase       = D.Fbase; 
Fscripts    = D.Fscripts; 
Fdcm        = D.Fdcm; 
Fanalysis   = D.Fanalysis; 
  
mind        = D.mind; 
Tplot       = D.Tplot;      Tlabel      = D.Tlabel; 
Gplot       = D.Gplot;      Glabel      = D.Glabel; 
  
load([Fanalysis fs 'DCM_All.mat']); 
LFP = spm_eeg_load([Fanalysis fs 'LFP_MEEG']); 
clear D 
  
load([Fdcm fs 'Full Empirical Bayes.mat']) 
  
%% Illustrate parameter space using first principal eigenmodes 
%=======================================================================
=== 
% Extract parameters from reduced first level models 
%-----------------------------------------------------------------------
--- 
for r = 1:length(FEB.RCM) 
    T(r,:) = FEB.RCM{r}.Ep.T; 
    G(r,:) = FEB.RCM{r}.Ep.G; 
end 
  
% Do principal component decomposition 
%-----------------------------------------------------------------------
--- 
T = full(T); 
G = full(G); 
  
[Tcf Tsc] = pca(T, 'Algorithm', 'eig'); 
[Gcf Gsc] = pca(G, 'Algorithm', 'eig'); 
  
% Map first principal components separately for T and G parameters 
%-----------------------------------------------------------------------
--- 
seps = linspace(0, length(FEB.RCM), 5); 
cols = cbrewer('qual', 'Paired', 10); 
cols = cols([7 8 9 10],:); 
  
for s = 2:length(seps) 
    plid    = seps(s-1) + 1:seps(s); 
     
    subplot(2,5,[2 3 7 8]); 
    % Plot 
        scatter(Tsc(plid,1), Gsc(plid,1), [], cols(s-1,:), 'filled'); 
hold on 
    % Labels 
        xlabel('Time constant component'); 
        ylabel('Connection strength component'); 
    % Settings 
        xlim([-3 3]); ylim([-5 5]); 
        axis square 
end 
legend({'Control, pre PTZ', 'Control, post PTZ', 'Antibody, pre PTZ', 
'Antibody, post PTZ'}); 
  
subplot(2,5,1),  
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% Plot     
    bar(Tcf(Tplot,1));  
% Labels     
    title('Time constants: First component') 
% Settings 
    xlim([0 length(Tlabel)+1]);  
    set(gca, 'XTick', 1:length(Tlabel), 'XTickLabel', Tlabel); 
  
subplot(2,5,6),  
% Plot   
    bar(Gcf(Gplot,1));  
% Labels     
    title('Connection strengths: First component'); 
% Settings 
    xlim([0 length(Glabel)+1]);  
    set(gca, 'XTick', 1:length(Glabel), 'XTickLabel', Glabel); 
  
subplot(2,5,[5 5 9 10]); 
for s = 2:length(seps) 
    plid    = seps(s-1) + 1:seps(s); 
    scatter3(T(plid,1), T(plid,2), G(plid,7), [], cols(s-1,:), 
'filled'); hold on 
    xlabel('T(1)'); 
    ylabel('T(2)'); 
    zlabel('G(7)'); 
end 
  
set(gcf, 'Position', [300 300 1200 500]); 
  
%% Forward modelling 
%-----------------------------------------------------------------------
--- 
range1 = [-4 3]; 
range2 = [-5 5]; 
stps   = 200; 
steps1 = linspace(range1(1), range1(2), stps); 
steps2 = linspace(range2(1), range2(2), stps); 
Ts     = Tcf(:,1) * steps1;  
Gs     = Gcf(:,2) * steps2; 
  
OCM    = FEB.RCM{1}; 
Nc     = length(FEB.BMA.Xnames); 
Np     = length(FEB.BMA.Pnames); 
  
BasePs.T    = OCM.M.pE.T + FEB.BMA.Ep([1:4] + (Np * (Nc - 1)))'; 
BasePs.G    = OCM.M.pE.G + FEB.BMA.Ep([5:Np] + (Np * (Nc - 1)))'; 
  
clear delta_all Hc_all 
  
for d1 = 1:length(steps1)-1 
d1 
for d2 = 1:length(steps2) 
    Ps          = OCM.Ep; 
    Ps.T        = BasePs.T + Ts(:,d1)'; 
    Ps.G        = BasePs.G + Gs(:,d2)'; 
    Hctemp      = spm_csd_mtf(Ps, OCM.M, OCM.xU); 
    Hc_all{d1,d2}   = Hctemp{1};     
    delta_all(d2,d1)    = mean(abs(Hc_all{d1,d2}(1:4))); 
end 
end 
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%% 
  
figure 
imagesc(steps1, steps2, log(delta_all)); 
set(gca, 'Ydir', 'normal'); 
axis square; colorbar 
colormap gray 
xlim([-3 3]); ylim([-5 5]); 
  
%% Calculate and plot heatmaps 
%-----------------------------------------------------------------------
--- 
clear dens plid 
  
seps = linspace(0, length(FEB.RCM), 5); 
for s = 2:length(seps) 
    plid{s-1} = seps(s-1) + 1:seps(s); 
end 
  
for p = 1:length(plid) 
for s1 = 2:length(steps1)-1    
for s2 = 2:length(steps2) 
     
    % find parameters in t-range 
    tT  = Tsc(plid{p}); 
    hTi = find(tT >= steps1(s1-1) ); 
    lTi = find(tT < steps1(s1)); 
    Ti  = intersect(hTi, lTi); 
     
    % find parametrs in g-range 
    tG  = Gsc(plid{p}); 
    hGi = find(tG >= steps2(s2-1)); 
    lGi = find(tG < steps2(s2)); 
    Gi  = intersect(hGi, lGi); 
     
    % find overlap and save occurance number 
    both = intersect(Ti, Gi); 
    dens{p}(s2,s1) = length(both); 
     
end 
end 
end 
  
%% Plotting routine 
heatcols = flip(cbrewer('div', 'Spectral', 100)); 
  
for d = 1:length(dens) 
     
    sm          = fspecial('gaussian', 20, 20); 
    sdens{d}     = filter2(sm, dens{d});  
    for sm = 1:3 
        sdens{d}     = filter2(sm, sdens{d});     
    end 
  
    subplot(1,4,d),  
        limz = [min(min([sdens{:}])) max(max([sdens{:}])) ]; 
        imagesc(steps1, steps2, sdens{d}, limz); hold on 
        axis square 
        set(gca, 'Ydir', 'normal'); 
        colormap(heatcols) 
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        xlim([-3 3]); ylim([-5 5]); 
         
end 
  
figure 
subplot(1,3,1) 
    contour(steps1(1:end-1), steps2, delta_all, 4); 
    xlim([-3 3]); ylim([-5 5]); 
    set(gca, 'Ydir', 'normal'); 
     
    title('Delta power contours'); 
    colormap gray; axis square 
  
subplot(1,3,2) 
    contour(steps1(1:end-1), steps2, log(delta_all), 4); 
    xlim([-3 3]); ylim([-5 5]); 
    set(gca, 'Ydir', 'normal'); 
     
    title('Delta power contours: Log transformed'); 
    colormap gray; axis square 
     
subplot(1,3,3) 
    delts       = reshape(delta_all, 
[size(delta_all,1)*size(delta_all,2), 1]); 
    dlimvalues  = [50 75 95 99]; 
     
    for l = 1:length(dlimvalues) 
        deltlims(l)   = prctile(delts,dlimvalues(l)); 
    end 
     
    contour(steps1(1:end-1), steps2, delta_all, deltlims) 
    xlim([-3 3]); ylim([-5 5]); 
    set(gca, 'Ydir', 'normal'); 
    colormap gray; axis square 
     
    title('Delta power contours: Centiles'); 
  
  
  
  
%% Integrating Testing for additional variance based on human data 
%=======================================================================
=== 
% Find human data file and organise everything in structures 
%-----------------------------------------------------------------------
--- 
Base    = fileparts(Fbase); 
load([Base fs 'Patients' fs 'Matlab Files' fs 'Patient_PCA.mat']); 
  
% Mouse PCA 
%-----------------------------------------------------------------------
--- 
M.BasePs    = BasePs; 
M.Tsc       = Tsc;      M.Tcf   = Tcf; 
M.Gsc       = Gsc;      M.Gcf   = Gcf; 
  
% Human PCA 
%-----------------------------------------------------------------------
--- 
H.Tsc       = Pt.dTsc;  H.Tcf   = Pt.dTcf; 
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% Collate (M) condition specific indices 
%-----------------------------------------------------------------------
--- 
seps = linspace(0, length(FEB.RCM), 5); 
clear plid 
  
for s = 2:length(seps) 
    plid{s-1}    = seps(s-1) + 1:seps(s); 
end 
  
pid{1} = [plid{1} plid{2}]; 
pid{2} = [plid{3} plid{4}]; 
  
conds = [1 2];  % Control vs Antibody 
clear Hc mDelta 
  
for c = 1:length(conds) 
  
condid  = conds(c);    
M.Tmd   = median(M.Tsc(pid{condid})); 
M.Gmd   = median(M.Gsc(pid{condid})); 
  
% Set up 'median' antibody condition for mice 
%-----------------------------------------------------------------------
--- 
BPs     = M.BasePs; 
BPs.T   = BPs.T + M.Tmd * M.Tcf(:,1)'; 
BPs.G   = BPs.G + M.Gmd * M.Gcf(:,1)'; 
  
stps    = 200; 
steps   = linspace(-2.5, 2.5, stps);  
cols    = flip(cbrewer('div', 'Spectral', stps)); 
  
for s = 1:length(steps) 
    Ps          = OCM.Ep; 
    Ps.T        = BPs.T + steps(s) * H.Tcf(:,1)'; 
    Ps.G        = BPs.G; 
    Hctemp      = spm_csd_mtf(Ps, OCM.M, OCM.xU); 
    Hc{c}(s,:)     = abs(Hctemp{1}); 
     
    figure(1) 
        subplot(2,1,c) 
        if ~mod(s,10) 
        plot(log(abs(Hctemp{1})), 'color', cols(s,:)); hold on 
        xlim([1 60]); 
        ylim([-6 8]); 
        end 
         
    mDelta{c}(s) = mean(Hc{c}(s,1:4)); 
end 
end 
  
mx = max(max(log([Hc{1} Hc{2}]))); 
mn = min(min(log([Hc{1} Hc{2}]))); 
sccols = cbrewer('qual', 'Paired', 10); 
sccols = sccols([8 10],:); 
  
for h = 1:length(Hc) 
    figure(2) 
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    subplot(2,2,h) 
        imagesc(OCM.M.Hz, steps, log(Hc{h}), [mn mx]); 
        set(gca, 'Ydir', 'normal') 
         
    subplot(2,2,[3 4]) 
        scplot = fix(linspace(1,length(steps), 50)); 
        scatter(steps(scplot), log(mDelta{h}(scplot)), [], sccols(h,:), 
'filled'); hold on 
end 
 
 
A.6.2.4  nae_sources 
% nae sources 
%=======================================================================
=== 
% This function will source localise the abnormal activity (paroxysmal 
and 
% rhythmic) using an IID approach and extract a virtual-electrode 
response 
% at the cortical source of maximal power 
  
clear all 
D       = nae_housekeeping; 
fs      = filesep; 
Fdata   = D.Fdata; 
files   = cellstr(spm_select('List', Fdata, '^N.*\.mat$')); 
  
%% Prepare files 
%=======================================================================
=== 
for f = 1:length(files) 
     
% Set default 10/20 EEG sensors 
%-----------------------------------------------------------------------
--- 
MEEG        = spm_eeg_load([Fdata fs files{f}]);     
S.task      = 'defaulteegsens'; 
S.D         = MEEG; 
MEEG        = spm_eeg_prep(S); 
S           = []; 
save(MEEG) 
  
% Compute leadfields for inverse solutions 
%-----------------------------------------------------------------------
--- 
conds = condlist(MEEG); 
clear job   
job{1}.spm.meeg.source.invert.D = {[Fdata fs files{f}]}; 
job{1}.spm.meeg.source.invert.val = 1; 
job{1}.spm.meeg.source.invert.whatconditions.condlabel = conds(2:end); 
job{1}.spm.meeg.source.invert.isstandard.custom.invtype = 'IID'; 
job{1}.spm.meeg.source.invert.isstandard.custom.woi = [-Inf Inf]; 
job{1}.spm.meeg.source.invert.isstandard.custom.foi = [0 256]; 
job{1}.spm.meeg.source.invert.isstandard.custom.hanning = 1; 
job{1}.spm.meeg.source.invert.isstandard.custom.priors.priorsmask = 
{''}; 
job{1}.spm.meeg.source.invert.isstandard.custom.priors.space = 1; 
job{1}.spm.meeg.source.invert.isstandard.custom.restrict.locs = zeros(0, 
3); 
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job{1}.spm.meeg.source.invert.isstandard.custom.restrict.radius = 32; 
job{1}.spm.meeg.source.invert.isstandard.custom.restrict.mask = {''}; 
job{1}.spm.meeg.source.invert.modality = {'EEG'}; 
spm_jobman('run', job) 
end 
  
%% Extract maximum intensity MNI voxel locations from source inversion 
%=======================================================================
=== 
for f = 1:length(files) 
    load(files{f}) 
     
    clear mMAP xMAP 
    for d = 1:length(D.other.inv{1}.inverse.J) 
        mMAP{d} = mean(D.other.inv{1}.inverse.J{d},2); 
        xMAP(d) = max(mMAP{d}); 
    end 
    [v i] = max(xMAP); 
    [v l] = max(mMAP{i}); 
     
    L(f).xyz = fix(D.other.inv{1}.forward.mesh.vert(l,:) * 1000); 
    L(f).name = files{f}(1:end-4); 
end 
save([Fdata fs 'MIP_Locations.mat'], 'L'); 
  
%% Extract source waveforms 
%=======================================================================
=== 
clear L 
load([Fdata fs 'MIP_Locations.mat']); 
  
for l = 1:length(L) 
    MEEG            = spm_eeg_load([Fdata fs L(l).name '.mat']); 
    xyz             = L(l).xyz; 
    scalefactor     = sqrt(xyz(1)^2 + xyz(2)^2 + xyz(3)^2);     
     
    S.D             = [Fdata fs L(l).name '.mat']; 
    S.dipoles.pnt   = L(l).xyz;  
    S.dipoles.ori   = L(l).xyz / scalefactor; 
    S.dipoles.label = {'LFP'}; 
     
    sD              = spm_eeg_dipole_waveforms(S); 
    save(sD); 
end 
 
A.6.2.5  nae_dcm 
% Housekeeping 
%=======================================================================
=== 
clear all 
D           = nae_housekeeping; 
fs          = filesep; 
Fdata       = D.Fdata; 
Fdcm        = D.Fdcm; 
files       = cellstr(spm_select('List', Fdata, '^N.*\.mat$')); 
  
%% 
for f = 1:length(files) 
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% Set up DCM structure and invert baseline 
%=======================================================================
=== 
DCM = []; 
  
sub = files{f}(1:end-4); 
% Fix directory of canonical forward matrix 
%-----------------------------------------------------------------------
--- 
DCM.xY.Dfile        = [Fdata fs 'M' files{f}]; 
  
% Load MEEG object and extract sampling rate and info 
%-----------------------------------------------------------------------
--- 
LFP                 = spm_eeg_load(DCM.xY.Dfile); 
Fs                  = fsample(LFP); 
smpls               = size(LFP,2); 
timax               = linspace(0, smpls/Fs, smpls); 
clist               = condlist(LFP); 
  
for c = 1:length(clist) 
% Set up DCM details 
%-----------------------------------------------------------------------
--- 
DCM.options.analysis    = 'CSD';    % cross-spectral density  
DCM.options.model       = 'CMC';    % structure cannonical microcircuit 
(for now) 
DCM.options.spatial     = 'LFP';    % virtual electrode input    
DCM.options.Tdcm        = [timax(1) timax(end)] * 1000;     % time in ms 
  
DCM.options.Fdcm    = [1 60];       % frequency range   
DCM.options.D       = 1;            % frequency bin, 1 = no downsampling 
DCM.options.Nmodes  = 8;            % number of eigenmodes 
DCM.options.han     = 0;            % no hanning  
DCM.options.trials  = c;            % index of ERPs within file 
  
DCM.Sname           = chanlabels(LFP); 
DCM.M.Hz            = 
DCM.options.Fdcm(1):DCM.options.D:DCM.options.Fdcm(2); 
DCM.xY.Hz           = DCM.M.Hz; 
  
% Create DCM Struct and specify DCM.options  
%-----------------------------------------------------------------------
--- 
DCM.A       = {1 1 1}; 
DCM.B       = {}; 
DCM.C       = sparse(length(DCM.A{1}),0); 
  
% Reorganise model parameters in specific structure 
%=======================================================================
=== 
DCM.M.dipfit.Nm     = DCM.options.Nmodes; 
DCM.M.dipfit.model  = DCM.options.model; 
DCM.M.dipfit.type   = DCM.options.spatial; 
DCM.M.dipfit.Nc     = size(LFP,1); 
DCM.M.dipfit.Ns     = length(DCM.A{1}); 
  
% Load empirical priors 
%-----------------------------------------------------------------------
--- 
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[pE,pC]             = nae_spm_cmc_priors(DCM.A,DCM.B,DCM.C); 
load([Fdcm fs 'Priors' fs 'Priors.mat']); 
pE                  = Priors.pE; 
pC                  = Priors.pC; 
  
DCM.M.pE    = pE; 
DCM.M.pC    = pC; 
  
DCM.name            = [Fdcm fs 'DCM_' sub '_' clist{c} '.mat']; 
DCM                 = nae_spm_dcm_csd(DCM); 
end 
end 
  
%% Review DCM fits 
%=======================================================================
=== 
subfiles = cellstr(spm_select('List', Fdata, '^N.*\.mat$')); 
  
for s = 1:length(subfiles) 
     
sub         = subfiles{s}(1:end-4); 
dcmfiles    = cellstr(spm_select('FPList', Fdcm, ['^DCM_' sub 
'.*.mat$'])); 
conds       = []; 
cols        = flip(cbrewer('qual','Paired', 6)); 
  
for d = 1:length(dcmfiles)  
    conds{d} = dcmfiles{d}(end-4);  
    load(dcmfiles{d}); 
    subplot(4,2,s) 
    plot(log(abs(DCM.Hc{1})), 'color', cols(2*d,:)); hold on 
    plot(log(abs(DCM.xY.y{1})), 'color', cols(2*d-1,:)); hold on 
end 
end 
legend({'B pred', 'B obs', 'P pred', 'P obs', 'R pred', 'R obs'}); 
hold off 
  
%% Plot N004 example traces 
%-----------------------------------------------------------------------
--- 
subfiles = cellstr(spm_select('List', Fdata, '^N.*\.mat$')); 
s = 4; 
  
sub         = subfiles{s}(1:end-4); 
MEEG        = spm_eeg_load([Fdata fs subfiles{s}]); 
  
trials      = [5 52 81]; 
chid        = [1 11 15 9 2 12 15 10 3 5 7 13 4 6 8 14 17 18 19]; 
  
for t = 1:length(trials) 
    subplot(2, length(trials), t) 
    for c = 1:size(MEEG,1) 
        plot(squeeze(MEEG(chid(c),:,trials(t)))-c*100); 
        hold on 
        ylim([-2100 200]); 
        yvals(c)   = -c*100; 
    end 
end 
  
subplot(2,length(trials),1) 
chlabs = chanlabels(MEEG); 
 305 
set(gca, 'YTick', flip(yvals), 'YTickLabel', flip(chlabs(chid))); 
  
  
MEEG        = spm_eeg_load([Fdata fs 'M' subfiles{s}]); 
  
subplot(2, length(trials), [1:length(trials)]+length(trials)) 
  
for t = 1:length(trials) 
    plot(squeeze(MEEG(1,:,trials(t))) - t*100); hold on 
end 
 
  
A.6.2.6  nae_peb 
% nae_peb 
%=======================================================================
=== 
% This routine loads the inverted individual time window DCMs and 
performs 
% parametric empirical Bayesian analyiss 
  
clear all 
close all 
  
% Housekeeping 
%=======================================================================
=== 
D           = nae_housekeeping; 
fs          = filesep; 
Fbase       = D.Fbase; 
Fdata       = D.Fdata; 
Fscripts    = D.Fscripts; 
Fdcm        = D.Fdcm; 
  
clear D 
  
% PEB Analysis 
%=======================================================================
=== 
% Make second level model space 
%-----------------------------------------------------------------------
--- 
subfiles = cellstr(spm_select('List', Fdata, '^N.*\.mat$')); 
  
for s = 1:length(subfiles)  
     
sub         = subfiles{s}(1:end-4); 
dcmfiles    = cellstr(spm_select('FPList', Fdcm, ['^DCM_' sub 
'.*.mat$'])); 
conds       = []; 
cols        = flip(cbrewer('qual','Paired', 6)); 
  
for d = 1:length(dcmfiles), conds{d} = dcmfiles{d}(end-4); end 
  
X      = []; 
Xnames = {'All', conds{:}}; 
X(:,1) = ones(length(conds),1); 
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for c = 1:length(conds) 
    X(:,1+c) = zeros(1,length(conds)); 
    X(c,1+c) = 1;  
end 
  
% Run PEB 
%-----------------------------------------------------------------------
--- 
FCM = spm_dcm_load(dcmfiles); 
  
M.X         = X; 
M.Xnames    = Xnames; 
M.Q         = 'all'; 
  
% Time constant parameters  
%-----------------------------------------------------------------------
--- 
% G(:,1)  ss -> ss (-ve self)  4    MOD 
% G(:,2)  sp -> ss (-ve rec )  4    INH 
% G(:,3)  ii -> ss (-ve rec )  4    INH 
% G(:,4)  ii -> ii (-ve self)  4    MOD 
% G(:,5)  ss -> ii (+ve rec )  4    EXC 
% G(:,6)  dp -> ii (+ve rec )  2    EXC 
% G(:,7)  sp -> sp (-ve self)  4    MOD 
% G(:,8)  ss -> sp (+ve rec )  4    EXC 
% G(:,9)  ii -> dp (-ve rec )  2    INH 
% G(:,10) dp -> dp (-ve self)  1    MOD 
%  
% G Parameters: The order in the DCM structure is as follows 
% j     = [7 2 3 4 5 6 8 9 10 1]; 
% i.e.     M I I M E E E I M  M 
% new   =  1 2 3 4 5 6 7 8 9 10 
% 
% T Parameters: The order is as follows 
% ss sp ii dp 
%  1  2  3  4   
%  E  I  E  I 
  
% Model space by parameter type nae_spm_fx_cmc 
%-----------------------------------------------------------------------
--- 
clear fields F labels 
fields{1}   = {'T(1)', 'T(2)', 'T(3)', 'T(4)'};     % time constants 
fields{2}   = {'G(2)', 'G(3)', 'G(8)'};             % inh connections 
fields{3}   = {'G(5)', 'G(6)', 'G(7)'};             % exc connections 
fields{4}   = {'G(1)', 'G(4)', 'G(9)', 'G(10)'};    % mod connections 
  
labels  = { 't', 'g_i', 'g_e', 'g_m' }; 
  
saveit = 1; 
  
% Run PEB across reduced second level model space 
%=======================================================================
=== 
  
for f = 1:length(fields) 
     
    [PEB, RCM]  = spm_dcm_peb(FCM, M, fields{f}); 
    F(f) = PEB.F; 
     
    if saveit try load([Fdcm fs 'PEB']); catch P = []; end; end 
 307 
    P(s,f).PEB    = PEB; 
    P(s,f).fields = fields{f}; 
    P(s,f).F      = PEB.F; 
    if saveit, save([Fdcm fs 'PEB'], 'P'); end 
  
end 
end 
  
%% Identify overall winning PEB model 
%=======================================================================
=== 
if saveit, load([Fdcm fs 'PEB']); end 
  
clear Fs Fall 
for p = 1:size(P,1) 
for m = 1:size(P,2) 
    Fs(p,m) = P(p,m).F;  
end 
end 
Fall    = sum(Fs); 
  
% Plot free energies and model posteriors spm_dcm_bmc 
%-----------------------------------------------------------------------
--- 
subplot(3,1,1), bar(Fall - min(Fall)); 
subplot(3,1,2), plot(Fs' - min(Fs')); 
subplot(3,1,3),  
    [alpha, exp_r, xp] = spm_BMS(Fs, 1e6, 1, 0, 1); 
    bar(xp); title('RFX Analysis'); 
     
set(gca, 'XTick', 1:length(Fall), 'XTickLabel', labels);  
  
[v l] = max(Fall); 
  
%% Bayesian model reduction over winning PEB (Time constants and 
inhibitory) 
%----------------------------------------------------------------------- 
load([Fdcm fs 'PEB']); 
for p = 1:size(P,1) 
    clear Snames Sfixed sep macseps winseps 
    Snames = P(p,l).PEB.Snames 
     
    for s = 1:length(Snames) 
        macseps     = find(P(p,l).PEB.Snames{s} == '/'); 
        winseps     = find(P(p,l).PEB.Snames{s} == '\'); 
        if length(winseps) > length(macseps), sep = winseps(end); 
        else sep = macseps(end); end 
         
        Sfixed{s} = [Fdcm fs Snames{s}(sep + 1:end)]; 
    end 
     
    FCM         = spm_dcm_load(Sfixed); 
    M.X         = P(p,l).PEB.M.X 
    M.Xnames    = P(p,l).PEB.Xnames; 
    M.Q         = 'all'; 
    [PEB RCM]   = spm_dcm_peb(FCM', M, fields{l}); 
    try PMA         = spm_dcm_peb_bmc(PEB); catch PMA = []; end 
     
    FEB(p).PMA    = PMA; 
    FEB(p).RCM    = RCM; 
    FEB(p).PEB    = PEB; 
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end 
save([Fdcm fs 'Full Empirical Bayes'], 'FEB');  
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A.7  Mismatch negativity under ketamine – DCM analysis 
scripts 
 
The Matlab scripts shown here contain code that can be used to reproduce a dynamic 
causal modelling analysis for mismatch negativity and repetition suppression event related 
potentials measured with EEG in healthy probands under the influence of the NMDA 
receptor blocker ketamine. This code was used for the analysis presented in chapter 6 of 
this thesis.  
Below is a short summary of the code (included in the README file for the online 
repository), followed with exerpts of the custom code written for analysis. The code can be 
downloaded and run in full from an online repository accessible here: 
https://github.com/roschkoenig/Ketamine_DCM.  
 
The code runs on Mathworks Matlab (tested with 2016b) and requires the following freely 
available packages to run 
• Statistical Parametric Mapping - This academic freeware implements the DCM 
analysis applied here 
A.7.1  README description of code function 
The repository includes a number of different routines to be run manually to reproduce 
the different analysis steps included in the manuscript above. Most of these will produce a 
visual output and are further explained below. 
A.7.1.1  Perform sensor space analysis across the different conditions 
ket_sensorspace 
 
This routine performs the 'standard' sensor space ERP analysis based on the data provided 
(in the SPM-specific MEEG format, in the ~/SPM-ready Data/ folder) The figures it 
produces were the basis for Fig 2 in the manuscript accompanying this code. The first 
section will identify time periods of significant difference between (a) the deviant and the 
last standard, and (b) between the first and the last standard, stringently corrected for 
multiple comparisons. All ERPs and periods of significant difference will be plotted as 
below. 
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The second section will calculate the difference waveform between the first (i.e. deviant) 
and the last (i.e. standard 36) tone of the sequence (i.e. the mismatch negativity, MMN) 
and test for significant differences in peak amplitude. All testing up until this point is done 
at the Fz electrode, according to literature standards. 
 
The last section will plot all EEG channels over time for the three standard - deviant 
difference waves (left to right: D1-S2, D1-S6, D1-S36); with placebo in the top row and 
ketamine in the bottom row. This illustrates an overall reduction of the ERPs caused by 
ketamine across the scalp and for all of the different conditions. 
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A.7.1.2  Invert Dynamic Causal Models (DCM) and perform Bayesian Model Reduction 
(BMR) to explain the effect of tone repetition 
ket_dcm 
 
This routine will perform a 2-stage DCM inversion for the data described in the section 
above: In the first instance, a single DCM will be inverted for the repetition effects across 
grand mean averages of the ERP. This grand mean inversion is saved and posterior 
estimates of the parameters are then used as priors for inverting individual subject DCMs. 
Each participant's ERPs will then be inverted in individual DCMs for the ketamine and the 
placebo condition separately. The inversion can take approximately ~30 minutes per 
subject and drug-condition and should produce the visual output seen below. 
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After all models have been inverted, the routine will also display the first principal 
eigenmodes of the model fits for each of the subjects, again separately for ketamine and 
placebo-controlled conditions. For best effects, this should be run with the publicly 
available ‘cbrewer’ package installed to show paired colour codes shown below and 
corresponding to the colours in the manuscript. 
 
Based on the individually inverted (full) DCMs for the placebo condition, we then perform 
Bayesian model reduction, eliminating redundant model parameters and inferring which 
parameters are changed by repetition effects. The results will be shown in terms of free 
energy distribution over the model space, which consists of 3 sets of 8 models (i.e. 
combinations of the basis functions (3): monophasic decay, phasic response, or both; and 
synaptic parameters that are modulated (8): no extrinsic, forward, backward, or 
forward/backward modulations with and without intrinsic modulations). The winning 
model is that with the highest free energy, which is the full model (i.e. both basis functions, 
forward, backward and intrinsic effects). 
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The estimated parameter values for the reduced model were then averaged across 
participants (using Bayesian parameter averaging) to show the repetition-dependent 
parameter changes. 
 
 
A.7.1.3  Run Parametric Empirical Bayesian (PEB) group analysis to explain the 
difference between ketamine and placebo 
ket_peb 
 
This routine takes the DCMs inverted at the first level (or the DCMs provided in this 
repository) and estimates shared group effects across individual DCMs using parametric 
empirical Bayes. These group effects represent the effect of ketamine in this study design, 
and are estimated using different combinations of free parameters: broadly this model 
space for the ketamine effect is divided into modulations of extrinsic (between-source) and 
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intrinsic (within-source) coupling parameters. The routine will run the different second 
level models, and display the free energy distribution over the model space (for Bayesian 
model comparison). 
 
 
Selecting the winning model (one where only intrinsic connections are allowed to change 
depending on the drug condition), we then perform Bayesian model reduction to remove 
redundant model parameters and provide the best estimate for which connections are 
altered by ketamine across all subjects The standard SPM function will provide the 
following output. 
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A.7.1.4  Simulate the ketamine effects on intrinsic connectivity parameters to visualise 
the resultant changes 
ket_simulate 
 
In order to further explore the effect of the parameters identified on the PEB analysis we 
can simulate the model output for a range of parameter combinations. Here we take the 
grand mean model inversion as the starting pont and then push the STG and IFG 
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inhibitory parameters to the values estimated in the PEB - this shows that much of the 
measured effect can be reproduced by modulations of just these parameters. 
 
A.7.1.5  Other custom functions 
• ket_housekeeping - this function defines the folder structures used for the analysis 
by all the ohter functions 
• ket_bmr_gen_model_space - this function will generate the model space in terms of 
forward, backward and intrinsic connection used for DCM analysis at the first level 
(i.e. the effect of tone repetition) 
• ket_bmr_gen - this function will generate the DCM structure required for Bayesian 
model reduction according to the model space in question (without inverting it) 
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• ket_dcm_gm - this function is used to invert a single DCM for the grand mean ERP 
wave forms - the posteriors of this inversion are subsequently used as the priors for 
the subject-specific analysis 
• ket_dcm_sgl - this function will invert DCMs for single subjects, using the 
posteriors of the group inversion as priors 
A.7.2  Custom Routines 
A.7.2.1  ket_sensorspace 
% Housekeeping 
%=======================================================================
=== 
clear all 
D = ket_housekeeping; 
  
% Unpack housekeeping files 
%-----------------------------------------------------------------------
--- 
Fbase       = D.Fbase; 
Fspm        = D.Fspm; 
Fdata       = D.Fdata; 
Fanalysis   = D.Fanalysis; 
Fbmr        = D.Fbmr; 
GMFile      = D.GMFile; 
sub         = D.sub; 
fs          = filesep; 
  
%% Load individual subject ERPs into single cell array 
%=======================================================================
=== 
clist = {'S2P', 'S6P', 'S36P', 'D36P', 'S2K', 'S6K', 'S36K', 'D36K'}; 
clear D 
for s = 1:length(sub) 
    D{s}            = spm_eeg_load([Fdata fs 'm_meeg_' sub(s) '.mat']); 
    currentconds    = condlist(D{s}); 
    currentchans    = chanlabels(D{s}); 
    cz              = find(strcmp(currentchans, 'CZ')); 
    fz              = find(strcmp(currentchans, 'FZ')); 
     
    for c = 1:length(clist) 
        ci = find(strcmp(currentconds, clist{c})); 
        C{c}.name           = clist{c}; 
        C{c}.data(s,:,:)    = D{s}(:,:,ci); 
        C{c}.Fz(s,:)        = D{s}(fz,:,ci); 
        C{c}.Cz(s,:)        = D{s}(cz,:,ci); 
    end 
end 
  
%% Calculate ERP statistics 
%=======================================================================
=== 
% Calculate standard errors around the mean 
%-----------------------------------------------------------------------
--- 
for c = 1:length(C) 
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for t = 1:size(C{c}.Fz,2) 
    C{c}.FzSE(t)    = std(C{c}.Fz(:,t)) / sqrt(size(C{c}.Fz,1)); 
end 
C{c}.FzHI = mean(C{c}.Fz,1) + C{c}.FzSE; 
C{c}.FzLO = mean(C{c}.Fz,1) - C{c}.FzSE; 
end 
  
% Calculate time points of significant difference  
%-----------------------------------------------------------------------
--- 
for p = 1:2 
for t = 1:size(C{1}.Fz,2) 
     
    ci  = (p-1)*4; 
    bonferroni      = 0.05 / size(C{1}.Fz,2); 
     
    % Between S2 and S36 (i.e. repetition effect) 
    %-------------------------------------------------------------------
--- 
         
    s2  = C{1+ci}.Fz(:,t); 
    s36 = C{3+ci}.Fz(:,t); 
    
    [H P CI]        = ttest(s2, s36); 
    if P < bonferroni,  repfx(p,t) = 1; 
    else                repfx(p,t) = 0; end 
  
    % Between D1 and S36 (i.e. deviance effect) 
    %-------------------------------------------------------------------
--- 
    d36  = C{4+ci}.Fz(:,t); 
    s36 = C{3+ci}.Fz(:,t); 
     
    [H P CI]        = ttest(d36, s36); 
    if P < bonferroni,  devfx(p,t) = 1; 
    else                devfx(p,t) = 0; end 
  
end 
  
repdur(p) = sum(repfx(p,50:end)) * 2; 
devdur(p) = sum(devfx(p,50:end)) * 2; 
end 
  
% Plot ERPs and statistics 
%=======================================================================
=== 
cols_unsort     = jet(10);          % standard color scheme 
try cols_unsort = ccbrewer('qual', 'Paired', 10); end  % try nicer 
colour scheme 
figure  
  
cols(1:2,:) = cols_unsort(9:10,:);  % cbrewer: purple 
cols(3:4,:) = cols_unsort(1:2,:);   % cbrewer: blue 
cols(5:6,:) = cols_unsort(3:4,:);   % cbrewer: green 
cols(7:8,:) = cols_unsort(5:6,:);   % cbrewer: red 
  
clear legid  
  
for p = 1:2 
for c = 1:4 
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    ci = 4*(p-1) + c; 
    ti = time(D{1}); 
     
    subplot(2,1,p) 
     
    % Plotting ERPs and SE intervals around 
    %-------------------------------------------------------------------
--- 
    legid(c) = plot(ti,mean(C{ci}.Fz,1), 'Color', cols(2 + 2*(c-1),:)); 
hold on 
    plot(ti,C{ci}.FzHI, 'Color', cols(1 + 2*(c-1),:));  
    plot(ti,C{ci}.FzLO, 'Color', cols(1 + 2*(c-1),:)); 
     
    % The world's clumsiest way to illustrate the significant 
intervals... 
    %-------------------------------------------------------------------
--- 
    scatter(ti,repfx(p,:) * (-7) + 5, 50, 'k.');      
    scatter(ti,devfx(p,:) * 7 - 3, 50, 'r.'); 
     
    % Set thresholds and axis definitions 
    %-------------------------------------------------------------------
--- 
    ylim([-2 4]); 
    xlim([-0.1 0.3]); 
    legend(legid, {'S2', 'S6', 'S36', 'D1'}); 
    xlabel('Time in ms; red dots = deviance effect, black dots = 
repetition effect'); 
end 
end 
  
subplot(2,1,1), title('Placebo ERPs'); 
subplot(2,1,2), title('Ketamine ERPs');  
  
  
%% Calculate MMN statistics 
%=======================================================================
=== 
% Calculate standard errors around the mean 
%-----------------------------------------------------------------------
--- 
MMN{1}.dat = C{3}.Fz - C{4}.Fz; 
MMN{2}.dat = C{7}.Fz - C{8}.Fz; 
ti = time(D{1}); 
  
for m = 1:length(MMN) 
for t = 1:size(MMN{1}.dat,2) 
    MMN{m}.SEM(t) = std(MMN{m}.dat(:,t)) / sqrt(size(MMN{m}.dat,1)); 
end 
MMN{m}.HI = mean(MMN{m}.dat,1) + MMN{m}.SEM; 
MMN{m}.LO = mean(MMN{m}.dat,1) - MMN{m}.SEM; 
end 
  
% Test for attenuation of MMN around 200ms, where rep effects are 
strongest 
%-----------------------------------------------------------------------
--- 
p = MMN{1}.dat; 
k = MMN{2}.dat; 
  
ppeaks = max(p(:, 100:150)');   % note that time is indexed in 2ms steps 
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kpeaks = max(k(:, 100:150)'); 
[Hp Pp CIp Sp] = ttest(ppeaks, kpeaks, 'tail', 'right'); 
  
ptroughs = min(p(:, 150:200)');   % note that time is indexed in 2ms 
steps 
ktroughs = min(k(:, 150:200)'); 
[Ht Pt CIt St] = ttest(ptroughs, ktroughs, 'tail', 'left'); 
  
% Plot MMN for placebo and ketamine 
%=======================================================================
=== 
figure 
l(1) = plot(ti, mean(p,1), 'k', 'Linewidth', 1.5); hold on 
plot(ti, MMN{1}.HI, 'Color', [0.5 0.5 0.5]); 
plot(ti, MMN{1}.LO, 'Color', [0.5 0.5 0.5]); 
  
l(2) = plot(ti, mean(k,1), 'r', 'Linewidth', 1.5); hold on 
plot(ti, MMN{2}.HI, 'm'); 
plot(ti, MMN{2}.LO, 'm'); 
  
title('MMN for ketamine and placebo'); 
legend(l, {'Placebo', 'Ketamine'}); 
set(gcf, 'color', 'w'); 
ylabel('Voltage difference in uV'); 
xlabel('Time in s'); 
  
  
%% Plot MMN Scalp maps 
%-----------------------------------------------------------------------
--- 
cols    = flip(cbrewer('div', 'RdYlBu', 100)); 
colormap parula 
GM      = spm_eeg_load([Fdata fs 'gm_meeg_all']); 
order =  {'F7', 'T3', 'T5', 'O1', 'P3', 'C3', 'F3', 'FP1', ... 
          'CZ', 'FZ', 'PZ', ... 
          'FP2', 'F4', 'C4', 'P4', 'O2', 'T6', 'T4', 'F8'}; 
       
for o = 1:length(order) 
    clist       = chanlabels(GM); 
    oldind(o)   = find(strcmp(clist, order{o})); 
    data(o,:,:) = GM(oldind(o), :, :); 
end 
  
mmn_id{1} = [1 6;  7 12]; 
mmn_id{2} = [2 6;  8 12]; 
mmn_id{3} = [3 6;  9 12]; 
  
clear d 
for m = 1:length(mmn_id) 
    id      = mmn_id{m}; 
    d{1}    = data(:,:,id(1,1)) - data(o,:,id(1,2)); 
    d{2}    = data(:,:,id(2,1)) - data(o,:,id(2,2)); 
     
    subplot(2,3,m) 
    imagesc(d{1}(:,50:end)', [-2 2]); 
    subplot(2,3,m + 3) 
    imagesc(d{2}(:,50:end)', [-2 2]); 
end 
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A.7.2.2  ket_dcm 
%% Ketamine DCM analysis using Parametric Empirical Bayes 
%=======================================================================
=== 
% This code will run two functions, ket_dcm_gm - to invert the full 
% model, and ket_dcm to invert separate placebo and ketamine models for 
the 
% individual subjects.  
  
% Housekeeping 
%=======================================================================
=== 
clear all 
D = ket_housekeeping; 
  
% Unpack housekeeping files 
%-----------------------------------------------------------------------
--- 
Fbase       = D.Fbase; 
Fspm        = D.Fspm; 
Fdata       = D.Fdata; 
Fanalysis   = D.Fanalysis; 
Fbmr        = D.Fbmr; 
GMFile      = D.GMFile; 
sub         = D.sub; 
fs          = filesep; 
  
[rep_lin, rep_non] = ket_bmr_gen_model_space(); 
  
%% Invert DCMs 
%=======================================================================
=== 
% This section will take a   !/*long*/!  time. 
% A log of the model inversions is saved in the DCM folder that will 
% document inversion steps taken for the individual models to invert.  
  
% Invert DCM for grand mean 
%-----------------------------------------------------------------------
--- 
diary([Fanalysis fs 'DCM_ALL_log']); 
diary('on'); 
  
FCM = ket_dcm_gm(rep_lin{end}, rep_non{end}, Fanalysis, Fdata, Fspm); 
  
% Invert individual subjects 
%-----------------------------------------------------------------------
--- 
for s = 1:length(sub) 
    SCM{s} = ket_dcm_sgl(sub(s), GMFile, rep_lin{end}, rep_non{end}, ...  
                         [Fanalysis fs 'Individual'], Fdata, Fspm); 
end 
  
diary off 
  
%% Plot example modes (first mode for each of the conditions) 
%-----------------------------------------------------------------------
--- 
% This section loads the just inverted DCMs and plots the first 
principal 
% eigenmode of both observed ERPs and model predictions for each of the 
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% four conditions (D1, S2, S6, S36).  
  
files = cellstr(spm_select('FPList', [Fanalysis fs 'Individual'], 
'^*.mat')); 
  
cols_unsort     = jet(10);          % standard color scheme 
try cols_unsort = cbrewer('qual', 'Paired', 10); end  % try nicer colour 
scheme 
  
cols(1:2,:) = cols_unsort(5:6,:);   % cbrewer: red 
cols(3:4,:) = cols_unsort(9:10,:);  % cbrewer: purple 
cols(5:6,:) = cols_unsort(1:2,:);   % cbrewer: blue 
cols(7:8,:) = cols_unsort(3:4,:); 
  
  
for reps = 1:2 
figure 
for f = 1:18 
    DCM = load(files{f+(reps-1)*18}); 
    DCM = DCM.DCM; 
  
    subplot(9,2,f) 
    for c = 1:4 
        plot(DCM.H{c}(:,1), 'color', cols(c*2,:), 'Linewidth', 1.5); 
hold on 
        plot(DCM.H{c}(:,1) + DCM.R{c}(:,1), 'color', cols(c*2-1,:), 
'Linewidth', 1.5); 
        ylim([-10 10]); 
      
        xlabel(DCM.name(end-9:end-8)) 
        set(gcf, 'color', 'w'); 
        set(gcf, 'Position', [100 + 400*(reps-1) 100 400 800]); 
    end 
end 
end 
legend({'D1(pred)', 'D1(obs)', 'S2(pred)', 'S2(obs)', 'S6(pred)', 
'S6(obs)', 'S36(pred)', 'S36(obs)'}); 
 
 
A.7.2.3  ket_peb 
%% Ketamine DCM analysis using Parametric Empirical Bayes 
%=======================================================================
=== 
% This runs the second step of a two-level DCM analysis, modelling and  
% parameter changes induced by katemine. It requires the full inversions 
of 
% the first level DCMs to be available 
  
% Housekeeping 
%=======================================================================
=== 
clear all 
D = ket_housekeeping; 
  
% Unpack housekeeping files 
%-----------------------------------------------------------------------
--- 
Fbase       = D.Fbase; 
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Fspm        = D.Fspm; 
Fdata       = D.Fdata; 
Fanalysis   = D.Fanalysis; 
Fbmr        = D.Fbmr; 
GMFile      = D.GMFile; 
sub         = D.sub; 
fs          = filesep; 
  
[rep_lin, rep_non] = ket_bmr_gen_model_space(); 
  
  
%% Run PEB Analysis 
%=======================================================================
=== 
% This section sets up the between-DCM (2nd level) models, and runs PEB 
% recursively over a model space specified in terms of which parameters 
% contribute to explaining between-DCM variance.  
% The winning model is then explored further by using Bayesian model 
% reduction to identify parameter changes related to the main effect of 
% ketamine (effect 2 here) 
% This code will produce  
%       1) Figure of Bayesian model comparison at the second level 
%       2) The parameterised winning second level model (PEB{11}) 
%       3) A set of first level DCMs after second level inversion (RCM) 
%       4) A Bayesian model average of the second level model after 
%          exhaustive parameter seard (RMA) 
  
clear DCM X M 
  
% Load files into single cell array 
%-----------------------------------------------------------------------
--- 
files = cellstr(spm_select('FPList', [Fanalysis fs 'Individual'], 
'^*.mat')); 
for f = 1:length(files) 
    TCM = load(files{f}); 
    DCM{f} = TCM.DCM; 
end 
  
% Main Group Effect 
%-----------------------------------------------------------------------
--- 
X(:,1)  = ones(1,length(DCM)); 
  
  
% Main Effect of Ketamine 
%-----------------------------------------------------------------------
--- 
% This encodes the doses of ketamine: 0 = placebo, 1 = low, 2 = high 
dose 
%-----------------------------------------------------------------------
--- 
X(:,2)  = [2 0 2 0 2 0 1 0 1 0 2 0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 2 
0 2 0 1 0]; 
  
  
% Subject specific variation 
%-----------------------------------------------------------------------
--- 
% This model component is used to model between-subhect variations as 
% random effects of not interest  
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%-----------------------------------------------------------------------
--- 
subfx = zeros(length(DCM), length(sub)); 
for p = 1:length(sub) 
    subfx([1:2] + 2*(p-1), p) = [1 1]; 
end 
X   = [X, subfx]; 
  
M.X = X; 
M.Xnames{1}     = 'Group'; 
M.Xnames{2}     = 'Ketamine'; 
for s = 1:length(sub) 
    M.Xnames{2+s} = sub(s); 
end 
  
% Reduced models: Only extrinsic parameters 
%-----------------------------------------------------------------------
--- 
C{1} = {'A'};   % All extrinsic  
C{2} = {'B'};   % All extrinsic condition specific effects 
C{3} = {'A', 'B'};  % All extrinsic and conditional 
C{4} = {'A{1}(3,1)', 'A{1}(4,2)', 'A{1}(5,3)', 'A{1}(6,4)', 'A{2}(3,1)', 
'A{2}(4,2)', 'A{2}(5,3)', 'A{2}(6,4)'}; % Forward 
C{5} = {'A{3}(1,3)', 'A{3}(2,4)', 'A{3}(3,5)', 'A{3}(4,6)', 'A{4}(1,3)', 
'A{4}(2,4)', 'A{4}(3,5)', 'A{4}(4,6)'}; % Backward 
C{6} = {'B{1}(3,1)', 'B{1}(4,2)', 'B{1}(5,3)', 'B{1}(6,4)'};    % 
Forward conditional 
C{7} = {'B{1}(1,3)', 'B{1}(2,4)', 'B{1}(3,5)', 'B{1}(4,6)'};    % 
Backward conditional 
  
% Reduced models: Only intrinsic model parameters 
%-----------------------------------------------------------------------
--- 
C{8} = {'M'};       % Modulatory 
C{9} = {'N'};       % Modulatory conditional 
C{10} = {'M', 'N'}; % Modulatory and condition specific effects 
C{11} = {'G'};      % Intrinsic 
C{12} = {'T'};      % Time constants 
C{13} = {'M', 'N', 'G'};        % Intrinsic coupling 
C{14} = {'M', 'N', 'G', 'T'};   % all intrinsic 
  
labels = { 'A', 'B', 'A,B', 'A(Fwd)', 'A(Bwd)', 'B(Fwd)', 'B(Bwd)', ... 
           'M', 'N', 'M,N', 'G', 'T', 'M,N,T', 'M,N,T,G', 'all' }; 
clear PEB F 
  
%% Run PEB recursively over the set of reduced models defined in 'C' 
%-----------------------------------------------------------------------
--- 
for c = 1:length(C) 
    PEB{c} = spm_dcm_peb(DCM', M, C{c}); 
    F(c)   = PEB{c}.F; 
end 
  
%% Plot Bayesian model comparison between reduced second level models 
%-----------------------------------------------------------------------
--- 
% Plot free energy difference (approx log(model evidence)) 
%-----------------------------------------------------------------------
--- 
subplot(2,1,1) 
    bar(F-min(F)); 
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    % Labels and Titles 
    Franked = sort(F); 
    df = Franked(1) - Franked(2); 
    ylabel('Free Energy'); 
    title(['BMC, difference between winning and second best model: dF = 
' num2str(df)], 'Fontsize', 15); 
     
    % Plot settings 
    set(gca, 'XTickLabels', labels); 
  
% Plot posterior model probability 
%-----------------------------------------------------------------------
--- 
subplot(2,1,2) 
    title('Posterior Probability'); 
    bar(spm_softmax(F')) 
    ylabel('Posterior Probability'); 
     
set(gcf, 'color', 'w'); 
set(gcf, 'Position', [100 500 900 400]); 
  
%% Repeat PEB in the winning model (11) and run Baysian model reduction 
%-----------------------------------------------------------------------
--- 
[REB, RCM]  = spm_dcm_peb(DCM',M,C{11});    % winning model from the 
step above is M11 
RMA         = spm_dcm_peb_bmc(REB); 
 
A.7.2.4  ket_simulate 
%% Simulating the effects of parameter changes on the grand mean 
%=======================================================================
=== 
% Based on the PEB analysis specific parameter changes were identified 
in 
% the ii -> ss coupling. These are explored further by simulating data 
% based on the grand mean model inversion with the added PEB-derived 
% effects on ii -> ss coupling in STG and IFG. These are shown both in 
time 
% and in state space, illustrating that reduction in inhibitory 
connections 
% onto ss cells have impacts on superficial pyramidal cells and overall 
% model output.  
  
% Housekeeping 
%=======================================================================
=== 
clear all 
D = ket_housekeeping; 
  
% Unpack housekeeping files 
%-----------------------------------------------------------------------
--- 
Fbase       = D.Fbase; 
Fspm        = D.Fspm; 
Fdata       = D.Fdata; 
Fanalysis   = D.Fanalysis; 
Fbmr        = D.Fbmr; 
GMFile      = D.GMFile; 
sub         = D.sub; 
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fs          = filesep; 
  
% Load and prepare DCM file 
%-----------------------------------------------------------------------
--- 
DCM             = load(GMFile); 
DCM             = DCM.DCM; 
DCM.xY.Dfile    = [Fdata fs 'pgm_meeg_all']; 
DCM             = spm_dcm_erp_dipfit(DCM,1); 
DCM.name        = [Fanalysis fs 'Temp_DCM']; 
  
% Simulate DCM outoput for different parameter combinations 
%=======================================================================
=== 
% As identified from the PEB analysis, there are large opposing effects 
on 
% inhibitory interneuron connections on spiny stellate cells in IFG and 
% STG. To explore these further, here we simulate the effects of sliding 
% parameter changes of both IFG and STG ii -> ss inhibition.  
% ** steps ** defines the resolution of the simulation 
clear A1 STG IFG 
steps       = 10; 
G           = linspace(0, 2, steps); 
  
for s = 1:steps 
     
% Extract parameters and (symmetrically) change ii -> ss inhibition 
%-----------------------------------------------------------------------
--- 
Sp        = DCM.Ep; 
Sp.G(3,3) = Sp.G(3,3) + G(s); 
Sp.G(4,3) = Sp.G(4,3) + G(s); 
Sp.G(5,3) = Sp.G(5,3) - G(s); 
Sp.G(6,3) = Sp.G(6,3) - G(s); 
  
% Calculate model prediction based on the new parameterset 
%-----------------------------------------------------------------------
--- 
y       = spm_gen_erp(Sp, DCM.M, DCM.xU); 
  
% Extract population specific traces from regions 
%-----------------------------------------------------------------------
--- 
pops    = {'II', 'SP', 'SS', 'DP'}; 
  
for p = 1:4 
    pop = (p-1)*12; 
  
    A1{p}(:,s) = y{1}(:,1 + pop); 
    STG{p}(:,s) = y{1}(:,3 + pop); 
    IFG{p}(:,s) = y{1}(:,5 + pop); 
     
end 
  
end 
  
% Plot model predictions for increasing parameter changes - time 
resolved 
%-----------------------------------------------------------------------
--- 
figure 
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try     spectral = flip(cbrewer('div', 'Spectral', 100)); 
catch   spectral = jet(200);    end 
  
colormap(spectral) 
subplot(3,1,1) 
    imagesc(DCM.xY.pst, G, A1{2}'); 
    title('Effects of ketamine on A1 superficial pyramidal cells',  
'FontWeight', 'bold'); 
    xlabel('Peristimulus time'); 
    ylabel('Parameter change'); 
    colorbar 
subplot(3,1,2) 
    imagesc(DCM.xY.pst, G, STG{2}'); 
    title('Effects of ketamine on STG superficial pyramidal cells',  
'FontWeight', 'bold'); 
    xlabel('Peristimulus time');    
    ylabel('Parameter change'); 
    colorbar 
subplot(3,1,3) 
    imagesc(DCM.xY.pst, G, IFG{2}'); 
    title('Effects of ketamine on IFG superficial pyramidal cells', 
'FontWeight', 'bold'); 
    xlabel('Peristimulus time');  
    ylabel('Parameter change'); 
    colorbar 
     
set(gcf, 'color', 'w'); 
set(gcf, 'Position', [100 100 400 800]); 
  
  
% Plot model predictions for increasing parameter changes - state space 
%-----------------------------------------------------------------------
--- 
figure 
try     col50 = flip(cbrewer('div', 'RdYlBu', steps)); 
catch   col50 = jet(steps);    end 
  
p1 = 2;     % Superficial pyramidal cells     
p2 = 3;     % Spiny stellate interneurons 
  
subplot(3,1,1) 
for s = 1:size(A1{p1},2) 
    plot(A1{p1}(:,s), A1{p2}(:,s), 'color', col50(s,:), 'Linewidth', 2); 
hold on 
    xlabel(pops{p1}); 
    ylabel(pops{p2}); 
end 
  
subplot(3,1,2) 
for s = 1:size(A1{p1},2) 
    plot(STG{p1}(:,s), STG{p2}(:,s), 'color', col50(s,:), 'Linewidth', 
2); hold on 
    xlabel(pops{p1}); 
    ylabel(pops{p2}); 
end 
  
subplot(3,1,3) 
for s = 1:size(A1{p1},2) 
    plot(IFG{p1}(:,s), IFG{p2}(:,s), 'color', col50(s,:), 'Linewidth', 
2); hold on 
    xlabel(pops{p1}); 
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    ylabel(pops{p2}); 
end 
  
set(gcf, 'color', 'w'); 
set(gcf, 'Position', [500 100 400 800]); 
 
 
